BLASTP 2.2.26 [Sep-21-2011]
Reference: Altschul, Stephen F., Thomas L. Madden, Alejandro A. Schaffer,
Jinghui Zhang, Zheng Zhang, Webb Miller, and David J. Lipman (1997),
"Gapped BLAST and PSI-BLAST: a new generation of protein database search
programs", Nucleic Acids Res. 25:3389-3402.
Reference for compositional score matrix adjustment: Altschul, Stephen F.,
John C. Wootton, E. Michael Gertz, Richa Agarwala, Aleksandr Morgulis,
Alejandro A. Schaffer, and Yi-Kuo Yu (2005) "Protein database searches
using compositionally adjusted substitution matrices", FEBS J. 272:5101-5109.
Query= psy4294
(238 letters)
Database: pdbaa
62,578 sequences; 14,973,337 total letters
Searching..................................................done
>pdb|1Z8G|A Chain A, Crystal Structure Of The Extracellular Region Of The
Transmembrane Serine Protease Hepsin With Covalently
Bound Preferred Substrate
Length = 372
Score = 61.6 bits (148), Expect = 4e-10, Method: Compositional matrix adjust.
Identities = 63/249 (25%), Positives = 97/249 (38%), Gaps = 65/249 (26%)
Query: 30 GEVPYIVSLSLYGNLYCGGSLISLQWFLSARHCFVTENLVWNQFNPLIIAGSIYRNYKEQ 89
G P+ VSL G CGGSL+S W L+A HCF N V +++ + AG++ +
Sbjct: 127 GRWPWQVSLRYDGAHLCGGSLLSGDWVLTAAHCFPERNRVLSRWR--VFAGAV---AQAS 181
Query: 90 KRQPQLNEIALIYW------------HSDADLAMVKLKEPFRQTTFVKPLDYYTARETNY 137
QL A++Y + D+A+V L P T +++P+ A +
Sbjct: 182 PHGLQLGVQAVVYHGGYLPFRDPNSEENSNDIALVHLSSPLPLTEYIQPVCLPAAGQALV 241
Query: 138 INDVLSKTDRSEMSIVSGFGVTFQRDKDGIVSWGIG---------------CALGYP--- 179
+ + T Q + I+S + CA GYP
Sbjct: 242 DGKICTVTGWGNTQYYGQQAGVLQEARVPIISNDVCNGADFYGNQIKPKMFCA-GYPEGG 300
Query: 180 ---------------------------GIVSWGIGCALGY-PGVYVRVDHYDPWI-QSVK 210
GIVSWG GCAL PGVY +V + WI Q++K
Sbjct: 301 IDACQGDSGGPFVCEDSISRTPRWRLCGIVSWGTGCALAQKPGVYTKVSDFREWIFQAIK 360
Query: 211 NNGDNAGVL 219
+ + +G++
Sbjct: 361 THSEASGMV 369
>pdb|3T2N|A Chain A, Human Hepsin Protease In Complex With The Fab Fragment Of
An Inhibitory Antibody
pdb|3T2N|B Chain B, Human Hepsin Protease In Complex With The Fab Fragment Of
An Inhibitory Antibody
Length = 372
Score = 61.6 bits (148), Expect = 4e-10, Method: Compositional matrix adjust.
Identities = 63/249 (25%), Positives = 97/249 (38%), Gaps = 65/249 (26%)
Query: 30 GEVPYIVSLSLYGNLYCGGSLISLQWFLSARHCFVTENLVWNQFNPLIIAGSIYRNYKEQ 89
G P+ VSL G CGGSL+S W L+A HCF N V +++ + AG++ +
Sbjct: 127 GRWPWQVSLRYDGAHLCGGSLLSGDWVLTAAHCFPERNRVLSRWR--VFAGAV---AQAS 181
Query: 90 KRQPQLNEIALIYW------------HSDADLAMVKLKEPFRQTTFVKPLDYYTARETNY 137
QL A++Y + D+A+V L P T +++P+ A +
Sbjct: 182 PHGLQLGVQAVVYHGGYLPFRDPNSEENSNDIALVHLSSPLPLTEYIQPVCLPAAGQALV 241
Query: 138 INDVLSKTDRSEMSIVSGFGVTFQRDKDGIVSWGIG---------------CALGYP--- 179
+ + T Q + I+S + CA GYP
Sbjct: 242 DGKICTVTGWGNTQYYGQQAGVLQEARVPIISNDVCNGADFYGNQIKPKMFCA-GYPEGG 300
Query: 180 ---------------------------GIVSWGIGCALGY-PGVYVRVDHYDPWI-QSVK 210
GIVSWG GCAL PGVY +V + WI Q++K
Sbjct: 301 IDACQGDSGGPFVCEDSISRTPRWRLCGIVSWGTGCALAQKPGVYTKVSDFREWIFQAIK 360
Query: 211 NNGDNAGVL 219
+ + +G++
Sbjct: 361 THSEASGMV 369
>pdb|1O5E|H Chain H, Dissecting And Designing Inhibitor Selectivity
Determinants At The S1 Site Using An Artificial Ala190
Protease (ala190 Upa)
pdb|1O5F|H Chain H, Dissecting And Designing Inhibitor Selectivity
Determinants At The S1 Site Using An Artificial Ala190
Protease (Ala190 Upa)
pdb|1P57|B Chain B, Extracellular Domain Of Human Hepsin
Length = 255
Score = 61.6 bits (148), Expect = 4e-10, Method: Compositional matrix adjust.
Identities = 63/249 (25%), Positives = 97/249 (38%), Gaps = 65/249 (26%)
Query: 30 GEVPYIVSLSLYGNLYCGGSLISLQWFLSARHCFVTENLVWNQFNPLIIAGSIYRNYKEQ 89
G P+ VSL G CGGSL+S W L+A HCF N V +++ + AG++ +
Sbjct: 10 GRWPWQVSLRYDGAHLCGGSLLSGDWVLTAAHCFPERNRVLSRWR--VFAGAV---AQAS 64
Query: 90 KRQPQLNEIALIYW------------HSDADLAMVKLKEPFRQTTFVKPLDYYTARETNY 137
QL A++Y + D+A+V L P T +++P+ A +
Sbjct: 65 PHGLQLGVQAVVYHGGYLPFRDPNSEENSNDIALVHLSSPLPLTEYIQPVCLPAAGQALV 124
Query: 138 INDVLSKTDRSEMSIVSGFGVTFQRDKDGIVSWGIG---------------CALGYP--- 179
+ + T Q + I+S + CA GYP
Sbjct: 125 DGKICTVTGWGNTQYYGQQAGVLQEARVPIISNDVCNGADFYGNQIKPKMFCA-GYPEGG 183
Query: 180 ---------------------------GIVSWGIGCALGY-PGVYVRVDHYDPWI-QSVK 210
GIVSWG GCAL PGVY +V + WI Q++K
Sbjct: 184 IDACQGDSGGPFVCEDSISRTPRWRLCGIVSWGTGCALAQKPGVYTKVSDFREWIFQAIK 243
Query: 211 NNGDNAGVL 219
+ + +G++
Sbjct: 244 THSEASGMV 252
>pdb|3DFJ|A Chain A, Crystal Structure Of Human Prostasin
pdb|3DFL|A Chain A, Crystal Structure Of Human Prostasin Complexed To 4-
Guanidinobenzoic Acid
Length = 263
Score = 61.2 bits (147), Expect = 4e-10, Method: Compositional matrix adjust.
Identities = 59/232 (25%), Positives = 90/232 (38%), Gaps = 55/232 (23%)
Query: 30 GEVPYIVSLSLYGNLYCGGSLISLQWFLSARHCFVTENLVWNQFNPLIIAGSIYRNYKEQ 89
G+ P+ VS++ G CGGSL+S QW LSA HCF +E+ + + + +Y E
Sbjct: 10 GQWPWQVSITYEGVHVCGGSLVSEQWVLSAAHCFPSEHH--KEAYEVKLGAHQLDSYSED 67
Query: 90 KRQPQLNEI----ALIYWHSDADLAMVKLKEPFRQTTFVKPLDYYTA------------- 132
+ L +I + + S D+A+++L P + +++P+ A
Sbjct: 68 AKVSTLKDIIPHPSYLQEGSQGDIALLQLSRPITFSRYIRPISLPAANASFPNGLHCTVT 127
Query: 133 --------------------------RET-NYINDVLSKTDRSEM--------SIVSGFG 157
RET N + ++ +K + V G
Sbjct: 128 GWGHVAPSVSLLTPKPLQQLEVPLISRETCNALYNIDAKPEEPHFVQEDMVCAGYVEGGK 187
Query: 158 VTFQRDKDGIVSWGIGCALGYPGIVSWGIGC-ALGYPGVYVRVDHYDPWIQS 208
Q D G +S + GIVSWG C A PGVY Y WIQS
Sbjct: 188 DACQGDSGGPLSCPVEGLWYLTGIVSWGDACGARNRPGVYTLASSYASWIQS 239
>pdb|3GYL|B Chain B, Structure Of Prostasin At 1.3 Angstroms Resolution In
Complex With A Calcium Ion.
pdb|3GYM|A Chain A, Structure Of Prostasin In Complex With Aprotinin
pdb|3GYM|B Chain B, Structure Of Prostasin In Complex With Aprotinin
Length = 261
Score = 61.2 bits (147), Expect = 5e-10, Method: Compositional matrix adjust.
Identities = 59/232 (25%), Positives = 90/232 (38%), Gaps = 55/232 (23%)
Query: 30 GEVPYIVSLSLYGNLYCGGSLISLQWFLSARHCFVTENLVWNQFNPLIIAGSIYRNYKEQ 89
G+ P+ VS++ G CGGSL+S QW LSA HCF +E+ + + + +Y E
Sbjct: 10 GQWPWQVSITYEGVHVCGGSLVSEQWVLSAAHCFPSEHH--KEAYEVKLGAHQLDSYSED 67
Query: 90 KRQPQLNEI----ALIYWHSDADLAMVKLKEPFRQTTFVKPLDYYTA------------- 132
+ L +I + + S D+A+++L P + +++P+ A
Sbjct: 68 AKVSTLKDIIPHPSYLQEGSQGDIALLQLSRPITFSRYIRPISLPAAQASFPNGLHCTVT 127
Query: 133 --------------------------RET-NYINDVLSKTDRSEM--------SIVSGFG 157
RET N + ++ +K + V G
Sbjct: 128 GWGHVAPSVSLLTPKPLQQLEVPLISRETCNSLYNIDAKPEEPHFVQEDMVCAGYVEGGK 187
Query: 158 VTFQRDKDGIVSWGIGCALGYPGIVSWGIGC-ALGYPGVYVRVDHYDPWIQS 208
Q D G +S + GIVSWG C A PGVY Y WIQS
Sbjct: 188 DACQGDSGGPLSCPVEGLWYLTGIVSWGDACGARNRPGVYTLASSYASWIQS 239
>pdb|3E0P|B Chain B, The X-Ray Structure Of Human Prostasin In Complex With A
Covalent Benzoxazole Inhibitor
pdb|3E16|B Chain B, X-Ray Structure Of Human Prostasin In Complex With
Benzoxazole Warhead Peptidomimic, Lysine In P3
pdb|3E1X|B Chain B, The Crystal Structure Of Apo Prostasin At 1.7 Angstroms
Resolution
pdb|3FVF|B Chain B, The Crystal Structure Of Prostasin Complexed With Camostat
At 1.6 Angstroms Resolution
pdb|3E0N|B Chain B, The X-Ray Structure Of Human Prostasin In Complex With
Dffr- Chloromethyl Ketone Inhibitor
Length = 271
Score = 61.2 bits (147), Expect = 5e-10, Method: Compositional matrix adjust.
Identities = 59/232 (25%), Positives = 90/232 (38%), Gaps = 55/232 (23%)
Query: 30 GEVPYIVSLSLYGNLYCGGSLISLQWFLSARHCFVTENLVWNQFNPLIIAGSIYRNYKEQ 89
G+ P+ VS++ G CGGSL+S QW LSA HCF +E+ + + + +Y E
Sbjct: 10 GQWPWQVSITYEGVHVCGGSLVSEQWVLSAAHCFPSEHH--KEAYEVKLGAHQLDSYSED 67
Query: 90 KRQPQLNEI----ALIYWHSDADLAMVKLKEPFRQTTFVKPLDYYTA------------- 132
+ L +I + + S D+A+++L P + +++P+ A
Sbjct: 68 AKVSTLKDIIPHPSYLQEGSQGDIALLQLSRPITFSRYIRPISLPAAQASFPNGLHCTVT 127
Query: 133 --------------------------RET-NYINDVLSKTDRSEM--------SIVSGFG 157
RET N + ++ +K + V G
Sbjct: 128 GWGHVAPSVSLLTPKPLQQLEVPLISRETCNSLYNIDAKPEEPHFVQEDMVCAGYVEGGK 187
Query: 158 VTFQRDKDGIVSWGIGCALGYPGIVSWGIGC-ALGYPGVYVRVDHYDPWIQS 208
Q D G +S + GIVSWG C A PGVY Y WIQS
Sbjct: 188 DACQGDSGGPLSCPVEGLWYLTGIVSWGDACGARNRPGVYTLASSYASWIQS 239
>pdb|2R9P|A Chain A, Human Mesotrypsin Complexed With Bovine Pancreatic Trypsin
Inhibitor(Bpti)
pdb|2R9P|B Chain B, Human Mesotrypsin Complexed With Bovine Pancreatic Trypsin
Inhibitor(Bpti)
pdb|2R9P|C Chain C, Human Mesotrypsin Complexed With Bovine Pancreatic Trypsin
Inhibitor(Bpti)
pdb|2R9P|D Chain D, Human Mesotrypsin Complexed With Bovine Pancreatic Trypsin
Inhibitor(Bpti)
pdb|3L33|A Chain A, Human Mesotrypsin Complexed With Amyloid Precursor Protein
Inhibitor(Appi)
pdb|3L33|B Chain B, Human Mesotrypsin Complexed With Amyloid Precursor Protein
Inhibitor(Appi)
pdb|3L33|C Chain C, Human Mesotrypsin Complexed With Amyloid Precursor Protein
Inhibitor(Appi)
pdb|3L33|D Chain D, Human Mesotrypsin Complexed With Amyloid Precursor Protein
Inhibitor(Appi)
pdb|3L3T|A Chain A, Human Mesotrypsin Complexed With Amyloid Precursor Protein
Inhibitor Variant (Appir15k)
pdb|3L3T|B Chain B, Human Mesotrypsin Complexed With Amyloid Precursor Protein
Inhibitor Variant (Appir15k)
pdb|3L3T|C Chain C, Human Mesotrypsin Complexed With Amyloid Precursor Protein
Inhibitor Variant (Appir15k)
pdb|3L3T|D Chain D, Human Mesotrypsin Complexed With Amyloid Precursor Protein
Inhibitor Variant (Appir15k)
pdb|3P92|A Chain A, Human Mesotrypsin Complexed With Bovine Pancreatic Trypsin
Inhibitor Variant (Bpti-K15rR17G)
pdb|3P95|A Chain A, Human Mesotrypsin Complexed With Bovine Pancreatic Trypsin
Inhibitor Variant (Bpti-K15rR17D)
Length = 224
Score = 60.1 bits (144), Expect = 1e-09, Method: Compositional matrix adjust.
Identities = 66/218 (30%), Positives = 91/218 (41%), Gaps = 50/218 (22%)
Query: 32 VPYIVSLSLYGNLYCGGSLISLQWFLSARHCFVTE-NLVWNQFNPLIIAGS-IYRNYKEQ 89
+PY VSL+ G+ +CGGSLIS QW +SA HC+ T + + N ++ G+ + N +
Sbjct: 12 LPYQVSLN-SGSHFCGGSLISEQWVVSAAHCYKTRIQVRLGEHNIKVLEGNEQFINAAKI 70
Query: 90 KRQPQLNEIALIYWHSDADLAMVKLKEP----FRQTTFVKPLDYYTARETNYIN------ 139
R P+ N L D D+ ++KL P R +T P A I+
Sbjct: 71 IRHPKYNRDTL-----DNDIMLIKLSSPAVINARVSTISLPTAPPAAGTECLISGWGNTL 125
Query: 140 -------DVLSKTDRSEMSIV------------SGFGVTF--------QRDKDGIVSWGI 172
D L D ++ S F V F QRD G V
Sbjct: 126 SFGADYPDELKCLDAPVLTQAECKASYPGKITNSMFCVGFLEGGKDSCQRDAGGPVV--- 182
Query: 173 GCALGYPGIVSWGIGCA-LGYPGVYVRVDHYDPWIQSV 209
C G+VSWG GCA PGVY +V +Y WI+
Sbjct: 183 -CNGQLQGVVSWGHGCAWKNRPGVYTKVYNYVDWIKDT 219
>pdb|1H4W|A Chain A, Structure Of Human Trypsin Iv (Brain Trypsin)
Length = 224
Score = 59.7 bits (143), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 66/216 (30%), Positives = 91/216 (42%), Gaps = 50/216 (23%)
Query: 32 VPYIVSLSLYGNLYCGGSLISLQWFLSARHCFVTE-NLVWNQFNPLIIAGS-IYRNYKEQ 89
+PY VSL+ G+ +CGGSLIS QW +SA HC+ T + + N ++ G+ + N +
Sbjct: 12 LPYQVSLN-SGSHFCGGSLISEQWVVSAAHCYKTRIQVRLGEHNIKVLEGNEQFINAVKI 70
Query: 90 KRQPQLNEIALIYWHSDADLAMVKLKEP----FRQTTFVKPLDYYTARETNYIN------ 139
R P+ N L D D+ ++KL P R +T P A I+
Sbjct: 71 IRHPKYNRDTL-----DNDIMLIKLSSPAVINARVSTISLPTAPPAAGTECLISGWGNTL 125
Query: 140 -------DVLSKTDRSEMSIV------------SGFGVTF--------QRDKDGIVSWGI 172
D L D ++ S F V F QRD G V
Sbjct: 126 SFGADYPDELKCLDAPVLTQAECKASYPGKITNSMFCVGFLEGGKDSCQRDSGGPVV--- 182
Query: 173 GCALGYPGIVSWGIGCA-LGYPGVYVRVDHYDPWIQ 207
C G+VSWG GCA PGVY +V +Y WI+
Sbjct: 183 -CNGQLQGVVSWGHGCAWKNRPGVYTKVYNYVDWIK 217
>pdb|4DG4|A Chain A, Human Mesotrypsin-S39y Complexed With Bovine Pancreatic
Trypsin Inhibitor (Bpti)
pdb|4DG4|B Chain B, Human Mesotrypsin-S39y Complexed With Bovine Pancreatic
Trypsin Inhibitor (Bpti)
pdb|4DG4|D Chain D, Human Mesotrypsin-S39y Complexed With Bovine Pancreatic
Trypsin Inhibitor (Bpti)
pdb|4DG4|G Chain G, Human Mesotrypsin-S39y Complexed With Bovine Pancreatic
Trypsin Inhibitor (Bpti)
Length = 224
Score = 58.5 bits (140), Expect = 3e-09, Method: Compositional matrix adjust.
Identities = 63/218 (28%), Positives = 86/218 (39%), Gaps = 50/218 (22%)
Query: 32 VPYIVSLSLYGNLYCGGSLISLQWFLSARHCFVTE-NLVWNQFNPLIIAGS-IYRNYKEQ 89
+PY VSL+ G +CGGSLIS QW +SA HC+ T + + N ++ G+ + N +
Sbjct: 12 LPYQVSLN-SGYHFCGGSLISEQWVVSAAHCYKTRIQVRLGEHNIKVLEGNEQFINAAKI 70
Query: 90 KRQPQLNEIALIYWHSDADLAMVKLKEP----FRQTTFVKPL------------------ 127
R P+ N L D D+ ++KL P R +T P
Sbjct: 71 IRHPKYNRDTL-----DNDIMLIKLSSPAVINARVSTISLPTAPPAAGTECLISGWGNTL 125
Query: 128 -------DYYTARETNYINDVLSKTDRSEMSIVSGFGVTF--------QRDKDGIVSWGI 172
D + + K S F V F QRD G V
Sbjct: 126 SFGADYPDELKCLDAPVLTQAECKASYPGKITNSMFCVGFLEGGKDSCQRDAGGPVV--- 182
Query: 173 GCALGYPGIVSWGIGCA-LGYPGVYVRVDHYDPWIQSV 209
C G+VSWG GCA PGVY +V +Y WI+
Sbjct: 183 -CNGQLQGVVSWGHGCAWKNRPGVYTKVYNYVDWIKDT 219
>pdb|2TLD|E Chain E, Crystal Structure Of An Engineered Subtilisin Inhibitor
Complexed With Bovine Trypsin
Length = 220
Score = 58.2 bits (139), Expect = 4e-09, Method: Compositional matrix adjust.
Identities = 63/214 (29%), Positives = 89/214 (41%), Gaps = 38/214 (17%)
Query: 32 VPYIVSLSLYGNLYCGGSLISLQWFLSARHCFVT--------ENLVWNQFNPLIIAGSIY 83
VPY VSL+ G +CGGSLI+ QW +SA HC+ + +N+ + N I+ S
Sbjct: 12 VPYQVSLN-SGYHFCGGSLINSQWVVSAAHCYKSGIQVRLGEDNINVVEGNEQFISASKS 70
Query: 84 RNYKEQKRQPQLNEIALIYWHSDADL----AMVKLKEPFRQT---TFVKPLDYYTARETN 136
+ N+I LI S A L A + L + + T+
Sbjct: 71 IVHPSYNSNTLNNDIMLIKLKSAASLNSRVASISLPTSCASAGTQCLISGWGNTKSSGTS 130
Query: 137 Y--INDVLSKTDRSEMSIVSGF---------------GVTFQRDKDGIVSWGIGCALGYP 179
Y + L S+ S S + G + Q D G V C+
Sbjct: 131 YPDVLKCLKAPILSDSSCKSAYPGQITSNMFCAGLEGGDSCQGDSGGPVV----CSGKLQ 186
Query: 180 GIVSWGIGCALGYPGVYVRVDHYDPWI-QSVKNN 212
GIVSWG GCA PGVY +V +Y WI Q++ +N
Sbjct: 187 GIVSWGSGCAKNKPGVYTKVCNYVSWIKQTIASN 220
>pdb|1UTJ|A Chain A, Trypsin Specificity As Elucidated By Lie Calculations,
X-Ray Structures And Association Constant Measurements
pdb|1UTK|A Chain A, Trypsin Specificity As Elucidated By Lie Calculations,
X-Ray Structures And Association Constant Measurements
pdb|1UTL|M Chain M, Trypsin Specificity As Elucidated By Lie Calculations,
X-Ray Structures And Association Constant Measurements
pdb|1UTM|A Chain A, Trypsin Specificity As Elucidated By Lie Calculations,
X-Ray Structures And Association Constant Measurements
Length = 242
Score = 57.8 bits (138), Expect = 6e-09, Method: Compositional matrix adjust.
Identities = 59/227 (25%), Positives = 92/227 (40%), Gaps = 63/227 (27%)
Query: 29 PGEVPYIVSLSLYGNLYCGGSLISLQWFLSARHCFVTE-NLVWNQFNPLIIAGS-IYRNY 86
P P+ VSL+ G +CGGSL++ W +SA HC+ + + + N + GS + +
Sbjct: 29 PYSQPHQVSLN-SGYHFCGGSLVNENWVVSAAHCYKSRVEVRLGEHNIKVTEGSEQFISS 87
Query: 87 KEQKRQPQLNEIALIYWHSDADLAMVKLKEPFRQTTFVKPLDYYTARETNYINDVLSKTD 146
R P + ++ D D+ ++KL +P T+V+P+ T S
Sbjct: 88 SRVIRHPNYSS-----YNIDNDIMLIKLSKPATLNTYVQPVALPT-----------SCAP 131
Query: 147 RSEMSIVSGFGVTFQRDKD----------------------GIVSWGIGCA--------- 175
M VSG+G T D G+++ + CA
Sbjct: 132 AGTMCTVSGWGNTMSSTADSNKLQCLNIPILSYSDCNNSYPGMITNAMFCAGYLEGGKDS 191
Query: 176 ----LGYP--------GIVSWGIGCAL-GYPGVYVRVDHYDPWIQSV 209
G P G+VSWG GCA G PGVY +V ++ W+ S
Sbjct: 192 CQGDSGGPVVCNGELQGVVSWGYGCAEPGNPGVYAKVCIFNDWLTST 238
>pdb|1HJ8|A Chain A, 1.00 Aa Trypsin From Atlantic Salmon
Length = 222
Score = 57.0 bits (136), Expect = 8e-09, Method: Compositional matrix adjust.
Identities = 58/223 (26%), Positives = 91/223 (40%), Gaps = 63/223 (28%)
Query: 33 PYIVSLSLYGNLYCGGSLISLQWFLSARHCFVTE-NLVWNQFNPLIIAGS-IYRNYKEQK 90
P+ VSL+ G +CGGSL++ W +SA HC+ + + + N + GS + +
Sbjct: 13 PHQVSLN-SGYHFCGGSLVNENWVVSAAHCYKSRVEVRLGEHNIKVTEGSEQFISSSRVI 71
Query: 91 RQPQLNEIALIYWHSDADLAMVKLKEPFRQTTFVKPLDYYTARETNYINDVLSKTDRSEM 150
R P + ++ D D+ ++KL +P T+V+P+ T S M
Sbjct: 72 RHPNYSS-----YNIDNDIMLIKLSKPATLNTYVQPVALPT-----------SCAPAGTM 115
Query: 151 SIVSGFGVTFQRDKD----------------------GIVSWGIGCA------------- 175
VSG+G T D G+++ + CA
Sbjct: 116 CTVSGWGNTMSSTADSNKLQCLNIPILSYSDCNNSYPGMITNAMFCAGYLEGGKDSCQGD 175
Query: 176 LGYP--------GIVSWGIGCAL-GYPGVYVRVDHYDPWIQSV 209
G P G+VSWG GCA G PGVY +V ++ W+ S
Sbjct: 176 SGGPVVCNGELQGVVSWGYGCAEPGNPGVYAKVCIFNDWLTST 218
>pdb|1BZX|E Chain E, The Crystal Structure Of Anionic Salmon Trypsin In Complex
With Bovine Pancreatic Trypsin Inhibitor
pdb|2STA|E Chain E, Anionic Salmon Trypsin In Complex With Squash Seed
Inhibitor (Cucurbita Maxima Trypsin Inhibitor I)
pdb|2STB|E Chain E, Anionic Salmon Trypsin In Complex With Squash Seed
Inhibitor (cucurbita Pepo Trypsin Inhibitor Ii)
Length = 222
Score = 57.0 bits (136), Expect = 9e-09, Method: Compositional matrix adjust.
Identities = 59/227 (25%), Positives = 92/227 (40%), Gaps = 63/227 (27%)
Query: 29 PGEVPYIVSLSLYGNLYCGGSLISLQWFLSARHCFVTE-NLVWNQFNPLIIAGS-IYRNY 86
P P+ VSL+ G +CGGSL++ W +SA HC+ + + + N + GS + +
Sbjct: 9 PYSQPHQVSLN-SGYHFCGGSLVNENWVVSAAHCYKSRVEVRLGEHNIKVTEGSEQFISS 67
Query: 87 KEQKRQPQLNEIALIYWHSDADLAMVKLKEPFRQTTFVKPLDYYTARETNYINDVLSKTD 146
R P + ++ D D+ ++KL +P T+V+P+ T S
Sbjct: 68 SRVIRHPNYSS-----YNIDNDIMLIKLSKPATLNTYVQPVALPT-----------SCAP 111
Query: 147 RSEMSIVSGFGVTFQRDKD----------------------GIVSWGIGCA--------- 175
M VSG+G T D G+++ + CA
Sbjct: 112 AGTMCTVSGWGNTMSSTADSNKLQCLNIPILSYSDCNNSYPGMITNAMFCAGYLEGGKDS 171
Query: 176 ----LGYP--------GIVSWGIGCAL-GYPGVYVRVDHYDPWIQSV 209
G P G+VSWG GCA G PGVY +V ++ W+ S
Sbjct: 172 CQGDSGGPVVCNGELQGVVSWGYGCAEPGNPGVYAKVCIFNDWLTST 218
>pdb|2ZPR|A Chain A, Crystal Structure Of Anionic Trypsin Isoform 2 From Chum
Salmon
pdb|2ZPR|B Chain B, Crystal Structure Of Anionic Trypsin Isoform 2 From Chum
Salmon
Length = 222
Score = 57.0 bits (136), Expect = 9e-09, Method: Compositional matrix adjust.
Identities = 59/224 (26%), Positives = 90/224 (40%), Gaps = 65/224 (29%)
Query: 33 PYIVSLSLYGNLYCGGSLISLQWFLSARHCFVTENLV-WNQFNPLIIAGS-IYRNYKEQK 90
P+ VSL+ G +CGGSL++ W +SA HC+ + V + N + GS + +
Sbjct: 13 PHQVSLN-SGYHFCGGSLVNENWVVSAAHCYKSRVAVRLGEHNIKVTEGSEQFISSSRVI 71
Query: 91 RQPQLNEIALIYWHSDADLAMVKLKEPFRQTTFVKPLDYYTARETNYINDVLSKTDRSEM 150
R P + ++ D D+ ++KL +P T+V+P+ + S M
Sbjct: 72 RHPNYSS-----YNIDNDIMLIKLSKPATLNTYVQPVALPS-----------SCAPAGTM 115
Query: 151 SIVSGFGVTFQRDKDG---------IVSWGIGCALGYP---------------------- 179
VSG+G T DG I+S+ C YP
Sbjct: 116 CTVSGWGNTMSSTADGDKLQCLNIPILSYS-DCNNSYPGMITNAMFCAGYLEGGKDSCQG 174
Query: 180 -------------GIVSWGIGCAL-GYPGVYVRVDHYDPWIQSV 209
G+VSWG GCA G PGVY +V ++ W+ S
Sbjct: 175 DSGGPVVCNGELQGVVSWGYGCAEPGNPGVYAKVCIFNDWLTST 218
>pdb|1K9O|E Chain E, Crystal Structure Of Michaelis Serpin-Trypsin Complex
pdb|1YKT|A Chain A, TrypsinBPTI COMPLEX MUTANT
pdb|1YLC|A Chain A, TrypsinBPTI COMPLEX MUTANT
pdb|1YLD|A Chain A, TrypsinBPTI COMPLEX MUTANT
pdb|3FP7|E Chain E, Anionic Trypsin Variant S195a In Complex With Bovine
Pancreatic Trypsin Inhibitor (Bpti) Cleaved At The
Scissile Bond (Lys15-Ala16) Determined To The 1.46 A
Resolution Limit
pdb|3FP8|E Chain E, Anionic Trypsin Variant S195a In Complex With Bovine
Pancreatic Trypsin Inhibitor (Bpti) Determined To The
1.46 A Resolution Limit
Length = 223
Score = 57.0 bits (136), Expect = 9e-09, Method: Compositional matrix adjust.
Identities = 59/214 (27%), Positives = 87/214 (40%), Gaps = 42/214 (19%)
Query: 32 VPYIVSLSLYGNLYCGGSLISLQWFLSARHCFVTE-NLVWNQFNPLIIAGS-IYRNYKEQ 89
VPY VSL+ G +CGGSLI+ QW +SA HC+ + + + N ++ G+ + N +
Sbjct: 12 VPYQVSLN-SGYHFCGGSLINDQWVVSAAHCYKSRIQVRLGEHNINVLEGNEQFVNAAKI 70
Query: 90 KRQPQLNEIALIYWHSDADLAMVKLKEPF----RQTTFVKPLDYYTARETNYIN------ 139
+ P + L + D+ ++KL P R T P A I+
Sbjct: 71 IKHPNFDRKTL-----NNDIMLIKLSSPVKLNARVATVALPSSCAPAGTQCLISGWGNTL 125
Query: 140 -------DVLSKTDR----------------SEMSIVSGFGVTFQRDKDGIVSWGIGCAL 176
D+L D ++ + GF + G + C
Sbjct: 126 SSGVNEPDLLQCLDAPLLPQADCEASYPGKITDNMVCVGFLEGGKDSCQGDAGGPVVCNG 185
Query: 177 GYPGIVSWGIGCAL-GYPGVYVRVDHYDPWIQSV 209
GIVSWG GCAL PGVY +V +Y WIQ
Sbjct: 186 ELQGIVSWGYGCALPDNPGVYTKVCNYVDWIQDT 219
>pdb|2ZPS|A Chain A, Crystal Structure Of Anionic Trypsin Isoform 3 From Chum
Salmon
Length = 222
Score = 57.0 bits (136), Expect = 1e-08, Method: Compositional matrix adjust.
Identities = 58/223 (26%), Positives = 91/223 (40%), Gaps = 63/223 (28%)
Query: 33 PYIVSLSLYGNLYCGGSLISLQWFLSARHCFVTE-NLVWNQFNPLIIAGS-IYRNYKEQK 90
P+ VSL+ G +CGGSL++ W +SA HC+ T + + N + GS + +
Sbjct: 13 PHQVSLN-SGYHFCGGSLVNENWVVSAAHCYKTRVEVRLGEHNIKVTEGSEQFISSSRVI 71
Query: 91 RQPQLNEIALIYWHSDADLAMVKLKEPFRQTTFVKPLDYYTARETNYINDVLSKTDRSEM 150
R P + ++ D D+ ++KL +P T+V+P+ + S M
Sbjct: 72 RHPNYSS-----YNIDNDIMLIKLSKPATLNTYVQPVALPS-----------SCAPAGTM 115
Query: 151 SIVSGFGVTFQRDKD----------------------GIVSWGIGCA------------- 175
VSG+G T D G+++ + CA
Sbjct: 116 CTVSGWGNTMSSTADKNKLQCLNIPILSYSDCNNSYPGMITNAMFCAGYLEGGKDSCQGD 175
Query: 176 LGYP--------GIVSWGIGCAL-GYPGVYVRVDHYDPWIQSV 209
G P G+VSWG GCA G PGVY +V ++ W+ S
Sbjct: 176 SGGPVVCNGELQGVVSWGYGCAEPGNPGVYAKVCIFNNWLTST 218
>pdb|1DPO|A Chain A, Structure Of Rat Trypsin
Length = 223
Score = 56.6 bits (135), Expect = 1e-08, Method: Compositional matrix adjust.
Identities = 59/214 (27%), Positives = 87/214 (40%), Gaps = 42/214 (19%)
Query: 32 VPYIVSLSLYGNLYCGGSLISLQWFLSARHCFVTE-NLVWNQFNPLIIAGS-IYRNYKEQ 89
VPY VSL+ G +CGGSLI+ QW +SA HC+ + + + N ++ G+ + N +
Sbjct: 12 VPYQVSLN-SGYHFCGGSLINDQWVVSAAHCYKSRIQVRLGEHNINVLEGNEQFVNAAKI 70
Query: 90 KRQPQLNEIALIYWHSDADLAMVKLKEPF----RQTTFVKPLDYYTARETNYIN------ 139
+ P + L + D+ ++KL P R T P A I+
Sbjct: 71 IKHPNFDRKTL-----NNDIMLIKLSSPVKLNARVATVALPSSCAPAGTQCLISGWGNTL 125
Query: 140 -------DVLSKTDR----------------SEMSIVSGFGVTFQRDKDGIVSWGIGCAL 176
D+L D ++ + GF + G + C
Sbjct: 126 SSGVNEPDLLQCLDAPLLPQADCEASYPGKITDNMVCVGFLEGGKDSCQGDCGGPVVCNG 185
Query: 177 GYPGIVSWGIGCAL-GYPGVYVRVDHYDPWIQSV 209
GIVSWG GCAL PGVY +V +Y WIQ
Sbjct: 186 ELQGIVSWGYGCALPDNPGVYTKVCNYVDWIQDT 219
>pdb|3TGJ|E Chain E, S195a Trypsinogen Complexed With Bovine Pancreatic Trypsin
Inhibitor (Bpti)
Length = 233
Score = 56.6 bits (135), Expect = 1e-08, Method: Compositional matrix adjust.
Identities = 59/214 (27%), Positives = 87/214 (40%), Gaps = 42/214 (19%)
Query: 32 VPYIVSLSLYGNLYCGGSLISLQWFLSARHCFVTE-NLVWNQFNPLIIAGS-IYRNYKEQ 89
VPY VSL+ G +CGGSLI+ QW +SA HC+ + + + N ++ G+ + N +
Sbjct: 22 VPYQVSLN-SGYHFCGGSLINDQWVVSAAHCYKSRIQVRLGEHNINVLEGNEQFVNAAKI 80
Query: 90 KRQPQLNEIALIYWHSDADLAMVKLKEPF----RQTTFVKPLDYYTARETNYIN------ 139
+ P + L + D+ ++KL P R T P A I+
Sbjct: 81 IKHPNFDRKTL-----NNDIMLIKLSSPVKLNARVATVALPSSCAPAGTQCLISGWGNTL 135
Query: 140 -------DVLSKTDR----------------SEMSIVSGFGVTFQRDKDGIVSWGIGCAL 176
D+L D ++ + GF + G + C
Sbjct: 136 SSGVNEPDLLQCLDAPLLPQADCEASYPGKITDNMVCVGFLEGGKDSCQGDAGGPVVCNG 195
Query: 177 GYPGIVSWGIGCAL-GYPGVYVRVDHYDPWIQSV 209
GIVSWG GCAL PGVY +V +Y WIQ
Sbjct: 196 ELQGIVSWGYGCALPDNPGVYTKVCNYVDWIQDT 229
>pdb|1SLW|B Chain B, Rat Anionic N143h, E151h Trypsin Complexed To A86h Ecotin;
Nickel- Bound
Length = 223
Score = 56.6 bits (135), Expect = 1e-08, Method: Compositional matrix adjust.
Identities = 59/215 (27%), Positives = 87/215 (40%), Gaps = 42/215 (19%)
Query: 31 EVPYIVSLSLYGNLYCGGSLISLQWFLSARHCFVTE-NLVWNQFNPLIIAGS-IYRNYKE 88
VPY VSL+ G +CGGSLI+ QW +SA HC+ + + + N ++ G+ + N +
Sbjct: 11 SVPYQVSLN-SGYHFCGGSLINDQWVVSAAHCYKSRIQVRLGEHNINVLEGNEQFVNAAK 69
Query: 89 QKRQPQLNEIALIYWHSDADLAMVKLKEPF----RQTTFVKPLDYYTARETNYIN----- 139
+ P + L + D+ ++KL P R T P A I+
Sbjct: 70 IIKHPNFDRKTL-----NNDIMLIKLSSPVKLNARVATIALPSSCAPAGTQCLISGWGHT 124
Query: 140 --------DVLSKTDR----------------SEMSIVSGFGVTFQRDKDGIVSWGIGCA 175
D+L D ++ + GF + G + C
Sbjct: 125 LSSGVNHPDLLQCLDAPLLPQADCEASYPGKITDNMVCVGFLEGGKDSCQGDSGGPVVCN 184
Query: 176 LGYPGIVSWGIGCAL-GYPGVYVRVDHYDPWIQSV 209
GIVSWG GCAL PGVY +V +Y WIQ
Sbjct: 185 GELQGIVSWGYGCALPDNPGVYTKVCNYVDWIQDT 219
>pdb|1AMH|A Chain A, Uncomplexed Rat Trypsin Mutant With Asp 189 Replaced With
Ser (D189s)
pdb|1AMH|B Chain B, Uncomplexed Rat Trypsin Mutant With Asp 189 Replaced With
Ser (D189s)
Length = 223
Score = 56.6 bits (135), Expect = 1e-08, Method: Compositional matrix adjust.
Identities = 59/213 (27%), Positives = 87/213 (40%), Gaps = 42/213 (19%)
Query: 31 EVPYIVSLSLYGNLYCGGSLISLQWFLSARHCFVTE-NLVWNQFNPLIIAGS-IYRNYKE 88
VPY VSL+ G +CGGSLI+ QW +SA HC+ + + + N ++ G+ + N +
Sbjct: 11 SVPYQVSLN-SGYHFCGGSLINDQWVVSAAHCYKSRIQVRLGEHNINVLEGNEQFVNAAK 69
Query: 89 QKRQPQLNEIALIYWHSDADLAMVKLKEPF----RQTTFVKPLDYYTARETNYIN----- 139
+ P + L + D+ ++KL P R T P A I+
Sbjct: 70 IIKHPNFDRKTL-----NNDIMLIKLSSPVKLNARVATVALPSSCAPAGTQCLISGWGNT 124
Query: 140 --------DVLSKTDR----------------SEMSIVSGFGVTFQRDKDGIVSWGIGCA 175
D+L D ++ + GF + G + C
Sbjct: 125 LSSGVNEPDLLQCLDAPLLPQADCEASYPGKITDNMVCVGFLEGGKSSCQGDSGGPVVCN 184
Query: 176 LGYPGIVSWGIGCAL-GYPGVYVRVDHYDPWIQ 207
GIVSWG GCAL PGVY +V +Y WIQ
Sbjct: 185 GELQGIVSWGYGCALPDNPGVYTKVCNYVDWIQ 217
>pdb|1SLX|B Chain B, Rat Anionic N143h, E151h Trypsin Complexed To A86h Ecotin;
Zinc-Bound
pdb|1SLV|B Chain B, Rat Anionic N143h, E151h Trypsin Complexed To A86h Ecotin;
Copper- Bound
pdb|1SLU|B Chain B, Rat Anionic N143h, E151h Trypsin Complexed To A86h Ecotin
Length = 223
Score = 56.2 bits (134), Expect = 1e-08, Method: Compositional matrix adjust.
Identities = 59/215 (27%), Positives = 87/215 (40%), Gaps = 42/215 (19%)
Query: 31 EVPYIVSLSLYGNLYCGGSLISLQWFLSARHCFVTE-NLVWNQFNPLIIAGS-IYRNYKE 88
VPY VSL+ G +CGGSLI+ QW +SA HC+ + + + N ++ G+ + N +
Sbjct: 11 SVPYQVSLN-SGYHFCGGSLINDQWVVSAAHCYKSRIQVRLGEHNINVLEGNEQFVNAAK 69
Query: 89 QKRQPQLNEIALIYWHSDADLAMVKLKEPF----RQTTFVKPLDYYTARETNYIN----- 139
+ P + L + D+ ++KL P R T P A I+
Sbjct: 70 IIKHPNFDRKTL-----NNDIMLIKLSSPVKLNARVATVALPSSCAPAGTQCLISGWGHT 124
Query: 140 --------DVLSKTDR----------------SEMSIVSGFGVTFQRDKDGIVSWGIGCA 175
D+L D ++ + GF + G + C
Sbjct: 125 LSSGVNHPDLLQCLDAPLLPQADCEASYPGKITDNMVCVGFLEGGKDSCQGDSGGPVVCN 184
Query: 176 LGYPGIVSWGIGCAL-GYPGVYVRVDHYDPWIQSV 209
GIVSWG GCAL PGVY +V +Y WIQ
Sbjct: 185 GELQGIVSWGYGCALPDNPGVYTKVCNYVDWIQDT 219
>pdb|1AND|A Chain A, Anionic Trypsin Mutant With Arg 96 Replaced By His
Length = 223
Score = 56.2 bits (134), Expect = 1e-08, Method: Compositional matrix adjust.
Identities = 59/214 (27%), Positives = 87/214 (40%), Gaps = 42/214 (19%)
Query: 32 VPYIVSLSLYGNLYCGGSLISLQWFLSARHCFVTE-NLVWNQFNPLIIAGS-IYRNYKEQ 89
VPY VSL+ G +CGGSLI+ QW +SA HC+ + + + N ++ G+ + N +
Sbjct: 12 VPYQVSLN-SGYHFCGGSLINDQWVVSAAHCYKSRIQVRLGEHNINVLEGNEQFVNAAKI 70
Query: 90 KRQPQLNEIALIYWHSDADLAMVKLKEPF----RQTTFVKPLDYYTARETNYIN------ 139
+ P + L + D+ ++KL P R T P A I+
Sbjct: 71 IKHPNFDHKTL-----NNDIMLIKLSSPVKLNARVATVALPSSCAPAGTQCLISGWGNTL 125
Query: 140 -------DVLSKTDR----------------SEMSIVSGFGVTFQRDKDGIVSWGIGCAL 176
D+L D ++ + GF + G + C
Sbjct: 126 SSGVNEPDLLQCLDAPLLPQADCEASYPGKITDNMVCVGFLEGGKDSCQGDSGGPVVCNG 185
Query: 177 GYPGIVSWGIGCAL-GYPGVYVRVDHYDPWIQSV 209
GIVSWG GCAL PGVY +V +Y WIQ
Sbjct: 186 ELQGIVSWGYGCALPDNPGVYTKVCNYVDWIQDT 219
>pdb|3TGI|E Chain E, Wild-Type Rat Anionic Trypsin Complexed With Bovine
Pancreatic Trypsin Inhibitor (Bpti)
pdb|1ANE|A Chain A, Anionic Trypsin Wild Type
pdb|3FP6|E Chain E, Anionic Trypsin In Complex With Bovine Pancreatic Trypsin
Inhibitor (Bpti) Determined To The 1.49 A Resolution
Limit
Length = 223
Score = 56.2 bits (134), Expect = 2e-08, Method: Compositional matrix adjust.
Identities = 59/214 (27%), Positives = 87/214 (40%), Gaps = 42/214 (19%)
Query: 32 VPYIVSLSLYGNLYCGGSLISLQWFLSARHCFVTE-NLVWNQFNPLIIAGS-IYRNYKEQ 89
VPY VSL+ G +CGGSLI+ QW +SA HC+ + + + N ++ G+ + N +
Sbjct: 12 VPYQVSLN-SGYHFCGGSLINDQWVVSAAHCYKSRIQVRLGEHNINVLEGNEQFVNAAKI 70
Query: 90 KRQPQLNEIALIYWHSDADLAMVKLKEPF----RQTTFVKPLDYYTARETNYIN------ 139
+ P + L + D+ ++KL P R T P A I+
Sbjct: 71 IKHPNFDRKTL-----NNDIMLIKLSSPVKLNARVATVALPSSCAPAGTQCLISGWGNTL 125
Query: 140 -------DVLSKTDR----------------SEMSIVSGFGVTFQRDKDGIVSWGIGCAL 176
D+L D ++ + GF + G + C
Sbjct: 126 SSGVNEPDLLQCLDAPLLPQADCEASYPGKITDNMVCVGFLEGGKDSCQGDSGGPVVCNG 185
Query: 177 GYPGIVSWGIGCAL-GYPGVYVRVDHYDPWIQSV 209
GIVSWG GCAL PGVY +V +Y WIQ
Sbjct: 186 ELQGIVSWGYGCALPDNPGVYTKVCNYVDWIQDT 219
>pdb|1F7Z|A Chain A, Rat Trypsinogen K15a Complexed With Bovine Pancreatic
Trypsin Inhibitor
Length = 233
Score = 56.2 bits (134), Expect = 2e-08, Method: Compositional matrix adjust.
Identities = 59/214 (27%), Positives = 87/214 (40%), Gaps = 42/214 (19%)
Query: 32 VPYIVSLSLYGNLYCGGSLISLQWFLSARHCFVTE-NLVWNQFNPLIIAGS-IYRNYKEQ 89
VPY VSL+ G +CGGSLI+ QW +SA HC+ + + + N ++ G+ + N +
Sbjct: 22 VPYQVSLN-SGYHFCGGSLINDQWVVSAAHCYKSRIQVRLGEHNINVLEGNEQFVNAAKI 80
Query: 90 KRQPQLNEIALIYWHSDADLAMVKLKEPF----RQTTFVKPLDYYTARETNYIN------ 139
+ P + L + D+ ++KL P R T P A I+
Sbjct: 81 IKHPNFDRKTL-----NNDIMLIKLSSPVKLNARVATVALPSSCAPAGTQCLISGWGNTL 135
Query: 140 -------DVLSKTDR----------------SEMSIVSGFGVTFQRDKDGIVSWGIGCAL 176
D+L D ++ + GF + G + C
Sbjct: 136 SSGVNEPDLLQCLDAPLLPQADCEASYPGKITDNMVCVGFLEGGKDSCQGDSGGPVVCNG 195
Query: 177 GYPGIVSWGIGCAL-GYPGVYVRVDHYDPWIQSV 209
GIVSWG GCAL PGVY +V +Y WIQ
Sbjct: 196 ELQGIVSWGYGCALPDNPGVYTKVCNYVDWIQDT 229
>pdb|1F5R|A Chain A, Rat Trypsinogen Mutant Complexed With Bovine Pancreatic
Trypsin Inhibitor
Length = 231
Score = 55.8 bits (133), Expect = 2e-08, Method: Compositional matrix adjust.
Identities = 59/214 (27%), Positives = 87/214 (40%), Gaps = 42/214 (19%)
Query: 32 VPYIVSLSLYGNLYCGGSLISLQWFLSARHCFVTE-NLVWNQFNPLIIAGS-IYRNYKEQ 89
VPY VSL+ G +CGGSLI+ QW +SA HC+ + + + N ++ G+ + N +
Sbjct: 20 VPYQVSLN-SGYHFCGGSLINDQWVVSAAHCYKSRIQVRLGEHNINVLEGNEQFVNAAKI 78
Query: 90 KRQPQLNEIALIYWHSDADLAMVKLKEPF----RQTTFVKPLDYYTARETNYIN------ 139
+ P + L + D+ ++KL P R T P A I+
Sbjct: 79 IKHPNFDRKTL-----NNDIMLIKLSSPVKLNARVATVALPSSCAPAGTQCLISGWGNTL 133
Query: 140 -------DVLSKTDR----------------SEMSIVSGFGVTFQRDKDGIVSWGIGCAL 176
D+L D ++ + GF + G + C
Sbjct: 134 SSGVNEPDLLKCLDAPLLPQADCEASYPGKITDNMVCVGFLEGGKDSCQGDSGGPVVCNG 193
Query: 177 GYPGIVSWGIGCAL-GYPGVYVRVDHYDPWIQSV 209
GIVSWG GCAL PGVY +V +Y WIQ
Sbjct: 194 ELQGIVSWGYGCALPDNPGVYTKVCNYVDWIQDT 227
>pdb|3MYW|A Chain A, The Bowman-Birk Type Inhibitor From Mung Bean In Ternary
Complex With Porcine Trypsin
pdb|3MYW|B Chain B, The Bowman-Birk Type Inhibitor From Mung Bean In Ternary
Complex With Porcine Trypsin
Length = 223
Score = 55.8 bits (133), Expect = 2e-08, Method: Compositional matrix adjust.
Identities = 62/217 (28%), Positives = 86/217 (39%), Gaps = 50/217 (23%)
Query: 31 EVPYIVSLSLYGNLYCGGSLISLQWFLSARHCFVTE-NLVWNQFNPLIIAGS-IYRNYKE 88
VPY VSL+ G+ +CGGSLI+ QW +SA HC+ + + + N ++ G+ + N +
Sbjct: 11 SVPYQVSLN-SGSHFCGGSLINSQWVVSAAHCYKSRIQVRLGEHNIDVLEGNEQFINAAK 69
Query: 89 QKRQPQLNEIALIYWHSDADLAMVKLKEPF----RQTTFVKPLDYYTARETNYIND---- 140
P N L D D+ ++KL P R T P A I+
Sbjct: 70 IITHPNFNGNTL-----DNDIMLIKLSSPATLNSRVATVSLPRSCAAAGTECLISGWGNT 124
Query: 141 -----------------VLSKTDRSE------------MSIVSGFGVTFQRDKDGIVSWG 171
VLS + + + G + Q D G V
Sbjct: 125 KSSGSSYPSLLQCLKAPVLSDSSCKSAYPGQITGNMICVGFLEGGKDSCQGDSGGPVV-- 182
Query: 172 IGCALGYPGIVSWGIGCAL-GYPGVYVRVDHYDPWIQ 207
C GIVSWG GCA PGVY +V +Y WIQ
Sbjct: 183 --CNGQLQGIVSWGYGCAQKNKPGVYTKVCNYVNWIQ 217
>pdb|1FY8|E Chain E, Crystal Structure Of The Deltaile16val17 Rat Anionic
Trypsinogen-Bpti Complex
Length = 231
Score = 55.8 bits (133), Expect = 2e-08, Method: Compositional matrix adjust.
Identities = 59/214 (27%), Positives = 87/214 (40%), Gaps = 42/214 (19%)
Query: 32 VPYIVSLSLYGNLYCGGSLISLQWFLSARHCFVTE-NLVWNQFNPLIIAGS-IYRNYKEQ 89
VPY VSL+ G +CGGSLI+ QW +SA HC+ + + + N ++ G+ + N +
Sbjct: 20 VPYQVSLN-SGYHFCGGSLINDQWVVSAAHCYKSRIQVRLGEHNINVLEGNEQFVNAAKI 78
Query: 90 KRQPQLNEIALIYWHSDADLAMVKLKEPF----RQTTFVKPLDYYTARETNYIN------ 139
+ P + L + D+ ++KL P R T P A I+
Sbjct: 79 IKHPNFDRKTL-----NNDIMLIKLSSPVKLNARVATVALPSSCAPAGTQCLISGWGNTL 133
Query: 140 -------DVLSKTDR----------------SEMSIVSGFGVTFQRDKDGIVSWGIGCAL 176
D+L D ++ + GF + G + C
Sbjct: 134 SSGVNEPDLLQCLDAPLLPQADCEASYPGKITDNMVCVGFLEGGKDSCQGDSGGPVVCNG 193
Query: 177 GYPGIVSWGIGCAL-GYPGVYVRVDHYDPWIQSV 209
GIVSWG GCAL PGVY +V +Y WIQ
Sbjct: 194 ELQGIVSWGYGCALPDNPGVYTKVCNYVDWIQDT 227
>pdb|3TGK|E Chain E, Trypsinogen Mutant D194n And Deletion Of Ile 16-Val 17
Complexed With Bovine Pancreatic Trypsin Inhibitor
(Bpti)
Length = 231
Score = 55.8 bits (133), Expect = 2e-08, Method: Compositional matrix adjust.
Identities = 59/214 (27%), Positives = 87/214 (40%), Gaps = 42/214 (19%)
Query: 32 VPYIVSLSLYGNLYCGGSLISLQWFLSARHCFVTE-NLVWNQFNPLIIAGS-IYRNYKEQ 89
VPY VSL+ G +CGGSLI+ QW +SA HC+ + + + N ++ G+ + N +
Sbjct: 20 VPYQVSLN-SGYHFCGGSLINDQWVVSAAHCYKSRIQVRLGEHNINVLEGNEQFVNAAKI 78
Query: 90 KRQPQLNEIALIYWHSDADLAMVKLKEPF----RQTTFVKPLDYYTARETNYIN------ 139
+ P + L + D+ ++KL P R T P A I+
Sbjct: 79 IKHPNFDRKTL-----NNDIMLIKLSSPVKLNARVATVALPSSCAPAGTQCLISGWGNTL 133
Query: 140 -------DVLSKTDR----------------SEMSIVSGFGVTFQRDKDGIVSWGIGCAL 176
D+L D ++ + GF + G + C
Sbjct: 134 SSGVNEPDLLQCLDAPLLPQADCEASYPGKITDNMVCVGFLEGGKDSCQGNSGGPVVCNG 193
Query: 177 GYPGIVSWGIGCAL-GYPGVYVRVDHYDPWIQSV 209
GIVSWG GCAL PGVY +V +Y WIQ
Sbjct: 194 ELQGIVSWGYGCALPDNPGVYTKVCNYVDWIQDT 227
>pdb|2ANY|A Chain A, Expression, Crystallization And The Three-Dimensional
Structure Of The Catalytic Domain Of Human Plasma
Kallikrein: Implications For Structure-Based Design Of
Protease Inhibitors
Length = 241
Score = 55.8 bits (133), Expect = 2e-08, Method: Compositional matrix adjust.
Identities = 63/237 (26%), Positives = 90/237 (37%), Gaps = 59/237 (24%)
Query: 30 GEVPYIVSLSLY---GNLYCGGSLISLQWFLSARHCFVTENL--VWNQFNPLIIAGSIYR 84
GE P+ VSL + CGGSLI QW L+A HCF L VW ++ ++ I +
Sbjct: 10 GEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILELSDITK 69
Query: 85 NYKEQKRQPQLNEIALIYWHS-------DADLAMVKLKEPFRQTTFVKPLDY-------- 129
+ ++I I H + D+A++KL+ P T F KP+
Sbjct: 70 DTP-------FSQIKEIIIHQNYKVSEGNHDIALIKLQAPLEYTEFQKPISLPSKGDTST 122
Query: 130 -YT---------ARETNYINDVLSK------TDRSEMSIVSGFGVTFQRDKDGIVSWGIG 173
YT ++E I ++L K T+ + +T + G G
Sbjct: 123 IYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKD 182
Query: 174 CALGYP---------------GIVSWGIGCA-LGYPGVYVRVDHYDPWIQSVKNNGD 214
G GI SWG GCA PGVY +V Y WI + D
Sbjct: 183 ACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSD 239
>pdb|1MCT|A Chain A, The Refined 1.6 Angstroms Resolution Crystal Structure Of
The Complex Formed Between Porcine Beta-trypsin And
Mcti-a, A Trypsin Inhibitor Of Squash Family
pdb|1QQU|A Chain A, Crystal Structure Of Porcine Beta Trypsin With Bound
Acetate Ion
pdb|1FMG|A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.04%
Polydocanol
pdb|1FN6|A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.1%
Polydocanol
pdb|1FNI|A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01%
Polydocanol
Length = 223
Score = 55.8 bits (133), Expect = 2e-08, Method: Compositional matrix adjust.
Identities = 61/217 (28%), Positives = 86/217 (39%), Gaps = 50/217 (23%)
Query: 31 EVPYIVSLSLYGNLYCGGSLISLQWFLSARHCFVTE-NLVWNQFNPLIIAGS-IYRNYKE 88
+PY VSL+ G+ +CGGSLI+ QW +SA HC+ + + + N ++ G+ + N +
Sbjct: 11 SIPYQVSLN-SGSHFCGGSLINSQWVVSAAHCYKSRIQVRLGEHNIDVLEGNEQFINAAK 69
Query: 89 QKRQPQLNEIALIYWHSDADLAMVKLKEPF----RQTTFVKPLDYYTARETNYIND---- 140
P N L D D+ ++KL P R T P A I+
Sbjct: 70 IITHPNFNGNTL-----DNDIMLIKLSSPATLNSRVATVSLPRSCAAAGTECLISGWGNT 124
Query: 141 -----------------VLSKTDRSE------------MSIVSGFGVTFQRDKDGIVSWG 171
VLS + + + G + Q D G V
Sbjct: 125 KSSGSSYPSLLQCLKAPVLSNSSCKSSYPGQITGNMICVGFLQGGKDSCQGDSGGPVV-- 182
Query: 172 IGCALGYPGIVSWGIGCAL-GYPGVYVRVDHYDPWIQ 207
C GIVSWG GCA PGVY +V +Y WIQ
Sbjct: 183 --CNGQLQGIVSWGYGCAQKNKPGVYTKVCNYVNWIQ 217
>pdb|2ZPQ|A Chain A, Crystal Structure Of Anionic Trypsin Isoform 1 From Chum
Salmon
pdb|2ZPQ|B Chain B, Crystal Structure Of Anionic Trypsin Isoform 1 From Chum
Salmon
Length = 222
Score = 55.5 bits (132), Expect = 2e-08, Method: Compositional matrix adjust.
Identities = 57/223 (25%), Positives = 91/223 (40%), Gaps = 63/223 (28%)
Query: 33 PYIVSLSLYGNLYCGGSLISLQWFLSARHCFVTE-NLVWNQFNPLIIAGS-IYRNYKEQK 90
P+ VSL+ G +CGGSL++ W +SA HC+ + + + N + GS + +
Sbjct: 13 PHQVSLN-SGYHFCGGSLVNENWVVSAAHCYKSRVEVRLGEHNIKVTEGSEQFISSSRVI 71
Query: 91 RQPQLNEIALIYWHSDADLAMVKLKEPFRQTTFVKPLDYYTARETNYINDVLSKTDRSEM 150
R P + ++ D D+ ++KL +P T+V+P+ + S M
Sbjct: 72 RHPNYSS-----YNIDNDIMLIKLSKPATLNTYVQPVALPS-----------SCAPAGTM 115
Query: 151 SIVSGFGVTFQRDKD----------------------GIVSWGIGCA------------- 175
VSG+G T D G+++ + CA
Sbjct: 116 CTVSGWGNTMSSTADKNKLQCLNIPILSYSDCNNSYPGMITNAMFCAGYLEGGKDSCQGD 175
Query: 176 LGYP--------GIVSWGIGCAL-GYPGVYVRVDHYDPWIQSV 209
G P G+VSWG GCA G PGVY +V ++ W+ S
Sbjct: 176 SGGPVVCNGELQGVVSWGYGCAEPGNPGVYAKVCIFNDWLTST 218
>pdb|2ANW|A Chain A, Expression, Crystallization And Three-Dimensional
Structure Of The Catalytic Domain Of Human Plasma
Kallikrein: Implications For Structure-Based Design Of
Protease Inhibitors
Length = 241
Score = 55.5 bits (132), Expect = 2e-08, Method: Compositional matrix adjust.
Identities = 63/237 (26%), Positives = 90/237 (37%), Gaps = 59/237 (24%)
Query: 30 GEVPYIVSLSLY---GNLYCGGSLISLQWFLSARHCFVTENL--VWNQFNPLIIAGSIYR 84
GE P+ VSL + CGGSLI QW L+A HCF L VW ++ ++
Sbjct: 10 GEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGIL------- 62
Query: 85 NYKEQKRQPQLNEIALIYWHS-------DADLAMVKLKEPFRQTTFVKPLDY-------- 129
N + + ++I I H + D+A++KL+ P T F KP+
Sbjct: 63 NLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPISLPSKGDTST 122
Query: 130 -YT---------ARETNYINDVLSK------TDRSEMSIVSGFGVTFQRDKDGIVSWGIG 173
YT ++E I ++L K T+ + +T + G G
Sbjct: 123 IYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKD 182
Query: 174 CALGYP---------------GIVSWGIGCA-LGYPGVYVRVDHYDPWIQSVKNNGD 214
G GI SWG GCA PGVY +V Y WI + D
Sbjct: 183 ACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSD 239
>pdb|1J15|A Chain A, Benzamidine In Complex With Rat Trypsin Mutant X99175190RT
pdb|1J16|A Chain A, Benzamidine In Complex With Rat Trypsin Mutant X99175190RT
pdb|1J17|T Chain T, Factor Xa Specific Inhibitor In Complex With Rat Trypsin
Mutant X99175190RT
Length = 223
Score = 55.5 bits (132), Expect = 3e-08, Method: Compositional matrix adjust.
Identities = 61/212 (28%), Positives = 90/212 (42%), Gaps = 42/212 (19%)
Query: 32 VPYIVSLSLYGNLYCGGSLISLQWFLSARHCFVTE-NLVWNQFNPLIIAGS-IYRNYKEQ 89
VPY VSL+ G +CGGSLI+ QW +SA HC+ + + + N ++ G+ + N +
Sbjct: 12 VPYQVSLN-SGYHFCGGSLINDQWVVSAAHCYKSRIQVRLGEHNINVLEGNEQFVNAAKI 70
Query: 90 KRQPQLNEIALIYWHSDADLAMVKLKEPF----RQTTFVKPLDYYTARETNYIN------ 139
+ P + + D+ ++KL P R T P A I+
Sbjct: 71 IKHPNFDRETY-----NNDIMLIKLSSPVKLNARVATVALPSSCAPAGTQCLISGWGNTL 125
Query: 140 -------DVLSKTD-----RSEMSIVSGFGVT--------FQRDKD---GIVSWGIGCAL 176
D+L D +++ S F +T + KD G + C
Sbjct: 126 SSGVNEPDLLQCLDAPLLPQADCEASSSFIITDNMVCVGFLEGGKDACQGDSGGPVVCNG 185
Query: 177 GYPGIVSWGIGCAL-GYPGVYVRVDHYDPWIQ 207
GIVSWG GCAL PGVY +V +Y WIQ
Sbjct: 186 ELQGIVSWGYGCALPDNPGVYTKVCNYVDWIQ 217
>pdb|1TFX|A Chain A, Complex Of The Second Kunitz Domain Of Tissue Factor
Pathway Inhibitor With Porcine Trypsin
pdb|1TFX|B Chain B, Complex Of The Second Kunitz Domain Of Tissue Factor
Pathway Inhibitor With Porcine Trypsin
pdb|1LDT|T Chain T, Complex Of Leech-Derived Tryptase Inhibitor With Porcine
Trypsin
pdb|1AVW|A Chain A, Complex Porcine Pancreatic TrypsinSOYBEAN TRYPSIN
Inhibitor, Orthorhombic Crystal Form
pdb|1AVX|A Chain A, Complex Porcine Pancreatic TrypsinSOYBEAN TRYPSIN
Inhibitor, Tetragonal Crystal Form
pdb|1EJA|A Chain A, Structure Of Porcine Trypsin Complexed With Bdellastasin,
An Antistasin-Type Inhibitor
pdb|1S5S|A Chain A, Porcine Trypsin Complexed With Guanidine-3-Propanol
Inhibitor
pdb|1S6F|A Chain A, Porcine Trypsin Covalent Complex With Borate And
Guanidine- 3 Inhibitor
pdb|1S6H|A Chain A, Porcine Trypsin Complexed With Guanidine-3-Propanol
Inhibitor
pdb|1S81|A Chain A, Porcine Trypsin With No Inhibitor Bound
pdb|1S82|A Chain A, Porcine Trypsin Complexed With Borate And Ethylene Glycol
pdb|1S83|A Chain A, Porcine Trypsin Complexed With 4-amino Propanol
pdb|1S84|A Chain A, Porcine Trypsin Covalent Complex With 4-Amino Butanol,
Borate And Ethylene Glycol
pdb|1S85|A Chain A, Porcine Trypsin Complexed With P-Hydroxymethyl Benzamidine
And Borate
pdb|1H9I|E Chain E, Complex Of Eeti-Ii Mutant With Porcine Trypsin
pdb|1V6D|A Chain A, The Crystal Structure Of The Trypsin Complex With
Synthetic Heterochiral Peptide
pdb|1TX6|A Chain A, Trypsin:bbi Complex
pdb|1TX6|B Chain B, Trypsin:bbi Complex
pdb|1TX6|C Chain C, Trypsin:bbi Complex
pdb|1TX6|D Chain D, Trypsin:bbi Complex
pdb|1Z7K|A Chain A, Crystal Structure Of Trypsin- Ovomucoid Turkey Egg White
Inhibitor Complex
pdb|1YF4|A Chain A, Crystal Structure Of Trypsin-Vasopressin Complex
Length = 223
Score = 55.5 bits (132), Expect = 3e-08, Method: Compositional matrix adjust.
Identities = 61/217 (28%), Positives = 86/217 (39%), Gaps = 50/217 (23%)
Query: 31 EVPYIVSLSLYGNLYCGGSLISLQWFLSARHCFVTE-NLVWNQFNPLIIAGS-IYRNYKE 88
+PY VSL+ G+ +CGGSLI+ QW +SA HC+ + + + N ++ G+ + N +
Sbjct: 11 SIPYQVSLN-SGSHFCGGSLINSQWVVSAAHCYKSRIQVRLGEHNIDVLEGNEQFINAAK 69
Query: 89 QKRQPQLNEIALIYWHSDADLAMVKLKEPF----RQTTFVKPLDYYTARETNYIND---- 140
P N L D D+ ++KL P R T P A I+
Sbjct: 70 IITHPNFNGNTL-----DNDIMLIKLSSPATLNSRVATVSLPRSCAAAGTECLISGWGNT 124
Query: 141 -----------------VLSKTDRSE------------MSIVSGFGVTFQRDKDGIVSWG 171
VLS + + + G + Q D G V
Sbjct: 125 KSSGSSYPSLLQCLKAPVLSDSSCKSSYPGQITGNMICVGFLEGGKDSCQGDSGGPVV-- 182
Query: 172 IGCALGYPGIVSWGIGCAL-GYPGVYVRVDHYDPWIQ 207
C GIVSWG GCA PGVY +V +Y WIQ
Sbjct: 183 --CNGQLQGIVSWGYGCAQKNKPGVYTKVCNYVNWIQ 217
>pdb|1CO7|E Chain E, R117h Mutant Rat Anionic Trypsin Complexed With Bovine
Pancreatic Trypsin Inhibitor (Bpti)
Length = 245
Score = 55.5 bits (132), Expect = 3e-08, Method: Compositional matrix adjust.
Identities = 62/216 (28%), Positives = 85/216 (39%), Gaps = 44/216 (20%)
Query: 31 EVPYIVSLSLYGNLYCGGSLISLQWFLSARHCFVT--------ENLVWNQFNPLIIAGSI 82
VPY VSL+ G +CGGSLI+ QW +SA HC+ + N+ + N + +
Sbjct: 33 SVPYQVSLN-SGYHFCGGSLINDQWVVSAAHCYKSRIQVRLGEHNINVLEGNEQFVNAAK 91
Query: 83 YRNYKEQKRQPQLNEIALIYWHS----DADLAMVKL------------------------ 114
+ R+ N+I LI S +A +A V L
Sbjct: 92 IIKHPNFDRKTLNNDIMLIKLSSPVKLNAHVATVALPSSCAPAGTQCLISGWGNTLSSGV 151
Query: 115 KEPFRQTTFVKPLDYYTARETNYINDVLSKTDRSEMSIVSGFGVTFQRDKDGIVSWGIGC 174
EP PL E +Y + + + + G + Q D G V C
Sbjct: 152 NEPDLLQCLDAPLLPQADCEASYPGKITD--NMVCVGFLEGGKDSCQGDSGGPVV----C 205
Query: 175 ALGYPGIVSWGIGCAL-GYPGVYVRVDHYDPWIQSV 209
GIVSWG GCAL PGVY +V +Y WIQ
Sbjct: 206 NGELQGIVSWGYGCALPDNPGVYTKVCNYVDWIQDT 241
>pdb|1AN1|E Chain E, Leech-Derived Tryptase InhibitorTRYPSIN COMPLEX
pdb|1C9P|A Chain A, Complex Of Bdellastasin With Porcine Trypsin
Length = 223
Score = 55.5 bits (132), Expect = 3e-08, Method: Compositional matrix adjust.
Identities = 61/217 (28%), Positives = 86/217 (39%), Gaps = 50/217 (23%)
Query: 31 EVPYIVSLSLYGNLYCGGSLISLQWFLSARHCFVTE-NLVWNQFNPLIIAGS-IYRNYKE 88
+PY VSL+ G+ +CGGSLI+ QW +SA HC+ + + + N ++ G+ + N +
Sbjct: 11 SIPYQVSLN-SGSHFCGGSLINSQWVVSAAHCYKSRIQVRLGEHNIDVLEGNEQFINAAK 69
Query: 89 QKRQPQLNEIALIYWHSDADLAMVKLKEPF----RQTTFVKPLDYYTARETNYIND---- 140
P N L D D+ ++KL P R T P A I+
Sbjct: 70 IITHPNFNGNTL-----DNDIMLIKLSSPATLXSRVATVSLPRSCAAAGTECLISGWGNT 124
Query: 141 -----------------VLSKTDRSE------------MSIVSGFGVTFQRDKDGIVSWG 171
VLS + + + G + Q D G V
Sbjct: 125 KSSGSSYPSLLQCLKAPVLSDSSCKSSYPGQITGNMICVGFLEGGKDSCQGDSGGPVV-- 182
Query: 172 IGCALGYPGIVSWGIGCAL-GYPGVYVRVDHYDPWIQ 207
C GIVSWG GCA PGVY +V +Y WIQ
Sbjct: 183 --CNGQLQGIVSWGYGCAQKNKPGVYTKVCNYVNWIQ 217
>pdb|1QL9|A Chain A, Factor Xa Specific Inhibitor In Complex With Rat Trypsin
Mutant X99rt
pdb|1J14|A Chain A, Benzamidine In Complex With Rat Trypsin Mutant X99rt
Length = 223
Score = 55.5 bits (132), Expect = 3e-08, Method: Compositional matrix adjust.
Identities = 62/215 (28%), Positives = 85/215 (39%), Gaps = 44/215 (20%)
Query: 32 VPYIVSLSLYGNLYCGGSLISLQWFLSARHCFVT--------ENLVWNQFNPLIIAGSIY 83
VPY VSL+ G +CGGSLI+ QW +SA HC+ + N+ + N + +
Sbjct: 12 VPYQVSLN-SGYHFCGGSLINDQWVVSAAHCYKSRIQVRLGEHNINVLEGNEQFVNAAKI 70
Query: 84 RNYKEQKRQPQLNEIALIYWHS----DADLAMVKL------------------------K 115
+ R+ N+I LI S +A +A V L
Sbjct: 71 IKHPNFDRETYNNDIMLIKLSSPVKLNARVATVALPSSCAPAGTQCLISGWGNTLSSGVN 130
Query: 116 EPFRQTTFVKPLDYYTARETNYINDVLSKTDRSEMSIVSGFGVTFQRDKDGIVSWGIGCA 175
EP PL E +Y + + + + G + Q D G V C
Sbjct: 131 EPDLLQCLDAPLLPQADCEASYPGKITD--NMVCVGFLEGGKDSCQGDSGGPVV----CN 184
Query: 176 LGYPGIVSWGIGCAL-GYPGVYVRVDHYDPWIQSV 209
GIVSWG GCAL PGVY +V +Y WIQ
Sbjct: 185 GELQGIVSWGYGCALPDNPGVYTKVCNYVDWIQDT 219
>pdb|2A31|A Chain A, Trypsin In Complex With Borate
pdb|2A32|A Chain A, Trypsin In Complex With Benzene Boronic Acid
Length = 223
Score = 55.1 bits (131), Expect = 3e-08, Method: Compositional matrix adjust.
Identities = 61/217 (28%), Positives = 86/217 (39%), Gaps = 50/217 (23%)
Query: 31 EVPYIVSLSLYGNLYCGGSLISLQWFLSARHCFVTE-NLVWNQFNPLIIAGS-IYRNYKE 88
+PY VSL+ G+ +CGGSLI+ QW +SA HC+ + + + N ++ G+ + N +
Sbjct: 11 SIPYQVSLN-SGSHFCGGSLINSQWVVSAAHCYKSRIQVRLGEHNIDVLEGNEQFINAAK 69
Query: 89 QKRQPQLNEIALIYWHSDADLAMVKLKEPF----RQTTFVKPLDYYTARETNYIND---- 140
P N L D D+ ++KL P R T P A I+
Sbjct: 70 IITHPNFNGNTL-----DNDIMLIKLSSPATLNSRVATVSLPRSCAAAGTECLISGWGNT 124
Query: 141 -----------------VLSKTDRSE------------MSIVSGFGVTFQRDKDGIVSWG 171
VLS + + + G + Q D G V
Sbjct: 125 KSSGSSYPSLLQCLKAPVLSDSSCKSSYPGQITGNMICVGFLEGGKDSCQGDSGGPVV-- 182
Query: 172 IGCALGYPGIVSWGIGCAL-GYPGVYVRVDHYDPWIQ 207
C GIVSWG GCA PGVY +V +Y WIQ
Sbjct: 183 --CNGQLQGIVSWGYGCAQKNKPGVYTKVCNYVNWIQ 217
>pdb|1BIT|A Chain A, The Crystal Structure Of Anionic Salmon Trypsin In A
Second Crystal Form
Length = 237
Score = 55.1 bits (131), Expect = 3e-08, Method: Compositional matrix adjust.
Identities = 54/214 (25%), Positives = 85/214 (39%), Gaps = 62/214 (28%)
Query: 42 GNLYCGGSLISLQWFLSARHCFVTE-NLVWNQFNPLIIAGS-IYRNYKEQKRQPQLNEIA 99
G +CGGSL++ W +SA HC+ + + + N + GS + + R P +
Sbjct: 36 GYHFCGGSLVNENWVVSAAHCYKSRVEVRLGEHNIKVTEGSEQFISSSRVIRHPNYSS-- 93
Query: 100 LIYWHSDADLAMVKLKEPFRQTTFVKPLDYYTARETNYINDVLSKTDRSEMSIVSGFGVT 159
++ D D+ ++KL +P T+V+P+ T S M VSG+G T
Sbjct: 94 ---YNIDNDIMLIKLSKPATLNTYVQPVALPT-----------SCAPAGTMCTVSGWGNT 139
Query: 160 FQRDKD----------------------GIVSWGIGCA-------------LGYP----- 179
D G+++ + CA G P
Sbjct: 140 MSSTADSNKLQCLNIPILSYSDCNNSYPGMITNAMFCAGYLEGGKDSCQGDSGGPVVCNG 199
Query: 180 ---GIVSWGIGCAL-GYPGVYVRVDHYDPWIQSV 209
G+VSWG GCA G PGVY +V ++ W+ S
Sbjct: 200 ELQGVVSWGYGCAEPGNPGVYAKVCIFNDWLTST 233
>pdb|1QRZ|A Chain A, Catalytic Domain Of Plasminogen
pdb|1QRZ|B Chain B, Catalytic Domain Of Plasminogen
pdb|1QRZ|C Chain C, Catalytic Domain Of Plasminogen
pdb|1QRZ|D Chain D, Catalytic Domain Of Plasminogen
Length = 246
Score = 55.1 bits (131), Expect = 3e-08, Method: Compositional matrix adjust.
Identities = 60/242 (24%), Positives = 91/242 (37%), Gaps = 77/242 (31%)
Query: 28 NPGEVPYIVSL-SLYGNLYCGGSLISLQWFLSARHCFVTENLVWNQFNPLIIAGSIYRNY 86
+P P+ VSL + +G +CGG+LIS +W L+A HC + +I G+ +
Sbjct: 24 HPHSWPWQVSLRTRFGQHFCGGTLISPEWVLTAAHCLEKSP---RPSSYKVILGA----H 76
Query: 87 KEQKRQPQLNEIA---LIYWHSDADLAMVKLKEPFRQTTFVKPL-----DYYTARETN-- 136
+E +P + EI L + D+A++KL P T V P +Y A T
Sbjct: 77 QEVNLEPHVQEIEVSRLFLEPTRKDIALLKLSSPAVITDKVIPACLPSPNYMVADRTECF 136
Query: 137 ---------------------------------YINDVLSKTDRSEMSIVSGFG------ 157
++N + T+ + G
Sbjct: 137 ITGWGETQGTFGAGLLKEAQLPVIENKVCNRYEFLNGRVQSTELCAGHLAGGTDSCQGDS 196
Query: 158 ----VTFQRDK---DGIVSWGIGCALGYPGIVSWGIGCALGYPGVYVRVDHYDPWIQSVK 210
V F++DK G+ SWG+GCA PGVYVRV + WI+ V
Sbjct: 197 GGPLVCFEKDKYILQGVTSWGLGCA-------------RPNKPGVYVRVSRFVTWIEGVL 243
Query: 211 NN 212
N
Sbjct: 244 RN 245
>pdb|4AN7|A Chain A, Kunitz Type Trypsin Inhibitor Complex With Porcine Trypsin
Length = 231
Score = 55.1 bits (131), Expect = 4e-08, Method: Compositional matrix adjust.
Identities = 61/217 (28%), Positives = 86/217 (39%), Gaps = 50/217 (23%)
Query: 31 EVPYIVSLSLYGNLYCGGSLISLQWFLSARHCFVTE-NLVWNQFNPLIIAGS-IYRNYKE 88
+PY VSL+ G+ +CGGSLI+ QW +SA HC+ + + + N ++ G+ + N +
Sbjct: 19 SIPYQVSLN-SGSHFCGGSLINSQWVVSAAHCYKSRIQVRLGEHNIDVLEGNEQFINAAK 77
Query: 89 QKRQPQLNEIALIYWHSDADLAMVKLKEPF----RQTTFVKPLDYYTARETNYIND---- 140
P N L D D+ ++KL P R T P A I+
Sbjct: 78 IITHPNFNGNTL-----DNDIMLIKLSSPATLNSRVATVSLPRSCAAAGTECLISGWGNT 132
Query: 141 -----------------VLSKTDRSE------------MSIVSGFGVTFQRDKDGIVSWG 171
VLS + + + G + Q D G V
Sbjct: 133 KSSGSSYPSLLQCLKAPVLSDSSCKSSYPGQITGNMICVGFLEGGKDSCQGDSGGPVV-- 190
Query: 172 IGCALGYPGIVSWGIGCAL-GYPGVYVRVDHYDPWIQ 207
C GIVSWG GCA PGVY +V +Y WIQ
Sbjct: 191 --CNGQLQGIVSWGYGCAQKNKPGVYTKVCNYVNWIQ 225
>pdb|1BML|A Chain A, Complex Of The Catalytic Domain Of Human Plasmin And
Streptokinase
pdb|1BML|B Chain B, Complex Of The Catalytic Domain Of Human Plasmin And
Streptokinase
Length = 250
Score = 54.7 bits (130), Expect = 5e-08, Method: Compositional matrix adjust.
Identities = 60/242 (24%), Positives = 91/242 (37%), Gaps = 77/242 (31%)
Query: 28 NPGEVPYIVSL-SLYGNLYCGGSLISLQWFLSARHCFVTENLVWNQFNPLIIAGSIYRNY 86
+P P+ VSL + +G +CGG+LIS +W L+A HC + +I G+ +
Sbjct: 28 HPHSWPWQVSLRTRFGMHFCGGTLISPEWVLTAAHCLEKSP---RPSSYKVILGA----H 80
Query: 87 KEQKRQPQLNEIA---LIYWHSDADLAMVKLKEPFRQTTFVKPL-----DYYTARETN-- 136
+E +P + EI L + D+A++KL P T V P +Y A T
Sbjct: 81 QEVNLEPHVQEIEVSRLFLEPTRKDIALLKLSSPAVITDKVIPACLPSPNYVVADRTECF 140
Query: 137 ---------------------------------YINDVLSKTDRSEMSIVSGFG------ 157
++N + T+ + G
Sbjct: 141 ITGWGETQGTFGAGLLKEAQLPVIENKVCNRYEFLNGRVQSTELCAGHLAGGTDSCQGDA 200
Query: 158 ----VTFQRDK---DGIVSWGIGCALGYPGIVSWGIGCALGYPGVYVRVDHYDPWIQSVK 210
V F++DK G+ SWG+GCA PGVYVRV + WI+ V
Sbjct: 201 GGPLVCFEKDKYILQGVTSWGLGCA-------------RPNKPGVYVRVSRFVTWIEGVM 247
Query: 211 NN 212
N
Sbjct: 248 RN 249
>pdb|1ANB|A Chain A, Anionic Trypsin Mutant With Ser 214 Replaced By Glu
Length = 223
Score = 54.7 bits (130), Expect = 5e-08, Method: Compositional matrix adjust.
Identities = 58/214 (27%), Positives = 86/214 (40%), Gaps = 42/214 (19%)
Query: 32 VPYIVSLSLYGNLYCGGSLISLQWFLSARHCFVTE-NLVWNQFNPLIIAGS-IYRNYKEQ 89
VPY VSL+ G +CGGSLI+ QW +SA HC+ + + + N ++ G+ + N +
Sbjct: 12 VPYQVSLN-SGYHFCGGSLINDQWVVSAAHCYKSRIQVRLGEHNINVLEGNEQFVNAAKI 70
Query: 90 KRQPQLNEIALIYWHSDADLAMVKLKEPF----RQTTFVKPLDYYTARETNYIN------ 139
+ P + L + D+ ++KL P R T P A I+
Sbjct: 71 IKHPNFDRKTL-----NNDIMLIKLSSPVKLNARVATVALPSSCAPAGTQCLISGWGNTL 125
Query: 140 -------DVLSKTDR----------------SEMSIVSGFGVTFQRDKDGIVSWGIGCAL 176
D+L D ++ + GF + G + C
Sbjct: 126 SSGVNEPDLLQCLDAPLLPQADCEASYPGKITDNMVCVGFLEGGKDSCQGDSGGPVVCNG 185
Query: 177 GYPGIVSWGIGCAL-GYPGVYVRVDHYDPWIQSV 209
GIV WG GCAL PGVY +V +Y WIQ
Sbjct: 186 ELQGIVEWGYGCALPDNPGVYTKVCNYVDWIQDT 219
>pdb|1ANC|A Chain A, Anionic Trypsin Mutant With Ser 214 Replaced By Lys
Length = 223
Score = 54.7 bits (130), Expect = 5e-08, Method: Compositional matrix adjust.
Identities = 58/214 (27%), Positives = 86/214 (40%), Gaps = 42/214 (19%)
Query: 32 VPYIVSLSLYGNLYCGGSLISLQWFLSARHCFVTE-NLVWNQFNPLIIAGS-IYRNYKEQ 89
VPY VSL+ G +CGGSLI+ QW +SA HC+ + + + N ++ G+ + N +
Sbjct: 12 VPYQVSLN-SGYHFCGGSLINDQWVVSAAHCYKSRIQVRLGEHNINVLEGNEQFVNAAKI 70
Query: 90 KRQPQLNEIALIYWHSDADLAMVKLKEPF----RQTTFVKPLDYYTARETNYIN------ 139
+ P + L + D+ ++KL P R T P A I+
Sbjct: 71 IKHPNFDRKTL-----NNDIMLIKLSSPVKLNARVATVALPSSCAPAGTQCLISGWGNTL 125
Query: 140 -------DVLSKTDR----------------SEMSIVSGFGVTFQRDKDGIVSWGIGCAL 176
D+L D ++ + GF + G + C
Sbjct: 126 SSGVNEPDLLQCLDAPLLPQADCEASYPGKITDNMVCVGFLEGGKDSCQGDSGGPVVCNG 185
Query: 177 GYPGIVSWGIGCAL-GYPGVYVRVDHYDPWIQSV 209
GIV WG GCAL PGVY +V +Y WIQ
Sbjct: 186 ELQGIVKWGYGCALPDNPGVYTKVCNYVDWIQDT 219
>pdb|1L4D|A Chain A, Crystal Structure Of Microplasminogen-streptokinase Alpha
Domain Complex
Length = 249
Score = 54.7 bits (130), Expect = 5e-08, Method: Compositional matrix adjust.
Identities = 60/242 (24%), Positives = 91/242 (37%), Gaps = 77/242 (31%)
Query: 28 NPGEVPYIVSL-SLYGNLYCGGSLISLQWFLSARHCFVTENLVWNQFNPLIIAGSIYRNY 86
+P P+ VSL + +G +CGG+LIS +W L+A HC + +I G+ +
Sbjct: 27 HPHSWPWQVSLRTRFGMHFCGGTLISPEWVLTAAHCLEKSP---RPSSYKVILGA----H 79
Query: 87 KEQKRQPQLNEIA---LIYWHSDADLAMVKLKEPFRQTTFVKPL-----DYYTARETN-- 136
+E +P + EI L + D+A++KL P T V P +Y A T
Sbjct: 80 QEVNLEPHVQEIEVSRLFLEPTRKDIALLKLSSPAVITDKVIPACLPSPNYVVADRTECF 139
Query: 137 ---------------------------------YINDVLSKTDRSEMSIVSGFG------ 157
++N + T+ + G
Sbjct: 140 ITGWGETQGTFGAGLLKEAQLPVIENKVCNRYEFLNGRVQSTELCAGHLAGGTDSCQGDA 199
Query: 158 ----VTFQRDK---DGIVSWGIGCALGYPGIVSWGIGCALGYPGVYVRVDHYDPWIQSVK 210
V F++DK G+ SWG+GCA PGVYVRV + WI+ V
Sbjct: 200 GGPLVCFEKDKYILQGVTSWGLGCA-------------RPNKPGVYVRVSRFVTWIEGVM 246
Query: 211 NN 212
N
Sbjct: 247 RN 248
>pdb|1BUI|A Chain A, Structure Of The Ternary
Microplasmin-Staphylokinase-Microplasmin Complex: A
Proteinase-Cofactor-Substrate Complex In Action
pdb|1BUI|B Chain B, Structure Of The Ternary
Microplasmin-Staphylokinase-Microplasmin Complex: A
Proteinase-Cofactor-Substrate Complex In Action
Length = 250
Score = 54.7 bits (130), Expect = 5e-08, Method: Compositional matrix adjust.
Identities = 60/242 (24%), Positives = 91/242 (37%), Gaps = 77/242 (31%)
Query: 28 NPGEVPYIVSL-SLYGNLYCGGSLISLQWFLSARHCFVTENLVWNQFNPLIIAGSIYRNY 86
+P P+ VSL + +G +CGG+LIS +W L+A HC + +I G+ +
Sbjct: 28 HPHSWPWQVSLRTRFGMHFCGGTLISPEWVLTAAHCLEKSP---RPSSYKVILGA----H 80
Query: 87 KEQKRQPQLNEIA---LIYWHSDADLAMVKLKEPFRQTTFVKPL-----DYYTARETN-- 136
+E +P + EI L + D+A++KL P T V P +Y A T
Sbjct: 81 QEVNLEPHVQEIEVSRLFLEPTRKDIALLKLSSPAVITDKVIPACLPSPNYVVADRTECF 140
Query: 137 ---------------------------------YINDVLSKTDRSEMSIVSGFG------ 157
++N + T+ + G
Sbjct: 141 ITGWGETQGTFGAGLLKEAQLPVIENKVCNRYEFLNGRVQSTELCAGHLAGGTDSCQGDS 200
Query: 158 ----VTFQRDK---DGIVSWGIGCALGYPGIVSWGIGCALGYPGVYVRVDHYDPWIQSVK 210
V F++DK G+ SWG+GCA PGVYVRV + WI+ V
Sbjct: 201 GGPLVCFEKDKYILQGVTSWGLGCA-------------RPNKPGVYVRVSRFVTWIEGVM 247
Query: 211 NN 212
N
Sbjct: 248 RN 249
>pdb|1DDJ|A Chain A, Crystal Structure Of Human Plasminogen Catalytic Domain
pdb|1DDJ|B Chain B, Crystal Structure Of Human Plasminogen Catalytic Domain
pdb|1DDJ|C Chain C, Crystal Structure Of Human Plasminogen Catalytic Domain
pdb|1DDJ|D Chain D, Crystal Structure Of Human Plasminogen Catalytic Domain
Length = 247
Score = 54.7 bits (130), Expect = 5e-08, Method: Compositional matrix adjust.
Identities = 60/242 (24%), Positives = 91/242 (37%), Gaps = 77/242 (31%)
Query: 28 NPGEVPYIVSL-SLYGNLYCGGSLISLQWFLSARHCFVTENLVWNQFNPLIIAGSIYRNY 86
+P P+ VSL + +G +CGG+LIS +W L+A HC + +I G+ +
Sbjct: 25 HPHSWPWQVSLRTRFGMHFCGGTLISPEWVLTAAHCLEKSP---RPSSYKVILGA----H 77
Query: 87 KEQKRQPQLNEIA---LIYWHSDADLAMVKLKEPFRQTTFVKPL-----DYYTARETN-- 136
+E +P + EI L + D+A++KL P T V P +Y A T
Sbjct: 78 QEVNLEPHVQEIEVSRLFLEPTRKDIALLKLSSPAVITDKVIPACLPSPNYVVADRTECF 137
Query: 137 ---------------------------------YINDVLSKTDRSEMSIVSGFG------ 157
++N + T+ + G
Sbjct: 138 ITGWGETQGTFGAGLLKEAQLPVIENKVCNRYEFLNGRVQSTELCAGHLAGGTDSCQGDA 197
Query: 158 ----VTFQRDK---DGIVSWGIGCALGYPGIVSWGIGCALGYPGVYVRVDHYDPWIQSVK 210
V F++DK G+ SWG+GCA PGVYVRV + WI+ V
Sbjct: 198 GGPLVCFEKDKYILQGVTSWGLGCA-------------RPNKPGVYVRVSRFVTWIEGVM 244
Query: 211 NN 212
N
Sbjct: 245 RN 246
>pdb|2TBS|A Chain A, Cold-Adaption Of Enzymes: Structural Comparison Between
Salmon And Bovine Trypsins
Length = 222
Score = 54.7 bits (130), Expect = 5e-08, Method: Compositional matrix adjust.
Identities = 50/203 (24%), Positives = 90/203 (44%), Gaps = 40/203 (19%)
Query: 42 GNLYCGGSLISLQWFLSARHCFVTE-NLVWNQFNPLIIAGS-IYRNYKEQKRQPQLNEIA 99
G +CGGSL++ W +SA HC+ + + + N + GS + + R P +
Sbjct: 21 GYHFCGGSLVNENWVVSAAHCYKSRVEVRLGEHNIKVTEGSEQFISSSRVIRHPNYSS-- 78
Query: 100 LIYWHSDADLAMVKLKEPFRQTTFVKPLDYYTARE--------TNYINDVLSKTDRSEMS 151
++ D D+ ++KL +P T+V+P+ T+ + + N + S D ++
Sbjct: 79 ---YNIDNDIMLIKLSKPATLNTYVQPVALPTSCAPAGTMCTVSGWGNTMSSTADSDKLQ 135
Query: 152 IVSGFGVTFQRDKD---GIVSWGIGCA-------------LGYP--------GIVSWGIG 187
++ +++ D G+++ + CA G P G+VSWG G
Sbjct: 136 CLNIPILSYSDCNDSYPGMITNAMFCAGYLEGGKDSCQGDSGGPVVCNGELQGVVSWGYG 195
Query: 188 CAL-GYPGVYVRVDHYDPWIQSV 209
CA G PGVY +V + W+ S
Sbjct: 196 CAEPGNPGVYAKVCIFSDWLTST 218
>pdb|3UIR|A Chain A, Crystal Structure Of The Plasmin-Textilinin-1 Complex
pdb|3UIR|B Chain B, Crystal Structure Of The Plasmin-Textilinin-1 Complex
Length = 247
Score = 54.7 bits (130), Expect = 5e-08, Method: Compositional matrix adjust.
Identities = 60/242 (24%), Positives = 91/242 (37%), Gaps = 77/242 (31%)
Query: 28 NPGEVPYIVSL-SLYGNLYCGGSLISLQWFLSARHCFVTENLVWNQFNPLIIAGSIYRNY 86
+P P+ VSL + +G +CGG+LIS +W L+A HC + +I G+ +
Sbjct: 25 HPHSWPWQVSLRTRFGMHFCGGTLISPEWVLTAAHCLEKSP---RPSSYKVILGA----H 77
Query: 87 KEQKRQPQLNEIA---LIYWHSDADLAMVKLKEPFRQTTFVKPL-----DYYTARETN-- 136
+E +P + EI L + D+A++KL P T V P +Y A T
Sbjct: 78 QEVNLEPHVQEIEVSRLFLEPTRKDIALLKLSSPAVITDKVIPACLPSPNYVVADRTECF 137
Query: 137 ---------------------------------YINDVLSKTDRSEMSIVSGFG------ 157
++N + T+ + G
Sbjct: 138 ITGWGETQGTFGAGLLKEAQLPVIENKVCNRYEFLNGRVQSTELCAGHLAGGTDSCQGDS 197
Query: 158 ----VTFQRDK---DGIVSWGIGCALGYPGIVSWGIGCALGYPGVYVRVDHYDPWIQSVK 210
V F++DK G+ SWG+GCA PGVYVRV + WI+ V
Sbjct: 198 GGPLVCFEKDKYILQGVTSWGLGCA-------------RPNKPGVYVRVSRFVTWIEGVM 244
Query: 211 NN 212
N
Sbjct: 245 RN 246
>pdb|1L4Z|A Chain A, X-Ray Crystal Structure Of The Complex Of Microplasminogen
With Alpha Domain Of Streptokinase In The Presence
Cadmium Ions
Length = 248
Score = 54.7 bits (130), Expect = 5e-08, Method: Compositional matrix adjust.
Identities = 60/242 (24%), Positives = 91/242 (37%), Gaps = 77/242 (31%)
Query: 28 NPGEVPYIVSL-SLYGNLYCGGSLISLQWFLSARHCFVTENLVWNQFNPLIIAGSIYRNY 86
+P P+ VSL + +G +CGG+LIS +W L+A HC + +I G+ +
Sbjct: 26 HPHSWPWQVSLRTRFGMHFCGGTLISPEWVLTAAHCLEKSP---RPSSYKVILGA----H 78
Query: 87 KEQKRQPQLNEIA---LIYWHSDADLAMVKLKEPFRQTTFVKPL-----DYYTARETN-- 136
+E +P + EI L + D+A++KL P T V P +Y A T
Sbjct: 79 QEVNLEPHVQEIEVSRLFLEPTRKDIALLKLSSPAVITDKVIPACLPSPNYVVADRTECF 138
Query: 137 ---------------------------------YINDVLSKTDRSEMSIVSGFG------ 157
++N + T+ + G
Sbjct: 139 ITGWGETQGTFGAGLLKEAQLPVIENKVCNRYEFLNGRVQSTELCAGHLAGGTDSCQGDA 198
Query: 158 ----VTFQRDK---DGIVSWGIGCALGYPGIVSWGIGCALGYPGVYVRVDHYDPWIQSVK 210
V F++DK G+ SWG+GCA PGVYVRV + WI+ V
Sbjct: 199 GGPLVCFEKDKYILQGVTSWGLGCA-------------RPNKPGVYVRVSRFVTWIEGVM 245
Query: 211 NN 212
N
Sbjct: 246 RN 247
>pdb|1TRM|A Chain A, The Three-Dimensional Structure Of Asn102 Mutant Of
Trypsin. Role Of Asp102 In Serine Protease Catalysis
pdb|1TRM|B Chain B, The Three-Dimensional Structure Of Asn102 Mutant Of
Trypsin. Role Of Asp102 In Serine Protease Catalysis
pdb|2TRM|A Chain A, The Three-Dimensional Structure Of Asn102 Mutant Of
Trypsin. Role Of Asp102 In Serine Protease Catalysis
Length = 223
Score = 54.3 bits (129), Expect = 5e-08, Method: Compositional matrix adjust.
Identities = 62/214 (28%), Positives = 84/214 (39%), Gaps = 44/214 (20%)
Query: 31 EVPYIVSLSLYGNLYCGGSLISLQWFLSARHCFVT--------ENLVWNQFNPLIIAGSI 82
VPY VSL+ G +CGGSLI+ QW +SA HC+ + N+ + N + +
Sbjct: 11 SVPYQVSLN-SGYHFCGGSLINDQWVVSAAHCYKSRIQVRLGEHNINVLEGNEQFVNAAK 69
Query: 83 YRNYKEQKRQPQLNEIALIYWHS----DADLAMVKL------------------------ 114
+ R+ N I LI S +A +A V L
Sbjct: 70 IIKHPNFDRKTLNNNIMLIKLSSPVKLNARVATVALPSSCAPAGTQCLISGWGNTLSSGV 129
Query: 115 KEPFRQTTFVKPLDYYTARETNYINDVLSKTDRSEMSIVSGFGVTFQRDKDGIVSWGIGC 174
EP PL E +Y + + + + G + Q D G V C
Sbjct: 130 NEPDLLQCLDAPLLPQADCEASYPGKITD--NMVCVGFLEGGKDSCQGDSGGPVV----C 183
Query: 175 ALGYPGIVSWGIGCAL-GYPGVYVRVDHYDPWIQ 207
GIVSWG GCAL PGVY +V +Y WIQ
Sbjct: 184 NGELQGIVSWGYGCALPDNPGVYTKVCNYVDWIQ 217
>pdb|4DUR|A Chain A, The X-Ray Crystal Structure Of Full-Length Type Ii Human
Plasminogen
pdb|4DUR|B Chain B, The X-Ray Crystal Structure Of Full-Length Type Ii Human
Plasminogen
pdb|4DUU|A Chain A, The X-Ray Crystal Structure Of Full-Length Type I Human
Plasminogen
pdb|4A5T|S Chain S, Structural Basis For The Conformational Modulation
Length = 791
Score = 54.3 bits (129), Expect = 5e-08, Method: Composition-based stats.
Identities = 60/242 (24%), Positives = 91/242 (37%), Gaps = 77/242 (31%)
Query: 28 NPGEVPYIVSL-SLYGNLYCGGSLISLQWFLSARHCFVTENLVWNQFNPLIIAGSIYRNY 86
+P P+ VSL + +G +CGG+LIS +W L+A HC + +I G+ +
Sbjct: 569 HPHSWPWQVSLRTRFGMHFCGGTLISPEWVLTAAHCLEKSP---RPSSYKVILGA----H 621
Query: 87 KEQKRQPQLNEIA---LIYWHSDADLAMVKLKEPFRQTTFVKPL-----DYYTARET--- 135
+E +P + EI L + D+A++KL P T V P +Y A T
Sbjct: 622 QEVNLEPHVQEIEVSRLFLEPTRKDIALLKLSSPAVITDKVIPACLPSPNYVVADRTECF 681
Query: 136 --------------------------------NYINDVLSKTDRSEMSIVSGFG------ 157
++N + T+ + G
Sbjct: 682 ITGWGETQGTFGAGLLKEAQLPVIENKVCNRYEFLNGRVQSTELCAGHLAGGTDSCQGDS 741
Query: 158 ----VTFQRDK---DGIVSWGIGCALGYPGIVSWGIGCALGYPGVYVRVDHYDPWIQSVK 210
V F++DK G+ SWG+GCA PGVYVRV + WI+ V
Sbjct: 742 GGPLVCFEKDKYILQGVTSWGLGCA-------------RPNKPGVYVRVSRFVTWIEGVM 788
Query: 211 NN 212
N
Sbjct: 789 RN 790
>pdb|1RJX|B Chain B, Human Plasminogen Catalytic Domain, K698m Mutant
Length = 247
Score = 54.3 bits (129), Expect = 6e-08, Method: Compositional matrix adjust.
Identities = 60/241 (24%), Positives = 90/241 (37%), Gaps = 77/241 (31%)
Query: 29 PGEVPYIVSL-SLYGNLYCGGSLISLQWFLSARHCFVTENLVWNQFNPLIIAGSIYRNYK 87
P P+ VSL + +G +CGG+LIS +W L+A HC + +I G+ ++
Sbjct: 26 PHSWPWQVSLRTRFGMHFCGGTLISPEWVLTAAHCLEKSP---RPSSYKVILGA----HQ 78
Query: 88 EQKRQPQLNEIA---LIYWHSDADLAMVKLKEPFRQTTFVKPL-----DYYTARETN--- 136
E +P + EI L + D+A++KL P T V P +Y A T
Sbjct: 79 EVNLEPHVQEIEVSRLFLEPTRKDIALLKLSSPAVITDKVIPACLPSPNYVVADRTECFI 138
Query: 137 --------------------------------YINDVLSKTDRSEMSIVSGFG------- 157
++N + T+ + G
Sbjct: 139 TGWGETQGTFGAGLLMEAQLPVIENKVCNRYEFLNGRVQSTELCAGHLAGGTDSCQGDSG 198
Query: 158 ---VTFQRDK---DGIVSWGIGCALGYPGIVSWGIGCALGYPGVYVRVDHYDPWIQSVKN 211
V F++DK G+ SWG+GCA PGVYVRV + WI+ V
Sbjct: 199 GPLVCFEKDKYILQGVTSWGLGCA-------------RPNKPGVYVRVSRFVTWIEGVMR 245
Query: 212 N 212
N
Sbjct: 246 N 246
>pdb|3QK1|A Chain A, Crystal Structure Of Enterokinase-Like Trypsin Variant
Length = 229
Score = 54.3 bits (129), Expect = 6e-08, Method: Compositional matrix adjust.
Identities = 66/221 (29%), Positives = 97/221 (43%), Gaps = 49/221 (22%)
Query: 32 VPYIVSLSLYGNLYCGGSLISLQWFLSARHCFVT--------ENLVWNQFNPLIIAGS-- 81
VPY VSL+ G +CGGSLI+ QW +SA HC+ + +N+ + N I+ S
Sbjct: 12 VPYQVSLN-SGYHFCGGSLINSQWVVSAAHCYKSGIQVRLGEDNINVVEGNEQFISASKS 70
Query: 82 -IYRNYKEQKRQPQLNEIALIYWHSDADL----AMVKLKEPFRQT---TFVKPLDYYTAR 133
++ +Y ++++ N+I LI S A L A + L + +
Sbjct: 71 IVHPSYNKRRKN---NDIMLIKLKSAASLNSRVASISLPTSCASAGTQCLISGWGNTKSS 127
Query: 134 ETNYINDVLSK------TDRSEMSI--------------VSGFGVTFQRDKDGIVSWGIG 173
T+Y DVL +D S S + G + Q D G V
Sbjct: 128 GTSYP-DVLKCLKAPILSDSSCKSAYPGQITSNMFCAGYLEGGKDSCQGDSGGPVV---- 182
Query: 174 CALGYPGIVSWGIGCAL-GYPGVYVRVDHYDPWI-QSVKNN 212
C+ GIVSWG GCA PGVY +V +Y WI Q++ +N
Sbjct: 183 CSGKLQGIVSWGSGCAQKNKPGVYTKVCNYVSWIKQTIASN 223
>pdb|1HJ9|A Chain A, Atomic Resolution Structures Of Trypsin Provide Insight
Into Structural Radiation Damage
Length = 223
Score = 53.9 bits (128), Expect = 7e-08, Method: Compositional matrix adjust.
Identities = 66/218 (30%), Positives = 91/218 (41%), Gaps = 43/218 (19%)
Query: 32 VPYIVSLSLYGNLYCGGSLISLQWFLSARHCFVT--------ENLVWNQFNPLIIAGSIY 83
VPY VSL+ G +CGGSLI+ QW +SA HC+ + +N+ + N I+ S
Sbjct: 12 VPYQVSLN-SGYHFCGGSLINSQWVVSAAHCYKSGIQVRLGEDNINVVEGNEQFISASKS 70
Query: 84 RNYKEQKRQPQLNEIALIYWHSDADL----AMVKLKEPFRQT---TFVKPLDYYTARETN 136
+ N+I LI S A L A + L + + T+
Sbjct: 71 IVHPSYNSNTLNNDIMLIKLKSAASLNSRVASISLPTSCASAGTQCLISGWGNTKSSGTS 130
Query: 137 YINDVLSK------TDRSEMSI--------------VSGFGVTFQRDKDGIVSWGIGCAL 176
Y DVL +D S S + G G + Q D G V C+
Sbjct: 131 YP-DVLKCLKAPILSDSSCKSAYPGQITSNMFCAYGLEGKGDSCQGDSGGPVV----CSG 185
Query: 177 GYPGIVSWGIGC-ALGYPGVYVRVDHYDPWI-QSVKNN 212
GIVSWG GC A PGVY +V +Y WI Q++ +N
Sbjct: 186 KLQGIVSWGSGCQAKNKPGVYTKVCNYVSWIKQTIASN 223
>pdb|1EZS|C Chain C, Crystal Structure Of Ecotin Mutant M84r, W67a, G68a, Y69a,
D70a Bound To Rat Anionic Trypsin Ii
pdb|1EZS|D Chain D, Crystal Structure Of Ecotin Mutant M84r, W67a, G68a, Y69a,
D70a Bound To Rat Anionic Trypsin Ii
pdb|1EZU|C Chain C, Ecotin Y69f, D70p Bound To D102n Trypsin
pdb|1EZU|D Chain D, Ecotin Y69f, D70p Bound To D102n Trypsin
Length = 223
Score = 53.9 bits (128), Expect = 7e-08, Method: Compositional matrix adjust.
Identities = 63/215 (29%), Positives = 86/215 (40%), Gaps = 44/215 (20%)
Query: 32 VPYIVSLSLYGNLYCGGSLISLQWFLSARHCFVTE-NLVWNQFNPLIIAG-SIYRNYKEQ 89
VPY VSL+ G +CGGSLI+ QW +SA HC+ + + + N ++ G + N +
Sbjct: 12 VPYQVSLN-SGYHFCGGSLINDQWVVSAAHCYKSRIQVRLGEHNINVLEGDEQFVNAAKI 70
Query: 90 KRQPQL------NEIALIYWHS----DADLAMVKL------------------------K 115
+ P N I LI S +A +A V L
Sbjct: 71 IKHPNFDRKTLNNNIMLIKLSSPVKLNARVATVALPSSCAPAGTQCLISGWGNTLSSGVN 130
Query: 116 EPFRQTTFVKPLDYYTARETNYINDVLSKTDRSEMSIVSGFGVTFQRDKDGIVSWGIGCA 175
EP PL E +Y + + + + G + Q D G V C
Sbjct: 131 EPDLLQCLDAPLLPQADCEASYPGKITD--NMVCVGFLEGGKDSCQGDSGGPVV----CN 184
Query: 176 LGYPGIVSWGIGCAL-GYPGVYVRVDHYDPWIQSV 209
GIVSWG GCAL PGVY +V +Y WIQ
Sbjct: 185 GELQGIVSWGYGCALPDNPGVYTKVCNYVDWIQDT 219
>pdb|4DGJ|A Chain A, Structure Of A Human Enteropeptidase Light Chain Variant
pdb|4DGJ|B Chain B, Structure Of A Human Enteropeptidase Light Chain Variant
pdb|4DGJ|C Chain C, Structure Of A Human Enteropeptidase Light Chain Variant
pdb|4DGJ|D Chain D, Structure Of A Human Enteropeptidase Light Chain Variant
Length = 235
Score = 53.5 bits (127), Expect = 1e-07, Method: Compositional matrix adjust.
Identities = 57/224 (25%), Positives = 89/224 (39%), Gaps = 46/224 (20%)
Query: 30 GEVPYIVSLSLYGNLYCGGSLISLQWFLSARHCFVTENLVWNQFNPLIIAGSIYRNYKEQ 89
G P++V L L CG SL+S W +SA HC NL +++ I+ + N
Sbjct: 10 GAWPWVVGLYYDDRLLCGASLVSSDWLVSAAHCVYGRNLEPSKWT-AILGLHMKSNLTSP 68
Query: 90 KRQPQLNEIALIYWH-----SDADLAMVKLKEPFRQTTFVKPLD---------------- 128
+ P+L + +I H D D+AM+ L+ T +++P+
Sbjct: 69 QTVPRLIDEIVINPHYNRRRKDNDIAMMHLEFKVNYTDYIQPISLPEENQVFPPGRNCSI 128
Query: 129 --YYTARETNYINDVLSKTDR-----------------SEMSIVSGF---GV-TFQRDKD 165
+ T D+L + D +E I +G+ G+ + Q D
Sbjct: 129 AGWGTVVYQGTTADILQEADVPLLSNERCQQQMPEYNITENMICAGYEEGGIDSCQGDSG 188
Query: 166 GIVSWGIGCALGYPGIVSWGIGCAL-GYPGVYVRVDHYDPWIQS 208
G + G+ S+G CAL PGVY RV + WIQS
Sbjct: 189 GPLMCQENNRWFLAGVTSFGYECALPNRPGVYARVSRFTEWIQS 232
>pdb|1BRB|E Chain E, Crystal Structures Of Rat Anionic Trypsin Complexed With
The Protein Inhibitors Appi And Bpti
pdb|1BRC|E Chain E, Relocating A Negative Charge In The Binding Pocket Of
Trypsin
pdb|1BRA|A Chain A, Relocating A Negative Charge In The Binding Pocket Of
Trypsin
Length = 223
Score = 53.1 bits (126), Expect = 1e-07, Method: Compositional matrix adjust.
Identities = 58/214 (27%), Positives = 86/214 (40%), Gaps = 42/214 (19%)
Query: 32 VPYIVSLSLYGNLYCGGSLISLQWFLSARHCFVTE-NLVWNQFNPLIIAGS-IYRNYKEQ 89
VPY VSL+ G +CGGSLI+ QW +SA HC+ + + + N ++ G+ + N +
Sbjct: 12 VPYQVSLN-SGYHFCGGSLINDQWVVSAAHCYKSRIQVRLGEHNINVLEGNEQFVNAAKI 70
Query: 90 KRQPQLNEIALIYWHSDADLAMVKLKEPF----RQTTFVKPLDYYTARETNYIN------ 139
+ P + L + D+ ++KL P R T P A I+
Sbjct: 71 IKHPNFDRKTL-----NNDIMLIKLSSPVKLNARVATVALPSSCAPAGTQCLISGWGNTL 125
Query: 140 -------DVLSKTDR----------------SEMSIVSGFGVTFQRDKDGIVSWGIGCAL 176
D+L D ++ + GF + G + C
Sbjct: 126 SSGVNEPDLLQCLDAPLLPQADCEASYPGKITDNMVCVGFLEGGKGSCQGDSGGPVVCNG 185
Query: 177 GYPGIVSWGIGCAL-GYPGVYVRVDHYDPWIQSV 209
GIVSWG GCAL P VY +V +Y WIQ
Sbjct: 186 ELQGIVSWGYGCALPDNPDVYTKVCNYVDWIQDT 219
>pdb|1DAN|H Chain H, Complex Of Active Site Inhibited Human Blood Coagulation
Factor Viia With Human Recombinant Soluble Tissue Factor
pdb|1QFK|H Chain H, Structure Of Human Factor Viia And Its Implications For
The Triggering Of Blood Coagulation
pdb|1CVW|H Chain H, Crystal Structure Of Active Site-inhibited Human
Coagulation Factor Viia (des-gla)
pdb|1FAK|H Chain H, Human Tissue Factor Complexed With Coagulation Factor Viia
Inhibited With A Bpti-Mutant
pdb|1DVA|H Chain H, Crystal Structure Of The Complex Between The Peptide
Exosite Inhibitor E-76 And Coagulation Factor Viia
pdb|1DVA|I Chain I, Crystal Structure Of The Complex Between The Peptide
Exosite Inhibitor E-76 And Coagulation Factor Viia
pdb|1JBU|H Chain H, Coagulation Factor Vii Zymogen (Egf2PROTEASE) IN COMPLEX
WITH Inhibitory Exosite Peptide A-183
pdb|1KLI|H Chain H, Cofactor-And Substrate-Assisted Activation Of Factor Viia
pdb|1KLJ|H Chain H, Crystal Structure Of Uninhibited Factor Viia
pdb|1J9C|H Chain H, Crystal Structure Of Tissue Factor-Factor Viia Complex
pdb|1W0Y|H Chain H, Tf7a_3771 Complex
pdb|1YGC|H Chain H, Short Factor Viia With A Small Molecule Inhibitor
pdb|1Z6J|H Chain H, Crystal Structure Of A Ternary Complex Of Factor
Viia/tissue Factor/pyrazinone Inhibitor
pdb|1W2K|H Chain H, Tf7a_4380 Complex
pdb|1WQV|H Chain H, Human Factor Viia-Tissue Factor Complexed With
Propylsulfonamide-D- Thr-Met-P-Aminobenzamidine
pdb|1W7X|H Chain H, Factor7- 413 Complex
pdb|1W8B|H Chain H, Factor7 - 413 Complex
pdb|1WSS|H Chain H, Human Factor Viia-Tissue Factor In Complex With Peprid
Mimetic Inhibitor That Has Two Charge Groups In P2 And
P4
pdb|1WTG|H Chain H, Human Factor Viia-Tissue Factor Complexed With
Ethylsulfonamide-D-Biphenylalanine-Gln-P-
Aminobenzamidine
pdb|1WUN|H Chain H, Human Factor Viia-Tissue Factor Complexed With
Ethylsulfonamide-D-Trp-Gln-P-Aminobenzamidine
pdb|1WV7|H Chain H, Human Factor Viia-tissue Factor Complexed With
Ethylsulfonamide-d-5-propoxy-trp-gln-p-aminobenzamidine
pdb|2B7D|H Chain H, Factor Viia Inhibitors: Chemical Optimization, Preclinical
Pharmacokinetics, Pharmacodynamics, And Efficacy In A
Baboon Thrombosis Model
pdb|2F9B|H Chain H, Discovery Of Novel Heterocyclic Factor Viia Inhibitors
pdb|2FLB|H Chain H, Discovery Of A Novel Hydroxy Pyrazole Based Factor Ixa
Inhibitor
pdb|2A2Q|H Chain H, Complex Of Active-Site Inhibited Human Coagulation Factor
Viia With Human Soluble Tissue Factor In The Presence Of
Ca2+, Mg2+, Na+, And Zn2+
pdb|2AER|H Chain H, Crystal Structure Of Benzamidine-Factor ViiaSOLUBLE TISSUE
Factor Complex.
pdb|2AEI|H Chain H, Crystal Structure Of A Ternary Complex Of Factor
ViiaTISSUE FACTOR And
2-[[6-[3-(Aminoiminomethyl)phenoxy]-3,
5-Difluro-4-[(1-Methyl-3-
Phenylpropyl)amino]-2-Pyridinyl]oxy]-Benzoic Acid
pdb|2FIR|H Chain H, Crystal Structure Of Dfpr-ViiaSTF
pdb|2C4F|H Chain H, Crystal Structure Of Factor Vii.Stf Complexed With
Pd0297121
pdb|2FLR|H Chain H, Novel 5-azaindole Factor Viia Inhibitors
pdb|2B8O|H Chain H, Crystal Structure Of Glu-gly-arg-chloromethyl
Ketone-factor Viia/soluble Tissue Factor Complex
pdb|2PUQ|H Chain H, Crystal Structure Of Active Site Inhibited Coagulation
Factor Viia In Complex With Soluble Tissue Factor
pdb|2EC9|H Chain H, Crystal Structure Analysis Of Human Factor Viia , Souluble
Tissue Factor Complexed With Bcx-3607
pdb|2ZP0|H Chain H, Human Factor Viia-Tissue Factor Complexed With
Benzylsulfonamide-D- Ile-Gln-P-Aminobenzamidine
pdb|2ZWL|H Chain H, Human Factor Viia-Tissue Factor Complexed With Highly
Selective Peptide Inhibitor
pdb|2ZZU|H Chain H, Human Factor Viia-Tissue Factor Complexed With
Ethylsulfonamide-D-5-
(3-Carboxybenzyloxy)-Trp-Gln-P-Aminobenzamidine
pdb|3TH2|H Chain H, Mg2+ Is Required For Optimal Folding Of The
Gamma-Carboxyglutamic Acid (Gla) Domains Of Vitamin
K-Dependent Clotting Factors At Physiological Ca2+
pdb|3TH3|H Chain H, Mg2+ Is Required For Optimal Folding Of The
Gamma-Carboxyglutamic Acid (Gla) Domains Of Vitamin
K-Dependent Clotting Factors At Physiological Ca2+
pdb|3TH4|H Chain H, Mg2+ Is Required For Optimal Folding Of The
Gamma-Carboxyglutamic Acid (Gla) Domains Of Vitamin
K-Dependent Clotting Factors At Physiological Ca2+
pdb|1O5D|H Chain H, Dissecting And Designing Inhibitor Selectivity
Determinants At The S1 Site Using An Artificial Ala190
Protease (Ala190 Upa)
pdb|2BZ6|H Chain H, Orally Available Factor7a Inhibitor
pdb|4ISI|H Chain H, Structure Of Factor Viia In Complex With The Inhibitor
(6s)-n-(4-
Carbamimidoylbenzyl)-1-chloro-3-(cyclobutylamino)-8,
8-diethyl-4-oxo-
4,6,7,8-tetrahydropyrrolo[1,2-a]pyrazine-6-carboxamide
Length = 254
Score = 53.1 bits (126), Expect = 1e-07, Method: Compositional matrix adjust.
Identities = 64/245 (26%), Positives = 103/245 (42%), Gaps = 55/245 (22%)
Query: 30 GEVPYIVSLSLYGNLYCGGSLISLQWFLSARHCFVTENLVWNQFNPLIIAG----SIYRN 85
GE P+ V L + G CGG+LI+ W +SA HCF + + N N + + G S +
Sbjct: 10 GECPWQVLLLVNGAQLCGGTLINTIWVVSAAHCF---DKIKNWRNLIAVLGEHDLSEHDG 66
Query: 86 YKEQKRQPQL------------NEIALIYWH-----SDADLAMVKLKEPFRQTTFV---- 124
++ +R Q+ ++IAL+ H +D + + + F + T
Sbjct: 67 DEQSRRVAQVIIPSTYVPGTTNHDIALLRLHQPVVLTDHVVPLCLPERTFSERTLAFVRF 126
Query: 125 -------KPLDY-YTARETNYIN-------DVLSKTDR-------SEMSIVSGFGV---- 158
+ LD TA E +N D L ++ + +E +G+
Sbjct: 127 SLVSGWGQLLDRGATALELMVLNVPRLMTQDCLQQSRKVGDSPNITEYMFCAGYSDGSKD 186
Query: 159 TFQRDKDGIVSWGIGCALGYPGIVSWGIGCA-LGYPGVYVRVDHYDPWIQSVKNNGDNAG 217
+ + D G + GIVSWG GCA +G+ GVY RV Y W+Q + + G
Sbjct: 187 SCKGDSGGPHATHYRGTWYLTGIVSWGQGCATVGHFGVYTRVSQYIEWLQKLMRSEPRPG 246
Query: 218 VLISA 222
VL+ A
Sbjct: 247 VLLRA 251
>pdb|3VEQ|B Chain B, A Binary Complex Betwwen Bovine Pancreatic Trypsin And A
Engineered Mutant Trypsin Inhibitor
Length = 223
Score = 53.1 bits (126), Expect = 1e-07, Method: Compositional matrix adjust.
Identities = 67/218 (30%), Positives = 90/218 (41%), Gaps = 43/218 (19%)
Query: 32 VPYIVSLSLYGNLYCGGSLISLQWFLSARHCFVT--------ENLVWNQFNPLIIAGSIY 83
VPY VSL+ G +CGGSLI+ QW +SA HC+ + +N+ + N I+ S
Sbjct: 12 VPYQVSLN-SGYHFCGGSLINSQWVVSAAHCYKSGIQVRLGEDNINVVEGNEQFISASKS 70
Query: 84 RNYKEQKRQPQLNEIALIYWHSDADL----AMVKLKEPFRQT---TFVKPLDYYTARETN 136
+ N+I LI S A L A V L + + T+
Sbjct: 71 IVHPSYNSNTLNNDIMLIKLKSAASLNSRVASVSLPTSCASAGTQCLISGWGNTKSSGTS 130
Query: 137 YINDVLSK------TDRSEMSI--------------VSGFGVTFQRDKDGIVSWGIGCAL 176
Y DVL +D S S + G + Q D G V CA
Sbjct: 131 YP-DVLKCLKAPILSDSSCKSAYPGQITSNMFCAGYLEGGKDSCQGDSGGPVV----CAG 185
Query: 177 GYPGIVSWGIGCAL-GYPGVYVRVDHYDPWI-QSVKNN 212
GIVSWG GCA PGVY +V +Y WI Q++ +N
Sbjct: 186 KLQGIVSWGSGCAQKNKPGVYTKVCNYVSWIKQTIASN 223
>pdb|1EQ9|A Chain A, Crystal Structure Of Fire Ant Chymotrypsin Complexed To
Pmsf
pdb|1EQ9|B Chain B, Crystal Structure Of Fire Ant Chymotrypsin Complexed To
Pmsf
Length = 222
Score = 52.8 bits (125), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 53/215 (24%), Positives = 83/215 (38%), Gaps = 42/215 (19%)
Query: 30 GEVPYIVSLSLYGNLYCGGSLISLQWFLSARHCFVTENLVWNQFNPLIIAGSIYRNYKEQ 89
G+ PY VSL L G+ CG S++ L+A HC + N L + + NY +
Sbjct: 10 GKYPYQVSLRLSGSHRCGASILDNNNVLTAAHCVDG----LSNLNRLKV--HVGTNYLSE 63
Query: 90 KRQPQLNEIALIYWHSDA-----DLAMVKLKEPFRQTTFVKPLDYYTARET--------- 135
E A++ + D D+A+V L P + V+P+ T E
Sbjct: 64 SGDVYDVEDAVVNKNYDDFLLRNDVALVHLTNPIKFNDLVQPIKLSTNDEDLESNPCTLT 123
Query: 136 ------------NYINDV------LSKTDRSEMSIVSGFGVTFQRDKDGIVSWGIGCAL- 176
N + ++ + +R + ++ T + +G G L
Sbjct: 124 GWGSTRLGGNTPNALQEIELIVHPQKQCERDQWRVIDSHICTLTKRGEGACHGDSGGPLV 183
Query: 177 ---GYPGIVSWGIGCALGYPGVYVRVDHYDPWIQS 208
GIVS+G CALG P VY RV + WI +
Sbjct: 184 ANGAQIGIVSFGSPCALGEPDVYTRVSSFVSWINA 218
>pdb|1MBQ|A Chain A, Anionic Trypsin From Pacific Chum Salmon
Length = 220
Score = 52.4 bits (124), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 56/223 (25%), Positives = 90/223 (40%), Gaps = 63/223 (28%)
Query: 33 PYIVSLSLYGNLYCGGSLISLQWFLSARHCFVTE-NLVWNQFNPLIIAGS-IYRNYKEQK 90
P+ VSL+ G +CGGSL++ W +SA HC+ + + + N + GS + +
Sbjct: 13 PHQVSLN-SGYHFCGGSLVNENWVVSAAHCYKSRVEVRLGEHNIKVTEGSEQFISSSRVI 71
Query: 91 RQPQLNEIALIYWHSDADLAMVKLKEPFRQTTFVKPLDYYTARETNYINDVLSKTDRSEM 150
R P + ++ D D+ ++KL + T+V+P+ + S M
Sbjct: 72 RHPNYSS-----YNIDNDIMLIKLSKSATLNTYVQPVALPS-----------SCAPAGTM 115
Query: 151 SIVSGFGVTFQRDKD----------------------GIVSWGIGCA------------- 175
VSG+G T D G+++ + CA
Sbjct: 116 CTVSGWGNTMSSTADKNKLQCLNIPILSYSDCNNSYPGMITNAMFCAGYLEGGKDSCQGD 175
Query: 176 LGYP--------GIVSWGIGCAL-GYPGVYVRVDHYDPWIQSV 209
G P G+VSWG GCA G PGVY +V ++ W+ S
Sbjct: 176 SGGPVVCNGELQGVVSWGYGCAEPGNPGVYAKVCIFNDWLTST 218
>pdb|1TRN|A Chain A, Crystal Structure Of Human Trypsin 1: Unexpected
Phosphorylation Of Tyrosine 151
pdb|1TRN|B Chain B, Crystal Structure Of Human Trypsin 1: Unexpected
Phosphorylation Of Tyrosine 151
Length = 224
Score = 52.0 bits (123), Expect = 3e-07, Method: Compositional matrix adjust.
Identities = 59/215 (27%), Positives = 86/215 (40%), Gaps = 44/215 (20%)
Query: 32 VPYIVSLSLYGNLYCGGSLISLQWFLSARHCFVTE-NLVWNQFNPLIIAGS-IYRNYKEQ 89
VPY VSL+ G +CGGSLI+ QW +SA HC+ + + + N ++ G+ + N +
Sbjct: 12 VPYQVSLN-SGYHFCGGSLINEQWVVSAGHCYKSRIQVRLGEHNIEVLEGNEQFINAAKI 70
Query: 90 KRQPQL------NEIALIYWHSDA----------------------------DLAMVKLK 115
R PQ N+I LI S A + A
Sbjct: 71 IRHPQYDRKTLNNDIMLIKLSSRAVINARVSTISLPTAPPATGTKCLISGWGNTASSGAD 130
Query: 116 EPFRQTTFVKPLDYYTARETNYINDVLSKTDRSEMSIVSGFGVTFQRDKDGIVSWGIGCA 175
P P+ E +Y + S + + + G + Q D G V C
Sbjct: 131 XPDELQCLDAPVLSQAKCEASYPGKITS--NMFCVGFLEGGKDSCQGDSGGPVV----CN 184
Query: 176 LGYPGIVSWGIGCAL-GYPGVYVRVDHYDPWIQSV 209
G+VSWG GCA PGVY +V +Y WI++
Sbjct: 185 GQLQGVVSWGDGCAQKNKPGVYTKVYNYVKWIKNT 219
>pdb|1Y59|T Chain T, Dianhydrosugar-Based Benzamidine, Factor Xa Specific
Inhibitor In Complex With Bovine Trypsin Mutant
pdb|1Y5A|T Chain T, Dianhydrosugar-Based Benzamidine, Factor Xa Specific
Inhibitor In Complex With Bovine Trypsin Mutant
pdb|1Y5B|T Chain T, Dianhydrosugar-Based Benzamidine, Factor Xa Specific
Inhibitor In Complex With Bovine Trypsin Mutant
pdb|1Y5U|T Chain T, Dianhydrosugar-Based Benzamidine, Factor Xa Specific
Inhibitor In Complex With Bovine Trypsin Mutant
Length = 223
Score = 52.0 bits (123), Expect = 3e-07, Method: Compositional matrix adjust.
Identities = 65/218 (29%), Positives = 91/218 (41%), Gaps = 43/218 (19%)
Query: 32 VPYIVSLSLYGNLYCGGSLISLQWFLSARHCFVT--------ENLVWNQFNPLIIAGSIY 83
VPY VSL+ G +CGGSLI+ QW +SA HC+ + +N+ + N I+ S
Sbjct: 12 VPYQVSLN-SGYHFCGGSLINSQWVVSAAHCYKSGIQVRLGEDNINVVEGNEQFISASKS 70
Query: 84 RNYKEQKRQPQLNEIALIYWHSDADL----AMVKLKEPFRQT---TFVKPLDYYTARETN 136
+ + N+I LI S A L A + L + + T+
Sbjct: 71 IVHPSYNSETYNNDIMLIKLKSAASLNSRVASISLPTSCASAGTQCLISGWGNTKSSGTS 130
Query: 137 YINDVLSK------TDRSEMSI--------------VSGFGVTFQRDKDGIVSWGIGCAL 176
Y DVL +D S S + G + Q D G V C+
Sbjct: 131 YP-DVLKCLKAPILSDSSCKSAYPGQITSNMFCAGYLEGGKDSCQGDSGGPVV----CSG 185
Query: 177 GYPGIVSWGIGCAL-GYPGVYVRVDHYDPWI-QSVKNN 212
GIVSWG GCA PGVY +V +Y WI Q++ +N
Sbjct: 186 KLQGIVSWGSGCAQKNKPGVYTKVCNYVSWIKQTIASN 223
>pdb|2WPH|S Chain S, Factor Ixa Superactive Triple Mutant
pdb|2WPJ|S Chain S, Factor Ixa Superactive Triple Mutant, Nacl-Soaked
pdb|2WPK|S Chain S, Factor Ixa Superactive Triple Mutant, Ethylene
Glycol-Soaked
pdb|2WPL|S Chain S, Factor Ixa Superactive Triple Mutant, Edta-Soaked
Length = 235
Score = 52.0 bits (123), Expect = 3e-07, Method: Compositional matrix adjust.
Identities = 55/237 (23%), Positives = 93/237 (39%), Gaps = 72/237 (30%)
Query: 29 PGEVPYIVSLSLYGNLYCGGSLISLQWFLSARHCFVTENLVWNQFNPLIIAGSIYRNYKE 88
PG+ P+ V L+ + +CGGS+++ +W ++A HC T + ++AG N +E
Sbjct: 9 PGQFPWQVVLNGKVDAFCGGSIVNEKWIVTAAHCVETGVKI------TVVAGE--HNIEE 60
Query: 89 QKRQPQLNEIALIYWHS---------DADLAMVKLKEPFRQTTFVKPLDYYTARETNYIN 139
+ Q + I H + D+A+++L EP ++V P+ + Y N
Sbjct: 61 TEHTEQKRNVIRIIPHHNFNAAINTYNHDIALLELDEPLVLNSYVTPI---CIADKEYTN 117
Query: 140 DVLSKTDRSEMSIVSGFGVTFQRDKDGIV----------------------SWGIGCA-- 175
L + VSG+G F + + +V + + CA
Sbjct: 118 IFL----KFGSGYVSGWGRVFHKGRSALVLQYLRVPLVDRATCLRSTKFTITNNMFCAGF 173
Query: 176 -----------LGYP------------GIVSWGIGCAL-GYPGVYVRVDHYDPWIQS 208
G P GI+SWG CA+ G G+Y +V Y WI+
Sbjct: 174 HEGGRDSCQGDSGGPHVTEVEGTSFLTGIISWGEECAMKGKYGIYTKVSRYVNWIKE 230
>pdb|2WPI|S Chain S, Factor Ixa Superactive Double Mutant
Length = 235
Score = 52.0 bits (123), Expect = 3e-07, Method: Compositional matrix adjust.
Identities = 55/237 (23%), Positives = 93/237 (39%), Gaps = 72/237 (30%)
Query: 29 PGEVPYIVSLSLYGNLYCGGSLISLQWFLSARHCFVTENLVWNQFNPLIIAGSIYRNYKE 88
PG+ P+ V L+ + +CGGS+++ +W ++A HC T + ++AG N +E
Sbjct: 9 PGQFPWQVVLNGKVDAFCGGSIVNEKWIVTAAHCVETGVKI------TVVAGE--HNIEE 60
Query: 89 QKRQPQLNEIALIYWHS---------DADLAMVKLKEPFRQTTFVKPLDYYTARETNYIN 139
+ Q + I H + D+A+++L EP ++V P+ + Y N
Sbjct: 61 TEHTEQKRNVIRIIPHHNYNAAINTYNHDIALLELDEPLVLNSYVTPI---CIADKEYTN 117
Query: 140 DVLSKTDRSEMSIVSGFGVTFQRDKDGIV----------------------SWGIGCA-- 175
L + VSG+G F + + +V + + CA
Sbjct: 118 IFL----KFGSGYVSGWGRVFHKGRSALVLQYLRVPLVDRATCLRSTKFTITNNMFCAGF 173
Query: 176 -----------LGYP------------GIVSWGIGCAL-GYPGVYVRVDHYDPWIQS 208
G P GI+SWG CA+ G G+Y +V Y WI+
Sbjct: 174 HEGGRDSCQGDSGGPHVTEVEGTSFLTGIISWGEECAMKGKYGIYTKVSRYVNWIKE 230
>pdb|1SI5|H Chain H, Protease-Like Domain From 2-Chain Hepatocyte Growth Factor
Length = 240
Score = 51.6 bits (122), Expect = 4e-07, Method: Compositional matrix adjust.
Identities = 41/137 (29%), Positives = 64/137 (46%), Gaps = 12/137 (8%)
Query: 32 VPYIVSLSLYGNLYCGGSLISLQWFLSARHCFVTENLVWNQFNPLIIAGSIYRNYKEQKR 91
+ ++VSL CGGSLI W L+AR CF + +L + + ++ E+ +
Sbjct: 11 IGWMVSLRYRNKHICGGSLIKESWVLTARQCFPSRDL--KDYEAWLGIHDVHGRGDEKCK 68
Query: 92 QPQLNEIALIYWHSDADLAMVKLKEPFRQTTFVKPLDYYTARETNYINDVLSKTDRSEMS 151
Q LN L+Y +DL ++KL P FV +D NY + + KT S
Sbjct: 69 Q-VLNVSQLVYGPEGSDLVLMKLARPAVLDDFVSTIDL-----PNYGSTIPEKTSCS--- 119
Query: 152 IVSGFGVTFQRDKDGIV 168
V G+G T + DG++
Sbjct: 120 -VYGWGYTGLINYDGLL 135
Score = 30.0 bits (66), Expect = 1.3, Method: Compositional matrix adjust.
Identities = 13/31 (41%), Positives = 20/31 (64%), Gaps = 1/31 (3%)
Query: 180 GIVSWGIGCAL-GYPGVYVRVDHYDPWIQSV 209
G++ G GCA+ PG++VRV +Y WI +
Sbjct: 195 GVIVPGRGCAIPNRPGIFVRVAYYAKWIHKI 225
>pdb|1SHY|A Chain A, The Crystal Structure Of Hgf Beta-Chain In Complex With
The Sema Domain Of The Met Receptor
Length = 234
Score = 51.6 bits (122), Expect = 4e-07, Method: Compositional matrix adjust.
Identities = 41/137 (29%), Positives = 64/137 (46%), Gaps = 12/137 (8%)
Query: 32 VPYIVSLSLYGNLYCGGSLISLQWFLSARHCFVTENLVWNQFNPLIIAGSIYRNYKEQKR 91
+ ++VSL CGGSLI W L+AR CF + +L + + ++ E+ +
Sbjct: 11 IGWMVSLRYRNKHICGGSLIKESWVLTARQCFPSRDL--KDYEAWLGIHDVHGRGDEKCK 68
Query: 92 QPQLNEIALIYWHSDADLAMVKLKEPFRQTTFVKPLDYYTARETNYINDVLSKTDRSEMS 151
Q LN L+Y +DL ++KL P FV +D NY + + KT S
Sbjct: 69 Q-VLNVSQLVYGPEGSDLVLMKLARPAVLDDFVSTIDL-----PNYGSTIPEKTSCS--- 119
Query: 152 IVSGFGVTFQRDKDGIV 168
V G+G T + DG++
Sbjct: 120 -VYGWGYTGLINYDGLL 135
Score = 30.0 bits (66), Expect = 1.3, Method: Compositional matrix adjust.
Identities = 13/31 (41%), Positives = 20/31 (64%), Gaps = 1/31 (3%)
Query: 180 GIVSWGIGCAL-GYPGVYVRVDHYDPWIQSV 209
G++ G GCA+ PG++VRV +Y WI +
Sbjct: 195 GVIVPGRGCAIPNRPGIFVRVAYYAKWIHKI 225
>pdb|2WPM|S Chain S, Factor Ixa Superactive Mutant, Egr-Cmk Inhibited
Length = 235
Score = 51.6 bits (122), Expect = 4e-07, Method: Compositional matrix adjust.
Identities = 55/237 (23%), Positives = 93/237 (39%), Gaps = 72/237 (30%)
Query: 29 PGEVPYIVSLSLYGNLYCGGSLISLQWFLSARHCFVTENLVWNQFNPLIIAGSIYRNYKE 88
PG+ P+ V L+ + +CGGS+++ +W ++A HC T + ++AG N +E
Sbjct: 9 PGQFPWQVVLNGKVDAFCGGSIVNEKWIVTAAHCVETGVKI------TVVAGE--HNIEE 60
Query: 89 QKRQPQLNEIALIYWHS---------DADLAMVKLKEPFRQTTFVKPLDYYTARETNYIN 139
+ Q + I H + D+A+++L EP ++V P+ + Y N
Sbjct: 61 TEHTEQKRNVIRIIPHHNFNAAINTYNHDIALLELDEPLVLNSYVTPI---CIADKEYTN 117
Query: 140 DVLSKTDRSEMSIVSGFGVTFQRDKDGIV----------------------SWGIGCA-- 175
L + VSG+G F + + +V + + CA
Sbjct: 118 IFL----KFGSGYVSGWGRVFHKGRAALVLQYLRVPLVDRATCLRSTKFTITNNMFCAGF 173
Query: 176 -----------LGYP------------GIVSWGIGCAL-GYPGVYVRVDHYDPWIQS 208
G P GI+SWG CA+ G G+Y +V Y WI+
Sbjct: 174 HEGGRDSCQGDSGGPHVTEVEGTSFLTGIISWGEECAMKGKYGIYTKVSRYVNWIKE 230
>pdb|2RA3|A Chain A, Human Cationic Trypsin Complexed With Bovine Pancreatic
Trypsin Inhibitor (bpti)
pdb|2RA3|B Chain B, Human Cationic Trypsin Complexed With Bovine Pancreatic
Trypsin Inhibitor (bpti)
Length = 224
Score = 51.2 bits (121), Expect = 4e-07, Method: Compositional matrix adjust.
Identities = 59/215 (27%), Positives = 89/215 (41%), Gaps = 44/215 (20%)
Query: 32 VPYIVSLSLYGNLYCGGSLISLQWFLSARHCFVTE-NLVWNQFNPLIIAGS-IYRNYKEQ 89
VPY VSL+ G +CGGSLI+ QW +SA HC+ + + + N ++ G+ + N +
Sbjct: 12 VPYQVSLN-SGYHFCGGSLINEQWVVSAGHCYKSRIQVRLGEHNIEVLEGNEQFINAAKI 70
Query: 90 KRQPQL------NEIALIYWHS----DADLAMVKLKE----------------------- 116
R PQ N+I LI S +A ++ + L
Sbjct: 71 IRHPQYDRKTLNNDIMLIKLSSRAVINAHVSTISLPTAPPATGTKCLISGWGNTASSGAD 130
Query: 117 -PFRQTTFVKPLDYYTARETNYINDVLSKTDRSEMSIVSGFGVTFQRDKDGIVSWGIGCA 175
P P+ E +Y + S + + + G + Q D G V C
Sbjct: 131 YPDELQCLDAPVLSQAKCEASYPGKITS--NMFCVGFLEGGKDSCQGDAGGPVV----CN 184
Query: 176 LGYPGIVSWGIGCAL-GYPGVYVRVDHYDPWIQSV 209
G+VSWG GCA PGVY +V +Y WI++
Sbjct: 185 GQLQGVVSWGDGCAQKNKPGVYTKVYNYVKWIKNT 219
>pdb|3BN9|B Chain B, Crystal Structure Of Mt-Sp1 In Complex With Fab Inhibitor
E2
pdb|3BN9|A Chain A, Crystal Structure Of Mt-Sp1 In Complex With Fab Inhibitor
E2
pdb|3NCL|A Chain A, Crystal Structure Of Mt-Sp1 Bound To Benzamidine
Phosphonate Inhibitor
pdb|3NPS|A Chain A, Crystal Structure Of Membrane-Type Serine Protease 1
(Mt-Sp1) In Complex With The Fab Inhibitor S4
pdb|3SO3|A Chain A, Structures Of Fab-Protease Complexes Reveal A Highly
Specific Non- Canonical Mechanism Of Inhibition
Length = 241
Score = 51.2 bits (121), Expect = 5e-07, Method: Compositional matrix adjust.
Identities = 57/235 (24%), Positives = 89/235 (37%), Gaps = 59/235 (25%)
Query: 28 NPGEVPYIVSLSLYGNLY-CGGSLISLQWFLSARHCFV-------TENLVWNQFNPL--- 76
+ GE P+ VSL G + CG SLIS W +SA HC++ ++ W F L
Sbjct: 8 DEGEWPWQVSLHALGQGHICGASLISPNWLVSAAHCYIDDRGFRYSDPTQWTAFLGLHDQ 67
Query: 77 ---IIAGSIYRNYKEQKRQPQLNEIALIYWHSDADLAMVKLKEPFRQTTFVKPLDYYTAR 133
G R K P N+ Y D+A+++L++P ++ V+P+ A
Sbjct: 68 SQRSAPGVQERRLKRIISHPFFNDFTFDY-----DIALLELEKPAEYSSMVRPISLPDAS 122
Query: 134 ---------------ETNYINDVLSKTDRSEMSIVSGFG--------VTFQRDKDGIVSW 170
T Y + E+ +++ +T + G +S
Sbjct: 123 HVFPAGKAIWVTGWGHTQYGGTGALILQKGEIRVINQTTCENLLPQQITPRMMCVGFLSG 182
Query: 171 GIGCALG----------------YPGIVSWGIGCA-LGYPGVYVRVDHYDPWIQS 208
G+ G G+VSWG GCA PGVY R+ + WI+
Sbjct: 183 GVDSCQGDSGGPLSSVEADGRIFQAGVVSWGDGCAQRNKPGVYTRLPLFRDWIKE 237
>pdb|1TAW|A Chain A, Bovine Trypsin Complexed To Appi
pdb|1ZR0|A Chain A, Crystal Structure Of Kunitz Domain 1 Of Tissue Factor
Pathway Inhibitor-2 With Bovine Trypsin
pdb|1ZR0|C Chain C, Crystal Structure Of Kunitz Domain 1 Of Tissue Factor
Pathway Inhibitor-2 With Bovine Trypsin
Length = 223
Score = 51.2 bits (121), Expect = 5e-07, Method: Compositional matrix adjust.
Identities = 64/218 (29%), Positives = 88/218 (40%), Gaps = 43/218 (19%)
Query: 32 VPYIVSLSLYGNLYCGGSLISLQWFLSARHCFVT--------ENLVWNQFNPLIIAGSIY 83
VPY VSL+ G +CGGSLI+ QW +SA HC+ + +N+ + N I+ S
Sbjct: 12 VPYQVSLN-SGYHFCGGSLINSQWVVSAAHCYKSGIQVRLGEDNINVVEGNEQFISASKS 70
Query: 84 RNYKEQKRQPQLNEIALIYWHSDADL----AMVKLKEPFRQT---TFVKPLDYYTARETN 136
+ N+I LI S A L A + L + + T+
Sbjct: 71 IVHPSYNSNTLNNDIMLIKLKSAASLNSRVASISLPTSCASAGTQCLISGWGNTKSSGTS 130
Query: 137 YINDVLSKTDRSEMSIVS--------------------GFGVTFQRDKDGIVSWGIGCAL 176
Y DVL +S S G + Q D G V C+
Sbjct: 131 YP-DVLKCLKAPILSTSSCKSAYPGQITSNMFCAGYLEGGKDSCQGDSGGPVV----CSG 185
Query: 177 GYPGIVSWGIGCAL-GYPGVYVRVDHYDPWI-QSVKNN 212
GIVSWG GCA PGVY +V +Y WI Q++ +N
Sbjct: 186 KLQGIVSWGSGCAQKNKPGVYTKVCNYVSWIKQTIASN 223
>pdb|2FI5|E Chain E, Crystal Structure Of A Bpti Variant (Cys38->ser) In
Complex With Trypsin
pdb|2FTM|A Chain A, Crystal Structure Of Trypsin Complexed With The Bpti
Variant (Tyr35- >gly)
Length = 224
Score = 51.2 bits (121), Expect = 5e-07, Method: Compositional matrix adjust.
Identities = 64/219 (29%), Positives = 91/219 (41%), Gaps = 44/219 (20%)
Query: 32 VPYIVSLSLYGNLYCGGSLISLQWFLSARHCFVT--------ENLVWNQFNPLIIAGSIY 83
VPY VSL+ G +CGGSLI+ QW +SA HC+ + +N+ + N I+ S
Sbjct: 12 VPYQVSLN-SGYHFCGGSLINSQWVVSAAHCYKSGIQVRLGEDNINVVEGNEQFISASKS 70
Query: 84 RNYKEQKRQPQLNEIALIYWHSDADLAMVKLKEPFRQTT--------FVKPLDYYTARET 135
+ N+I LI S A L ++ T+ + + T
Sbjct: 71 IVHPSYNSNTLNNDIMLIKLKSAASLXDSRVASISLPTSCASAGTQCLISGWGNTKSSGT 130
Query: 136 NYINDVLSK------TDRSEMSI--------------VSGFGVTFQRDKDGIVSWGIGCA 175
+Y DVL +D S S + G + Q D G V C+
Sbjct: 131 SYP-DVLKCLKAPILSDSSCKSAYPGQITSNMFCAGYLEGGKDSCQGDSGGPVV----CS 185
Query: 176 LGYPGIVSWGIGCAL-GYPGVYVRVDHYDPWI-QSVKNN 212
GIVSWG GCA PGVY +V +Y WI Q++ +N
Sbjct: 186 GKLQGIVSWGSGCAQKNKPGVYTKVCNYVSWIKQTIASN 224
>pdb|1ZZZ|A Chain A, Trypsin Inhibitors With Rigid Tripeptidyl Aldehydes
Length = 237
Score = 51.2 bits (121), Expect = 5e-07, Method: Compositional matrix adjust.
Identities = 65/218 (29%), Positives = 90/218 (41%), Gaps = 43/218 (19%)
Query: 32 VPYIVSLSLYGNLYCGGSLISLQWFLSARHCFVT--------ENLVWNQFNPLIIAGSIY 83
VPY VSL+ G +CGGSLI+ QW +SA HC+ + +N+ + N I+ S
Sbjct: 26 VPYQVSLN-SGYHFCGGSLINSQWVVSAAHCYKSGIQVRLGEDNINVVEGNEQFISASKS 84
Query: 84 RNYKEQKRQPQLNEIALIYWHSDADL----AMVKLKEPFRQT---TFVKPLDYYTARETN 136
+ N+I LI S A L A + L + + T+
Sbjct: 85 IVHPSYNSNTLNNDIMLIKLKSAASLNSRVASISLPTSCASAGTQCLISGWGNTKSSGTS 144
Query: 137 YINDVLSK------TDRSEMSI--------------VSGFGVTFQRDKDGIVSWGIGCAL 176
Y DVL +D S S + G + Q D G V C+
Sbjct: 145 YP-DVLKCLKAPILSDSSCKSAYPGQITSNMFCAGYLEGGKDSCQGDSGGPVV----CSG 199
Query: 177 GYPGIVSWGIGCAL-GYPGVYVRVDHYDPWI-QSVKNN 212
GIVSWG GCA PGVY +V +Y WI Q++ +N
Sbjct: 200 KLQGIVSWGSGCAQKNKPGVYTKVCNYVSWIKQTIASN 237
>pdb|1DST|A Chain A, Mutant Of Factor D With Enhanced Catalytic Activity
Length = 228
Score = 51.2 bits (121), Expect = 5e-07, Method: Compositional matrix adjust.
Identities = 55/216 (25%), Positives = 85/216 (39%), Gaps = 41/216 (18%)
Query: 33 PYIVSLSLYGNLYCGGSLISLQWFLSARHCFVTENLVWNQFNPLIIAGSIYRNYKEQKRQ 92
PY+ S+ L G CGG L++ QW LSA HC E+ + L+ A S+ + ++
Sbjct: 13 PYMASVQLNGAHLCGGVLVAEQWVLSAAHCL--EDAADGKVQVLLGAHSLSQPEPSKRLY 70
Query: 93 PQLNEIALIYWHSDA---DLAMVKLKEPFRQTTFVKPL-----DYYTARET-------NY 137
L + + D DL +++L E V+PL D A T
Sbjct: 71 DVLRAVPHPDYQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGI 130
Query: 138 INDVLSKTDRSE---MSIVSGFGVTFQRDKDGIVSWGIGCA-----------LGYP---- 179
+N + D + + ++ + DG ++ + CA G P
Sbjct: 131 VNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCG 190
Query: 180 ----GIVSWG--IGCALGYPGVYVRVDHYDPWIQSV 209
G+VSWG + PG+Y RV Y WI SV
Sbjct: 191 GVLEGVVSWGSRVCGNRKKPGIYTRVASYAAWIDSV 226
>pdb|1TAB|E Chain E, Structure Of The Trypsin-Binding Domain Of Bowman-Birk
Type Protease Inhibitor And Its Interaction With Trypsin
pdb|1TPA|E Chain E, The Geometry Of The Reactive Site And Of The Peptide
Groups In Trypsin, Trypsinogen And Its Complexes With
Inhibitors
pdb|2PTC|E Chain E, The Geometry Of The Reactive Site And Of The Peptide
Groups In Trypsin, Trypsinogen And Its Complexes With
Inhibitors
pdb|1PPC|E Chain E, Geometry Of Binding Of The Benzamidine-and Arginine-based
Inhibitors
N-alpha-(2-naphthyl-sulphonyl-glycyl)-dl-p-
amidinophenylalanyl- Piperidine (napap) And
(2r,4r)-4-methyl-1-[n-alpha-(3-methyl-1,2,3,4-
Tetrahydro-8-quinolinesulphonyl)-l-arginyl]-2-piperidine
Carboxylic Acid (mqpa) To Human Alpha-thrombin: X-ray
Crystallographic Determination Of The Napap-trypsin
Complex And Modeling Of Napap- Thrombin And
Mqpa-thrombin
pdb|1PPE|E Chain E, The Refined 2.0 Angstroms X-Ray Crystal Structure Of The
Complex Formed Between Bovine Beta-Trypsin And Cmti-I, A
Trypsin Inhibitor From Squash Seeds (Cucurbita Maxima):
Topological Similarity Of The Squash Seed Inhibitors
With The Carboxypeptidase A Inhibitor From Potatoes
pdb|1PPH|E Chain E, Geometry Of Binding Of The Nalpha-Tosylated Piperidides Of
M-Amidino-, P-Amidino-And P-Guanidino Phenylalanine To
Thrombin And Trypsin: X- Ray Crystal Structures Of Their
Trypsin Complexes And Modeling Of Their Thrombin
Complexes
pdb|1SMF|E Chain E, Studies On An Artificial Trypsin Inhibitor Peptide Derived
From The Mung Bean Inhibitor
pdb|1JRT|A Chain A, Hemiacetal Complex Between Leupeptin And Trypsin
pdb|1JRS|A Chain A, Hemiacetal Complex Between Leupeptin And Trypsin
pdb|1CE5|A Chain A, Bovine Pancreas Beta-Trypsin In Complex With Benzamidine
pdb|2BZA|A Chain A, Bovine Pancreas Beta-Trypsin In Complex With Benzylamine
pdb|1QCP|A Chain A, Crystal Structure Of The Rwj-51084 Bovine Pancreatic Beta-
Trypsin At 1.8 A
pdb|1SBW|A Chain A, Crystal Structure Of Mung Bean Inhibitor Lysine Active
Fragment Complex With Bovine Beta-Trypsin At 1.8a
Resolution
pdb|1YYY|1 Chain 1, Trypsin Inhibitors With Rigid Tripeptidyl Aldehydes
pdb|1SFI|A Chain A, High Resolution Structure Of A Potent, Cyclic Protease
Inhibitor From Sunflower Seeds
pdb|1TIO|A Chain A, High Packing Density Form Of Bovine Beta-trypsin In
Cyclohexane
pdb|2TIO|A Chain A, Low Packing Density Form Of Bovine Beta-Trypsin In
Cyclohexane
pdb|2BTC|E Chain E, Bovine Trypsin In Complex With Squash Seed Inhibitor
(Cucurbita Pepo Trypsin Inhibitor Ii)
pdb|3BTE|E Chain E, The Crystal Structures Of The Complexes Between Bovine
Beta-Trypsin And Ten P1 Variants Of Bpti.
pdb|3BTD|E Chain E, The Crystal Structures Of The Complexes Between The Bovine
Beta- Trypsin And Ten P1 Variants Of Bpti.
pdb|3BTF|E Chain E, The Crystal Structures Of The Complexes Between Bovine
Beta- Trypsin And Ten P1 Variants Of Bpti.
pdb|3BTG|E Chain E, The Crystal Structures Of The Complexes Between Bovine
Beta- Trypsin And Ten P1 Variants Of Bpti
pdb|3BTH|E Chain E, The Crystal Structures Of The Complexes Between Bovine
Beta- Trypsin And Ten P1 Variants Of Bpti
pdb|3BTK|E Chain E, The Crystal Structures Of The Complexes Between Bovine
Beta- Trypsin And Ten P1 Variants Of Bpti
pdb|3BTM|E Chain E, The Crystal Structures Of The Complexes Between Bovine
Beta- Trypsin And Ten P1 Variants Of Bpti
pdb|3BTQ|E Chain E, The Crystal Structures Of The Complexes Between Bovine
Beta- Trypsin And Ten P1 Variants Of Bpti
pdb|3BTT|E Chain E, The Crystal Structures Of The Complexes Between Bovine
Beta- Trypsin And Ten P1 Variants Of Bpti
pdb|3BTW|E Chain E, The Crystal Structures Of The Complexes Between Bovine
Beta- Trypsin And Ten P1 Variants Of Bpti
pdb|1QBN|A Chain A, Bovine Trypsin 2-[amino(Imino)methyl]-2-Hydroxyphenoxy]-6-
[3-(4,5-Dihydro-1h-Imidazol-2-Yl)phenoxy]pyridine-4-
Carboxylic Acid (Zk-806688) Complex
pdb|1QBO|A Chain A, Bovine Trypsin
7-[[6-[[1-(1-Iminoethyl)piperidin-4-Yl]oxy]-
2-Methyl-Benzimidazol-1-Yl]methyl]naphthalene-2-
Carboximidamid Zk-806711 Inhibitor Complex
pdb|1QB9|A Chain A, Bovine Trypsin
7-[[2-[[1-(1-Iminoethyl)piperidin-4-Yl]oxy]-
9h-Carbozol-9-Yl] Methyl]naphthalene-2-Carboximidamide
(Zk- 806450) Complex
pdb|1QB1|A Chain A, Bovine Trypsin With 1-[2-[5-[amino(imino)methyl]-2-
Hydroxyphenoxy]-6-[3-(4,
5-dihydro-1-methyl-1h-imidazol-2-
Yl)phenoxy]pyridin-4-yl]piperidine-3-carboxylic Acid
(zk- 806974)
pdb|1QB6|A Chain A, Bovine Trypsin 3,3'-[3,5-Difluoro-4-Methyl-2, 6-
Pyridinediylbis(Oxy)]bis(Benzenecarboximidamide) (Zk-
805623) Complex
pdb|1QA0|A Chain A, Bovine Trypsin 2-Aminobenzimidazole Complex
pdb|1F2S|E Chain E, Crystal Structure Of The Complex Formed Between Bovine
Beta- Trypsin And Mcti-A, A Trypsin Inhibitor Of Squash
Family At 1.8 A Resolution
pdb|1D6R|A Chain A, Crystal Structure Of Cancer Chemopreventive Bowman-Birk
Inhibitor In Ternary Complex With Bovine Trypsin At 2.3
A Resolution. Structural Basis Of Janus-Faced Serine
Protease Inhibitor Specificity
pdb|1C9T|A Chain A, Complex Of Bdellastasin With Bovine Trypsin
pdb|1C9T|B Chain B, Complex Of Bdellastasin With Bovine Trypsin
pdb|1C9T|C Chain C, Complex Of Bdellastasin With Bovine Trypsin
pdb|1C9T|D Chain D, Complex Of Bdellastasin With Bovine Trypsin
pdb|1C9T|E Chain E, Complex Of Bdellastasin With Bovine Trypsin
pdb|1C9T|F Chain F, Complex Of Bdellastasin With Bovine Trypsin
pdb|1QL7|A Chain A, Factor Xa Specific Inhibitor In Complex With Bovine
Trypsin
pdb|1QL8|A Chain A, Factor Xa Specific Inhibitor In Complex With Bovine
Trypsin
pdb|1G9I|E Chain E, Crystal Structure Of Beta-Trysin Complex In Cyclohexane
pdb|1EJM|A Chain A, Crystal Structure Of The Bpti Ala16leu Mutant In Complex
With Bovine Trypsin
pdb|1EJM|C Chain C, Crystal Structure Of The Bpti Ala16leu Mutant In Complex
With Bovine Trypsin
pdb|1EJM|E Chain E, Crystal Structure Of The Bpti Ala16leu Mutant In Complex
With Bovine Trypsin
pdb|1JIR|A Chain A, Crystal Structure Of Trypsin Complex With Amylamine In
Cyclohexane
pdb|1J8A|A Chain A, Crystal Structure Of Benzamidine Inhibited Bovine
Pancreatic Trypsin At 105k To 1.21a Resolution From
Laboratory Source With High Number Of Waters Modelled
pdb|1G36|A Chain A, Trypsin Inhibitor Complex
pdb|1K1P|A Chain A, Bovine Trypsin-Inhibitor Complex
pdb|1K1O|A Chain A, Bovine Trypsin-Inhibitor Complex
pdb|1K1N|A Chain A, Bovine Trypsin-Inhibitor Complex
pdb|1K1M|A Chain A, Bovine Trypsin-Inhibitor Complex
pdb|1K1L|A Chain A, Bovine Trypsin-Inhibitor Complex
pdb|1K1J|A Chain A, Bovine Trypsin-Inhibitor Complex
pdb|1K1I|A Chain A, Bovine Trypsin-Inhibitor Complex
pdb|1EB2|A Chain A, Trypsin Inhibitor Complex (Bpo)
pdb|1GJ6|A Chain A, Engineering Inhibitors Highly Selective For The S1 Sites
Of Ser190 Trypsin-Like Serine Protease Drug Targets
pdb|1N6X|A Chain A, Rip-Phasing On Bovine Trypsin
pdb|1N6Y|A Chain A, Rip-Phasing On Bovine Trypsin
pdb|1OYQ|A Chain A, Trypsin Inhibitor Complex
pdb|1O2H|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O2I|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O2J|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O2K|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O2L|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O2M|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O2N|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-directed Serine Protease
Inhibitors
pdb|1O2O|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O2P|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O2Q|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O2R|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O2S|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O2T|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O2U|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O2V|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O2W|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O2X|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O2Y|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O2Z|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O30|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O31|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-directed Serine Protease
Inhibitors
pdb|1O32|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O33|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O34|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O35|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-directed Serine Protease
Inhibitors
pdb|1O36|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-directed Serine Protease
Inhibitors
pdb|1O37|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O38|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O39|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O3A|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O3B|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O3C|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O3D|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O3E|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O3F|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O3G|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O3H|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O3I|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O3J|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O3K|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O3L|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O3M|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-directed Serine Protease
Inhibitors
pdb|1O3N|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O3O|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-directed Serine Protease
Inhibitors
pdb|1NC6|A Chain A, Potent, Small Molecule Inhibitors Of Human Mast Cell
Tryptase. Anti-Asthmatic Action Of A Dipeptide-Based
Transition State Analogue Containing Benzothiazole
Ketone
pdb|1P2I|A Chain A, Structural Consequences Of Accommodation Of Four Non-
Cognate Amino-Acid Residues In The S1 Pocket Of Bovine
Trypsin And Chymotrypsin
pdb|1P2J|A Chain A, Structural Consequences Of Accommodation Of Four Non-
Cognate Amino-Acid Residues In The S1 Pocket Of Bovine
Trypsin And Chymotrypsin
pdb|1P2K|A Chain A, Structural Consequences Of Accommodation Of Four Non-
Cognate Amino-Acid Residues In The S1 Pocket Of Bovine
Trypsin And Chymotrypsin
pdb|1OX1|A Chain A, Crystal Structure Of The Bovine Trypsin Complex With A
Synthetic 11 Peptide Inhibitor
pdb|1RXP|A Chain A, Structure Of Trypsin (Orthorhombic) With 1-(4-Tert-
Butylcarbamoyl- Piperazine-1-Carbonyl)-3-(3-Guanidino-
Propyl)-4-Oxo-Azetidine-2-Carboxylic Acid
pdb|1S0Q|A Chain A, Native Bovine Pancreatic Trypsin
pdb|1S0R|A Chain A, Bovine Pancreatic Trypsin Inhibited With Benzamidine At
Atomic Resolution
pdb|2A7H|A Chain A, On The Routine Use Of Soft X-Rays In Macromolecular
Crystallography, Part Iii- The Optimal Data Collection
Wavelength
pdb|1TX7|A Chain A, Bovine Trypsin Complexed With P-
Amidinophenylmethylphosphinic Acid (Ampa)
pdb|2BLV|A Chain A, Trypsin Before A High Dose X-Ray "burn"
pdb|2BLW|A Chain A, Trypsin After A High Dose X-Ray "burn"
pdb|1TX8|A Chain A, Bovine Trypsin Complexed With Amso
pdb|1Y3U|A Chain A, Trypsin Inhibitor Complex
pdb|1Y3V|A Chain A, Trypsin Inhibitor Complex
pdb|1Y3W|A Chain A, Trypsin Inhibitor Complex
pdb|1Y3X|A Chain A, Trypsin Inhibitor Complex
pdb|1Y3Y|A Chain A, Trypsin Inhibitor Complex
pdb|1YP9|A Chain A, Trypsin Inhibitor Complex
pdb|2AYW|A Chain A, Crystal Structure Of The Complex Formed Between Trypsin
And A Designed Synthetic Highly Potent Inhibitor In The
Presence Of Benzamidine At 0.97 A Resolution
pdb|2FI3|E Chain E, Crystal Structure Of A Bpti Variant (Cys14->ser,
Cys38->ser) In Complex With Trypsin
pdb|2FX4|A Chain A, Bovine Trypsin Bound By 4-piperidinebutyrate To Make
Acylenzyme Complex
pdb|2FX6|A Chain A, Bovine Trypsin Complexed With 2-Aminobenzamidazole
pdb|2AGE|X Chain X, Succinyl-Aapr-Trypsin Acyl-Enzyme At 1.15 A Resolution
pdb|2AGG|X Chain X, Succinyl-Aapk-Trypsin Acyl-Enzyme At 1.28 A Resolution
pdb|2AGI|X Chain X, The Leupeptin-Trypsin Covalent Complex At 1.14 A
Resolution
pdb|2AH4|X Chain X, Guanidinobenzoyl-Trypsin Acyl-Enzyme At 1.13 A Resolution
pdb|2G5N|A Chain A, Indole-Amidine Complexes With Bovine Trypsin
pdb|2G5V|A Chain A, Indole-Amidine Complexes With Bovine Trypsin
pdb|2G8T|A Chain A, Indole-Amidine Complexes With Bovine Trypsin
pdb|2F3C|E Chain E, Crystal Structure Of Infestin 1, A Kazal-Type
Serineprotease Inhibitor, In Complex With Trypsin
pdb|2G81|E Chain E, Crystal Structure Of The Bowman-Birk Inhibitor From Vigna
Unguiculata Seeds In Complex With Beta-Trypsin At 1.55
Angstrons Resolution
pdb|2G55|A Chain A, Anomalous Substructure Of Trypsin (P3121)
pdb|2OTV|A Chain A, Crystal Structure Of The Complex Formed Between Bovine
Trypsin And Nicotinamide At 1.56 A Resolution
pdb|2J9N|A Chain A, Robotically Harvested Trypsin Complexed With Benzamidine
Containing Polypeptide Mediated Crystal Contacts
pdb|2OXS|A Chain A, Crytal Structure Of The Trypsin Complex With Benzamidine
At High Temperature (35 C)
pdb|2UUY|A Chain A, Structure Of A Tick Tryptase Inhibitor In Complex With
Bovine Trypsin
pdb|2ILN|A Chain A, Crystal Structure Of The Bowman-Birk Inhibitor From Snail
Medic Seeds In Complex With Bovine Trypsin
pdb|2ILN|B Chain B, Crystal Structure Of The Bowman-Birk Inhibitor From Snail
Medic Seeds In Complex With Bovine Trypsin
pdb|2CMY|A Chain A, Crystal Complex Between Bovine Trypsin And Veronica
Hederifolia Trypsin Inhibitor
pdb|1AQ7|A Chain A, Trypsin With Inhibitor Aeruginosin 98-b
pdb|1AUJ|A Chain A, Bovine Trypsin Complexed To Meta-Cyano-Benzylic Inhibitor
pdb|1AZ8|A Chain A, Bovine Trypsin Complexed To Bis-Phenylamidine Inhibitor
pdb|1BJU|A Chain A, Beta-Trypsin Complexed With Acpu
pdb|1BJV|A Chain A, Beta-Trypsin Complexed With Appu
pdb|1GBT|A Chain A, Structure Of An Acyl-Enzyme Intermediate During Catalysis:
(Guanidinobenzoyl) Trypsin
pdb|1MAX|A Chain A, Beta-Trypsin Phosphonate Inhibited
pdb|1MAY|A Chain A, Beta-Trypsin Phosphonate Inhibited
pdb|1MTS|A Chain A, Factor Xa Specific Inhibitor In Complex With Bovine
Trypsin
pdb|1MTU|A Chain A, Factor Xa Specific Inhibitor In Complex With Bovine
Trypsin
pdb|1MTV|A Chain A, Factor Xa Specific Inhibitor In Complex With Bovine
Trypsin
pdb|1MTW|A Chain A, Factor Xa Specific Inhibitor In Complex With Bovine
Trypsin
pdb|1TLD|A Chain A, Crystal Structure Of Bovine Beta-Trypsin At 1.5 Angstroms
Resolution In A Crystal Form With Low Molecular Packing
Density. Active Site Geometry, Ion Pairs And Solvent
Structure
pdb|1TPO|A Chain A, The Geometry Of The Reactive Site And Of The Peptide
Groups In Trypsin, Trypsinogen And Its Complexes With
Inhibitors
pdb|1TPP|A Chain A, The Geometry Of The Reactive Site And Of The Peptide
Groups In Trypsin, Trypsinogen And Its Complexes With
Inhibitors
pdb|1TPS|A Chain A, Atomic Structure Of The Trypsin-A90720a Complex: A Unified
Approach To Structure And Function
pdb|1TYN|A Chain A, Atomic Structure Of The Trypsin-cyclotheonamide A Complex:
Lessons For The Design Of Serine Protease Inhibitors
pdb|1XUF|A Chain A, Trypsin-Babim-Zn+2, Ph 8.2
pdb|1XUG|A Chain A, Trypsin-Babim-Zn+2, Ph 8.2
pdb|1XUH|A Chain A, Trypsin-Keto-Babim-Co+2, Ph 8.2
pdb|1XUI|A Chain A, Trypsin-Keto-Babim, Zn+2-Free, Ph 8.2
pdb|1XUJ|A Chain A, Trypsin-Keto-Babim-Zn+2, Ph 8.2
pdb|1XUK|A Chain A, Trypsin-Babim-Sulfate, Ph 5.9
pdb|2PLX|A Chain A, Trypsin Complexed To A Synthetic Peptide From Veronica
Hederifolia
pdb|2PTN|A Chain A, On The Disordered Activation Domain In Trypsinogen.
Chemical Labelling And Low-Temperature Crystallography
pdb|3PTB|A Chain A, The Geometry Of The Reactive Site And Of The Peptide
Groups In Trypsin, Trypsinogen And Its Complexes With
Inhibitors
pdb|3PTN|A Chain A, On The Disordered Activation Domain In Trypsinogen.
Chemical Labelling And Low-Temperature Crystallography
pdb|1C1N|A Chain A, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|1C1O|A Chain A, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|1C1P|A Chain A, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|1C1Q|A Chain A, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|1C1R|A Chain A, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|1C1T|A Chain A, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|1C2D|A Chain A, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|1C2E|A Chain A, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|1C2F|A Chain A, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|1C2G|A Chain A, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|1C2H|A Chain A, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|1C2I|A Chain A, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|1C2J|A Chain A, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|1C2K|A Chain A, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|1C2L|A Chain A, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|1C2M|A Chain A, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|1C5P|A Chain A, Structural Basis For Selectivity Of A Small Molecule, S1-
Binding, Sub-Micromolar Inhibitor Of Urokinase Type
Plasminogen Activator
pdb|1C5Q|A Chain A, Structural Basis For Selectivity Of A Small Molecule, S1-
Binding, Sub-Micromolar Inhibitor Of Urokinase Type
Plasminogen Activator
pdb|1C5R|A Chain A, Structural Basis For Selectivity Of A Small Molecule, S1-
Binding, Sub-Micromolar Inhibitor Of Urokinase Type
Plasminogen Activator
pdb|1C5S|A Chain A, Structural Basis For Selectivity Of A Small Molecule, S1-
Binding, Sub-Micromolar Inhibitor Of Urokinase Type
Plasminogen Activator
pdb|1C5T|A Chain A, Structural Basis For Selectivity Of A Small Molecule, S1-
Binding, Sub-Micromolar Inhibitor Of Urokinase Type
Plasminogen Activator
pdb|1C5U|A Chain A, Structural Basis For Selectivity Of A Small Molecule,
S1-Binding, Sub- Micromolar Inhibitor Of Urokinase Type
Plasminogen Activator
pdb|1C5V|A Chain A, Structural Basis For Selectivity Of A Small Molecule, S1-
Binding, Sub-Micromolar Inhibitor Of Urokinase Type
Plasminogen Activator
pdb|1GHZ|A Chain A, A Novel Serine Protease Inhibition Motif Involving A
Multi- Centered Short Hydrogen Bonding Network At The
Active Site
pdb|1GI0|A Chain A, A Novel Serine Protease Inhibition Motif Involving A
Multi-Centered Short Hydrogen Bonding Network At The
Active Site
pdb|1GI1|A Chain A, A Novel Serine Protease Inhibition Motif Involving A
Multi- Centered Short Hydrogen Bonding Network At The
Active Site
pdb|1GI2|A Chain A, A Novel Serine Protease Inhibition Motif Involving A
Multi- Centered Short Hydrogen Bonding Network At The
Active Site
pdb|1GI3|A Chain A, A Novel Serine Protease Inhibition Motif Involving A
Multi- Centered Short Hydrogen Bonding Network At The
Active Site
pdb|1GI4|A Chain A, A Novel Serine Protease Inhibition Motif Involving A
Multi- Centered Short Hydrogen Bonding Network At The
Active Site
pdb|1GI5|A Chain A, A Novel Serine Protease Inhibition Motif Involving A
Multi- Centered Short Hydrogen Bonding Network At The
Active Site
pdb|1GI6|A Chain A, A Novel Serine Protease Inhibition Motif Involving A
Multi- Centered Short Hydrogen Bonding Network At The
Active Site
pdb|2O9Q|A Chain A, The Crystal Structure Of Bovine Trypsin Complexed With A
Small Inhibition Peptide Orb2k
pdb|2QN5|T Chain T, Crystal Structure And Functional Study Of The Bowman-Birk
Inhibitor From Rice Bran In Complex With Bovine Trypsin
pdb|2QYI|A Chain A, Crystal Structure Of A Binary Complex Between An
Engineered Trypsin Inhibitor And Bovine Trypsin
pdb|2QYI|C Chain C, Crystal Structure Of A Binary Complex Between An
Engineered Trypsin Inhibitor And Bovine Trypsin
pdb|2ZDK|A Chain A, Exploring Trypsin S3 Pocket
pdb|2ZDL|A Chain A, Exploring Trypsin S3 Pocket
pdb|2ZDM|A Chain A, Exploring Trypsin S3 Pocket
pdb|2ZDN|A Chain A, Exploring Trypsin S3 Pocket
pdb|2ZFS|A Chain A, Exploring Trypsin S3 Pocket
pdb|2ZFT|A Chain A, Exploring Trypsin S3 Pocket
pdb|2ZHD|A Chain A, Exploring Trypsin S3 Pocket
pdb|3D65|E Chain E, Crystal Structure Of Textilinin-1, A Kunitz-Type Serine
Protease Inhibitor From The Australian Common Brown
Snake Venom, In Complex With Trypsin
pdb|3E8L|A Chain A, The Crystal Structure Of The Double-Headed Arrowhead
Protease Inhibitor A In Complex With Two Trypsins
pdb|3E8L|B Chain B, The Crystal Structure Of The Double-Headed Arrowhead
Protease Inhibitor A In Complex With Two Trypsins
pdb|2ZQ1|A Chain A, Exploring Trypsin S3 Pocket
pdb|2ZQ2|A Chain A, Exploring Trypsin S3 Pocket
pdb|3ITI|A Chain A, Structure Of Bovine Trypsin With The Mad Triangle B3c
pdb|3GY2|A Chain A, A Comparative Study On The Inhibition Of Bovine
Beta-Trypsin Benzamidines Diminazene And Pentamidine By
X-Ray Crystallog Itc
pdb|3GY3|A Chain A, A Comparative Study On The Inhibition Of Bovine
Beta-Trypsin Benzamidines Diminazene And Pentamidine By
X-Ray Crystallog Itc
pdb|3GY4|A Chain A, A Comparative Study On The Inhibition Of Bovine
Beta-Trypsin Benzamidines Diminazene And Pentamidine By
X-Ray Crystallog Itc
pdb|3GY5|A Chain A, A Comparative Study On The Inhibition Of Bovine
Beta-Trypsin Benzamidines Diminazene And Pentamidine By
X-Ray Crystallog Itc
pdb|3GY6|A Chain A, A Comparative Study On The Inhibition Of Bovine
Beta-Trypsin Bis-Benzamidines Diminazene And Pentamidine
pdb|3GY7|A Chain A, A Comparative Study On The Inhibition Of Bovine
Beta-Trypsin Benzamidines Diminazene And Pentamidine By
X-Ray Crystallog Itc
pdb|3GY8|A Chain A, A Comparative Study On The Inhibition Of Bovine
Beta-Trypsin Benzamidines Diminazene And Pentamidine By
X-Ray Crystallog Itc
pdb|3AAS|A Chain A, Bovine Beta-Trypsin Bound To Meta-Guanidino Schiff Base
Copper (Ii) Chelate
pdb|3AAU|A Chain A, Bovine Beta-Trypsin Bound To Meta-Diguanidino Schiff Base
Copper (Ii) Chelate
pdb|3AAV|A Chain A, Bovine Beta-Trypsin Bound To Meta-Diamidino Schiff Base
Copper (Ii) Chelate
pdb|3AAV|B Chain B, Bovine Beta-Trypsin Bound To Meta-Diamidino Schiff Base
Copper (Ii) Chelate
pdb|3M35|A Chain A, Trypsin In Complex With The Inhibitor 1-[3-(Aminomethyl)
Phenyl]-N-[3-Fluoro-2'-(Methylsulfonyl)biphenyl-4-Yl]-3-
(Trifluoromethyl)-1h-Pyrazole-5-Carboxamide (Dpc423)
pdb|3MFJ|A Chain A, Bovine Trypsin At 0.8 A Resolution, Restrained Refinement
pdb|3MI4|A Chain A, Bovine Trypsin At 0.8 A Resolution, Non-Restrained
Refinemen
pdb|3I29|A Chain A, Crystal Structure Of A Binary Complex Between An Mutant
Tryp Inhibitor With Bovine Trypsin
pdb|3A7T|A Chain A, Crystal Structure Of Trypsin Complexed With
4-Formylbenzimidamide
pdb|3A7V|A Chain A, Crystal Structure Of Trypsin Complexed With
3-Formylbenzimidamide
pdb|3A7W|A Chain A, Crystal Structure Of Trypsin Complexed With
(E)-4-((Tetrahydro-2h-
Pyran-2-Yloxyimino)methyl)benzimidamide (Soaking 4hours)
pdb|3A7X|A Chain A, Crystal Structure Of Trypsin Complexed With (E)-2-(4-
Carbamimidoylbenzylideneaminooxy)acetic Acid (Soaking
45seconds)
pdb|3A7Y|A Chain A, Crystal Structure Of Trypsin Complexed With
(E)-4-((1-Methylpiperidin-
3-Yloxyimino)methyl)benzimidamide (Soaking 2hours)
pdb|3A7Z|A Chain A, Crystal Structure Of Trypsin Complexed With
(E)-4-((1-Methylpiperidin-
4-Yloxyimino)methyl)benzimidamide (Soaking 3hours)
pdb|3A80|A Chain A, Crystal Structure Of Trypsin Complexed With (E)-2-(4-
Carbamimidoylbenzylideneaminooxy)-2-Methylpropanoic Acid
(Soaking 40seconds)
pdb|3A81|A Chain A, Crystal Structure Of Trypsin Complexed With (E)-4-((2-
Nicotinoylhydrazono)methyl)benzimidamide (Soaking 8
Hours)
pdb|3A82|A Chain A, Crystal Structure Of Trypsin Complexed With
Pre-Synthesized (E)-2-(4-
Carbamimidoylbenzylideneaminooxy)acetic Acid
pdb|3A83|A Chain A, Crystal Structure Of Trypsin Complexed With
Pre-Synthesized (E)-4-((2-
Nicotinoylhydrazono)methyl)benzimidamide
pdb|3A84|A Chain A, Crystal Structure Of Trypsin Complexed With(E)-2-(4-
Carbamimidoylbenzylideneaminooxy)acetic Acid (Soaking 5
Seconds)
pdb|3A85|A Chain A, Crystal Structure Of Trypsin Complexed With (E)-2-(4-
Carbamimidoylbenzylideneaminooxy)acetic Acid (Soaking 15
Seconds)
pdb|3A86|A Chain A, Crystal Structure Of Trypsin Complexed With (E)-2-(4-
Carbamimidoylbenzylideneaminooxy)acetic Acid (Soaking 30
Seconds)
pdb|3A87|A Chain A, Crystal Structure Of Trypsin Complexed With (E)-4-((2-
Nicotinoylhydrazono)methyl)benzimidamide (Soaking 5
Minutes)
pdb|3A88|A Chain A, Crystal Structure Of Trypsin Complexed With (E)-4-((2-
Nicotinoylhydrazono)methyl)benzimidamide (Soaking 30
Minutes)
pdb|3A89|A Chain A, Crystal Structure Of Trypsin Complexed With (E)-4-((2-
Nicotinoylhydrazono)methyl)benzimidamide (Soaking 4
Hours)
pdb|3A8A|A Chain A, Crystal Structure Of Trypsin Complexed With
4-Formylbenzimidamide And Aniline
pdb|3A8B|A Chain A, Crystal Structure Of Trypsin Complexed With (E)-4-((4-
Bromophenylimino)methyl)benzimidamide
pdb|3A8C|A Chain A, Crystal Structure Of Trypsin Complexed With (E)-2-(4-
Carbamimidoylbenzylideneaminooxy)acetic Acid (Soaking
With Mixture Of
[(E)-2-(4-Carbamimidoylbenzylideneaminooxy)acetic Acid]
And [(E)-2-
(4-Carbamimidoylbenzylideneaminooxy)-2-Methylpropanoic
Acid])
pdb|3A8D|A Chain A, Crystal Structure Of Trypsin Complexed With (E)-2-(4-
Carbamimidoylbenzylideneaminooxy)acetic Acid (Under
Aniline-Free Condition)
pdb|3LJJ|A Chain A, Bovine Trypsin In Complex With Ub-Thr 10
pdb|3LJO|A Chain A, Bovine Trypsin In Complex With Ub-Thr 11
pdb|2XTT|B Chain B, Bovine Trypsin In Complex With Evolutionary Enhanced
Schistocerca Gregaria Protease Inhibitor 1 (Sgpi-1-P02)
pdb|3NK8|A Chain A, Trypsin In Complex With Fluorine-Containing Fragment
pdb|3NKK|A Chain A, Trypsin In Complex With Fluorine Containing Fragment
pdb|3M7Q|A Chain A, Crystal Structure Of Recombinant Kunitz Type Serine
Protease Inhibitor-1 From The Caribbean Sea Anemone
Stichodactyla Helianthus In Complex With Bovine
Pancreatic Trypsin
pdb|3RDZ|A Chain A, Crystal Structure Of Rbti-Trypsin Complex At 2.26 Angstrom
Resolution
pdb|3RDZ|B Chain B, Crystal Structure Of Rbti-Trypsin Complex At 2.26 Angstrom
Resolution
pdb|3ATI|A Chain A, Crystal Structure Of Trypsin Complexed With
(3-Methoxyphenyl) Methanamine
pdb|3ATK|A Chain A, Crystal Structure Of Trypsin Complexed With
Cycloheptanamine
pdb|3ATL|A Chain A, Crystal Structure Of Trypsin Complexed With Benzamidine
pdb|3ATM|A Chain A, Crystal Structure Of Trypsin Complexed With
2-(1h-Indol-3-Yl) Ethanamine
pdb|3RXA|A Chain A, Crystal Structure Of Trypsin Complexed With
Cycloheptanamine
pdb|3RXB|A Chain A, Crystal Structure Of Trypsin Complexed With
4-Guanidinobutanoic Acid
pdb|3RXC|A Chain A, Crystal Structure Of Trypsin Complexed With
2-Aminopyridine
pdb|3RXD|A Chain A, Crystal Structure Of Trypsin Complexed With
(3-Methoxyphenyl) Methanamine
pdb|3RXE|A Chain A, Crystal Structure Of Trypsin Complexed With Benzamide
pdb|3RXF|A Chain A, Crystal Structure Of Trypsin Complexed With
4-Aminopyridine
pdb|3RXG|A Chain A, Crystal Structure Of Trypsin Complexed With
4-Aminocyclohexanol
pdb|3RXH|A Chain A, Crystal Structure Of Trypsin Complexed With
2-(1h-Imidazol-4-Yl) Ethanamine
pdb|3RXI|A Chain A, Crystal Structure Of Trypsin Complexed With
2-(1h-Indol-3-Yl) Ethanamine
pdb|3RXJ|A Chain A, Crystal Structure Of Trypsin Complexed With
4-Guanidinobenzoic Acid
pdb|3RXK|A Chain A, Crystal Structure Of Trypsin Complexed With Methyl
4-Amino-1-Methyl- Pyrrolidine-2-Carboxylate
pdb|3RXL|A Chain A, Crystal Structure Of Trypsin Complexed With
(2,5-Dimethyl-3-Furyl) Methanamine
pdb|3RXM|A Chain A, Crystal Structure Of Trypsin Complexed With
[2-(2-Thienyl)thiazol-4- Yl]methanamine
pdb|3RXO|A Chain A, Crystal Structure Of Trypsin Complexed With
(3-Pyrrol-1-Ylphenyl) Methanamine
pdb|3RXP|A Chain A, Crystal Structure Of Trypsin Complexed With
(1,5-Dimethylpyrazol-3- Yl)methanamine
pdb|3RXQ|A Chain A, Crystal Structure Of Trypsin Complexed With Benzamide (F01
And F05, Cocktail Experiment)
pdb|3RXR|A Chain A, Crystal Structure Of Trypsin Complexed With
Cycloheptanamine (F01 And F03, Cocktail Experiment)
pdb|3RXS|A Chain A, Crystal Structure Of Trypsin Complexed With
(3-Methoxyphenyl) Methanamine (F04 And A06, Cocktail
Experiment)
pdb|3RXT|A Chain A, Crystal Structure Of Trypsin Complexed With
(3-Methoxyphenyl) Methanamin (F04 And F03, Cocktail
Experiment)
pdb|3RXU|A Chain A, Crystal Structure Of Trypsin Complexed With Benzamide (F05
And A06, Cocktail Experiment)
pdb|3RXV|A Chain A, Crystal Structure Of Trypsin Complexed With Benzamide (F05
And F03, Cocktail Experiment)
pdb|3T25|A Chain A, Tmao-Grown Orthorhombic Trypsin (Bovine)
pdb|3T26|A Chain A, Orthorhombic Trypsin (Bovine) In The Presence Of Sarcosine
pdb|3T27|A Chain A, Orthorhombic Trypsin (Bovine) In The Presence Of Betaine
pdb|3T28|A Chain A, Tmao-Grown Trypsin (Bovine)-Previously Unreported
Tetragonal Crystal Form
pdb|3T29|A Chain A, Tmao-Grown Trigonal Trypsin (Bovine)
pdb|4AB8|A Chain A, Fragments Bound To Bovine Trypsin For The Sampl Challenge
pdb|4AB9|A Chain A, Fragments Bound To Bovine Trypsin For The Sampl Challenge
pdb|4ABA|A Chain A, Fragments Bound To Bovine Trypsin For The Sampl Challenge
pdb|4ABB|A Chain A, Fragments Bound To Bovine Trypsin For The Sampl Challenge
pdb|4ABD|A Chain A, Fragments Bound To Bovine Trypsin For The Sampl Challenge
pdb|4ABE|A Chain A, Fragments Bound To Bovine Trypsin For The Sampl Challenge
pdb|4ABF|A Chain A, Fragments Bound To Bovine Trypsin For The Sampl Challenge
pdb|4ABG|A Chain A, Fragments Bound To Bovine Trypsin For The Sampl Challenge
pdb|4ABH|A Chain A, Fragments Bound To Bovine Trypsin For The Sampl Challenge
pdb|4ABI|A Chain A, Co-Complex Structure Of Bovine Trypsin With A Modified
Bowman-Birk Inhibitor (Pta)sfti-1(1,14), That Was 1,4-
Disubstituted With A 1,2,3-Trizol To Mimic A Trans Amide
Bond
pdb|4ABJ|A Chain A, Co-Complex Structure Of Bovine Trypsin With A Modified
Bowman-Birk Inhibitor (Ica)sfti-1(1,14), That Was 1,5-
Disubstituted With 1,2,3-Trizol To Mimic A Cis Amide
Bond
pdb|3VPK|A Chain A, Crystal Structure Of 6-guanidinohexanoyl Trypsin
pdb|3UNR|A Chain A, Bond Length Analysis Of Asp, Glu And His Residues In
Trypsin At 1.2a Resolution
pdb|3RU4|T Chain T, Crystal Structure Of The Bowman-Birk Serine Protease
Inhibitor Btci In Complex With Trypsin And Chymotrypsin
pdb|1C1S|A Chain A, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|4I8G|A Chain A, Bovine Trypsin At 0.8 Resolution
pdb|4I8H|A Chain A, Bovine Trypsin At 0.75 Resolution
pdb|4I8J|A Chain A, Bovine Trypsin At 0.87 A Resolution
pdb|4I8K|A Chain A, Bovine Trypsin At 0.85 Resolution
pdb|4I8L|A Chain A, Bovine Trypsin At 0.87 Resolution
pdb|4AOQ|A Chain A, Cationic Trypsin In Complex With Mutated Spinacia Oleracea
Trypsin Inhibitor Iii (soti-iii) (f14a)
pdb|4AOQ|B Chain B, Cationic Trypsin In Complex With Mutated Spinacia Oleracea
Trypsin Inhibitor Iii (soti-iii) (f14a)
pdb|4AOQ|C Chain C, Cationic Trypsin In Complex With Mutated Spinacia Oleracea
Trypsin Inhibitor Iii (soti-iii) (f14a)
pdb|4AOR|A Chain A, Cationic Trypsin In Complex With The Spinacia Oleracea
Trypsin Inhibitor Iii (soti-iii)
pdb|4AOR|B Chain B, Cationic Trypsin In Complex With The Spinacia Oleracea
Trypsin Inhibitor Iii (soti-iii)
pdb|4AOR|C Chain C, Cationic Trypsin In Complex With The Spinacia Oleracea
Trypsin Inhibitor Iii (soti-iii)
Length = 223
Score = 51.2 bits (121), Expect = 5e-07, Method: Compositional matrix adjust.
Identities = 65/218 (29%), Positives = 90/218 (41%), Gaps = 43/218 (19%)
Query: 32 VPYIVSLSLYGNLYCGGSLISLQWFLSARHCFVT--------ENLVWNQFNPLIIAGSIY 83
VPY VSL+ G +CGGSLI+ QW +SA HC+ + +N+ + N I+ S
Sbjct: 12 VPYQVSLN-SGYHFCGGSLINSQWVVSAAHCYKSGIQVRLGEDNINVVEGNEQFISASKS 70
Query: 84 RNYKEQKRQPQLNEIALIYWHSDADL----AMVKLKEPFRQT---TFVKPLDYYTARETN 136
+ N+I LI S A L A + L + + T+
Sbjct: 71 IVHPSYNSNTLNNDIMLIKLKSAASLNSRVASISLPTSCASAGTQCLISGWGNTKSSGTS 130
Query: 137 YINDVLSK------TDRSEMSI--------------VSGFGVTFQRDKDGIVSWGIGCAL 176
Y DVL +D S S + G + Q D G V C+
Sbjct: 131 YP-DVLKCLKAPILSDSSCKSAYPGQITSNMFCAGYLEGGKDSCQGDSGGPVV----CSG 185
Query: 177 GYPGIVSWGIGCAL-GYPGVYVRVDHYDPWI-QSVKNN 212
GIVSWG GCA PGVY +V +Y WI Q++ +N
Sbjct: 186 KLQGIVSWGSGCAQKNKPGVYTKVCNYVSWIKQTIASN 223
>pdb|2FI4|E Chain E, Crystal Structure Of A Bpti Variant (Cys14->ser) In
Complex With Trypsin
pdb|2FTL|E Chain E, Crystal Structure Of Trypsin Complexed With Bpti At 100k
Length = 223
Score = 51.2 bits (121), Expect = 5e-07, Method: Compositional matrix adjust.
Identities = 65/218 (29%), Positives = 90/218 (41%), Gaps = 43/218 (19%)
Query: 32 VPYIVSLSLYGNLYCGGSLISLQWFLSARHCFVT--------ENLVWNQFNPLIIAGSIY 83
VPY VSL+ G +CGGSLI+ QW +SA HC+ + +N+ + N I+ S
Sbjct: 12 VPYQVSLN-SGYHFCGGSLINSQWVVSAAHCYKSGIQVRLGEDNINVVEGNEQFISASKS 70
Query: 84 RNYKEQKRQPQLNEIALIYWHSDADL----AMVKLKEPFRQT---TFVKPLDYYTARETN 136
+ N+I LI S A L A + L + + T+
Sbjct: 71 IVHPSYNSNTLNNDIMLIKLKSAASLXSRVASISLPTSCASAGTQCLISGWGNTKSSGTS 130
Query: 137 YINDVLSK------TDRSEMSI--------------VSGFGVTFQRDKDGIVSWGIGCAL 176
Y DVL +D S S + G + Q D G V C+
Sbjct: 131 YP-DVLKCLKAPILSDSSCKSAYPGQITSNMFCAGYLEGGKDSCQGDSGGPVV----CSG 185
Query: 177 GYPGIVSWGIGCAL-GYPGVYVRVDHYDPWI-QSVKNN 212
GIVSWG GCA PGVY +V +Y WI Q++ +N
Sbjct: 186 KLQGIVSWGSGCAQKNKPGVYTKVCNYVSWIKQTIASN 223
>pdb|1G3B|A Chain A, Bovine Beta-Trypsin Bound To Meta-Amidino Schiff Base
Magnesium(Ii) Chelate
pdb|1G3C|A Chain A, Bovine Beta-Trypsin Bound To Para-Amidino Schiff Base
Iron(Iii) Chelate
pdb|1G3D|A Chain A, Bovine Beta-Trypsin Bound To Meta-Amidino Schiff Base
Copper (Ii) Chelate
pdb|1G3E|A Chain A, Bovine Beta-Trypsin Bound To Para-Amidino Schiff-Base
Copper (Ii) Chelate
Length = 228
Score = 51.2 bits (121), Expect = 5e-07, Method: Compositional matrix adjust.
Identities = 65/218 (29%), Positives = 90/218 (41%), Gaps = 43/218 (19%)
Query: 32 VPYIVSLSLYGNLYCGGSLISLQWFLSARHCFVT--------ENLVWNQFNPLIIAGSIY 83
VPY VSL+ G +CGGSLI+ QW +SA HC+ + +N+ + N I+ S
Sbjct: 17 VPYQVSLN-SGYHFCGGSLINSQWVVSAAHCYKSGIQVRLGEDNINVVEGNEQFISASKS 75
Query: 84 RNYKEQKRQPQLNEIALIYWHSDADL----AMVKLKEPFRQT---TFVKPLDYYTARETN 136
+ N+I LI S A L A + L + + T+
Sbjct: 76 IVHPSYNSNTLNNDIMLIKLKSAASLNSRVASISLPTSCASAGTQCLISGWGNTKSSGTS 135
Query: 137 YINDVLSK------TDRSEMSI--------------VSGFGVTFQRDKDGIVSWGIGCAL 176
Y DVL +D S S + G + Q D G V C+
Sbjct: 136 YP-DVLKCLKAPILSDSSCKSAYPGQITSNMFCAGYLEGGKDSCQGDSGGPVV----CSG 190
Query: 177 GYPGIVSWGIGCAL-GYPGVYVRVDHYDPWI-QSVKNN 212
GIVSWG GCA PGVY +V +Y WI Q++ +N
Sbjct: 191 KLQGIVSWGSGCAQKNKPGVYTKVCNYVSWIKQTIASN 228
>pdb|2D8W|A Chain A, Structure Of Hyper-Vil-Trypsin
Length = 223
Score = 51.2 bits (121), Expect = 5e-07, Method: Compositional matrix adjust.
Identities = 62/217 (28%), Positives = 89/217 (41%), Gaps = 41/217 (18%)
Query: 32 VPYIVSLSLYGNLYCGGSLISLQWFLSARHCFVT--------ENLVWNQFNPLIIAGSIY 83
VPY VSL+ G +CGGSLI+ QW +SA HC + +N+ + N I+ S
Sbjct: 12 VPYQVSLN-SGYHFCGGSLINSQWVVSAAHCXKSGIQVRLGEDNINVVEGNEQFISASKS 70
Query: 84 RNYKEQKRQPQLNEIALIYWHSDADL----AMVKLKEPF--------------RQTTFVK 125
+ N+I LI S A L A + L +++
Sbjct: 71 IVHPSYNSNTLNNDIMLIKLKSAASLNSRVASISLPTSCASAGTQCLISGWGNTKSSGTS 130
Query: 126 PLDYYTARETNYINDVLSKTD-----RSEM---SIVSGFGVTFQRDKDGIVSWGIGCALG 177
D + ++D K+ S M + G + Q D G V C+
Sbjct: 131 XPDVLKCLKAPILSDSSCKSAYPGQITSNMFCAGXLEGGKDSCQGDSGGPVV----CSGK 186
Query: 178 YPGIVSWGIGCAL-GYPGVYVRVDHYDPWI-QSVKNN 212
GIVSWG GCA PGVY +V +Y WI Q++ +N
Sbjct: 187 LQGIVSWGSGCAQKNKPGVYTKVCNYVSWIKQTIASN 223
>pdb|1TGS|Z Chain Z, Three-Dimensional Structure Of The Complex Between
Pancreatic Secretory Inhibitor (Kazal Type) And
Trypsinogen At 1.8 Angstroms Resolution. Structure
Solution, Crystallographic Refinement And Preliminary
Structural Interpretation
pdb|2TGP|Z Chain Z, The Geometry Of The Reactive Site And Of The Peptide
Groups In Trypsin, Trypsinogen And Its Complexes With
Inhibitors
pdb|2TPI|Z Chain Z, On The Disordered Activation Domain In Trypsinogen.
Chemical Labelling And Low-Temperature Crystallography
pdb|3TPI|Z Chain Z, The Geometry Of The Reactive Site And Of The Peptide
Groups In Trypsin, Trypsinogen And Its Complexes With
Inhibitors
pdb|4TPI|Z Chain Z, The Refined 2.2-angstroms (0.22-nm) X-ray Crystal
Structure Of The Ternary Complex Formed By Bovine
Trypsinogen, Valine-valine And The Arg15 Analogue Of
Bovine Pancreatic Trypsin Inhibitor
pdb|1BTZ|A Chain A, Episelection: Novel Ki ~nanomolar Inhibitors Of Serine
Proteases Selected By Binding Or Chemistry On An Enzyme
Surface
pdb|1BTX|A Chain A, Episelection: Novel Ki ~nanomolar Inhibitors Of Serine
Proteases Selected By Binding Or Chemistry On An Enzyme
Surface
pdb|1BTW|A Chain A, Episelection: Novel Ki ~nanomolar Inhibitors Of Serine
Proteases Selected By Binding Or Chemistry On An Enzyme
Surface
pdb|1BTP|A Chain A, Unique Binding Of A Novel Synthetic Inhibitor, N-[3-[4-[4-
(Amidinophenoxy)-Carbonyl]phenyl]-2-Methyl-2-Propenoyl]-
N- Allylglycine Methanesulfonate To Bovine Trypsin,
Revealed By The Crystal Structure Of The Complex
pdb|1BTY|A Chain A, Crystal Structure Of Beta-Trypsin In Complex With
Benzamidine
pdb|1TGB|A Chain A, Crystal Structure Of Bovine Trypsinogen At 1.8 Angstroms
Resolution. Ii. Crystallographic Refinement, Refined
Crystal Structure And Comparison With Bovine Trypsin
pdb|1TGC|A Chain A, On The Disordered Activation Domain In Trypsinogen.
Chemical Labelling And Low-Temperature Crystallography
pdb|1TGN|A Chain A, Structure Of Bovine Trypsinogen At 1.9 Angstroms
Resolution
pdb|1TGT|A Chain A, On The Disordered Activation Domain In Trypsinogen.
Chemical Labelling And Low-Temperature Crystallography
pdb|1TNG|A Chain A, Prediction Of Novel Serine Protease Inhibitors
pdb|1TNH|A Chain A, Prediction Of Novel Serine Protease Inhibitors
pdb|1TNI|A Chain A, Prediction Of Novel Serine Protease Inhibitors
pdb|1TNJ|A Chain A, Prediction Of Novel Serine Protease Inhibitors
pdb|1TNK|A Chain A, Prediction Of Novel Serine Protease Inhibitors
pdb|1TNL|A Chain A, Prediction Of Novel Serine Protease Inhibitors
pdb|2TGA|A Chain A, On The Disordered Activation Domain In Trypsinogen.
Chemical Labelling And Low-Temperature Crystallography
pdb|2TGD|A Chain A, Lack Of The Transition State Stabilization Site Is A
Factor In The Inactivity Of Trypsinogen, A Serine
Protease Zymogen. Structure Of Dfp Inhibited Bovine
Trypsinogen At 2.1 Angstroms Resolution
pdb|2TGT|A Chain A, On The Disordered Activation Domain In Trypsinogen.
Chemical Labelling And Low-Temperature Crystallography
Length = 229
Score = 51.2 bits (121), Expect = 6e-07, Method: Compositional matrix adjust.
Identities = 65/218 (29%), Positives = 90/218 (41%), Gaps = 43/218 (19%)
Query: 32 VPYIVSLSLYGNLYCGGSLISLQWFLSARHCFVT--------ENLVWNQFNPLIIAGSIY 83
VPY VSL+ G +CGGSLI+ QW +SA HC+ + +N+ + N I+ S
Sbjct: 18 VPYQVSLN-SGYHFCGGSLINSQWVVSAAHCYKSGIQVRLGEDNINVVEGNEQFISASKS 76
Query: 84 RNYKEQKRQPQLNEIALIYWHSDADL----AMVKLKEPFRQT---TFVKPLDYYTARETN 136
+ N+I LI S A L A + L + + T+
Sbjct: 77 IVHPSYNSNTLNNDIMLIKLKSAASLNSRVASISLPTSCASAGTQCLISGWGNTKSSGTS 136
Query: 137 YINDVLSK------TDRSEMSI--------------VSGFGVTFQRDKDGIVSWGIGCAL 176
Y DVL +D S S + G + Q D G V C+
Sbjct: 137 YP-DVLKCLKAPILSDSSCKSAYPGQITSNMFCAGYLEGGKDSCQGDSGGPVV----CSG 191
Query: 177 GYPGIVSWGIGCAL-GYPGVYVRVDHYDPWI-QSVKNN 212
GIVSWG GCA PGVY +V +Y WI Q++ +N
Sbjct: 192 KLQGIVSWGSGCAQKNKPGVYTKVCNYVSWIKQTIASN 229
>pdb|1OPH|B Chain B, Non-Covalent Complex Between Alpha-1-Pi-Pittsburgh And
S195a Trypsin
Length = 243
Score = 50.8 bits (120), Expect = 6e-07, Method: Compositional matrix adjust.
Identities = 62/214 (28%), Positives = 89/214 (41%), Gaps = 35/214 (16%)
Query: 32 VPYIVSLSLYGNLYCGGSLISLQWFLSARHCFVT--------ENLVWNQFNPLIIAGSIY 83
VPY VSL+ G +CGGSLI+ QW +SA HC+ + +N+ + N I+ S
Sbjct: 32 VPYQVSLN-SGYHFCGGSLINSQWVVSAAHCYKSGIQVRLGEDNINVVEGNEQFISASKS 90
Query: 84 RNYKEQKRQPQLNEIALIYWHSDADL----AMVKLKEPFRQT---TFVKPLDYYTARETN 136
+ N+I LI S A L A + L + + T+
Sbjct: 91 IVHPSYNSNTLNNDIMLIKLKSAASLNSRVASISLPTSCASAGTQCLISGWGNTKSSGTS 150
Query: 137 YINDVLSK------TDRSEMS----------IVSGFGVTFQRDKDGIVSWGIGCALGYPG 180
Y DVL +D S S +G+ + G + C+ G
Sbjct: 151 Y-PDVLKCLKAPILSDSSCKSAYPGQITSNMFCAGYLEGGKDSCQGDAGGPVVCSGKLQG 209
Query: 181 IVSWGIGCAL-GYPGVYVRVDHYDPWI-QSVKNN 212
IVSWG GCA PGVY +V +Y WI Q++ +N
Sbjct: 210 IVSWGSGCAQKNKPGVYTKVCNYVSWIKQTIASN 243
>pdb|1F0T|A Chain A, Bovine Trypsin Complexed With Rpr131247
pdb|1F0U|A Chain A, Bovine Trypsin Complexed With Rpr128515
pdb|1EZX|C Chain C, Crystal Structure Of A Serpin:protease Complex
pdb|1LQE|A Chain A, Crystal Structure Of Trypsin In Complex With 79.
pdb|1UTN|A Chain A, Trypsin Specificity As Elucidated By Lie Calculations,
X-Ray Structures And Association Constant Measurements
pdb|1UTO|A Chain A, Trypsin Specificity As Elucidated By Lie Calculations,
X-ray Structures And Association Constant Measurements
pdb|1UTP|A Chain A, Trypsin Specificity As Elucidated By Lie Calculations,
X-Ray Structures And Association Constant Measurements
pdb|1UTQ|A Chain A, Trypsin Specificity As Elucidated By Lie Calculations,
X-Ray Structures And Association Constant Measurements
pdb|2BY5|X Chain X, Is Radiation Damage Dependent On The Dose-Rate Used During
Macromolecular Crystallography Data Collection
pdb|2BY6|X Chain X, Is Radiation Damage Dependent On The Dose-Rate Used During
Macromolecular Crystallography Data Collection
pdb|2BY7|X Chain X, Is Radiation Damage Dependent On The Dose-Rate Used During
Macromolecular Crystallography Data Collection
pdb|2BY8|X Chain X, Is Radiation Damage Dependent On The Dose-Rate Used During
Macromolecular Crystallography Data Collection
pdb|2BY9|X Chain X, Is Radiation Damage Dependent On The Dose-Rate Used During
Macromolecular Crystallography Data Collection
pdb|2BYA|X Chain X, Is Radiation Damage Dependent On The Dose-Rate Used During
Macromolecular Crystallography Data Collection
Length = 243
Score = 50.8 bits (120), Expect = 6e-07, Method: Compositional matrix adjust.
Identities = 65/218 (29%), Positives = 90/218 (41%), Gaps = 43/218 (19%)
Query: 32 VPYIVSLSLYGNLYCGGSLISLQWFLSARHCFVT--------ENLVWNQFNPLIIAGSIY 83
VPY VSL+ G +CGGSLI+ QW +SA HC+ + +N+ + N I+ S
Sbjct: 32 VPYQVSLN-SGYHFCGGSLINSQWVVSAAHCYKSGIQVRLGEDNINVVEGNEQFISASKS 90
Query: 84 RNYKEQKRQPQLNEIALIYWHSDADL----AMVKLKEPFRQT---TFVKPLDYYTARETN 136
+ N+I LI S A L A + L + + T+
Sbjct: 91 IVHPSYNSNTLNNDIMLIKLKSAASLNSRVASISLPTSCASAGTQCLISGWGNTKSSGTS 150
Query: 137 YINDVLSK------TDRSEMSI--------------VSGFGVTFQRDKDGIVSWGIGCAL 176
Y DVL +D S S + G + Q D G V C+
Sbjct: 151 Y-PDVLKCLKAPILSDSSCKSAYPGQITSNMFCAGYLEGGKDSCQGDSGGPVV----CSG 205
Query: 177 GYPGIVSWGIGCAL-GYPGVYVRVDHYDPWI-QSVKNN 212
GIVSWG GCA PGVY +V +Y WI Q++ +N
Sbjct: 206 KLQGIVSWGSGCAQKNKPGVYTKVCNYVSWIKQTIASN 243
>pdb|3OTJ|E Chain E, A Crystal Structure Of Trypsin Complexed With Bpti (Bovine
Pancreatic Trypsin Inhibitor) By X-RayNEUTRON JOINT
REFINEMENT
Length = 223
Score = 50.8 bits (120), Expect = 6e-07, Method: Compositional matrix adjust.
Identities = 63/212 (29%), Positives = 86/212 (40%), Gaps = 42/212 (19%)
Query: 32 VPYIVSLSLYGNLYCGGSLISLQWFLSARHCFVT--------ENLVWNQFNPLIIAGSIY 83
VPY VSL+ G +CGGSLI+ QW +SA HC+ + +N+ + N I+ S
Sbjct: 12 VPYQVSLN-SGYHFCGGSLINSQWVVSAAHCYKSGIQVRLGEDNINVVEGNEQFISASKS 70
Query: 84 RNYKEQKRQPQLNEIALIYWHSDADL----AMVKLKEPFRQT---TFVKPLDYYTARETN 136
+ N+I LI S A L A + L + + T+
Sbjct: 71 IVHPSYNSNTLNNDIMLIKLKSAASLNSRVASISLPTSCASAGTQCLISGWGNTKSSGTS 130
Query: 137 YINDVLSK------TDRSEMSI--------------VSGFGVTFQRDKDGIVSWGIGCAL 176
Y DVL +D S S + G + Q D G V C+
Sbjct: 131 YP-DVLKCLKAPILSDSSCKSAYPGQITSNMFCAGYLEGGKDSCQGDSGGPVV----CSG 185
Query: 177 GYPGIVSWGIGCAL-GYPGVYVRVDHYDPWIQ 207
GIVSWG GCA PGVY +V +Y WI+
Sbjct: 186 KLQGIVSWGSGCAQKNKPGVYTKVCNYVSWIK 217
>pdb|5PTP|A Chain A, Structure Of Hydrolase (Serine Proteinase)
Length = 223
Score = 50.8 bits (120), Expect = 6e-07, Method: Compositional matrix adjust.
Identities = 65/218 (29%), Positives = 90/218 (41%), Gaps = 43/218 (19%)
Query: 32 VPYIVSLSLYGNLYCGGSLISLQWFLSARHCFVT--------ENLVWNQFNPLIIAGSIY 83
VPY VSL+ G +CGGSLI+ QW +SA HC+ + +N+ + N I+ S
Sbjct: 12 VPYQVSLN-SGYHFCGGSLINSQWVVSAAHCYKSGIQVRLGEDNINVVEGNEQFISASKS 70
Query: 84 RNYKEQKRQPQLNEIALIYWHSDADL----AMVKLKEPFRQT---TFVKPLDYYTARETN 136
+ N+I LI S A L A + L + + T+
Sbjct: 71 IVHPSYNSNTLNNDIMLIKLKSAASLNSRVASISLPTSCASAGTQCLISGWGNTKSSGTS 130
Query: 137 YINDVLSK------TDRSEMSI--------------VSGFGVTFQRDKDGIVSWGIGCAL 176
Y DVL +D S S + G + Q D G V C+
Sbjct: 131 YP-DVLKCLKAPILSDSSCKSAYPGQITSNMFCAGYLEGGKDSCQGDXGGPVV----CSG 185
Query: 177 GYPGIVSWGIGCAL-GYPGVYVRVDHYDPWI-QSVKNN 212
GIVSWG GCA PGVY +V +Y WI Q++ +N
Sbjct: 186 KLQGIVSWGSGCAQKNKPGVYTKVCNYVSWIKQTIASN 223
>pdb|1NTP|A Chain A, Use Of The Neutron Diffraction HD EXCHANGE TECHNIQUE TO
Determine The Conformational Dynamics Of Trypsin
Length = 223
Score = 50.1 bits (118), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 62/212 (29%), Positives = 86/212 (40%), Gaps = 42/212 (19%)
Query: 32 VPYIVSLSLYGNLYCGGSLISLQWFLSARHCFVT--------ENLVWNQFNPLIIAGSIY 83
VPY VSL+ G +CGGSLI QW +SA HC+ + +N+ + N I+ S
Sbjct: 12 VPYQVSLN-SGYHFCGGSLIDSQWVVSAAHCYKSGIQVRLGEDNINVVEGNEQFISASKS 70
Query: 84 RNYKEQKRQPQLNEIALIYWHS----DADLAMVKLKEPFRQT---TFVKPLDYYTARETN 136
+ N+I LI S D+ +A + L + + T+
Sbjct: 71 IVHPSYDSNTLNNDIMLIKLKSAASLDSRVASISLPTSCASAGTQCLISGWGNTKSSGTS 130
Query: 137 YINDVLSK------TDRSEMSI--------------VSGFGVTFQRDKDGIVSWGIGCAL 176
Y DVL +D S S + G + Q D G V C+
Sbjct: 131 Y-PDVLKCLKAPILSDSSCKSAYPGQITSNMFCAGYLEGGKDSCQGDSGGPVV----CSG 185
Query: 177 GYPGIVSWGIGCAL-GYPGVYVRVDHYDPWIQ 207
GIVSWG GCA PGVY +V +Y WI+
Sbjct: 186 KLQGIVSWGSGCAQKNKPGVYTKVCNYVSWIK 217
>pdb|1EAW|A Chain A, Crystal Structure Of The Mtsp1 (Matriptase)-Bpti
(Aprotinin) Complex
pdb|1EAW|C Chain C, Crystal Structure Of The Mtsp1 (Matriptase)-Bpti
(Aprotinin) Complex
pdb|1EAX|A Chain A, Crystal Structure Of Mtsp1 (Matriptase)
pdb|2GV6|A Chain A, Crystal Structure Of Matriptase With Inhibitor Cj-730
pdb|2GV7|A Chain A, Structure Of Matriptase In Complex With Inhibitor Cj-672
Length = 241
Score = 50.1 bits (118), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 57/235 (24%), Positives = 89/235 (37%), Gaps = 59/235 (25%)
Query: 28 NPGEVPYIVSLSLYGNLY-CGGSLISLQWFLSARHCFV-------TENLVWNQFNPL--- 76
+ GE P+ VSL G + CG SLIS W +SA HC++ ++ W F L
Sbjct: 8 DEGEWPWQVSLHALGQGHICGASLISPNWLVSAAHCYIDDRGFRYSDPTQWTAFLGLHDQ 67
Query: 77 ---IIAGSIYRNYKEQKRQPQLNEIALIYWHSDADLAMVKLKEPFRQTTFVKPLDYYTAR 133
G R K P N+ Y D+A+++L++P ++ V+P+ A
Sbjct: 68 SQRSAPGVQERRLKRIISHPFFNDFTFDY-----DIALLELEKPAEYSSMVRPICLPDAS 122
Query: 134 ---------------ETNYINDVLSKTDRSEMSIVSGFG--------VTFQRDKDGIVSW 170
T Y + E+ +++ +T + G +S
Sbjct: 123 HVFPAGKAIWVTGWGHTQYGGTGALILQKGEIRVINQTTCENLLPQQITPRMMCVGFLSG 182
Query: 171 GIGCALG----------------YPGIVSWGIGCA-LGYPGVYVRVDHYDPWIQS 208
G+ G G+VSWG GCA PGVY R+ + WI+
Sbjct: 183 GVDSCQGDSGGPLSSVEADGRIFQAGVVSWGDGCAQRNKPGVYTRLPLFRDWIKE 237
>pdb|3P8G|A Chain A, Crystal Structure Of Mt-Sp1 In Complex With Benzamidine
pdb|3P8F|A Chain A, Crystal Structure Of Mt-Sp1 In Complex With Sfti-1
Length = 241
Score = 50.1 bits (118), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 57/235 (24%), Positives = 88/235 (37%), Gaps = 59/235 (25%)
Query: 28 NPGEVPYIVSLSLYGNLY-CGGSLISLQWFLSARHCFV-------TENLVWNQFNPL--- 76
+ GE P+ VSL G + CG SLIS W +SA HC++ ++ W F L
Sbjct: 8 DEGEWPWQVSLHALGQGHICGASLISPNWLVSAAHCYIDDRGFRYSDPTQWTAFLGLHDQ 67
Query: 77 ---IIAGSIYRNYKEQKRQPQLNEIALIYWHSDADLAMVKLKEPFRQTTFVKPLDYYTAR 133
G R K P N+ Y D+A+++L++P ++ V+P+ A
Sbjct: 68 SQRSAPGVQERRLKRIISHPFFNDFTFDY-----DIALLELEKPAEYSSMVRPICLPDAS 122
Query: 134 ---------------ETNYINDVLSKTDRSEMSIVSGFG--------VTFQRDKDGIVSW 170
T Y + E+ ++ +T + G +S
Sbjct: 123 HVFPAGKAIWVTGWGHTQYGGTGALILQKGEIRVIQQTTCENLLPQQITPRMMCVGFLSG 182
Query: 171 GIGCALG----------------YPGIVSWGIGCA-LGYPGVYVRVDHYDPWIQS 208
G+ G G+VSWG GCA PGVY R+ + WI+
Sbjct: 183 GVDSCQGDSGGPLSSVEADGRIFQAGVVSWGDGCAQRNKPGVYTRLPLFRDWIKE 237
>pdb|1V2Q|T Chain T, Trypsin Inhibitor In Complex With Bovine Trypsin Variant
X(Sswi)bt.B4
Length = 223
Score = 50.1 bits (118), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 58/222 (26%), Positives = 91/222 (40%), Gaps = 51/222 (22%)
Query: 32 VPYIVSLSLYGNLYCGGSLISLQWFLSARHCFVTE-NLVWNQFNPLIIAGS-IYRNYKEQ 89
VPY VSL+ G +CGGSLI+ QW +SA HC+ + + + N ++ G+ + + +
Sbjct: 12 VPYQVSLN-SGYHFCGGSLINSQWVVSAAHCYKSGIQVRLGEDNINVVEGNEQFISASKS 70
Query: 90 KRQPQLNEIALIYWHSDADLAMVKLKEPFRQTTFVKPLDYYTARETNYINDVLSKTDRSE 149
P N L + D+ ++KLK + V + T+ + ++S ++
Sbjct: 71 IVHPSYNSNTL-----NNDIMLIKLKSAASLNSRVASISLPTSCASAGTQCLISGWGNTK 125
Query: 150 MSIVS-------------------------------------GFGVTFQRDKDGIVSWGI 172
S S G + Q D G V
Sbjct: 126 SSGTSYPDVLKCLKAPILSDSSCKSASSWIITSNMFCAGYLEGGKDSCQGDSGGPVV--- 182
Query: 173 GCALGYPGIVSWGIGCAL-GYPGVYVRVDHYDPWI-QSVKNN 212
C+ GIVSWG GCA PGVY +V +Y WI Q++ +N
Sbjct: 183 -CSGKLQGIVSWGSGCAQKNKPGVYTKVCNYVSWIKQTIASN 223
>pdb|1RFN|A Chain A, Human Coagulation Factor Ixa In Complex With P-Amino
Benzamidine
pdb|3LC3|A Chain A, Benzothiophene Inhibitors Of Factor Ixa
pdb|3LC3|C Chain C, Benzothiophene Inhibitors Of Factor Ixa
pdb|3LC5|A Chain A, Selective Benzothiophine Inhibitors Of Factor Ixa
Length = 235
Score = 50.1 bits (118), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 37/149 (24%), Positives = 68/149 (45%), Gaps = 24/149 (16%)
Query: 29 PGEVPYIVSLSLYGNLYCGGSLISLQWFLSARHCFVTENLVWNQFNPLIIAGSIYRNYKE 88
PG+ P+ V L+ + +CGGS+++ +W ++A HC T + ++AG N +E
Sbjct: 9 PGQFPWQVVLNGKVDAFCGGSIVNEKWIVTAAHCVETGVKI------TVVAGE--HNIEE 60
Query: 89 QKRQPQLNEIALIYWHS---------DADLAMVKLKEPFRQTTFVKPLDYYTARETNYIN 139
+ Q + I H + D+A+++L EP ++V P+ + Y N
Sbjct: 61 TEHTEQKRNVIRIIPHHNYNAAINKYNHDIALLELDEPLVLNSYVTPI---CIADKEYTN 117
Query: 140 DVLSKTDRSEMSIVSGFGVTFQRDKDGIV 168
L + VSG+G F + + +V
Sbjct: 118 IFL----KFGSGYVSGWGRVFHKGRSALV 142
>pdb|3KCG|H Chain H, Crystal Structure Of The Antithrombin-Factor Ixa-
Pentasaccharide Complex
Length = 235
Score = 50.1 bits (118), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 37/149 (24%), Positives = 68/149 (45%), Gaps = 24/149 (16%)
Query: 29 PGEVPYIVSLSLYGNLYCGGSLISLQWFLSARHCFVTENLVWNQFNPLIIAGSIYRNYKE 88
PG+ P+ V L+ + +CGGS+++ +W ++A HC T + ++AG N +E
Sbjct: 9 PGQFPWQVVLNGKVDAFCGGSIVNEKWIVTAAHCVETGVKI------TVVAGE--HNIEE 60
Query: 89 QKRQPQLNEIALIYWHS---------DADLAMVKLKEPFRQTTFVKPLDYYTARETNYIN 139
+ Q + I H + D+A+++L EP ++V P+ + Y N
Sbjct: 61 TEHTEQKRNVIRIIPHHNYNAAINKYNHDIALLELDEPLVLNSYVTPI---CIADKEYTN 117
Query: 140 DVLSKTDRSEMSIVSGFGVTFQRDKDGIV 168
L + VSG+G F + + +V
Sbjct: 118 IFL----KFGSGYVSGWGRVFHKGRSALV 142
>pdb|1V2U|T Chain T, Benzamidine In Complex With Bovine Trypsin Varinat X(Ssai)
Bt.D1
pdb|1V2V|T Chain T, Benzamidine In Complex With Bovine Trypsin Variant X(Ssai)
Bt.C1
pdb|1V2W|T Chain T, Trypsin Inhibitor In Complex With Bovine Trypsin Variant
X(Ssai)bt.B4
Length = 223
Score = 50.1 bits (118), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 58/222 (26%), Positives = 91/222 (40%), Gaps = 51/222 (22%)
Query: 32 VPYIVSLSLYGNLYCGGSLISLQWFLSARHCFVTE-NLVWNQFNPLIIAGS-IYRNYKEQ 89
VPY VSL+ G +CGGSLI+ QW +SA HC+ + + + N ++ G+ + + +
Sbjct: 12 VPYQVSLN-SGYHFCGGSLINSQWVVSAAHCYKSGIQVRLGEDNINVVEGNEQFISASKS 70
Query: 90 KRQPQLNEIALIYWHSDADLAMVKLKEPFRQTTFVKPLDYYTARETNYINDVLSKTDRSE 149
P N L + D+ ++KLK + V + T+ + ++S ++
Sbjct: 71 IVHPSYNSNTL-----NNDIMLIKLKSAASLNSRVASISLPTSCASAGTQCLISGWGNTK 125
Query: 150 MSIVS-------------------------------------GFGVTFQRDKDGIVSWGI 172
S S G + Q D G V
Sbjct: 126 SSGTSYPDVLKCLKAPILSDSSCKSASSAIITSNMFCAGYLEGGKDSCQGDSGGPVV--- 182
Query: 173 GCALGYPGIVSWGIGCAL-GYPGVYVRVDHYDPWI-QSVKNN 212
C+ GIVSWG GCA PGVY +V +Y WI Q++ +N
Sbjct: 183 -CSGKLQGIVSWGSGCAQKNKPGVYTKVCNYVSWIKQTIASN 223
>pdb|1V2J|T Chain T, Benzamidine In Complex With Bovine Trypsin Variant X(Ssri)
Bt.C1
pdb|1V2R|T Chain T, Trypsin Inhibitor In Complex With Bovine Trypsin Variant
X(Ssri)bt.B4
Length = 223
Score = 49.7 bits (117), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 58/222 (26%), Positives = 91/222 (40%), Gaps = 51/222 (22%)
Query: 32 VPYIVSLSLYGNLYCGGSLISLQWFLSARHCFVTE-NLVWNQFNPLIIAGS-IYRNYKEQ 89
VPY VSL+ G +CGGSLI+ QW +SA HC+ + + + N ++ G+ + + +
Sbjct: 12 VPYQVSLN-SGYHFCGGSLINSQWVVSAAHCYKSGIQVRLGEDNINVVEGNEQFISASKS 70
Query: 90 KRQPQLNEIALIYWHSDADLAMVKLKEPFRQTTFVKPLDYYTARETNYINDVLSKTDRSE 149
P N L + D+ ++KLK + V + T+ + ++S ++
Sbjct: 71 IVHPSYNSNTL-----NNDIMLIKLKSAASLNSRVASISLPTSCASAGTQCLISGWGNTK 125
Query: 150 MSIVS-------------------------------------GFGVTFQRDKDGIVSWGI 172
S S G + Q D G V
Sbjct: 126 SSGTSYPDVLKCLKAPILSDSSCKSASSRIITSNMFCAGYLEGGKDSCQGDSGGPVV--- 182
Query: 173 GCALGYPGIVSWGIGCAL-GYPGVYVRVDHYDPWI-QSVKNN 212
C+ GIVSWG GCA PGVY +V +Y WI Q++ +N
Sbjct: 183 -CSGKLQGIVSWGSGCAQKNKPGVYTKVCNYVSWIKQTIASN 223
>pdb|1V2O|T Chain T, Trypsin Inhibitor In Complex With Bovine Trypsin Variant
X(Ssyi)bt.B4
pdb|1V2P|T Chain T, Trypsin Inhibitor In Complex With Bovine Trypsin Variant
X(Ssyi)bt.A4
Length = 223
Score = 49.7 bits (117), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 58/222 (26%), Positives = 91/222 (40%), Gaps = 51/222 (22%)
Query: 32 VPYIVSLSLYGNLYCGGSLISLQWFLSARHCFVTE-NLVWNQFNPLIIAGS-IYRNYKEQ 89
VPY VSL+ G +CGGSLI+ QW +SA HC+ + + + N ++ G+ + + +
Sbjct: 12 VPYQVSLN-SGYHFCGGSLINSQWVVSAAHCYKSGIQVRLGEDNINVVEGNEQFISASKS 70
Query: 90 KRQPQLNEIALIYWHSDADLAMVKLKEPFRQTTFVKPLDYYTARETNYINDVLSKTDRSE 149
P N L + D+ ++KLK + V + T+ + ++S ++
Sbjct: 71 IVHPSYNSNTL-----NNDIMLIKLKSAASLNSRVASISLPTSCASAGTQCLISGWGNTK 125
Query: 150 MSIVS-------------------------------------GFGVTFQRDKDGIVSWGI 172
S S G + Q D G V
Sbjct: 126 SSGTSYPDVLKCLKAPILSDSSCKSASSYIITSNMFCAGYLEGGKDSCQGDSGGPVV--- 182
Query: 173 GCALGYPGIVSWGIGCAL-GYPGVYVRVDHYDPWI-QSVKNN 212
C+ GIVSWG GCA PGVY +V +Y WI Q++ +N
Sbjct: 183 -CSGKLQGIVSWGSGCAQKNKPGVYTKVCNYVSWIKQTIASN 223
>pdb|1V2N|T Chain T, Potent Factor Xa Inhibitor In Complex With Bovine Trypsin
Variant X(99175190)BT
Length = 223
Score = 49.3 bits (116), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 62/218 (28%), Positives = 88/218 (40%), Gaps = 43/218 (19%)
Query: 32 VPYIVSLSLYGNLYCGGSLISLQWFLSARHCFVT--------ENLVWNQFNPLIIAGSIY 83
VPY VSL+ G +CGGSLI+ QW +SA HC+ + +N+ + N I+ S
Sbjct: 12 VPYQVSLN-SGYHFCGGSLINSQWVVSAAHCYKSGIQVRLGEDNINVVEGNEQFISASKS 70
Query: 84 RNYKEQKRQPQLNEIALIYWHSDADL----AMVKLKEPFRQT---TFVKPLDYYTARETN 136
+ + N+I LI S A L A + L + + T+
Sbjct: 71 IVHPSYNSETYNNDIMLIKLKSAASLNSRVASISLPTSCASAGTQCLISGWGNTKSSGTS 130
Query: 137 YINDVLS--------------------KTDRSEMSIVSGFGVTFQRDKDGIVSWGIGCAL 176
Y DVL ++ + G Q D G V C+
Sbjct: 131 Y-PDVLKCLKAPILSDSSCKSASSFIITSNMFCAGYLEGGKDACQGDSGGPVV----CSG 185
Query: 177 GYPGIVSWGIGCAL-GYPGVYVRVDHYDPWI-QSVKNN 212
GIVSWG GCA PGVY +V +Y WI Q++ +N
Sbjct: 186 KLQGIVSWGSGCAQKNKPGVYTKVCNYVSWIKQTIASN 223
>pdb|4B1T|A Chain A, Structure Of The Factor Xa-Like Trypsin Variant Triple-Ala
( Ta) In Complex With Eglin C
pdb|4B1T|C Chain C, Structure Of The Factor Xa-Like Trypsin Variant Triple-Ala
( Ta) In Complex With Eglin C
Length = 223
Score = 49.3 bits (116), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 62/218 (28%), Positives = 88/218 (40%), Gaps = 43/218 (19%)
Query: 32 VPYIVSLSLYGNLYCGGSLISLQWFLSARHCFVT--------ENLVWNQFNPLIIAGSIY 83
VPY VSL+ G +CGGSLI+ QW +SA HC+ + +N+ + N I+ S
Sbjct: 12 VPYQVSLN-SGYHFCGGSLINSQWVVSAAHCYKSGIQVRLGEDNINVVEGNEQFISASKS 70
Query: 84 RNYKEQKRQPQLNEIALIYWHSDADL----AMVKLKEPFRQT---TFVKPLDYYTARETN 136
+ + N+I LI S A L A + L + + T+
Sbjct: 71 IVHPSYNSETYNNDIMLIKLKSAASLNSRVASISLPTSCASAGTQCLISGWGNTKSSGTS 130
Query: 137 YINDVLS--------------------KTDRSEMSIVSGFGVTFQRDKDGIVSWGIGCAL 176
Y DVL ++ + G Q D G V C+
Sbjct: 131 Y-PDVLKCLKAPILSDSSCKSASSFIITSNMFCAGYLEGGKDACQGDAGGPVV----CSG 185
Query: 177 GYPGIVSWGIGCAL-GYPGVYVRVDHYDPWI-QSVKNN 212
GIVSWG GCA PGVY +V +Y WI Q++ +N
Sbjct: 186 KLQGIVSWGSGCAQKNKPGVYTKVCNYVSWIKQTIASN 223
>pdb|1V2S|T Chain T, Benzamidine In Complex With Bovine Trypsin Variant
X(Ssfi.Glu)bt.D1
pdb|1V2T|T Chain T, Trypsin Inhibitor In Complex With Bovine Trypsin Variant
X(ssfi.glu)bt.b4
Length = 223
Score = 49.3 bits (116), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 58/222 (26%), Positives = 91/222 (40%), Gaps = 51/222 (22%)
Query: 32 VPYIVSLSLYGNLYCGGSLISLQWFLSARHCFVTE-NLVWNQFNPLIIAGS-IYRNYKEQ 89
VPY VSL+ G +CGGSLI+ QW +SA HC+ + + + N ++ G+ + + +
Sbjct: 12 VPYQVSLN-SGYHFCGGSLINSQWVVSAAHCYKSGIQVRLGEDNINVVEGNEQFISASKS 70
Query: 90 KRQPQLNEIALIYWHSDADLAMVKLKEPFRQTTFVKPLDYYTARETNYINDVLSKTDRSE 149
P N L + D+ ++KLK + V + T+ + ++S ++
Sbjct: 71 IVHPSYNSNTL-----NNDIMLIKLKSAASLNSRVASISLPTSCASAGTQCLISGWGNTK 125
Query: 150 MSIVS-------------------------------------GFGVTFQRDKDGIVSWGI 172
S S G + Q D G V
Sbjct: 126 SSGTSYPDVLKCLKAPILSDSSCKSASSFIITSNMFCAGYLEGGKDSCQGDSGGPVV--- 182
Query: 173 GCALGYPGIVSWGIGCAL-GYPGVYVRVDHYDPWI-QSVKNN 212
C+ GIVSWG GCA PGVY +V +Y WI Q++ +N
Sbjct: 183 -CSGKLQGIVSWGEGCAQKNKPGVYTKVCNYVSWIKQTIASN 223
>pdb|1PFX|C Chain C, Porcine Factor Ixa
pdb|1X7A|C Chain C, Porcine Factor Ixa Complexed To 1-{3-[amino(Imino)
Methyl]phenyl}-N-[4-(1h-Benzimidazol-1-Yl)-2-
Fluorophenyl]-
3-(Trifluoromethyl)-1h-Pyrazole-5-Carboxamide
Length = 235
Score = 49.3 bits (116), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 38/149 (25%), Positives = 67/149 (44%), Gaps = 22/149 (14%)
Query: 28 NPGEVPYIVSLSLYGNLYCGGSLISLQWFLSARHCFVTENLVWNQFNPLIIAGSIYRNYK 87
PG+ P+ V L+ + +CGGS+I+ +W ++A HC + ++AG Y +
Sbjct: 8 KPGQFPWQVLLNGKIDAFCGGSIINEKWVVTAAHC------IEPGVKITVVAGE-YNTEE 60
Query: 88 EQKRQPQLNEIALIYWHS--------DADLAMVKLKEPFRQTTFVKPLDYYTARETNYIN 139
+ + + N I I HS D+A+++L EP ++V P+ + Y N
Sbjct: 61 TEPTEQRRNVIRAIPHHSYNATVNKYSHDIALLELDEPLTLNSYVTPI---CIADKEYTN 117
Query: 140 DVLSKTDRSEMSIVSGFGVTFQRDKDGIV 168
L + VSG+G F R + +
Sbjct: 118 IFL----KFGSGYVSGWGRVFNRGRSATI 142
>pdb|1V2K|T Chain T, Factor Xa Specific Inhibitor In Complex With Bovine
Trypsin Variant X(Triple.Glu)bt.D2
pdb|1V2L|T Chain T, Benzamidine In Complex With Bovine Trypsin Variant
X(Triple.Glu)bt.D1
pdb|1V2M|T Chain T, Benzamidine In Complex With Bovine Trypsin Variant
X(Triple.Glu)bt.A1
Length = 223
Score = 49.3 bits (116), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 62/218 (28%), Positives = 88/218 (40%), Gaps = 43/218 (19%)
Query: 32 VPYIVSLSLYGNLYCGGSLISLQWFLSARHCFVT--------ENLVWNQFNPLIIAGSIY 83
VPY VSL+ G +CGGSLI+ QW +SA HC+ + +N+ + N I+ S
Sbjct: 12 VPYQVSLN-SGYHFCGGSLINSQWVVSAAHCYKSGIQVRLGEDNINVVEGNEQFISASKS 70
Query: 84 RNYKEQKRQPQLNEIALIYWHSDADL----AMVKLKEPFRQT---TFVKPLDYYTARETN 136
+ + N+I LI S A L A + L + + T+
Sbjct: 71 IVHPSYNSETYNNDIMLIKLKSAASLNSRVASISLPTSCASAGTQCLISGWGNTKSSGTS 130
Query: 137 YINDVLS--------------------KTDRSEMSIVSGFGVTFQRDKDGIVSWGIGCAL 176
Y DVL ++ + G Q D G V C+
Sbjct: 131 Y-PDVLKCLKAPILSDSSCKSASSFIITSNMFCAGYLEGGKDACQGDSGGPVV----CSG 185
Query: 177 GYPGIVSWGIGCAL-GYPGVYVRVDHYDPWI-QSVKNN 212
GIVSWG GCA PGVY +V +Y WI Q++ +N
Sbjct: 186 KLQGIVSWGEGCAQKNKPGVYTKVCNYVSWIKQTIASN 223
>pdb|4B2A|A Chain A, Structure Of The Factor Xa-Like Trypsin Variant Triple-Ala
(Tga) In Complex With Eglin C
pdb|4B2A|C Chain C, Structure Of The Factor Xa-Like Trypsin Variant Triple-Ala
(Tga) In Complex With Eglin C
Length = 223
Score = 48.9 bits (115), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 62/218 (28%), Positives = 88/218 (40%), Gaps = 43/218 (19%)
Query: 32 VPYIVSLSLYGNLYCGGSLISLQWFLSARHCFVT--------ENLVWNQFNPLIIAGSIY 83
VPY VSL+ G +CGGSLI+ QW +SA HC+ + +N+ + N I+ S
Sbjct: 12 VPYQVSLN-SGYHFCGGSLINSQWVVSAAHCYKSGIQVRLGEDNINVVEGNEQFISASKS 70
Query: 84 RNYKEQKRQPQLNEIALIYWHSDADL----AMVKLKEPFRQT---TFVKPLDYYTARETN 136
+ + N+I LI S A L A + L + + T+
Sbjct: 71 IVHPSYNSETYNNDIMLIKLKSAASLNSRVASISLPTSCASAGTQCLISGWGNTKSSGTS 130
Query: 137 YINDVLS--------------------KTDRSEMSIVSGFGVTFQRDKDGIVSWGIGCAL 176
Y DVL ++ + G Q D G V C+
Sbjct: 131 Y-PDVLKCLKAPILSDSSCKSASSFIITSNMFCAGYLEGGKDACQGDAGGPVV----CSG 185
Query: 177 GYPGIVSWGIGCAL-GYPGVYVRVDHYDPWI-QSVKNN 212
GIVSWG GCA PGVY +V +Y WI Q++ +N
Sbjct: 186 KLQGIVSWGEGCAQKNKPGVYTKVCNYVSWIKQTIASN 223
>pdb|3PMJ|A Chain A, Bovine Trypsin Variant X(Tripleile227) In Complex With
Small Molecule Inhibitor
pdb|3PLB|A Chain A, Bovine Trypsin Variant X(Tripleile227) In Complex With
Small Molecule Inhibitor
pdb|3PLP|A Chain A, Bovine Trypsin Variant X(Tripleile227) In Complex With
Small Molecule Inhibitor
pdb|3PM3|A Chain A, Bovine Trypsin Variant X(Tripleile227) In Complex With
Small Molecule Inhibitor
Length = 223
Score = 48.9 bits (115), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 61/218 (27%), Positives = 88/218 (40%), Gaps = 43/218 (19%)
Query: 32 VPYIVSLSLYGNLYCGGSLISLQWFLSARHCFVT--------ENLVWNQFNPLIIAGSIY 83
VPY VSL+ G +CGGSLI+ QW +SA HC+ + +N+ + N I+ S
Sbjct: 12 VPYQVSLN-SGYHFCGGSLINSQWVVSAAHCYKSGIQVRLGEDNINVVEGNEQFISASKS 70
Query: 84 RNYKEQKRQPQLNEIALIYWHSDADL----AMVKLKEPFRQT---TFVKPLDYYTARETN 136
+ + N+I LI S A L A + L + + T+
Sbjct: 71 IVHPSYNSETYNNDIMLIKLKSAASLNSRVASISLPTSCASAGTQCLISGWGNTKSSGTS 130
Query: 137 YINDVLS--------------------KTDRSEMSIVSGFGVTFQRDKDGIVSWGIGCAL 176
Y DVL ++ + G Q D G V C+
Sbjct: 131 Y-PDVLKCLKAPILSDSSCKSASSFIITSNMFCAGYLEGGKDACQGDSGGPVV----CSG 185
Query: 177 GYPGIVSWGIGCAL-GYPGVYVRVDHYDPWI-QSVKNN 212
GIVSWG GCA PG+Y +V +Y WI Q++ +N
Sbjct: 186 KLQGIVSWGSGCAQKNKPGIYTKVCNYVSWIKQTIASN 223
>pdb|1YM0|A Chain A, Crystal Structure Of Earthworm Fibrinolytic Enzyme
Component B: A Novel, Glycosylated Two-chained Trypsin
Length = 238
Score = 48.5 bits (114), Expect = 3e-06, Method: Compositional matrix adjust.
Identities = 61/232 (26%), Positives = 93/232 (40%), Gaps = 50/232 (21%)
Query: 29 PGEVPYIVSLSLYGN--LYCGGSLISLQWFLSARHCFVTE-----NLVWNQFNPLIIAGS 81
P E P+ VS+ + +CGGS+I+ +W + A HC E +LV + + A S
Sbjct: 9 PYEFPWQVSVRRKSSDSHFCGGSIINDRWVVCAAHCMQGEAPALVSLVVGEHDSS--AAS 66
Query: 82 IYRNYKE-------QKRQPQL--NEIALIYWHS----DADLAMVKLKEPFRQTTFVKP-- 126
R + + P N++++I D ++ + +P + K
Sbjct: 67 TVRQTHDVDSIFVNENYDPATLENDVSVIKTAVAITFDINVGPICAPDPANDYVYRKSQC 126
Query: 127 ----------------LDYYTAR-ETNYINDVLSKTDRSEMSIVSGFGVTFQRDKD---- 165
L Y T TN D + +D ++ T D+D
Sbjct: 127 SGWGTINSGGVCCPAVLRYVTLNITTNAFCDAVYTSDTIYDDMICATDNTGMTDRDSCQG 186
Query: 166 ---GIVSWGIGCAL-GYPGIVSWGIGCALGYPGVYVRVDHYDPWI-QSVKNN 212
G +S G + GIVSWGIGCA GYPGVY RV + WI ++ NN
Sbjct: 187 DSGGPLSVKDGSGIFSLVGIVSWGIGCASGYPGVYSRVGFHAGWITDTITNN 238
>pdb|3PWB|A Chain A, Bovine Trypsin Variant X(Tripleglu217ile227) In Complex
With Small Molecule Inhibitor
pdb|3PWC|A Chain A, Bovine Trypsin Variant X(Tripleglu217ile227) In Complex
With Small Molecule Inhibitor
pdb|3PYH|A Chain A, Bovine Trypsin Variant X(Tripleglu217ile227) In Complex
With Small Molecule Inhibitor
pdb|3Q00|A Chain A, Bovine Trypsin Variant X(Tripleglu217ile227) In Comlex
With Small Molecule Inhibitor
Length = 223
Score = 48.5 bits (114), Expect = 3e-06, Method: Compositional matrix adjust.
Identities = 61/218 (27%), Positives = 88/218 (40%), Gaps = 43/218 (19%)
Query: 32 VPYIVSLSLYGNLYCGGSLISLQWFLSARHCFVT--------ENLVWNQFNPLIIAGSIY 83
VPY VSL+ G +CGGSLI+ QW +SA HC+ + +N+ + N I+ S
Sbjct: 12 VPYQVSLN-SGYHFCGGSLINSQWVVSAAHCYKSGIQVRLGEDNINVVEGNEQFISASKS 70
Query: 84 RNYKEQKRQPQLNEIALIYWHSDADL----AMVKLKEPFRQT---TFVKPLDYYTARETN 136
+ + N+I LI S A L A + L + + T+
Sbjct: 71 IVHPSYNSETYNNDIMLIKLKSAASLNSRVASISLPTSCASAGTQCLISGWGNTKSSGTS 130
Query: 137 YINDVLS--------------------KTDRSEMSIVSGFGVTFQRDKDGIVSWGIGCAL 176
Y DVL ++ + G Q D G V C+
Sbjct: 131 Y-PDVLKCLKAPILSDSSCKSASSFIITSNMFCAGYLEGGKDACQGDSGGPVV----CSG 185
Query: 177 GYPGIVSWGIGCAL-GYPGVYVRVDHYDPWI-QSVKNN 212
GIVSWG GCA PG+Y +V +Y WI Q++ +N
Sbjct: 186 KLQGIVSWGEGCAQKNKPGIYTKVCNYVSWIKQTIASN 223
>pdb|1DLK|B Chain B, Crystal Structure Analysis Of Delta-Chymotrypsin Bound To
A Peptidyl Chloromethyl Ketone Inhibitor
pdb|1DLK|D Chain D, Crystal Structure Analysis Of Delta-Chymotrypsin Bound To
A Peptidyl Chloromethyl Ketone Inhibitor
Length = 230
Score = 48.1 bits (113), Expect = 4e-06, Method: Compositional matrix adjust.
Identities = 63/225 (28%), Positives = 89/225 (39%), Gaps = 55/225 (24%)
Query: 29 PGEVPYIVSL-SLYGNLYCGGSLISLQWFLSARHCFVTENLVWNQFNPLIIAGSIYRNYK 87
PG P+ VSL G +CGGSLI+ W ++A HC VT + V ++AG +
Sbjct: 9 PGSWPWQVSLQDKTGFHFCGGSLINENWVVTAAHCGVTTSDV-------VVAGEFDQGSS 61
Query: 88 EQKRQPQLNEIALIYWHS-------DADLAMVKLKEP--FRQTTFVKPL----DYYTARE 134
+K Q +IA ++ +S + D+ ++KL F QT L D + A
Sbjct: 62 SEKIQKL--KIAKVFKNSKYNSLTINNDITLLKLSTAASFSQTVSAVCLPSASDDFAAGT 119
Query: 135 ---------TNYIND------------VLSKTD---------RSEMSIVSGFGV-TFQRD 163
T Y N +LS T+ + M GV + D
Sbjct: 120 TCVTTGWGLTRYTNANTPDRLQQASLPLLSNTNCKKYWGTKIKDAMICAGASGVSSCMGD 179
Query: 164 KDGIVSWGIGCALGYPGIVSWGIG-CALGYPGVYVRVDHYDPWIQ 207
G + A GIVSWG C+ PGVY RV W+Q
Sbjct: 180 SGGPLVCKKNGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQ 224
>pdb|2ZEB|A Chain A, Potent, Nonpeptide Inhibitors Of Human Mast Cell Tryptase
pdb|2ZEB|B Chain B, Potent, Nonpeptide Inhibitors Of Human Mast Cell Tryptase
pdb|2ZEB|C Chain C, Potent, Nonpeptide Inhibitors Of Human Mast Cell Tryptase
pdb|2ZEB|D Chain D, Potent, Nonpeptide Inhibitors Of Human Mast Cell Tryptase
pdb|2ZEC|A Chain A, Potent, Nonpeptide Inhibitors Of Human Mast Cell Tryptase
pdb|2ZEC|B Chain B, Potent, Nonpeptide Inhibitors Of Human Mast Cell Tryptase
pdb|2ZEC|C Chain C, Potent, Nonpeptide Inhibitors Of Human Mast Cell Tryptase
pdb|2ZEC|D Chain D, Potent, Nonpeptide Inhibitors Of Human Mast Cell Tryptase
Length = 243
Score = 48.1 bits (113), Expect = 4e-06, Method: Compositional matrix adjust.
Identities = 59/235 (25%), Positives = 90/235 (38%), Gaps = 69/235 (29%)
Query: 33 PYIVSLSLYGNL---YCGGSLISLQWFLSARHCFVTENLVWNQFNPLIIAGSIYRNYKEQ 89
P+ VSL ++G +CGGSLI QW L+A HC + + ++ +EQ
Sbjct: 13 PWQVSLRVHGPYWMHFCGGSLIHPQWVLTAAHCVGPD---------VKDLAALRVQLREQ 63
Query: 90 KR--QPQLNEIALIYWHSD-------ADLAMVKLKEPFRQTTFVKPLDYYTARET----- 135
Q QL ++ I H AD+A+++L+EP + ++ V + A ET
Sbjct: 64 HLYYQDQLLPVSRIIVHPQFYTAQIGADIALLELEEPVKVSSHVHTVTLPPASETFPPGM 123
Query: 136 -------------------------------NYINDV---LSKTDRSEMSIVSGFGV--- 158
N+I D L ++ IV +
Sbjct: 124 PCWVTGWGDVDNDERLPPPFPLKQVKVPIMENHICDAKYHLGAYTGDDVRIVRDDMLCAG 183
Query: 159 -----TFQRDKDGIVSWGIGCALGYPGIVSWGIGCAL-GYPGVYVRVDHYDPWIQ 207
+ Q D G + + G+VSWG GCA PG+Y RV +Y WI
Sbjct: 184 NTRRDSCQGDSGGPLVCKVNGTWLQAGVVSWGEGCAQPNRPGIYTRVTYYLDWIH 238
>pdb|2CGA|A Chain A, Bovine Chymotrypsinogen A. X-Ray Crystal Structure
Analysis And Refinement Of A New Crystal Form At 1.8
Angstroms Resolution
pdb|2CGA|B Chain B, Bovine Chymotrypsinogen A. X-Ray Crystal Structure
Analysis And Refinement Of A New Crystal Form At 1.8
Angstroms Resolution
pdb|1ACB|E Chain E, Crystal And Molecular Structure Of The Bovine
Alpha-Chymotrypsin-Eglin C Complex At 2.0 Angstroms
Resolution
pdb|1CGI|E Chain E, Three-Dimensional Structure Of The Complexes Between
Bovine ChymotrypsinogenA And Two Recombinant Variants Of
Human Pancreatic Secretory Trypsin Inhibitor
(Kazal-Type)
pdb|1CGJ|E Chain E, Three-Dimensional Structure Of The Complexes Between
Bovine ChymotrypsinogenA And Two Recombinant Variants Of
Human Pancreatic Secretory Trypsin Inhibitor
(Kazal-Type)
pdb|1EX3|A Chain A, Crystal Structure Of Bovine Chymotrypsinogen A
(Tetragonal)
pdb|1GL1|A Chain A, Structure Of The Complex Between Bovine Alpha-Chymotrypsin
And Pmp-C, An Inhibitor From The Insect Locusta
Migratoria
pdb|1GL1|B Chain B, Structure Of The Complex Between Bovine Alpha-Chymotrypsin
And Pmp-C, An Inhibitor From The Insect Locusta
Migratoria
pdb|1GL1|C Chain C, Structure Of The Complex Between Bovine Alpha-Chymotrypsin
And Pmp-C, An Inhibitor From The Insect Locusta
Migratoria
pdb|1GL0|E Chain E, Structure Of The Complex Between Bovine Alpha-Chymotrypsin
And Pmp-D2v, An Inhibitor From The Insect Locusta
Migratoria
pdb|1K2I|1 Chain 1, Crystal Structure Of Gamma-Chymotrypsin In Complex With 7-
Hydroxycoumarin
pdb|1P2M|A Chain A, Structural Consequences Of Accommodation Of Four Non-
Cognate Amino-Acid Residues In The S1 Pocket Of Bovine
Trypsin And Chymotrypsin
pdb|1P2M|C Chain C, Structural Consequences Of Accommodation Of Four Non-
Cognate Amino-Acid Residues In The S1 Pocket Of Bovine
Trypsin And Chymotrypsin
pdb|1P2N|A Chain A, Structural Consequences Of Accommodation Of Four Non-
Cognate Amino-acid Residues In The S1 Pocket Of Bovine
Trypsin And Chymotrypsin
pdb|1P2N|C Chain C, Structural Consequences Of Accommodation Of Four Non-
Cognate Amino-acid Residues In The S1 Pocket Of Bovine
Trypsin And Chymotrypsin
pdb|1P2O|A Chain A, Structural Consequences Of Accommodation Of Four Non-
Cognate Amino-Acid Residues In The S1 Pocket Of Bovine
Trypsin And Chymotrypsin
pdb|1P2O|C Chain C, Structural Consequences Of Accommodation Of Four Non-
Cognate Amino-Acid Residues In The S1 Pocket Of Bovine
Trypsin And Chymotrypsin
pdb|1P2Q|A Chain A, Structural Consequences Of Accommodation Of Four Non-
Cognate Amino-Acid Residues In The S1 Pocket Of Bovine
Trypsin And Chymotrypsin
pdb|1P2Q|C Chain C, Structural Consequences Of Accommodation Of Four Non-
Cognate Amino-Acid Residues In The S1 Pocket Of Bovine
Trypsin And Chymotrypsin
pdb|1OXG|A Chain A, Crystal Structure Of A Complex Formed Between Organic
Solvent Treated Bovine Alpha-Chymotrypsin And Its
Autocatalytically Produced Highly Potent 14-Residue
Peptide At 2.2 Resolution
pdb|1T7C|A Chain A, Crystal Structure Of The P1 Glu Bpti Mutant- Bovine
Chymotrypsin Complex
pdb|1T7C|C Chain C, Crystal Structure Of The P1 Glu Bpti Mutant- Bovine
Chymotrypsin Complex
pdb|1T8L|A Chain A, Crystal Structure Of The P1 Met Bpti Mutant- Bovine
Chymotrypsin Complex
pdb|1T8L|C Chain C, Crystal Structure Of The P1 Met Bpti Mutant- Bovine
Chymotrypsin Complex
pdb|1T8M|A Chain A, Crystal Structure Of The P1 His Bpti Mutant- Bovine
Chymotrypsin Complex
pdb|1T8M|C Chain C, Crystal Structure Of The P1 His Bpti Mutant- Bovine
Chymotrypsin Complex
pdb|1T8N|A Chain A, Crystal Structure Of The P1 Thr Bpti Mutant- Bovine
Chymotrypsin Complex
pdb|1T8N|C Chain C, Crystal Structure Of The P1 Thr Bpti Mutant- Bovine
Chymotrypsin Complex
pdb|1T8O|A Chain A, Crystal Structure Of The P1 Trp Bpti Mutant- Bovine
Chymotrypsin Complex
pdb|1T8O|C Chain C, Crystal Structure Of The P1 Trp Bpti Mutant- Bovine
Chymotrypsin Complex
pdb|1CHG|A Chain A, Chymotrypsinogen,2.5 Angstroms Crystal Structure,
Comparison With Alpha-Chymotrypsin,And Implications For
Zymogen Activation
pdb|1GCD|A Chain A, Refined Crystal Structure Of "aged" And "non-Aged"
Organophosphoryl Conjugates Of Gamma-Chymotrypsin
pdb|2Y6T|A Chain A, Molecular Recognition Of Chymotrypsin By The Serine
Protease Inhibitor Ecotin From Yersinia Pestis
pdb|2Y6T|B Chain B, Molecular Recognition Of Chymotrypsin By The Serine
Protease Inhibitor Ecotin From Yersinia Pestis
pdb|2Y6T|C Chain C, Molecular Recognition Of Chymotrypsin By The Serine
Protease Inhibitor Ecotin From Yersinia Pestis
pdb|2Y6T|D Chain D, Molecular Recognition Of Chymotrypsin By The Serine
Protease Inhibitor Ecotin From Yersinia Pestis
pdb|3T62|A Chain A, Crystal Structure Of Recombinant Kunitz Type Serine
Protease Inhibitor-1 From The Caribbean Sea Anemone
Stichodactyla Helianthus In Complex With Bovine
Chymotrypsin
pdb|3T62|B Chain B, Crystal Structure Of Recombinant Kunitz Type Serine
Protease Inhibitor-1 From The Caribbean Sea Anemone
Stichodactyla Helianthus In Complex With Bovine
Chymotrypsin
pdb|3T62|C Chain C, Crystal Structure Of Recombinant Kunitz Type Serine
Protease Inhibitor-1 From The Caribbean Sea Anemone
Stichodactyla Helianthus In Complex With Bovine
Chymotrypsin
Length = 245
Score = 48.1 bits (113), Expect = 4e-06, Method: Compositional matrix adjust.
Identities = 63/225 (28%), Positives = 89/225 (39%), Gaps = 55/225 (24%)
Query: 29 PGEVPYIVSL-SLYGNLYCGGSLISLQWFLSARHCFVTENLVWNQFNPLIIAGSIYRNYK 87
PG P+ VSL G +CGGSLI+ W ++A HC VT + V ++AG +
Sbjct: 24 PGSWPWQVSLQDKTGFHFCGGSLINENWVVTAAHCGVTTSDV-------VVAGEFDQGSS 76
Query: 88 EQKRQPQLNEIALIYWHS-------DADLAMVKLKEP--FRQTTFVKPL----DYYTARE 134
+K Q +IA ++ +S + D+ ++KL F QT L D + A
Sbjct: 77 SEKIQKL--KIAKVFKNSKYNSLTINNDITLLKLSTAASFSQTVSAVCLPSASDDFAAGT 134
Query: 135 ---------TNYIND------------VLSKTD---------RSEMSIVSGFGV-TFQRD 163
T Y N +LS T+ + M GV + D
Sbjct: 135 TCVTTGWGLTRYTNANTPDRLQQASLPLLSNTNCKKYWGTKIKDAMICAGASGVSSCMGD 194
Query: 164 KDGIVSWGIGCALGYPGIVSWGIG-CALGYPGVYVRVDHYDPWIQ 207
G + A GIVSWG C+ PGVY RV W+Q
Sbjct: 195 SGGPLVCKKNGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQ 239
>pdb|3UQV|A Chain A, Bovine Trypsin Variant X(Triplephe227) In Complex With
Small Molecule Inhibitor
Length = 223
Score = 48.1 bits (113), Expect = 5e-06, Method: Compositional matrix adjust.
Identities = 61/218 (27%), Positives = 88/218 (40%), Gaps = 43/218 (19%)
Query: 32 VPYIVSLSLYGNLYCGGSLISLQWFLSARHCFVT--------ENLVWNQFNPLIIAGSIY 83
VPY VSL+ G +CGGSLI+ QW +SA HC+ + +N+ + N I+ S
Sbjct: 12 VPYQVSLN-SGYHFCGGSLINSQWVVSAAHCYKSGIQVRLGEDNINVVEGNEQFISASKS 70
Query: 84 RNYKEQKRQPQLNEIALIYWHSDADL----AMVKLKEPFRQT---TFVKPLDYYTARETN 136
+ + N+I LI S A L A + L + + T+
Sbjct: 71 IVHPSYNSETYNNDIMLIKLKSAASLNSRVASISLPTSCASAGTQCLISGWGNTKSSGTS 130
Query: 137 YINDVLS--------------------KTDRSEMSIVSGFGVTFQRDKDGIVSWGIGCAL 176
Y DVL ++ + G + Q D G V C+
Sbjct: 131 Y-PDVLKCLKAPILSDSSCKSASSFIITSNMFCAGYLEGGKDSCQGDSGGPVV----CSG 185
Query: 177 GYPGIVSWGIGCAL-GYPGVYVRVDHYDPWI-QSVKNN 212
GIVSWG GCA PG Y +V +Y WI Q++ +N
Sbjct: 186 KLQGIVSWGSGCAQKNKPGFYTKVCNYVSWIKQTIASN 223
>pdb|2BM2|A Chain A, Human Beta-Ii Tryptase In Complex With 4-(3-Aminomethyl-
Phenyl)-Piperidin-1-Yl-(5-Phenethyl- Pyridin-3-Yl)-
Methanone
pdb|2BM2|B Chain B, Human Beta-Ii Tryptase In Complex With 4-(3-Aminomethyl-
Phenyl)-Piperidin-1-Yl-(5-Phenethyl- Pyridin-3-Yl)-
Methanone
pdb|2BM2|C Chain C, Human Beta-Ii Tryptase In Complex With 4-(3-Aminomethyl-
Phenyl)-Piperidin-1-Yl-(5-Phenethyl- Pyridin-3-Yl)-
Methanone
pdb|2BM2|D Chain D, Human Beta-Ii Tryptase In Complex With 4-(3-Aminomethyl-
Phenyl)-Piperidin-1-Yl-(5-Phenethyl- Pyridin-3-Yl)-
Methanone
pdb|2FWW|A Chain A, Human Beta-Tryptase Ii Complexed With 4-Piperidinebutyrate
To Make Acylenzyme
pdb|2FWW|B Chain B, Human Beta-Tryptase Ii Complexed With 4-Piperidinebutyrate
To Make Acylenzyme
pdb|2FWW|C Chain C, Human Beta-Tryptase Ii Complexed With 4-Piperidinebutyrate
To Make Acylenzyme
pdb|2FWW|D Chain D, Human Beta-Tryptase Ii Complexed With 4-Piperidinebutyrate
To Make Acylenzyme
pdb|2FXR|A Chain A, Human Beta Tryptase Ii Complexed With Activated Ketone
Inhibitor Cra-29382
pdb|2FXR|B Chain B, Human Beta Tryptase Ii Complexed With Activated Ketone
Inhibitor Cra-29382
pdb|2FXR|C Chain C, Human Beta Tryptase Ii Complexed With Activated Ketone
Inhibitor Cra-29382
pdb|2FXR|D Chain D, Human Beta Tryptase Ii Complexed With Activated Ketone
Inhibitor Cra-29382
pdb|2FPZ|A Chain A, Human Tryptase With 2-Amino Benzimidazole
pdb|2FPZ|B Chain B, Human Tryptase With 2-Amino Benzimidazole
pdb|2FPZ|C Chain C, Human Tryptase With 2-Amino Benzimidazole
pdb|2FPZ|D Chain D, Human Tryptase With 2-Amino Benzimidazole
pdb|2FS8|A Chain A, Human Beta-Tryptase Ii With Inhibitor Cra-29382
pdb|2FS8|B Chain B, Human Beta-Tryptase Ii With Inhibitor Cra-29382
pdb|2FS8|C Chain C, Human Beta-Tryptase Ii With Inhibitor Cra-29382
pdb|2FS8|D Chain D, Human Beta-Tryptase Ii With Inhibitor Cra-29382
pdb|2FS9|A Chain A, Human Beta Tryptase Ii With Inhibitor Cra-28427
pdb|2FS9|B Chain B, Human Beta Tryptase Ii With Inhibitor Cra-28427
pdb|2FS9|C Chain C, Human Beta Tryptase Ii With Inhibitor Cra-28427
pdb|2FS9|D Chain D, Human Beta Tryptase Ii With Inhibitor Cra-28427
pdb|2GDD|A Chain A, Human Beta Ii Tryptase With Inhibitor Cra-27592
pdb|2GDD|B Chain B, Human Beta Ii Tryptase With Inhibitor Cra-27592
pdb|2GDD|C Chain C, Human Beta Ii Tryptase With Inhibitor Cra-27592
pdb|2GDD|D Chain D, Human Beta Ii Tryptase With Inhibitor Cra-27592
pdb|2ZA5|A Chain A, Crystal Structure Of Human Tryptase With Potent
Non-Peptide Inhibitor
pdb|2ZA5|B Chain B, Crystal Structure Of Human Tryptase With Potent
Non-Peptide Inhibitor
pdb|2ZA5|C Chain C, Crystal Structure Of Human Tryptase With Potent
Non-Peptide Inhibitor
pdb|2ZA5|D Chain D, Crystal Structure Of Human Tryptase With Potent
Non-Peptide Inhibitor
pdb|4A6L|A Chain A, Beta-Tryptase Inhibitor
pdb|4A6L|B Chain B, Beta-Tryptase Inhibitor
pdb|4A6L|C Chain C, Beta-Tryptase Inhibitor
pdb|4A6L|D Chain D, Beta-Tryptase Inhibitor
pdb|3V7T|A Chain A, Crystal Structure Of Human Beta-Tryptase Complexed With A
Synthetic Inhibitor With A Tropanylamide Scaffold
pdb|3V7T|B Chain B, Crystal Structure Of Human Beta-Tryptase Complexed With A
Synthetic Inhibitor With A Tropanylamide Scaffold
pdb|3V7T|C Chain C, Crystal Structure Of Human Beta-Tryptase Complexed With A
Synthetic Inhibitor With A Tropanylamide Scaffold
pdb|3V7T|D Chain D, Crystal Structure Of Human Beta-Tryptase Complexed With A
Synthetic Inhibitor With A Tropanylamide Scaffold
Length = 245
Score = 48.1 bits (113), Expect = 5e-06, Method: Compositional matrix adjust.
Identities = 59/235 (25%), Positives = 90/235 (38%), Gaps = 69/235 (29%)
Query: 33 PYIVSLSLYGNL---YCGGSLISLQWFLSARHCFVTENLVWNQFNPLIIAGSIYRNYKEQ 89
P+ VSL ++G +CGGSLI QW L+A HC + + ++ +EQ
Sbjct: 13 PWQVSLRVHGPYWMHFCGGSLIHPQWVLTAAHCVGPD---------VKDLAALRVQLREQ 63
Query: 90 K--RQPQLNEIALIYWHSD-------ADLAMVKLKEPFRQTTFVKPLDYYTARET----- 135
Q QL ++ I H AD+A+++L+EP + ++ V + A ET
Sbjct: 64 HLYYQDQLLPVSRIIVHPQFYTAQIGADIALLELEEPVKVSSHVHTVTLPPASETFPPGM 123
Query: 136 -------------------------------NYINDV---LSKTDRSEMSIVSGFGV--- 158
N+I D L ++ IV +
Sbjct: 124 PCWVTGWGDVDNDERLPPPFPLKQVKVPIMENHICDAKYHLGAYTGDDVRIVRDDMLCAG 183
Query: 159 -----TFQRDKDGIVSWGIGCALGYPGIVSWGIGCAL-GYPGVYVRVDHYDPWIQ 207
+ Q D G + + G+VSWG GCA PG+Y RV +Y WI
Sbjct: 184 NTRRDSCQGDSGGPLVCKVNGTWLQAGVVSWGEGCAQPNRPGIYTRVTYYLDWIH 238
>pdb|1A0L|A Chain A, Human Beta-Tryptase: A Ring-Like Tetramer With Active
Sites Facing A Central Pore
pdb|1A0L|B Chain B, Human Beta-Tryptase: A Ring-Like Tetramer With Active
Sites Facing A Central Pore
pdb|1A0L|C Chain C, Human Beta-Tryptase: A Ring-Like Tetramer With Active
Sites Facing A Central Pore
pdb|1A0L|D Chain D, Human Beta-Tryptase: A Ring-Like Tetramer With Active
Sites Facing A Central Pore
Length = 244
Score = 47.8 bits (112), Expect = 5e-06, Method: Compositional matrix adjust.
Identities = 59/235 (25%), Positives = 90/235 (38%), Gaps = 69/235 (29%)
Query: 33 PYIVSLSLYGNL---YCGGSLISLQWFLSARHCFVTENLVWNQFNPLIIAGSIYRNYKEQ 89
P+ VSL ++G +CGGSLI QW L+A HC + + ++ +EQ
Sbjct: 13 PWQVSLRVHGPYWMHFCGGSLIHPQWVLTAAHCVGPD---------VKDLAALRVQLREQ 63
Query: 90 K--RQPQLNEIALIYWHSD-------ADLAMVKLKEPFRQTTFVKPLDYYTARET----- 135
Q QL ++ I H AD+A+++L+EP + ++ V + A ET
Sbjct: 64 HLYYQDQLLPVSRIIVHPQFYTAQIGADIALLELEEPVKVSSHVHTVTLPPASETFPPGM 123
Query: 136 -------------------------------NYINDV---LSKTDRSEMSIVSGFGV--- 158
N+I D L ++ IV +
Sbjct: 124 PCWVTGWGDVDNDERLPPPFPLKQVKVPIMENHICDAKYHLGAYTGDDVRIVRDDMLCAG 183
Query: 159 -----TFQRDKDGIVSWGIGCALGYPGIVSWGIGCAL-GYPGVYVRVDHYDPWIQ 207
+ Q D G + + G+VSWG GCA PG+Y RV +Y WI
Sbjct: 184 NTRRDSCQGDSGGPLVCKVNGTWLQAGVVSWGEGCAQPNRPGIYTRVTYYLDWIH 238
>pdb|3PLK|A Chain A, Bovine Trypsin Variant X(Tripleile227) In Complex With
Small Molecule Inhibitor
Length = 223
Score = 47.8 bits (112), Expect = 5e-06, Method: Compositional matrix adjust.
Identities = 60/218 (27%), Positives = 88/218 (40%), Gaps = 43/218 (19%)
Query: 32 VPYIVSLSLYGNLYCGGSLISLQWFLSARHCFVT--------ENLVWNQFNPLIIAGSIY 83
VPY VSL+ G +CGGSL++ QW +SA HC+ + +N+ + N I+ S
Sbjct: 12 VPYQVSLN-SGYHFCGGSLLNSQWVVSAAHCYKSGIQVRLGEDNINVVEGNEQFISASKS 70
Query: 84 RNYKEQKRQPQLNEIALIYWHSDADL----AMVKLKEPFRQT---TFVKPLDYYTARETN 136
+ + N+I LI S A L A + L + + T+
Sbjct: 71 IVHPSYNSETYNNDIMLIKLKSAASLNSRVASISLPTSCASAGTQCLISGWGNTKSSGTS 130
Query: 137 YINDVLS--------------------KTDRSEMSIVSGFGVTFQRDKDGIVSWGIGCAL 176
Y DVL ++ + G Q D G V C+
Sbjct: 131 Y-PDVLKCLKAPILSDSSCKSASSFIITSNMFCAGYLEGGKDACQGDSGGPVV----CSG 185
Query: 177 GYPGIVSWGIGCAL-GYPGVYVRVDHYDPWI-QSVKNN 212
GIVSWG GCA PG+Y +V +Y WI Q++ +N
Sbjct: 186 KLQGIVSWGSGCAQKNKPGIYTKVCNYVSWIKQTIASN 223
>pdb|2ASU|B Chain B, Crystal Structure Of The Beta-Chain Of HgflMSP
Length = 234
Score = 47.8 bits (112), Expect = 5e-06, Method: Compositional matrix adjust.
Identities = 28/93 (30%), Positives = 51/93 (54%), Gaps = 8/93 (8%)
Query: 28 NPGEVPYIVSL-SLYGNLYCGGSLISLQWFLSARHCFVTENLVWNQFNPLIIAGSIYRNY 86
+PG P+ VSL + G +CGGSL+ QW L+AR CF + ++ + + G++++N
Sbjct: 5 HPGNSPWTVSLRNRQGQHFCGGSLVKEQWILTARQCFSSCHMPLTGYE--VWLGTLFQN- 61
Query: 87 KEQKRQPQLNEI---ALIYWHSDADLAMVKLKE 116
Q +P L + ++ S + L ++KL+
Sbjct: 62 -PQHGEPSLQRVPVAKMVCGPSGSQLVLLKLER 93
>pdb|3UWI|A Chain A, Bovine Trypsin Variant X(Tripleglu217phe227) In Complex
With Small Molecule Inhibitor
pdb|3UY9|A Chain A, Bovine Trypsin Variant X(Tripleglu217phe227) In Complex
With Small Molecule Inhibitor
pdb|3UY9|B Chain B, Bovine Trypsin Variant X(Tripleglu217phe227) In Complex
With Small Molecule Inhibitor
pdb|3UY9|C Chain C, Bovine Trypsin Variant X(Tripleglu217phe227) In Complex
With Small Molecule Inhibitor
pdb|3UY9|D Chain D, Bovine Trypsin Variant X(Tripleglu217phe227) In Complex
With Small Molecule Inhibitor
pdb|3UY9|E Chain E, Bovine Trypsin Variant X(Tripleglu217phe227) In Complex
With Small Molecule Inhibitor
pdb|3UY9|F Chain F, Bovine Trypsin Variant X(Tripleglu217phe227) In Complex
With Small Molecule Inhibitor
pdb|3UY9|G Chain G, Bovine Trypsin Variant X(Tripleglu217phe227) In Complex
With Small Molecule Inhibitor
pdb|3UY9|H Chain H, Bovine Trypsin Variant X(Tripleglu217phe227) In Complex
With Small Molecule Inhibitor
pdb|3UY9|I Chain I, Bovine Trypsin Variant X(Tripleglu217phe227) In Complex
With Small Molecule Inhibitor
pdb|3UY9|J Chain J, Bovine Trypsin Variant X(Tripleglu217phe227) In Complex
With Small Molecule Inhibitor
pdb|3UY9|K Chain K, Bovine Trypsin Variant X(Tripleglu217phe227) In Complex
With Small Molecule Inhibitor
pdb|3UY9|L Chain L, Bovine Trypsin Variant X(Tripleglu217phe227) In Complex
With Small Molecule Inhibitor
pdb|3UY9|M Chain M, Bovine Trypsin Variant X(Tripleglu217phe227) In Complex
With Small Molecule Inhibitor
pdb|3UY9|N Chain N, Bovine Trypsin Variant X(Tripleglu217phe227) In Complex
With Small Molecule Inhibitor
pdb|3UY9|O Chain O, Bovine Trypsin Variant X(Tripleglu217phe227) In Complex
With Small Molecule Inhibitor
pdb|3UY9|P Chain P, Bovine Trypsin Variant X(Tripleglu217phe227) In Complex
With Small Molecule Inhibitor
pdb|3V12|A Chain A, Bovine Trypsin Variant X(tripleglu217phe227) In Complex
With Small Molecule Inhibitor
pdb|3V13|A Chain A, Bovine Trypsin Variant X(Tripleglu217phe227) In Complex
With Small Molecule Inhibitor
Length = 223
Score = 47.8 bits (112), Expect = 6e-06, Method: Compositional matrix adjust.
Identities = 61/218 (27%), Positives = 88/218 (40%), Gaps = 43/218 (19%)
Query: 32 VPYIVSLSLYGNLYCGGSLISLQWFLSARHCFVT--------ENLVWNQFNPLIIAGSIY 83
VPY VSL+ G +CGGSLI+ QW +SA HC+ + +N+ + N I+ S
Sbjct: 12 VPYQVSLN-SGYHFCGGSLINSQWVVSAAHCYKSGIQVRLGEDNINVVEGNEQFISASKS 70
Query: 84 RNYKEQKRQPQLNEIALIYWHSDADL----AMVKLKEPFRQT---TFVKPLDYYTARETN 136
+ + N+I LI S A L A + L + + T+
Sbjct: 71 IVHPSYNSETYNNDIMLIKLKSAASLNSRVASISLPTSCASAGTQCLISGWGNTKSSGTS 130
Query: 137 YINDVLS--------------------KTDRSEMSIVSGFGVTFQRDKDGIVSWGIGCAL 176
Y DVL ++ + + G Q D G V C+
Sbjct: 131 Y-PDVLKCLKAPILSDSSCKSASSFIITSNMFCVGYLEGGKDACQGDSGGPVV----CSG 185
Query: 177 GYPGIVSWGIGCAL-GYPGVYVRVDHYDPWI-QSVKNN 212
GIVSWG GCA PG Y +V +Y WI Q++ +N
Sbjct: 186 KLQGIVSWGEGCAQKNKPGFYTKVCNYVSWIKQTIASN 223
>pdb|3ELA|H Chain H, Crystal Structure Of Active Site Inhibited Coagulation
Factor Viia Mutant In Complex With Soluble Tissue Factor
Length = 254
Score = 47.8 bits (112), Expect = 6e-06, Method: Compositional matrix adjust.
Identities = 41/146 (28%), Positives = 64/146 (43%), Gaps = 18/146 (12%)
Query: 30 GEVPYIVSLSLYGNLYCGGSLISLQWFLSARHCFVTENLVWNQFNPLIIAGSIYRNYKEQ 89
GE P+ V L + G CGG+LI+ W +SA HCF + + N N + + G + E
Sbjct: 10 GECPWQVLLLVNGAQLCGGTLINTIWVVSAAHCF---DKIKNWRNLIAVLGE--HDLSEH 64
Query: 90 KRQPQLNEIALIYWHS-------DADLAMVKLKEPFRQTTFVKPLDYYTARETNYINDVL 142
Q +A + S + D+A+++L +P T V PL E + L
Sbjct: 65 DGDEQSRRVAQVIIPSTYVPGTTNHDIALLRLHQPVVLTDHVVPL---CLPERTFSERTL 121
Query: 143 SKTDRSEMSIVSGFGVTFQRDKDGIV 168
+ S+VSG+G R +V
Sbjct: 122 AFV---RFSLVSGWGQLLDRGATALV 144
Score = 43.5 bits (101), Expect = 1e-04, Method: Compositional matrix adjust.
Identities = 22/44 (50%), Positives = 28/44 (63%), Gaps = 1/44 (2%)
Query: 180 GIVSWGIGCA-LGYPGVYVRVDHYDPWIQSVKNNGDNAGVLISA 222
GIVSWG GCA +G+ GVY RV Y W+Q + + GVL+ A
Sbjct: 208 GIVSWGQGCATVGHFGVYTRVSQYIEWLQKLMRSEPRPGVLLRA 251
>pdb|3V0X|A Chain A, Bovine Trypsin Variant X(Tripleglu217phe227) In Complex
With Small Molecule Inhibitor
Length = 223
Score = 47.8 bits (112), Expect = 6e-06, Method: Compositional matrix adjust.
Identities = 61/218 (27%), Positives = 88/218 (40%), Gaps = 43/218 (19%)
Query: 32 VPYIVSLSLYGNLYCGGSLISLQWFLSARHCFVT--------ENLVWNQFNPLIIAGSIY 83
VPY VSL+ G +CGGSLI+ QW +SA HC+ + +N+ + N I+ S
Sbjct: 12 VPYQVSLN-SGYHFCGGSLINSQWVVSAAHCYKSGIQVRLGEDNINVVEGNEQFISASKS 70
Query: 84 RNYKEQKRQPQLNEIALIYWHSDADL----AMVKLKEPFRQT---TFVKPLDYYTARETN 136
+ + N+I LI S A L A + L + + T+
Sbjct: 71 IVHPSYNSETYNNDIMLIKLKSAASLXSRVASISLPTSCASAGTQCLISGWGNTKSSGTS 130
Query: 137 YINDVLS--------------------KTDRSEMSIVSGFGVTFQRDKDGIVSWGIGCAL 176
Y DVL ++ + + G Q D G V C+
Sbjct: 131 Y-PDVLKCLKAPILSDSSCKSASSFIITSNMFCVGYLEGGKDACQGDSGGPVV----CSG 185
Query: 177 GYPGIVSWGIGCAL-GYPGVYVRVDHYDPWI-QSVKNN 212
GIVSWG GCA PG Y +V +Y WI Q++ +N
Sbjct: 186 KLQGIVSWGEGCAQKNKPGFYTKVCNYVSWIKQTIASN 223
>pdb|3UNS|A Chain A, Bovine Trypsin Variant X(Triplephe227) In Complex With
Small Molecule Inhibitor
pdb|3UOP|A Chain A, Bovine Trypsin Variant X(triplephe227) In Complex With
Small Molecule Inhibitor
pdb|3UQO|A Chain A, Bovine Trypsin Variant X(Triplephe227) In Complex With
Small Molecule Inhibitor
Length = 223
Score = 47.4 bits (111), Expect = 6e-06, Method: Compositional matrix adjust.
Identities = 61/218 (27%), Positives = 87/218 (39%), Gaps = 43/218 (19%)
Query: 32 VPYIVSLSLYGNLYCGGSLISLQWFLSARHCFVT--------ENLVWNQFNPLIIAGSIY 83
VPY VSL+ G +CGGSLI+ QW +SA HC+ + +N+ + N I+ S
Sbjct: 12 VPYQVSLN-SGYHFCGGSLINSQWVVSAAHCYKSGIQVRLGEDNINVVEGNEQFISASKS 70
Query: 84 RNYKEQKRQPQLNEIALIYWHSDADL----AMVKLKEPFRQT---TFVKPLDYYTARETN 136
+ + N+I LI S A L A + L + + T+
Sbjct: 71 IVHPSYNSETYNNDIMLIKLKSAASLNSRVASISLPTSCASAGTQCLISGWGNTKSSGTS 130
Query: 137 YINDVLS--------------------KTDRSEMSIVSGFGVTFQRDKDGIVSWGIGCAL 176
Y DVL ++ + G Q D G V C+
Sbjct: 131 Y-PDVLKCLKAPILSDSSCKSASSFIITSNMFCAGYLEGGKDACQGDSGGPVV----CSG 185
Query: 177 GYPGIVSWGIGCAL-GYPGVYVRVDHYDPWI-QSVKNN 212
GIVSWG GCA PG Y +V +Y WI Q++ +N
Sbjct: 186 KLQGIVSWGSGCAQKNKPGFYTKVCNYVSWIKQTIASN 223
>pdb|2OQ5|A Chain A, Crystal Structure Of Desc1, A New Member Of The Type Ii
Transmembrane Serine Proteinases Family
Length = 232
Score = 47.4 bits (111), Expect = 7e-06, Method: Compositional matrix adjust.
Identities = 61/226 (26%), Positives = 79/226 (34%), Gaps = 54/226 (23%)
Query: 30 GEVPYIVSLSLYGNLYCGGSLISLQWFLSARHCFVTENLVWNQFNPLIIAGSIYRNYKEQ 89
GE P+ SL G+ CG +LI+ W +SA HCF T NP S K
Sbjct: 10 GEWPWQASLQWDGSHRCGATLINATWLVSAAHCFTTYK------NPARWTASFGVTIKPS 63
Query: 90 KRQPQLNEIAL--IYWHS--DADLAMVKLKEPFRQTTFV------------KP------- 126
K + L I + Y H D D+++ +L P T V +P
Sbjct: 64 KMKRGLRRIIVHEKYKHPSHDYDISLAELSSPVPYTNAVHRVCLPDASYEFQPGDVMFVT 123
Query: 127 ----------------------LDYYTARETNYINDVLSKTDRSEMSIVSGFGVTFQRDK 164
+D T E ND ++ S+ G Q D
Sbjct: 124 GFGALKNDGYSQNHLRQAQVTLIDATTCNEPQAYNDAITPRMLCAGSL-EGKTDACQGDS 182
Query: 165 DGIVSWGIGCALGY-PGIVSWGIGCAL-GYPGVYVRVDHYDPWIQS 208
G + + Y GIVSWG CA PGVY RV WI S
Sbjct: 183 GGPLVSSDARDIWYLAGIVSWGDECAKPNKPGVYTRVTALRDWITS 228
>pdb|4B2C|A Chain A, Structure Of The Factor Xa-Like Trypsin Variant Triple-Ala
(Tpa) In Complex With Eglin C
pdb|4B2C|C Chain C, Structure Of The Factor Xa-Like Trypsin Variant Triple-Ala
(Tpa) In Complex With Eglin C
Length = 223
Score = 47.4 bits (111), Expect = 7e-06, Method: Compositional matrix adjust.
Identities = 61/218 (27%), Positives = 87/218 (39%), Gaps = 43/218 (19%)
Query: 32 VPYIVSLSLYGNLYCGGSLISLQWFLSARHCFVT--------ENLVWNQFNPLIIAGSIY 83
VPY VSL+ G +CGGSLI+ QW +SA HC+ + +N+ + N I+ S
Sbjct: 12 VPYQVSLN-SGYHFCGGSLINSQWVVSAAHCYKSGIQVRLGEDNINVVEGNEQFISASKS 70
Query: 84 RNYKEQKRQPQLNEIALIYWHSDADL----AMVKLKEPFRQT---TFVKPLDYYTARETN 136
+ + N+I LI S A L A + L + + T+
Sbjct: 71 IVHPSYNSETYNNDIMLIKLKSAASLNSRVASISLPTSCASAGTQCLISGWGNTKSSGTS 130
Query: 137 YINDVLS--------------------KTDRSEMSIVSGFGVTFQRDKDGIVSWGIGCAL 176
Y DVL ++ + G Q D G V C+
Sbjct: 131 Y-PDVLKCLKAPILSDSSCKSASSFIITSNMFCAGYLEGGKDACQGDAGGPVV----CSG 185
Query: 177 GYPGIVSWGIGCAL-GYPGVYVRVDHYDPWI-QSVKNN 212
GIVSWG GCA PG Y +V +Y WI Q++ +N
Sbjct: 186 KLQGIVSWGSGCAQKNKPGFYTKVCNYVSWIKQTIASN 223
>pdb|1AZZ|A Chain A, Fiddler Crab Collagenase Complexed To Ecotin
pdb|1AZZ|B Chain B, Fiddler Crab Collagenase Complexed To Ecotin
Length = 226
Score = 47.4 bits (111), Expect = 7e-06, Method: Compositional matrix adjust.
Identities = 55/212 (25%), Positives = 85/212 (40%), Gaps = 32/212 (15%)
Query: 29 PGEVPYIVSLSLYGNLYCGGSLISLQWFLSARHC-----FV-----TENLVWNQFNPLII 78
P P+ +L + +CGGSLIS +W L+A HC FV N+ ++ + I
Sbjct: 9 PNSWPHQAALFIDDMYFCGGSLISPEWILTAAHCMDGAGFVDVVLGAHNIREDEATQVTI 68
Query: 79 AGSIYRNYKEQKRQPQLNEIALIYWHSDADL--AMVKLKEPFRQT---TFVKPLDYYTAR 133
+ + ++ N+IA+I L A+ + P T V P +
Sbjct: 69 QSTDFTVHENYNSFVISNDIAVIRLPVPVTLTAAIATVGLPSTDVGVGTVVTPTGWGLPS 128
Query: 134 ETNY-INDVLSKTDRSEMS----------IVSGFGVTFQRDKDGIVSWGIGCALGYP--- 179
++ I+DVL + D MS + G G + G L Y
Sbjct: 129 DSALGISDVLRQVDVPIMSNADCDAVYGIVTDGNICIDSTGGKGTCNGDSGGPLNYNGLT 188
Query: 180 -GIVSWG--IGCALGYPGVYVRVDHYDPWIQS 208
GI S+G GC GYP + RV ++ WIQ+
Sbjct: 189 YGITSFGAAAGCEAGYPDAFTRVTYFLDWIQT 220
>pdb|4B2B|A Chain A, Structure Of The Factor Xa-Like Trypsin Variant Triple-Ala
(Tgpa) In Complex With Eglin C
pdb|4B2B|C Chain C, Structure Of The Factor Xa-Like Trypsin Variant Triple-Ala
(Tgpa) In Complex With Eglin C
Length = 223
Score = 47.0 bits (110), Expect = 9e-06, Method: Compositional matrix adjust.
Identities = 61/218 (27%), Positives = 87/218 (39%), Gaps = 43/218 (19%)
Query: 32 VPYIVSLSLYGNLYCGGSLISLQWFLSARHCFVT--------ENLVWNQFNPLIIAGSIY 83
VPY VSL+ G +CGGSLI+ QW +SA HC+ + +N+ + N I+ S
Sbjct: 12 VPYQVSLN-SGYHFCGGSLINSQWVVSAAHCYKSGIQVRLGEDNINVVEGNEQFISASKS 70
Query: 84 RNYKEQKRQPQLNEIALIYWHSDADL----AMVKLKEPFRQT---TFVKPLDYYTARETN 136
+ + N+I LI S A L A + L + + T+
Sbjct: 71 IVHPSYNSETYNNDIMLIKLKSAASLNSRVASISLPTSCASAGTQCLISGWGNTKSSGTS 130
Query: 137 YINDVLS--------------------KTDRSEMSIVSGFGVTFQRDKDGIVSWGIGCAL 176
Y DVL ++ + G Q D G V C+
Sbjct: 131 Y-PDVLKCLKAPILSDSSCKSASSFIITSNMFCAGYLEGGKDACQGDAGGPVV----CSG 185
Query: 177 GYPGIVSWGIGCAL-GYPGVYVRVDHYDPWI-QSVKNN 212
GIVSWG GCA PG Y +V +Y WI Q++ +N
Sbjct: 186 KLQGIVSWGEGCAQKNKPGFYTKVCNYVSWIKQTIASN 223
>pdb|1EKB|B Chain B, The Serine Protease Domain Of Enteropeptidase Bound To
Inhibitor Val- Asp-asp-asp-asp-lys-chloromethane
Length = 235
Score = 47.0 bits (110), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 52/224 (23%), Positives = 88/224 (39%), Gaps = 46/224 (20%)
Query: 30 GEVPYIVSLSLYGNLYCGGSLISLQWFLSARHCFVTENLVWNQFNPLIIAGSIYRNYKEQ 89
G P++V+L CG SL+S W +SA HC N+ +++ ++ + N
Sbjct: 10 GAWPWVVALYFDDQQVCGASLVSRDWLVSAAHCVYGRNMEPSKWK-AVLGLHMASNLTSP 68
Query: 90 KRQPQLNEIALIYWH-----SDADLAMVKLKEPFRQTTFVKPLDYYTARET--------- 135
+ + +L + +I H + D+AM+ L+ T +++P+ +
Sbjct: 69 QIETRLIDQIVINPHYNKRRKNNDIAMMHLEMKVNYTDYIQPICLPEENQVFPPGRICSI 128
Query: 136 ---------NYINDVLSKTDR-----------------SEMSIVSGF---GV-TFQRDKD 165
DVL + D +E + +G+ GV + Q D
Sbjct: 129 AGWGALIYQGSTADVLQEADVPLLSNEKCQQQMPEYNITENMVCAGYEAGGVDSCQGDSG 188
Query: 166 GIVSWGIGCALGYPGIVSWGIGCAL-GYPGVYVRVDHYDPWIQS 208
G + G+ S+G CAL PGVY RV + WIQS
Sbjct: 189 GPLMCQENNRWLLAGVTSFGYQCALPNRPGVYARVPRFTEWIQS 232
>pdb|1A0J|A Chain A, Crystal Structure Of A Non-Psychrophilic Trypsin From A
Cold-Adapted Fish Species.
pdb|1A0J|B Chain B, Crystal Structure Of A Non-Psychrophilic Trypsin From A
Cold-Adapted Fish Species.
pdb|1A0J|C Chain C, Crystal Structure Of A Non-Psychrophilic Trypsin From A
Cold-Adapted Fish Species.
pdb|1A0J|D Chain D, Crystal Structure Of A Non-Psychrophilic Trypsin From A
Cold-Adapted Fish Species
Length = 223
Score = 47.0 bits (110), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 50/202 (24%), Positives = 77/202 (38%), Gaps = 43/202 (21%)
Query: 45 YCGGSLISLQWFLSARHCFVTE-NLVWNQFNPLIIAGS-IYRNYKEQKRQPQLNEIALIY 102
+CGGSLIS W +SA HC+ + + + N + G+ + + + P N L
Sbjct: 24 FCGGSLISSTWVVSAAHCYKSRIQVRLGEHNIAVNEGTEQFIDSVKVIMHPSYNSRNL-- 81
Query: 103 WHSDADLAMVKLKEPFRQTTFVKPLDY------------------YTARETNYINDVLSK 144
D D+ ++KL +P ++V + + +NY D L
Sbjct: 82 ---DNDIMLIKLSKPASLNSYVSTVALPSSCASSGTRCLVSGWGNLSGSSSNYP-DTLRC 137
Query: 145 TDRSEMS----------------IVSGFGVTFQRDKDGIVSWGIGCALGYPGIVSWGIGC 188
D +S +GF + G + C G+VSWG GC
Sbjct: 138 LDLPILSSSSCNSAYPGQITSNMFCAGFMEGGKDSCQGDSGGPVVCNGQLQGVVSWGYGC 197
Query: 189 A-LGYPGVYVRVDHYDPWIQSV 209
A PGVY +V +Y WI S
Sbjct: 198 AQRNKPGVYTKVCNYRSWISST 219
>pdb|2VNT|A Chain A, Urokinase-Type Plasminogen Activator Inhibitor Complex
With A 1-(7-Sulphoamidoisoquinolinyl)guanidine
pdb|2VNT|B Chain B, Urokinase-Type Plasminogen Activator Inhibitor Complex
With A 1-(7-Sulphoamidoisoquinolinyl)guanidine
pdb|2VNT|C Chain C, Urokinase-Type Plasminogen Activator Inhibitor Complex
With A 1-(7-Sulphoamidoisoquinolinyl)guanidine
pdb|2VNT|D Chain D, Urokinase-Type Plasminogen Activator Inhibitor Complex
With A 1-(7-Sulphoamidoisoquinolinyl)guanidine
pdb|2VNT|E Chain E, Urokinase-Type Plasminogen Activator Inhibitor Complex
With A 1-(7-Sulphoamidoisoquinolinyl)guanidine
pdb|2VNT|F Chain F, Urokinase-Type Plasminogen Activator Inhibitor Complex
With A 1-(7-Sulphoamidoisoquinolinyl)guanidine
Length = 276
Score = 46.6 bits (109), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 24/49 (48%), Positives = 29/49 (59%), Gaps = 1/49 (2%)
Query: 161 QRDKDGIVSWGIGCALGYPGIVSWGIGCAL-GYPGVYVRVDHYDPWIQS 208
Q D G + + + GIVSWG GCAL PGVY RV H+ PWI+S
Sbjct: 218 QGDSGGPLVCSLQGRMTLTGIVSWGRGCALKDKPGVYTRVSHFLPWIRS 266
Score = 32.7 bits (73), Expect = 0.20, Method: Compositional matrix adjust.
Identities = 12/19 (63%), Positives = 15/19 (78%)
Query: 46 CGGSLISLQWFLSARHCFV 64
CGGSL+S W +SA HCF+
Sbjct: 54 CGGSLMSPCWVISATHCFI 72
>pdb|1H9H|E Chain E, Complex Of Eeti-Ii With Porcine Trypsin
Length = 231
Score = 46.6 bits (109), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 56/229 (24%), Positives = 81/229 (35%), Gaps = 67/229 (29%)
Query: 31 EVPYIVSLSLYGNLYCGGSLISLQWFLSARHCFVTENLV--WNQFNPLIIAGS-IYRNYK 87
+PY VSL+ + GGSLI+ QW +SA HC + + N ++ G+ + N
Sbjct: 12 SIPYQVSLNSGSHFCSGGSLINSQWVVSAAHCSYKSRIQVRLGEHNIDVLEGNEQFINAA 71
Query: 88 EQKRQPQLNEIALIYWHSDADLAMVKLKEPFRQTTFVKPLDYYTARETNYINDVLSKTDR 147
+ P N L D D+ ++KL P + V + +
Sbjct: 72 KIITHPNFNGNTL-----DNDIMLIKLSSPATLNSRVATVSLPRS----------CAAAG 116
Query: 148 SEMSIVSGFGVT----------FQRDKDGIVSWGIGCALGYP------------------ 179
+E S++SG+G T Q V C YP
Sbjct: 117 TECSLISGWGNTKSSGSSYPSLLQCSLKAPVLSDSSCKSSYPGQITGNMICVGFLEGGKD 176
Query: 180 -------------------GIVSWGIGCAL--GYPGVYVRVDHYDPWIQ 207
GIVSWG GC+ PGVY +V +Y WIQ
Sbjct: 177 SCSQGDSGGPVVCSNGQLQGIVSWGYGCSAQKNKPGVYTKVCNYVNWIQ 225
>pdb|1SC8|U Chain U, Urokinase Plasminogen Activator B-Chain-J435 Complex
pdb|1VJ9|U Chain U, Urokinase Plasminogen Activator B-Chain-Jt464 Complex
pdb|1VJA|U Chain U, Urokinase Plasminogen Activator B-Chain-Jt463 Complex
Length = 262
Score = 46.2 bits (108), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 24/49 (48%), Positives = 29/49 (59%), Gaps = 1/49 (2%)
Query: 161 QRDKDGIVSWGIGCALGYPGIVSWGIGCAL-GYPGVYVRVDHYDPWIQS 208
Q D G + + + GIVSWG GCAL PGVY RV H+ PWI+S
Sbjct: 210 QGDSGGPLVCSLQGRMTLTGIVSWGRGCALKDKPGVYTRVSHFLPWIRS 258
Score = 33.5 bits (75), Expect = 0.11, Method: Compositional matrix adjust.
Identities = 13/19 (68%), Positives = 15/19 (78%)
Query: 46 CGGSLISLQWFLSARHCFV 64
CGGSLIS W +SA HCF+
Sbjct: 46 CGGSLISPCWVISATHCFI 64
>pdb|1EJN|A Chain A, Urokinase Plasminogen Activator B-Chain Inhibitor Complex
pdb|1F5K|U Chain U, Urokinase Plasminogen Activator B-Chain-Benzamidine
Complex
pdb|1F5L|A Chain A, Urokinase Plasminogen Activator B-Chain-Amiloride Complex
pdb|1F92|A Chain A, Urokinase Plasminogen Activator B Chain-Uki-1d Complex
pdb|2R2W|U Chain U, Urokinase Plasminogen Activator B-Chain-Gppe Complex
pdb|2VIN|A Chain A, Fragment-Based Discovery Of Mexiletine Derivatives As
Orally Bioavailable Inhibitors Of Urokinase-Type
Plasminogen Activator
pdb|2VIO|A Chain A, Fragment-Based Discovery Of Mexiletine Derivatives As
Orally Bioavailable Inhibitors Of Urokinase-Type
Plasminogen Activator
pdb|2VIP|A Chain A, Fragment-Based Discovery Of Mexiletine Derivatives As
Orally Bioavailable Inhibitors Of Urokinase-Type
Plasminogen Activator
pdb|2VIQ|A Chain A, Fragment-based Discovery Of Mexiletine Derivatives As
Orally Bioavailable Inhibitors Of Urokinase-type
Plasminogen Activator
pdb|2VIV|A Chain A, Fragment-Based Discovery Of Mexiletine Derivatives As
Orally Bioavailable Inhibitors Of Urokinase-Type
Plasminogen Activator
pdb|2VIW|A Chain A, Fragment-Based Discovery Of Mexiletine Derivatives As
Orally Bioavailable Inhibitors Of Urokinase-Type
Plasminogen Activator
Length = 253
Score = 46.2 bits (108), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 24/49 (48%), Positives = 29/49 (59%), Gaps = 1/49 (2%)
Query: 161 QRDKDGIVSWGIGCALGYPGIVSWGIGCAL-GYPGVYVRVDHYDPWIQS 208
Q D G + + + GIVSWG GCAL PGVY RV H+ PWI+S
Sbjct: 195 QGDSGGPLVCSLQGRMTLTGIVSWGRGCALKDKPGVYTRVSHFLPWIRS 243
Score = 33.5 bits (75), Expect = 0.097, Method: Compositional matrix adjust.
Identities = 13/19 (68%), Positives = 15/19 (78%)
Query: 46 CGGSLISLQWFLSARHCFV 64
CGGSLIS W +SA HCF+
Sbjct: 31 CGGSLISPCWVISATHCFI 49
>pdb|3UNQ|A Chain A, Bovine Trypsin Variant X(Triplephe227) In Complex With
Small Molecule Inhibitor
pdb|3UPE|A Chain A, Bovine Trypsin Variant X(Triplephe227) In Complex With
Small Molecule Inhibitor
pdb|3UUZ|A Chain A, Bovine Trypsin Variant X(Triplephe227) In Complex With
Small Molecule Inhibitor
pdb|3UUZ|B Chain B, Bovine Trypsin Variant X(Triplephe227) In Complex With
Small Molecule Inhibitor
Length = 223
Score = 46.2 bits (108), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 60/218 (27%), Positives = 87/218 (39%), Gaps = 43/218 (19%)
Query: 32 VPYIVSLSLYGNLYCGGSLISLQWFLSARHCFVT--------ENLVWNQFNPLIIAGSIY 83
VPY VSL+ G +CGGSLI+ QW +SA HC+ + +N+ + N I+ S
Sbjct: 12 VPYQVSLN-SGYHFCGGSLINSQWVVSAAHCYKSGIQVRLGEDNINVVEGNEQFISASKS 70
Query: 84 RNYKEQKRQPQLNEIALIYWHSDADL----AMVKLKEPFRQT---TFVKPLDYYTARETN 136
+ + N+I LI S A L A + L + + T+
Sbjct: 71 IVHPSYNSETYNNDIMLIKLKSAASLNSRVASISLPTSCASAGTQCLISGWGNTKSSGTS 130
Query: 137 YINDVLS--------------------KTDRSEMSIVSGFGVTFQRDKDGIVSWGIGCAL 176
Y DVL ++ + G Q D G V C+
Sbjct: 131 Y-PDVLKCLKAPILSDSSCKSASSFIITSNMFCAGYLEGGKDACQGDSGGPVV----CSG 185
Query: 177 GYPGIVSWGIGCAL-GYPGVYVRVDHYDPWI-QSVKNN 212
GIVSWG GCA PG Y ++ +Y WI Q++ +N
Sbjct: 186 KLQGIVSWGSGCAQKNKPGFYTKLCNYVSWIKQTIASN 223
>pdb|2NWN|A Chain A, New Pharmacophore For Serine Protease Inhibition Revealed
By Crystal Structure Of Human Urokinase-Type Plasminogen
Activator Complexed With A Cyclic Peptidyl Inhibitor,
Upain-1
pdb|2O8T|A Chain A, Crystal Structure And Binding Epitopes Of Urokinase-Type
Plasminogen Activator (C122aN145Q) IN COMPLEX WITH
Inhibitors
pdb|3KGP|A Chain A, Crystal Structures Of Urokinase-Type Plasminogen Activator
In Complex With 4-(Aminomethyl) Benzoic Acid And 4-
(Aminomethyl-Phenyl)-Methanol
pdb|3KHV|A Chain A, Crystal Structures Of Urokinase-Type Plasminogen Activator
In Complex With 4-(Aminomethyl) Benzoic Acid And 4-
(Aminomethyl-Phenyl)-Methanol
pdb|3KID|U Chain U, The Crystal Structures Of 2-Aminobenzothiazole-Based
Inhibitors In Complexes With Urokinase-Type Plasminogen
Activator
pdb|3M61|U Chain U, Crystal Structure Of Complex Of Urokinase And A Upain-1
Variant(W3a) In Ph4.6 Condition
pdb|3OX7|U Chain U, The Crystal Structure Of Upa Complex With Peptide
Inhibitor Mh027 At Ph4.6
pdb|3OY5|U Chain U, The Crystal Structure Of Upa Complex With Peptide
Inhibitor Mh027 At Ph7.4
pdb|3OY6|U Chain U, The Crystal Structure Of Upa Complex With Peptide
Inhibitor Mh036 At Ph4.6
pdb|3QN7|A Chain A, Potent And Selective Bicyclic Peptide Inhibitor (Uk18) Of
Human Urokinase-Type Plasminogen Activator(Upa)
Length = 253
Score = 46.2 bits (108), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 24/49 (48%), Positives = 29/49 (59%), Gaps = 1/49 (2%)
Query: 161 QRDKDGIVSWGIGCALGYPGIVSWGIGCAL-GYPGVYVRVDHYDPWIQS 208
Q D G + + + GIVSWG GCAL PGVY RV H+ PWI+S
Sbjct: 195 QGDSGGPLVCSLQGRMTLTGIVSWGRGCALKDKPGVYTRVSHFLPWIRS 243
Score = 33.5 bits (75), Expect = 0.10, Method: Compositional matrix adjust.
Identities = 13/19 (68%), Positives = 15/19 (78%)
Query: 46 CGGSLISLQWFLSARHCFV 64
CGGSLIS W +SA HCF+
Sbjct: 31 CGGSLISPCWVISATHCFI 49
>pdb|1LMW|B Chain B, Lmw U-Pa Structure Complexed With Egrcmk (Glu-Gly-Arg
Chloromethyl Ketone)
pdb|1LMW|D Chain D, Lmw U-Pa Structure Complexed With Egrcmk (Glu-Gly-Arg
Chloromethyl Ketone)
Length = 253
Score = 46.2 bits (108), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 24/51 (47%), Positives = 30/51 (58%), Gaps = 1/51 (1%)
Query: 159 TFQRDKDGIVSWGIGCALGYPGIVSWGIGCAL-GYPGVYVRVDHYDPWIQS 208
+ Q D G + + + GIVSWG GCAL PGVY RV H+ PWI+S
Sbjct: 193 SCQGDSGGPLVCSLQGRMTLTGIVSWGRGCALKDKPGVYTRVSHFLPWIRS 243
Score = 32.3 bits (72), Expect = 0.22, Method: Compositional matrix adjust.
Identities = 12/19 (63%), Positives = 15/19 (78%)
Query: 46 CGGSLISLQWFLSARHCFV 64
CGGSL+S W +SA HCF+
Sbjct: 31 CGGSLMSPCWVISATHCFI 49
>pdb|1GJ7|B Chain B, Engineering Inhibitors Highly Selective For The S1 Sites
Of Ser190 Trypsin-Like Serine Protease Drug Targets
pdb|1GJ8|B Chain B, Engineering Inhibitors Highly Selective For The S1 Sites
Of Ser190 Trypsin-Like Serine Protease Drug Targets
pdb|1GJA|B Chain B, Engineering Inhibitors Highly Selective For The S1 Sites
Of Ser190 Trypsin-Like Serine Protease Drug Targets
pdb|1GJB|B Chain B, Engineering Inhibitors Highly Selective For The S1 Sites
Of Ser190 Trypsin-Like Serine Protease Drug Targets
pdb|1O3P|B Chain B, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1C5W|B Chain B, Structural Basis For Selectivity Of A Small Molecule, S1-
Binding, Sub-Micromolar Inhibitor Of Urokinase Type
Plasminogen Activator
pdb|1C5X|B Chain B, Structural Basis For Selectivity Of A Small Molecule, S1-
Binding, Sub-Micromolar Inhibitor Of Urokinase Type
Plasminogen Activator
pdb|1C5Y|B Chain B, Structural Basis For Selectivity Of A Small Molecule, S1-
Binding, Sub-Micromolar Inhibitor Of Urokinase Type
Plasminogen Activator
pdb|1C5Z|B Chain B, Structural Basis For Selectivity Of A Small Molecule, S1-
Binding, Sub-Micromolar Inhibitor Of Urokinase Type
Plasminogen Activator
pdb|1GJ9|B Chain B, Engineering Inhibitors Highly Selective For The S1 Sites
Of Ser190 Trypsin-Like Serine Protease Drug Targets
pdb|1GJD|B Chain B, Engineering Inhibitors Highly Selective For The S1 Sites
Of Ser190 Trypsin-Like Serine Protease Drug Targets
pdb|1GJC|B Chain B, Engineering Inhibitors Highly Selective For The S1 Sites
Of Ser190 Trypsin-Like Serine Protease Drug Targets
Length = 253
Score = 46.2 bits (108), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 24/51 (47%), Positives = 30/51 (58%), Gaps = 1/51 (1%)
Query: 159 TFQRDKDGIVSWGIGCALGYPGIVSWGIGCAL-GYPGVYVRVDHYDPWIQS 208
+ Q D G + + + GIVSWG GCAL PGVY RV H+ PWI+S
Sbjct: 193 SCQGDSGGPLVCSLQGRMTLTGIVSWGRGCALKDKPGVYTRVSHFLPWIRS 243
Score = 32.3 bits (72), Expect = 0.22, Method: Compositional matrix adjust.
Identities = 12/19 (63%), Positives = 15/19 (78%)
Query: 46 CGGSLISLQWFLSARHCFV 64
CGGSL+S W +SA HCF+
Sbjct: 31 CGGSLMSPCWVISATHCFI 49
>pdb|4D9Q|A Chain A, Inhibiting Alternative Pathway Complement Activation By
Targeting The Exosite On Factor D
pdb|4D9Q|B Chain B, Inhibiting Alternative Pathway Complement Activation By
Targeting The Exosite On Factor D
Length = 228
Score = 46.2 bits (108), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 53/220 (24%), Positives = 87/220 (39%), Gaps = 49/220 (22%)
Query: 33 PYIVSLSLYGNLYCGGSLISLQWFLSARHCFVTENLVWNQFNPLIIAGSIYRNYKEQKRQ 92
PY+ S+ + G CGG L++ QW LSA HC E+ + L+ A S+ + ++
Sbjct: 13 PYMASVQVNGEHLCGGVLVAEQWVLSAAHCL--EDAADGKVQVLLGAHSLSQPEPSKR-- 68
Query: 93 PQLNEIALIYWHSDA-------DLAMVKLKEPFRQTTFVKPLDYYTAR---ETNYINDVL 142
L ++ H D+ DL +++L E V+PL + E + DV
Sbjct: 69 --LYDVLRAVPHPDSRPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVEPGTLCDVA 126
Query: 143 S---------KTDRSE---MSIVSGFGVTFQRDKDGIVSWGIGCA-----------LGYP 179
+ DR + + ++ + DG ++ + CA G P
Sbjct: 127 GWGIVSHAGRRPDRLQHVLLPVLDRATCNRRTHHDGAITQRMMCAESNRRDSCKGDSGGP 186
Query: 180 --------GIVSWG--IGCALGYPGVYVRVDHYDPWIQSV 209
G+V+ G + PG+Y RV Y WI SV
Sbjct: 187 LVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSV 226
>pdb|3IG6|B Chain B, Low Molecular Weigth Human Urokinase Type Plasminogen
Activator 2-[6-
(3'-Aminomethyl-Biphenyl-3-Yloxy)-4-(3-Dimethylamino-
Pyrrolidin-1-
Yl)-3,
5-Difluoro-Pyridin-2-Yloxy]-4-Dimethylamino-Benzoic Acid
Complex
pdb|3IG6|D Chain D, Low Molecular Weigth Human Urokinase Type Plasminogen
Activator 2-[6-
(3'-Aminomethyl-Biphenyl-3-Yloxy)-4-(3-Dimethylamino-
Pyrrolidin-1-
Yl)-3,
5-Difluoro-Pyridin-2-Yloxy]-4-Dimethylamino-Benzoic Acid
Complex
Length = 253
Score = 46.2 bits (108), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 24/51 (47%), Positives = 30/51 (58%), Gaps = 1/51 (1%)
Query: 159 TFQRDKDGIVSWGIGCALGYPGIVSWGIGCAL-GYPGVYVRVDHYDPWIQS 208
+ Q D G + + + GIVSWG GCAL PGVY RV H+ PWI+S
Sbjct: 193 SCQGDSGGPLVCSLQGRMTLTGIVSWGRGCALKDKPGVYTRVSHFLPWIRS 243
Score = 33.5 bits (75), Expect = 0.11, Method: Compositional matrix adjust.
Identities = 13/19 (68%), Positives = 15/19 (78%)
Query: 46 CGGSLISLQWFLSARHCFV 64
CGGSLIS W +SA HCF+
Sbjct: 31 CGGSLISPCWVISATHCFI 49
>pdb|1O5A|B Chain B, Dissecting And Designing Inhibitor Selectivity
Determinants At The S1 Site Using An Artificial Ala190
Protease (Ala190 Upa)
pdb|1O5B|B Chain B, Dissecting And Designing Inhibitor Selectivity
Determinants At The S1 Site Using An Artificial Ala190
Protease (ala190 Upa)
pdb|1O5C|B Chain B, Dissecting And Designing Inhibitor Selectivity
Determinants At The S1 Site Using An Artificial Ala190
Protease (Ala190 Upa)
Length = 253
Score = 46.2 bits (108), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 24/49 (48%), Positives = 29/49 (59%), Gaps = 1/49 (2%)
Query: 161 QRDKDGIVSWGIGCALGYPGIVSWGIGCAL-GYPGVYVRVDHYDPWIQS 208
Q D G + + + GIVSWG GCAL PGVY RV H+ PWI+S
Sbjct: 195 QGDSGGPLVCSLQGRMTLTGIVSWGRGCALKDKPGVYTRVSHFLPWIRS 243
Score = 32.3 bits (72), Expect = 0.21, Method: Compositional matrix adjust.
Identities = 12/19 (63%), Positives = 15/19 (78%)
Query: 46 CGGSLISLQWFLSARHCFV 64
CGGSL+S W +SA HCF+
Sbjct: 31 CGGSLMSPCWVISATHCFI 49
>pdb|1FV9|A Chain A, Crystal Structure Of Human Microurokinase In Complex With
2- Amino-5-Hydroxy-Benzimidazole
Length = 245
Score = 46.2 bits (108), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 24/49 (48%), Positives = 29/49 (59%), Gaps = 1/49 (2%)
Query: 161 QRDKDGIVSWGIGCALGYPGIVSWGIGCAL-GYPGVYVRVDHYDPWIQS 208
Q D G + + + GIVSWG GCAL PGVY RV H+ PWI+S
Sbjct: 195 QGDSGGPLVCSLQGRMTLTGIVSWGRGCALKDKPGVYTRVSHFLPWIRS 243
Score = 32.3 bits (72), Expect = 0.21, Method: Compositional matrix adjust.
Identities = 12/19 (63%), Positives = 15/19 (78%)
Query: 46 CGGSLISLQWFLSARHCFV 64
CGGSL+S W +SA HCF+
Sbjct: 31 CGGSLMSPCWVISATHCFI 49
>pdb|4FU7|A Chain A, Crystal Structure Of The Urokinase
pdb|4FU8|A Chain A, Crystal Structure Of The Urokinase
pdb|4FU9|A Chain A, Crystal Structure Of The Urokinase
pdb|4FUB|A Chain A, Crystal Structure Of The Urokinase
pdb|4FUC|A Chain A, Crystal Structure Of The Urokinase
pdb|4FUD|A Chain A, Crystal Structure Of The Urokinase
pdb|4FUE|A Chain A, Crystal Structure Of The Urokinase
pdb|4FUF|A Chain A, Crystal Structure Of The Urokinase
pdb|4FUG|A Chain A, Crystal Structure Of The Urokinase
pdb|4FUH|A Chain A, Crystal Structure Of The Urokinase
pdb|4FUI|A Chain A, Crystal Structure Of The Urokinase
pdb|4FUJ|A Chain A, Crystal Structure Of The Urokinase
pdb|4DVA|U Chain U, The Crystal Structure Of Human Urokinase-type Plasminogen
Activator Catalytic Domain
pdb|4DW2|U Chain U, The Crystal Structure Of Upa In Complex With The Fab
Fragment Of Mab- 112
Length = 246
Score = 46.2 bits (108), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 24/49 (48%), Positives = 29/49 (59%), Gaps = 1/49 (2%)
Query: 161 QRDKDGIVSWGIGCALGYPGIVSWGIGCAL-GYPGVYVRVDHYDPWIQS 208
Q D G + + + GIVSWG GCAL PGVY RV H+ PWI+S
Sbjct: 195 QGDSGGPLVCSLQGRMTLTGIVSWGRGCALKDKPGVYTRVSHFLPWIRS 243
Score = 33.5 bits (75), Expect = 0.100, Method: Compositional matrix adjust.
Identities = 13/19 (68%), Positives = 15/19 (78%)
Query: 46 CGGSLISLQWFLSARHCFV 64
CGGSLIS W +SA HCF+
Sbjct: 31 CGGSLISPCWVISATHCFI 49
>pdb|3MWI|U Chain U, The Complex Crystal Structure Of Urokianse And
5-Nitro-1h-Indole-2- Amidine
Length = 246
Score = 46.2 bits (108), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 24/49 (48%), Positives = 29/49 (59%), Gaps = 1/49 (2%)
Query: 161 QRDKDGIVSWGIGCALGYPGIVSWGIGCAL-GYPGVYVRVDHYDPWIQS 208
Q D G + + + GIVSWG GCAL PGVY RV H+ PWI+S
Sbjct: 195 QGDSGGPLVCSLQGRMTLTGIVSWGRGCALKDKPGVYTRVSHFLPWIRS 243
Score = 33.5 bits (75), Expect = 0.098, Method: Compositional matrix adjust.
Identities = 13/19 (68%), Positives = 15/19 (78%)
Query: 46 CGGSLISLQWFLSARHCFV 64
CGGSLIS W +SA HCF+
Sbjct: 31 CGGSLISPCWVISATHCFI 49
>pdb|1W0Z|U Chain U, Urokinase Type Plasminogen Activator
pdb|1W10|U Chain U, Urokinase Type Plasminogen Activator
pdb|1W11|U Chain U, Urokinase Type Plasminogen Activator
pdb|1W12|U Chain U, Urokinase Type Plasminogen Activator
pdb|1W13|U Chain U, Urokinase Type Plasminogen Activator
pdb|1W14|U Chain U, Urokinase Type Plasminogen Activator
pdb|3MHW|U Chain U, The Complex Crystal Structure Of Urokianse And 2-
Aminobenzothiazole
Length = 247
Score = 46.2 bits (108), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 24/49 (48%), Positives = 29/49 (59%), Gaps = 1/49 (2%)
Query: 161 QRDKDGIVSWGIGCALGYPGIVSWGIGCAL-GYPGVYVRVDHYDPWIQS 208
Q D G + + + GIVSWG GCAL PGVY RV H+ PWI+S
Sbjct: 195 QGDSGGPLVCSLQGRMTLTGIVSWGRGCALKDKPGVYTRVSHFLPWIRS 243
Score = 33.5 bits (75), Expect = 0.100, Method: Compositional matrix adjust.
Identities = 13/19 (68%), Positives = 15/19 (78%)
Query: 46 CGGSLISLQWFLSARHCFV 64
CGGSLIS W +SA HCF+
Sbjct: 31 CGGSLISPCWVISATHCFI 49
>pdb|2O8U|A Chain A, Crystal Structure And Binding Epitopes Of Urokinase-Type
Plasminogen Activator (C122aN145QS195A) IN COMPLEX WITH
Inhibitors
pdb|2O8W|A Chain A, Crystal Structure And Binding Epitopes Of Urokinase-Type
Plasminogen Activator (C122aN145QS195A) IN COMPLEX WITH
Inhibitors
pdb|3PB1|E Chain E, Crystal Structure Of A Michaelis Complex Between
Plasminogen Activator Inhibitor-1 And Urokinase-Type
Plasminogen Activator
Length = 253
Score = 46.2 bits (108), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 24/49 (48%), Positives = 29/49 (59%), Gaps = 1/49 (2%)
Query: 161 QRDKDGIVSWGIGCALGYPGIVSWGIGCAL-GYPGVYVRVDHYDPWIQS 208
Q D G + + + GIVSWG GCAL PGVY RV H+ PWI+S
Sbjct: 195 QGDAGGPLVCSLQGRMTLTGIVSWGRGCALKDKPGVYTRVSHFLPWIRS 243
Score = 33.5 bits (75), Expect = 0.100, Method: Compositional matrix adjust.
Identities = 13/19 (68%), Positives = 15/19 (78%)
Query: 46 CGGSLISLQWFLSARHCFV 64
CGGSLIS W +SA HCF+
Sbjct: 31 CGGSLISPCWVISATHCFI 49
>pdb|1OWD|A Chain A, Substituted 2-naphthamidine Inhibitors Of Urokinase
pdb|1OWI|A Chain A, Substituted 2-Naphthamidine Inhibitors Of Urokinase
pdb|1OWJ|A Chain A, Substituted 2-naphthamidine Inhibitors Of Urokinase
pdb|1OWK|A Chain A, Substituted 2-Naphthamidine Inhibitors Of Urokinase
pdb|1SQT|A Chain A, Substituted 2-naphthamidine Inhibitors Of Urokinase
pdb|1U6Q|A Chain A, Substituted 2-naphthamadine Inhibitors Of Urokinase
Length = 245
Score = 45.8 bits (107), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 24/49 (48%), Positives = 29/49 (59%), Gaps = 1/49 (2%)
Query: 161 QRDKDGIVSWGIGCALGYPGIVSWGIGCAL-GYPGVYVRVDHYDPWIQS 208
Q D G + + + GIVSWG GCAL PGVY RV H+ PWI+S
Sbjct: 195 QGDSGGPLVCSLQGRMTLTGIVSWGRGCALKDKPGVYTRVSHFLPWIRS 243
Score = 32.3 bits (72), Expect = 0.22, Method: Compositional matrix adjust.
Identities = 12/19 (63%), Positives = 15/19 (78%)
Query: 46 CGGSLISLQWFLSARHCFV 64
CGGSL+S W +SA HCF+
Sbjct: 31 CGGSLMSPCWVISATHCFI 49
>pdb|1OWE|A Chain A, Substituted 2-Naphthamidine Inhibitors Of Urokinase
pdb|1OWH|A Chain A, Substituted 2-Naphthamidine Inhibitors Of Urokinase
pdb|1SQA|A Chain A, Substituted 2-Naphthamidine Inhibitors Of Urokinase
pdb|1SQO|A Chain A, Substituted 2-Naphthamidine Inhibitors Of Urokinase
Length = 245
Score = 45.8 bits (107), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 24/49 (48%), Positives = 29/49 (59%), Gaps = 1/49 (2%)
Query: 161 QRDKDGIVSWGIGCALGYPGIVSWGIGCAL-GYPGVYVRVDHYDPWIQS 208
Q D G + + + GIVSWG GCAL PGVY RV H+ PWI+S
Sbjct: 195 QGDSGGPLVCSLQGRMTLTGIVSWGRGCALKDKPGVYTRVSHFLPWIRS 243
Score = 32.3 bits (72), Expect = 0.22, Method: Compositional matrix adjust.
Identities = 12/19 (63%), Positives = 15/19 (78%)
Query: 46 CGGSLISLQWFLSARHCFV 64
CGGSL+S W +SA HCF+
Sbjct: 31 CGGSLMSPCWVISATHCFI 49
>pdb|1GI8|B Chain B, A Novel Serine Protease Inhibition Motif Involving A
Multi- Centered Short Hydrogen Bonding Network At The
Active Site
pdb|1GI7|B Chain B, A Novel Serine Protease Inhibition Motif Involving A
Multi-Centered Short Hydrogen Bonding Network At The
Active Site
pdb|1GI9|B Chain B, A Novel Serine Protease Inhibition Motif Involving A
Multi-Centered Short Hydrogen Bonding Network At The
Active Site
Length = 245
Score = 45.8 bits (107), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 24/49 (48%), Positives = 29/49 (59%), Gaps = 1/49 (2%)
Query: 161 QRDKDGIVSWGIGCALGYPGIVSWGIGCAL-GYPGVYVRVDHYDPWIQS 208
Q D G + + + GIVSWG GCAL PGVY RV H+ PWI+S
Sbjct: 195 QGDSGGPLVCSLQGRMTLTGIVSWGRGCALKDKPGVYTRVSHFLPWIRS 243
Score = 32.3 bits (72), Expect = 0.22, Method: Compositional matrix adjust.
Identities = 12/19 (63%), Positives = 15/19 (78%)
Query: 46 CGGSLISLQWFLSARHCFV 64
CGGSL+S W +SA HCF+
Sbjct: 31 CGGSLMSPCWVISATHCFI 49
>pdb|2XW9|A Chain A, Crystal Structure Of Complement Factor D Mutant S183a
pdb|2XWB|I Chain I, Crystal Structure Of Complement C3b In Complex With
Factors B And D
pdb|2XWB|J Chain J, Crystal Structure Of Complement C3b In Complex With
Factors B And D
Length = 228
Score = 45.4 bits (106), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 54/220 (24%), Positives = 86/220 (39%), Gaps = 49/220 (22%)
Query: 33 PYIVSLSLYGNLYCGGSLISLQWFLSARHCFVTENLVWNQFNPLIIAGSIYRNYKEQKRQ 92
PY+ S+ L G CGG L++ QW LSA HC E+ + L+ A S+ + ++
Sbjct: 13 PYMASVQLNGAHLCGGVLVAEQWVLSAAHCL--EDAADGKVQVLLGAHSLSQPEPSKR-- 68
Query: 93 PQLNEIALIYWHSDA-------DLAMVKLKEPFRQTTFVKPL-----DYYTARET----- 135
L ++ H D+ DL +++L E V+PL D A T
Sbjct: 69 --LYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVA 126
Query: 136 --NYINDVLSKTDRSE---MSIVSGFGVTFQRDKDGIVSWGIGCA-----------LGYP 179
+N + D + + ++ + DG ++ + CA G P
Sbjct: 127 GWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDAGGP 186
Query: 180 --------GIVSWG--IGCALGYPGVYVRVDHYDPWIQSV 209
G+V+ G + PG+Y RV Y WI SV
Sbjct: 187 LVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSV 226
>pdb|2XWA|A Chain A, Crystal Structure Of Complement Factor D Mutant R202a
pdb|2XWA|B Chain B, Crystal Structure Of Complement Factor D Mutant R202a
Length = 228
Score = 45.4 bits (106), Expect = 3e-05, Method: Compositional matrix adjust.
Identities = 55/220 (25%), Positives = 86/220 (39%), Gaps = 49/220 (22%)
Query: 33 PYIVSLSLYGNLYCGGSLISLQWFLSARHCFVTENLVWNQFNPLIIAGSIYRNYKEQKRQ 92
PY+ S+ L G CGG L++ QW LSA HC E+ + L+ A S+ + ++
Sbjct: 13 PYMASVQLNGAHLCGGVLVAEQWVLSAAHCL--EDAADGKVQVLLGAHSLSQPEPSKR-- 68
Query: 93 PQLNEIALIYWHSDA-------DLAMVKLKEPFRQTTFVKPL-----DYYTARET----- 135
L ++ H D+ DL +++L E V+PL D A T
Sbjct: 69 --LYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVA 126
Query: 136 --NYINDVLSKTDRSE---MSIVSGFGVTFQRDKDGIVSWGIGCA-----------LGYP 179
+N + D + + ++ + DG ++ + CA G P
Sbjct: 127 GWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGP 186
Query: 180 --------GIVSWGIG-CA-LGYPGVYVRVDHYDPWIQSV 209
G+V+ G C PG+Y RV Y WI SV
Sbjct: 187 LVCGGVLEGVVTSGSAVCGNRKKPGIYTRVASYAAWIDSV 226
>pdb|1FDP|A Chain A, Proenzyme Of Human Complement Factor D, Recombinant
Profactor D
pdb|1FDP|B Chain B, Proenzyme Of Human Complement Factor D, Recombinant
Profactor D
pdb|1FDP|C Chain C, Proenzyme Of Human Complement Factor D, Recombinant
Profactor D
pdb|1FDP|D Chain D, Proenzyme Of Human Complement Factor D, Recombinant
Profactor D
Length = 235
Score = 45.4 bits (106), Expect = 3e-05, Method: Compositional matrix adjust.
Identities = 54/220 (24%), Positives = 86/220 (39%), Gaps = 49/220 (22%)
Query: 33 PYIVSLSLYGNLYCGGSLISLQWFLSARHCFVTENLVWNQFNPLIIAGSIYRNYKEQKRQ 92
PY+ S+ L G CGG L++ QW LSA HC E+ + L+ A S+ + ++
Sbjct: 20 PYMASVQLNGAHLCGGVLVAEQWVLSAAHCL--EDAADGKVQVLLGAHSLSQPEPSKR-- 75
Query: 93 PQLNEIALIYWHSDA-------DLAMVKLKEPFRQTTFVKPL-----DYYTARET----- 135
L ++ H D+ DL +++L E V+PL D A T
Sbjct: 76 --LYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVA 133
Query: 136 --NYINDVLSKTDRSE---MSIVSGFGVTFQRDKDGIVSWGIGCA-----------LGYP 179
+N + D + + ++ + DG ++ + CA G P
Sbjct: 134 GWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGP 193
Query: 180 --------GIVSWG--IGCALGYPGVYVRVDHYDPWIQSV 209
G+V+ G + PG+Y RV Y WI SV
Sbjct: 194 LVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSV 233
>pdb|1FY3|A Chain A, [g175q]hbp, A Mutant Of Human Heparin Binding Protein
(cap37)
Length = 225
Score = 45.4 bits (106), Expect = 3e-05, Method: Compositional matrix adjust.
Identities = 52/218 (23%), Positives = 90/218 (41%), Gaps = 41/218 (18%)
Query: 29 PGEVPYIVSLSLYGNLYCGGSLISLQWFLSARHCFVTENLVWNQFNPLIIAGSIYRNYKE 88
P + P++ S+ G +CGG+LI ++ ++A CF ++N + +++ R +
Sbjct: 9 PRQFPFLASIQNQGRHFCGGALIHARFVMTAASCFQSQN---PGVSTVVLGAYDLRRRER 65
Query: 89 QKRQ-------------PQ--LNEIALIYWHSDADL--AMVKLKEPFRQTTFVKPLDYYT 131
Q RQ PQ LN++ L+ +A+L ++ L P + T
Sbjct: 66 QSRQTFSISSMSENGYDPQQNLNDLMLLQLDREANLTSSVTILPLPLQNATVEAGTRCQV 125
Query: 132 A------------RETNYINDVLSKTDRSEMSIVSGFGVTFQRDKDGIVSWGIG----CA 175
A R ++N ++ D+ + V GV +R GI + G C
Sbjct: 126 AGWGSQRSGGRLSRFPRFVNVTVTPEDQCRPNNVC-TGVLTRR--GGICNGDQGTPLVCE 182
Query: 176 LGYPGIVSWGIG-CALGYPGVYVRVDHYDPWIQSVKNN 212
G+ S+ +G C G P + RV + WI V NN
Sbjct: 183 GLAHGVASFSLGPCGRG-PDFFTRVALFRDWIDGVLNN 219
>pdb|1DSU|A Chain A, Human Factor D, Complement Activating Enzyme
pdb|1DSU|B Chain B, Human Factor D, Complement Activating Enzyme
pdb|1DFP|A Chain A, Factor D Inhibited By Diisopropyl Fluorophosphate
pdb|1DFP|B Chain B, Factor D Inhibited By Diisopropyl Fluorophosphate
pdb|1DIC|A Chain A, Structure Of 3,4-Dichloroisocoumarin-Inhibited Factor D
pdb|1BIO|A Chain A, Human Complement Factor D In Complex With Isatoic
Anhydride Inhibitor
pdb|1HFD|A Chain A, Human Complement Factor D In A P21 Crystal Form
pdb|4D9R|A Chain A, Inhibiting Alternative Pathway Complement Activation By
Targeting The Exosite On Factor D
pdb|4D9R|B Chain B, Inhibiting Alternative Pathway Complement Activation By
Targeting The Exosite On Factor D
Length = 228
Score = 45.1 bits (105), Expect = 3e-05, Method: Compositional matrix adjust.
Identities = 54/220 (24%), Positives = 86/220 (39%), Gaps = 49/220 (22%)
Query: 33 PYIVSLSLYGNLYCGGSLISLQWFLSARHCFVTENLVWNQFNPLIIAGSIYRNYKEQKRQ 92
PY+ S+ L G CGG L++ QW LSA HC E+ + L+ A S+ + ++
Sbjct: 13 PYMASVQLNGAHLCGGVLVAEQWVLSAAHCL--EDAADGKVQVLLGAHSLSQPEPSKR-- 68
Query: 93 PQLNEIALIYWHSDA-------DLAMVKLKEPFRQTTFVKPL-----DYYTARET----- 135
L ++ H D+ DL +++L E V+PL D A T
Sbjct: 69 --LYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVA 126
Query: 136 --NYINDVLSKTDRSE---MSIVSGFGVTFQRDKDGIVSWGIGCA-----------LGYP 179
+N + D + + ++ + DG ++ + CA G P
Sbjct: 127 GWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGP 186
Query: 180 --------GIVSWG--IGCALGYPGVYVRVDHYDPWIQSV 209
G+V+ G + PG+Y RV Y WI SV
Sbjct: 187 LVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSV 226
>pdb|1A7S|A Chain A, Atomic Resolution Structure Of Hbp
pdb|1AE5|A Chain A, Human Heparin Binding Protein
Length = 225
Score = 45.1 bits (105), Expect = 4e-05, Method: Compositional matrix adjust.
Identities = 52/218 (23%), Positives = 90/218 (41%), Gaps = 41/218 (18%)
Query: 29 PGEVPYIVSLSLYGNLYCGGSLISLQWFLSARHCFVTENLVWNQFNPLIIAGSIYRNYKE 88
P + P++ S+ G +CGG+LI ++ ++A CF ++N + +++ R +
Sbjct: 9 PRQFPFLASIQNQGRHFCGGALIHARFVMTAASCFQSQN---PGVSTVVLGAYDLRRRER 65
Query: 89 QKRQ-------------PQ--LNEIALIYWHSDADL--AMVKLKEPFRQTTFVKPLDYYT 131
Q RQ PQ LN++ L+ +A+L ++ L P + T
Sbjct: 66 QSRQTFSISSMSENGYDPQQNLNDLMLLQLDREANLTSSVTILPLPLQNATVEAGTRCQV 125
Query: 132 A------------RETNYINDVLSKTDRSEMSIVSGFGVTFQRDKDGIVSWGIG----CA 175
A R ++N ++ D+ + V GV +R GI + G C
Sbjct: 126 AGWGSQRSGGRLSRFPRFVNVTVTPEDQCRPNNVC-TGVLTRR--GGICNGDGGTPLVCE 182
Query: 176 LGYPGIVSWGIG-CALGYPGVYVRVDHYDPWIQSVKNN 212
G+ S+ +G C G P + RV + WI V NN
Sbjct: 183 GLAHGVASFSLGPCGRG-PDFFTRVALFRDWIDGVLNN 219
>pdb|2GD4|H Chain H, Crystal Structure Of The Antithrombin-S195a Factor
Xa-Pentasaccharide Complex
pdb|2GD4|B Chain B, Crystal Structure Of The Antithrombin-S195a Factor
Xa-Pentasaccharide Complex
Length = 241
Score = 45.1 bits (105), Expect = 4e-05, Method: Compositional matrix adjust.
Identities = 58/241 (24%), Positives = 97/241 (40%), Gaps = 71/241 (29%)
Query: 30 GEVPYIVSLSLYGNL-YCGGSLISLQWFLSARHCFVTENLVWNQFNPLIIAGSIYRNYKE 88
GE P+ L N +CGG+++S + L+A HC ++ + G RN ++
Sbjct: 10 GECPWQALLINEENEGFCGGTILSEFYILTAAHC------LYQAKRFKVRVGD--RNTEQ 61
Query: 89 QKRQPQLNEIALIYWHS-------DADLAMVKLKEPFRQTTFVKPLDYYTARETNYINDV 141
++ ++E+ ++ H+ D D+A+++LK P TF + E ++
Sbjct: 62 EEGGEAVHEVEVVIKHNRFTKETYDFDIAVLRLKTPI---TFRMNVAPACLPERDWAEST 118
Query: 142 LSKTDRSEMSIVSGFGVTFQRDKDG----------------------IVSWGIGCA---- 175
L + IVSGFG T ++ + I++ + CA
Sbjct: 119 LMT---QKTGIVSGFGRTHEKGRQSTRLKMLEVPYVDRNSCKLSSSFIITQNMFCAGYDT 175
Query: 176 ---------LGYP------------GIVSWGIGCAL-GYPGVYVRVDHYDPWI-QSVKNN 212
G P GIVSWG GCA G G+Y +V + WI +S+K
Sbjct: 176 KQEDACQGDAGGPHVTRFKDTYFVTGIVSWGEGCARKGKYGIYTKVTAFLKWIDRSMKTR 235
Query: 213 G 213
G
Sbjct: 236 G 236
>pdb|1C5M|D Chain D, Structural Basis For Selectivity Of A Small Molecule, S1-
Binding, Sub-Micromolar Inhibitor Of Urokinase Type
Plasminogen Activator
Length = 255
Score = 44.7 bits (104), Expect = 4e-05, Method: Compositional matrix adjust.
Identities = 58/242 (23%), Positives = 97/242 (40%), Gaps = 73/242 (30%)
Query: 30 GEVPYIVSLSLYGNL-YCGGSLISLQWFLSARHCFVTENLVWNQFNPLIIAGSIYRNYKE 88
GE P+ L N +CGG+++S + L+A HC ++ + G RN ++
Sbjct: 10 GECPWQALLINEENEGFCGGTILSEFYILTAAHC------LYQAKRFKVRVGD--RNTEQ 61
Query: 89 QKRQPQLNEIALIYWHS-------DADLAMVKLKEPFRQTTFVKPLDYYTARETNYINDV 141
++ ++E+ ++ H+ D D+A+++LK P TF + E ++
Sbjct: 62 EEGGEAVHEVEVVIKHNRFTKETYDFDIAVLRLKTPI---TFRMNVAPACLPERDWAEST 118
Query: 142 LSKTDRSEMSIVSGFGVTFQRDKDG----------------------IVSWGIGCALGY- 178
L + IVSGFG T ++ + I++ + CA GY
Sbjct: 119 LMT---QKTGIVSGFGRTHEKGRQSTRLKMLEVPYVDRNSCKLSSSFIITQNMFCA-GYD 174
Query: 179 -------------------------PGIVSWGIGCAL-GYPGVYVRVDHYDPWI-QSVKN 211
GIVSWG GCA G G+Y +V + WI +S+K
Sbjct: 175 TKQEDACQGDSGGPHVTRFKDTYFVTGIVSWGEGCARKGKYGIYTKVTAFLKWIDRSMKT 234
Query: 212 NG 213
G
Sbjct: 235 RG 236
>pdb|1EZQ|A Chain A, Crystal Structure Of Human Coagulation Factor Xa Complexed
With Rpr128515
pdb|1F0R|A Chain A, Crystal Structure Of Human Coagulation Factor Xa Complexed
With Rpr208815
pdb|1F0S|A Chain A, Crystal Structure Of Human Coagulation Factor Xa Complexed
With Rpr208707
pdb|1KSN|A Chain A, Crystal Structure Of Human Coagulation Factor Xa Complexed
With Fxv673
pdb|1NFU|A Chain A, Crystal Structure Of Human Coagulation Factor Xa Complexed
With Rpr132747
pdb|1NFW|A Chain A, Crystal Structure Of Human Coagulation Factor Xa Complexed
With Rpr209685
pdb|1NFX|A Chain A, Crystal Structure Of Human Coagulation Factor Xa Complexed
With Rpr208944
pdb|1NFY|A Chain A, Crystal Structure Of Human Coagulation Factor Xa Complexed
With Rpr200095
pdb|1LPG|B Chain B, Crystal Structure Of Fxa In Complex With 79.
pdb|1LPK|B Chain B, Crystal Structure Of Fxa In Complex With 125.
pdb|1LPZ|B Chain B, Crystal Structure Of Fxa In Complex With 41.
pdb|1LQD|B Chain B, Crystal Structure Of Fxa In Complex With 45.
pdb|1P0S|H Chain H, Crystal Structure Of Blood Coagulation Factor Xa In
Complex With Ecotin M84r
pdb|2BOH|B Chain B, Crystal Structure Of Factor Xa In Complex With Compound
"1"
pdb|2CJI|A Chain A, Crystal Structure Of A Human Factor Xa Inhibitor Complex
pdb|2J2U|A Chain A, Crystal Structure Of A Human Factor Xa Inhibitor Complex
pdb|2J34|A Chain A, Crystal Structure Of A Human Factor Xa Inhibitor Complex
pdb|2J38|A Chain A, Crystal Structure Of A Human Factor Xa Inhibitor Complex
pdb|2J4I|A Chain A, Crystal Structure Of A Human Factor Xa Inhibitor Complex
pdb|2J94|A Chain A, Crystal Structure Of A Human Factor Xa Inhibitor Complex
pdb|2J95|A Chain A, Crystal Structure Of A Human Factor Xa Inhibitor Complex
pdb|2UWL|A Chain A, Selective And Dual Action Orally Active Inhibitors Of
Thrombin And Factor Xa
pdb|2UWO|A Chain A, Selective And Dual Action Orally Active Inhibitors Of
Thrombin And Factor Xa
pdb|2UWP|A Chain A, Factor Xa Inhibitor Complex
pdb|2VH0|A Chain A, Structure And Property Based Design Of Factor Xa
Inhibitors: Biaryl Pyrrolidin-2-Ones Incorporating Basic
Heterocyclic Motifs
pdb|2VH6|A Chain A, Structure And Property Based Design Of Factor Xa
Inhibitors: Pyrrolidin-2-Ones With Biaryl P4 Motifs
pdb|2WYG|A Chain A, Structure And Property Based Design Of Factor Xa
Inhibitors: Pyrrolidin-2-Ones With Monoaryl P4 Motifs
pdb|2WYJ|A Chain A, Structure And Property Based Design Of Factor Xa
Inhibitors: Pyrrolidin-2-Ones With Monoaryl P4 Motifs
pdb|2Y7X|A Chain A, The Discovery Of Potent And Long-Acting Oral Factor Xa
Inhibitors With Tetrahydroisoquinoline And Benzazepine
P4 Motifs
pdb|2Y7Z|A Chain A, Structure And Property Based Design Of Factor Xa
Inhibitors: Pyrrolidin-2-Ones With Aminoindane And
Phenylpyrrolidine P4 Motifs
pdb|2Y80|A Chain A, Structure And Property Based Design Of Factor Xa
Inhibitors: Pyrrolidin-2-Ones With Aminoindane And
Phenylpyrrolidine P4 Motifs
pdb|2Y81|A Chain A, Structure And Property Based Design Of Factor Xa
Inhibitors: Pyrrolidin-2-Ones With Aminoindane And
Phenylpyrrolidine P4 Motifs
pdb|2Y82|A Chain A, Structure And Property Based Design Of Factor Xa
Inhibitors: Pyrrolidin-2-Ones With Aminoindane And
Phenylpyrrolidine P4 Motifs
pdb|4A7I|B Chain B, Factor Xa In Complex With A Potent 2-Amino-Ethane
Sulfonamide Inhibitor
Length = 254
Score = 44.7 bits (104), Expect = 4e-05, Method: Compositional matrix adjust.
Identities = 58/242 (23%), Positives = 97/242 (40%), Gaps = 73/242 (30%)
Query: 30 GEVPYIVSLSLYGNL-YCGGSLISLQWFLSARHCFVTENLVWNQFNPLIIAGSIYRNYKE 88
GE P+ L N +CGG+++S + L+A HC ++ + G RN ++
Sbjct: 10 GECPWQALLINEENEGFCGGTILSEFYILTAAHC------LYQAKRFKVRVGD--RNTEQ 61
Query: 89 QKRQPQLNEIALIYWHS-------DADLAMVKLKEPFRQTTFVKPLDYYTARETNYINDV 141
++ ++E+ ++ H+ D D+A+++LK P TF + E ++
Sbjct: 62 EEGGEAVHEVEVVIKHNRFTKETYDFDIAVLRLKTPI---TFRMNVAPACLPERDWAEST 118
Query: 142 LSKTDRSEMSIVSGFGVTFQRDKDG----------------------IVSWGIGCALGY- 178
L + IVSGFG T ++ + I++ + CA GY
Sbjct: 119 LMT---QKTGIVSGFGRTHEKGRQSTRLKMLEVPYVDRNSCKLSSSFIITQNMFCA-GYD 174
Query: 179 -------------------------PGIVSWGIGCAL-GYPGVYVRVDHYDPWI-QSVKN 211
GIVSWG GCA G G+Y +V + WI +S+K
Sbjct: 175 TKQEDACQGDSGGPHVTRFKDTYFVTGIVSWGEGCARKGKYGIYTKVTAFLKWIDRSMKT 234
Query: 212 NG 213
G
Sbjct: 235 RG 236
>pdb|1HCG|A Chain A, Structure Of Human Des(1-45) Factor Xa At 2.2 Angstroms
Resolution
pdb|3KL6|A Chain A, Discovery Of Tetrahydropyrimidin-2(1h)-One Derivative
Tak-44 Potent, Selective And Orally Active Factor Xa
Inhibitor
pdb|2XBW|A Chain A, Factor Xa In Complex With A Pyrrolidine-3,4-Dicarboxylic
Acid Inhibitor
pdb|2XBX|A Chain A, Factor Xa In Complex With A Pyrrolidine-3,4-Dicarboxylic
Acid Inhibitor
pdb|2XBY|A Chain A, Factor Xa In Complex With A Pyrrolidine-3,4-Dicarboxylic
Acid Inhibitor
pdb|2XC0|A Chain A, Factor Xa In Complex With A Pyrrolidine-3,4-Dicarboxylic
Acid Inhibitor
pdb|2XC4|A Chain A, Factor Xa In Complex With A Pyrrolidine-3,4-Dicarboxylic
Acid Inhibitor
pdb|2XC5|A Chain A, Factor Xa In Complex With A Pyrrolidine-3,4-Dicarboxylic
Acid Inhibitor
Length = 241
Score = 44.7 bits (104), Expect = 4e-05, Method: Compositional matrix adjust.
Identities = 58/242 (23%), Positives = 97/242 (40%), Gaps = 73/242 (30%)
Query: 30 GEVPYIVSLSLYGNL-YCGGSLISLQWFLSARHCFVTENLVWNQFNPLIIAGSIYRNYKE 88
GE P+ L N +CGG+++S + L+A HC ++ + G RN ++
Sbjct: 10 GECPWQALLINEENEGFCGGTILSEFYILTAAHC------LYQAKRFKVRVGD--RNTEQ 61
Query: 89 QKRQPQLNEIALIYWHS-------DADLAMVKLKEPFRQTTFVKPLDYYTARETNYINDV 141
++ ++E+ ++ H+ D D+A+++LK P TF + E ++
Sbjct: 62 EEGGEAVHEVEVVIKHNRFTKETYDFDIAVLRLKTPI---TFRMNVAPACLPERDWAEST 118
Query: 142 LSKTDRSEMSIVSGFGVTFQRDKDG----------------------IVSWGIGCALGY- 178
L + IVSGFG T ++ + I++ + CA GY
Sbjct: 119 LMT---QKTGIVSGFGRTHEKGRQSTRLKMLEVPYVDRNSCKLSSSFIITQNMFCA-GYD 174
Query: 179 -------------------------PGIVSWGIGCAL-GYPGVYVRVDHYDPWI-QSVKN 211
GIVSWG GCA G G+Y +V + WI +S+K
Sbjct: 175 TKQEDACQGDSGGPHVTRFKDTYFVTGIVSWGEGCARKGKYGIYTKVTAFLKWIDRSMKT 234
Query: 212 NG 213
G
Sbjct: 235 RG 236
>pdb|2QXG|A Chain A, Crystal Structure Of Human Kallikrein 7 In Complex With
Ala- Ala-phe-chloromethylketone
pdb|2QXG|B Chain B, Crystal Structure Of Human Kallikrein 7 In Complex With
Ala- Ala-phe-chloromethylketone
pdb|2QXH|A Chain A, Crystal Structure Of Human Kallikrein 7 In Complex With
Suc- Ala-Ala-Pro-Phe-Chloromethylketone
pdb|2QXI|A Chain A, High Resolution Structure Of Human Kallikrein 7 In Complex
With Suc-Ala-Ala-Pro-Phe-Chloromethylketone
pdb|2QXJ|A Chain A, Crystal Structure Of Human Kallikrein 7 In Complex With
Suc- Ala-ala-pro-phe-chloromethylketone And Copper
Length = 224
Score = 44.7 bits (104), Expect = 5e-05, Method: Compositional matrix adjust.
Identities = 49/208 (23%), Positives = 88/208 (42%), Gaps = 32/208 (15%)
Query: 30 GEVPYIVSLSLYGNLYCGGSLISLQWFLSARHCFVTE-------NLVWNQFNPLIIAGSI 82
G P+ V+L L+CGG L++ +W L+A HC + E + + ++ I A
Sbjct: 10 GSHPWQVALLSGNQLHCGGVLVNERWVLTAAHCKMNEYTVHLGSDTLGDRRAQRIKASKS 69
Query: 83 YRNYKEQKRQPQLNEIALIYWHSDADLAMVKLK-------EPFRQTTFVKPLDYYTARET 135
+R + Q +N++ L+ +S A L+ + K EP T V T+ +
Sbjct: 70 FR-HPGYSTQTHVNDLMLVKLNSQARLSSMVKKVRLPSRCEPPGTTCTVSGWGTTTSPDV 128
Query: 136 NYINDVL-------SKTDRSEM--------SIVSGFGVTFQRDKDGIVSWGIGCALGYPG 180
+ +D++ S D +++ + +G + + +G + C G
Sbjct: 129 TFPSDLMCVDVKLISPQDCTKVYKDLLENSMLCAGIPDSKKNACNGDSGGPLVCRGTLQG 188
Query: 181 IVSWGI-GCAL-GYPGVYVRVDHYDPWI 206
+VSWG C PGVY +V + WI
Sbjct: 189 LVSWGTFPCGQPNDPGVYTQVCKFTKWI 216
>pdb|3BSQ|A Chain A, Crystal Structure Of Human Kallikrein 7 Produced As A
Secretion Protein In E.Coli
pdb|3BSQ|B Chain B, Crystal Structure Of Human Kallikrein 7 Produced As A
Secretion Protein In E.Coli
pdb|3BSQ|C Chain C, Crystal Structure Of Human Kallikrein 7 Produced As A
Secretion Protein In E.Coli
Length = 227
Score = 44.7 bits (104), Expect = 5e-05, Method: Compositional matrix adjust.
Identities = 49/208 (23%), Positives = 88/208 (42%), Gaps = 32/208 (15%)
Query: 30 GEVPYIVSLSLYGNLYCGGSLISLQWFLSARHCFVTE-------NLVWNQFNPLIIAGSI 82
G P+ V+L L+CGG L++ +W L+A HC + E + + ++ I A
Sbjct: 10 GSHPWQVALLSGNQLHCGGVLVNERWVLTAAHCKMNEYTVHLGSDTLGDRRAQRIKASKS 69
Query: 83 YRNYKEQKRQPQLNEIALIYWHSDADLAMVKLK-------EPFRQTTFVKPLDYYTARET 135
+R + Q +N++ L+ +S A L+ + K EP T V T+ +
Sbjct: 70 FR-HPGYSTQTHVNDLMLVKLNSQARLSSMVKKVRLPSRCEPPGTTCTVSGWGTTTSPDV 128
Query: 136 NYINDVL-------SKTDRSEM--------SIVSGFGVTFQRDKDGIVSWGIGCALGYPG 180
+ +D++ S D +++ + +G + + +G + C G
Sbjct: 129 TFPSDLMCVDVKLISPQDCTKVYKDLLENSMLCAGIPDSKKNACNGDSGGPLVCRGTLQG 188
Query: 181 IVSWGI-GCAL-GYPGVYVRVDHYDPWI 206
+VSWG C PGVY +V + WI
Sbjct: 189 LVSWGTFPCGQPNDPGVYTQVCKFTKWI 216
>pdb|3ENS|B Chain B, Crystal Structure Of Human Fxa In Complex With Methyl
(2z)-3-[(3-
Chloro-1h-indol-7-yl)amino]-2-cyano-3-{[(3s)-2-oxo-1-(2-
oxo-2- Pyrrolidin-1-ylethyl)azepan-3-yl]amino}acrylate
pdb|3ENS|D Chain D, Crystal Structure Of Human Fxa In Complex With Methyl
(2z)-3-[(3-
Chloro-1h-indol-7-yl)amino]-2-cyano-3-{[(3s)-2-oxo-1-(2-
oxo-2- Pyrrolidin-1-ylethyl)azepan-3-yl]amino}acrylate
pdb|3HPT|B Chain B, Crystal Structure Of Human Fxa In Complex With
(S)-2-Cyano-1-(2-
Methylbenzofuran-5-Yl)-3-(2-Oxo-1-(2-Oxo-2-(Pyrrolidin-
1-Yl)ethyl) Azepan-3-Yl)guanidine
pdb|3HPT|D Chain D, Crystal Structure Of Human Fxa In Complex With
(S)-2-Cyano-1-(2-
Methylbenzofuran-5-Yl)-3-(2-Oxo-1-(2-Oxo-2-(Pyrrolidin-
1-Yl)ethyl) Azepan-3-Yl)guanidine
pdb|3K9X|B Chain B, X-Ray Crystal Structure Of Human Fxa In Complex With
(S)-N-((2- Methylbenzofuran-5-Ylamino)(2-Oxo-1-(2-Oxo-2-
(Pyrrolidin-1-Yl) Ethyl)azepan-3-
Ylamino)methylene)nicotinamide
pdb|3K9X|D Chain D, X-Ray Crystal Structure Of Human Fxa In Complex With
(S)-N-((2- Methylbenzofuran-5-Ylamino)(2-Oxo-1-(2-Oxo-2-
(Pyrrolidin-1-Yl) Ethyl)azepan-3-
Ylamino)methylene)nicotinamide
pdb|3SW2|B Chain B, X-Ray Crystal Structure Of Human Fxa In Complex With
6-Chloro-N-((3s)-
2-Oxo-1-(2-Oxo-2-((5s)-8-Oxo-5,6-Dihydro-1h-1,
5-Methanopyrido[1,2-
A][1,5]diazocin-3(2h,4h,
8h)-Yl)ethyl)piperidin-3-Yl)naphthalene-2- Sulfonamide
Length = 238
Score = 44.7 bits (104), Expect = 5e-05, Method: Compositional matrix adjust.
Identities = 58/242 (23%), Positives = 97/242 (40%), Gaps = 73/242 (30%)
Query: 30 GEVPYIVSLSLYGNL-YCGGSLISLQWFLSARHCFVTENLVWNQFNPLIIAGSIYRNYKE 88
GE P+ L N +CGG+++S + L+A HC ++ + G RN ++
Sbjct: 10 GECPWQALLINEENEGFCGGTILSEFYILTAAHC------LYQAKRFKVRVGD--RNTEQ 61
Query: 89 QKRQPQLNEIALIYWHS-------DADLAMVKLKEPFRQTTFVKPLDYYTARETNYINDV 141
++ ++E+ ++ H+ D D+A+++LK P TF + E ++
Sbjct: 62 EEGGEAVHEVEVVIKHNRFTKETYDFDIAVLRLKTPI---TFRMNVAPACLPERDWAEST 118
Query: 142 LSKTDRSEMSIVSGFGVTFQRDKDG----------------------IVSWGIGCALGY- 178
L + IVSGFG T ++ + I++ + CA GY
Sbjct: 119 LMT---QKTGIVSGFGRTHEKGRQSTRLKMLEVPYVDRNSCKLSSSFIITQNMFCA-GYD 174
Query: 179 -------------------------PGIVSWGIGCAL-GYPGVYVRVDHYDPWI-QSVKN 211
GIVSWG GCA G G+Y +V + WI +S+K
Sbjct: 175 TKQEDACQGDSGGPHVTRFKDTYFVTGIVSWGEGCARKGKYGIYTKVTAFLKWIDRSMKT 234
Query: 212 NG 213
G
Sbjct: 235 RG 236
>pdb|2F91|A Chain A, 1.2a Resolution Structure Of A Crayfish Trypsin Complexed
With A Peptide Inhibitor, Sgti
Length = 237
Score = 44.3 bits (103), Expect = 5e-05, Method: Compositional matrix adjust.
Identities = 54/228 (23%), Positives = 87/228 (38%), Gaps = 52/228 (22%)
Query: 30 GEVPYIVSLSL----YGNLYCGGSLISLQWFLSARHCFVTENLVWNQFNPLIIAGSIYRN 85
GE PY +S + +CG S+ + + ++A HC ++ N I+AG + +
Sbjct: 10 GEFPYQLSFQETFIGFSFHFCGASIYNENYAITAGHCVYGDDY-ENPSGLQIVAGELDMS 68
Query: 86 YKEQKRQPQLNEIALIYWHS-------DADLAMVKLKEPFRQTTFVKPL----------- 127
E Q + ++ I H D D++++KL V P+
Sbjct: 69 VNEGSEQ--IITVSKIILHENFDYNLLDNDISLLKLSGSLTFNDNVAPIALPEQGHTATG 126
Query: 128 -----DYYTARETNYINDVLSKTD---------RSE------------MSIVSGFGVTFQ 161
+ T E DVL K R++ + G + Q
Sbjct: 127 DVIVTGWGTTSEGGNTPDVLQKVTVPLVSDEDCRADYGADEILDSMICAGVPEGGKDSCQ 186
Query: 162 RDKDGIVSWGIGCALGYPGIVSWGIGCAL-GYPGVYVRVDHYDPWIQS 208
D G ++ + GIVSWG GCA GYPGVY V ++ WI++
Sbjct: 187 GDSGGPLAASDTGSTYLAGIVSWGYGCARPGYPGVYTEVSYHVDWIKA 234
>pdb|1AKS|A Chain A, Crystal Structure Of The First Active Autolysate Form Of
The Porcine Alpha Trypsin
pdb|1UHB|A Chain A, Crystal Structure Of Porcine Alpha Trypsin Bound With Auto
Catalyticaly Produced Native Peptide At 2.15 A
Resolution
Length = 125
Score = 44.3 bits (103), Expect = 6e-05, Method: Compositional matrix adjust.
Identities = 29/89 (32%), Positives = 47/89 (52%), Gaps = 8/89 (8%)
Query: 31 EVPYIVSLSLYGNLYCGGSLISLQWFLSARHCFVTE-NLVWNQFNPLIIAGS-IYRNYKE 88
+PY VSL+ G+ +CGGSLI+ QW +SA HC+ + + + N ++ G+ + N +
Sbjct: 11 SIPYQVSLN-SGSHFCGGSLINSQWVVSAAHCYKSRIQVRLGEHNIDVLEGNEQFINAAK 69
Query: 89 QKRQPQLNEIALIYWHSDADLAMVKLKEP 117
P N L D D+ ++KL P
Sbjct: 70 IITHPNFNGNTL-----DNDIMLIKLSSP 93
>pdb|2BOK|A Chain A, Factor Xa- Cation
pdb|2JKH|A Chain A, Factor Xa - Cation Inhibitor Complex
pdb|2VVC|A Chain A, Aminopyrrolidine Factor Xa Inhibitor
pdb|2VVC|B Chain B, Aminopyrrolidine Factor Xa Inhibitor
pdb|2VVU|A Chain A, Aminopyrrolidine Factor Xa Inhibitor
pdb|2VVV|A Chain A, Aminopyrrolidine-Related Triazole Factor Xa Inhibitor
pdb|2VWL|A Chain A, Aminopyrrolidine Factor Xa Inhibitor
pdb|2VWM|A Chain A, Aminopyrrolidine Factor Xa Inhibitor
pdb|2VWM|B Chain B, Aminopyrrolidine Factor Xa Inhibitor
pdb|2VWN|A Chain A, Aminopyrrolidine Factor Xa Inhibitor
pdb|2VWO|A Chain A, Aminopyrrolidine Factor Xa Inhibitor
pdb|2XBV|A Chain A, Factor Xa In Complex With A Pyrrolidine-3,4-Dicarboxylic
Acid Inhibitor
Length = 241
Score = 44.3 bits (103), Expect = 7e-05, Method: Compositional matrix adjust.
Identities = 58/242 (23%), Positives = 97/242 (40%), Gaps = 73/242 (30%)
Query: 30 GEVPYIVSLSLYGNL-YCGGSLISLQWFLSARHCFVTENLVWNQFNPLIIAGSIYRNYKE 88
GE P+ L N +CGG+++S + L+A HC ++ + G RN ++
Sbjct: 10 GECPWQALLINEENEGFCGGTILSEFYILTAAHC------LYQAKRFKVRVGD--RNTEQ 61
Query: 89 QKRQPQLNEIALIYWHS-------DADLAMVKLKEPFRQTTFVKPLDYYTARETNYINDV 141
++ ++E+ ++ H+ D D+A+++LK P TF + E ++
Sbjct: 62 EEGGEAVHEVEVVIKHNRFTKETYDFDIAVLRLKTPI---TFRMNVAPACLPERDWAEST 118
Query: 142 LSKTDRSEMSIVSGFGVTFQRDKDG----------------------IVSWGIGCALGY- 178
L + IVSGFG T ++ + I++ + CA GY
Sbjct: 119 LMT---QKTGIVSGFGRTHEKGEQSTRLKMLEVPYVDRNSCKLSSSFIITQNMFCA-GYD 174
Query: 179 -------------------------PGIVSWGIGCAL-GYPGVYVRVDHYDPWI-QSVKN 211
GIVSWG GCA G G+Y +V + WI +S+K
Sbjct: 175 TKQEDACQGDSGGPHVTRFKDTYFVTGIVSWGEGCARKGKYGIYTKVTAFLKWIDRSMKT 234
Query: 212 NG 213
G
Sbjct: 235 RG 236
>pdb|1FXY|A Chain A, Coagulation Factor Xa-Trypsin Chimera Inhibited With
D-Phe-Pro-Arg- Chloromethylketone
Length = 228
Score = 44.3 bits (103), Expect = 7e-05, Method: Compositional matrix adjust.
Identities = 57/226 (25%), Positives = 90/226 (39%), Gaps = 58/226 (25%)
Query: 30 GEVPYIVSLSLYGNL-YCGGSLISLQWFLSARHCFVTENLVWNQFNPLIIAGSIYRNYKE 88
GEVP+ L N +CGG+++S + L+A HC +F + G RN ++
Sbjct: 10 GEVPWQALLINEENEGFCGGTILSEFYILTAAHCLYQA----KRFK--VRVGD--RNTEQ 61
Query: 89 QKRQPQLNEIALIYWHS-------DADLAMVKLKEPFRQTTFVKPLDYYTARE------- 134
++ ++E+ ++ H+ D D+A+++LK P V P TA
Sbjct: 62 EEGGEAVHEVEVVIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPASLPTAPPATGTKCL 121
Query: 135 -TNYINDVLSKTD----------------RSEMS-------------IVSGFGVTFQRDK 164
+ + N S D + E S + G + Q D
Sbjct: 122 ISGWGNTASSGADYPDELQCLDAPVLSQAKCEASYPGKITSNMFCVGFLEGGKDSCQGDS 181
Query: 165 DGIVSWGIGCALGYPGIVSWGIGCAL-GYPGVYVRVDHYDPWIQSV 209
G V C G+VSWG GCA PGVY +V +Y WI++
Sbjct: 182 GGPVV----CNGQLQGVVSWGDGCAQKNKPGVYTKVYNYVKWIKNT 223
>pdb|2ZGC|A Chain A, Crystal Structure Of Active Human Granzyme M
pdb|2ZGH|A Chain A, Crystal Structure Of Active Granzyme M Bound To Its
Product
pdb|2ZKS|A Chain A, Structural Insights Into The Proteolytic Machinery Of
Apoptosis- Inducing Granzyme M
Length = 240
Score = 43.9 bits (102), Expect = 7e-05, Method: Compositional matrix adjust.
Identities = 35/137 (25%), Positives = 62/137 (45%), Gaps = 19/137 (13%)
Query: 29 PGEVPYIVSLSLYGNLYCGGSLISLQWFLSARHCFVTE----NLVWNQFNPLIIAGSIYR 84
P PY+ SL G+ CGG L+ +W L+A HC LV + L G +
Sbjct: 9 PHSRPYMASLQRNGSHLCGGVLVHPKWVLTAAHCLAQRMAQLRLVLG-LHTLDSPGLTF- 66
Query: 85 NYKEQKRQPQLNEIALIYWHSDADLAMVKLKEPFRQTTFVKPLDYYTARETNYINDVLSK 144
+ K + P+ + + + DLA+++L + + ++PL + R+ V++
Sbjct: 67 HIKAAIQHPRYKPVPAL----ENDLALLQLDGKVKPSRTIRPLALPSKRQ------VVAA 116
Query: 145 TDRSEMSIVSGFGVTFQ 161
R M +G+G+T Q
Sbjct: 117 GTRCSM---AGWGLTHQ 130
>pdb|1XVM|A Chain A, Trypsin From Fusarium Oxysporum- Room Temperature To
Atomic Resolution
pdb|1XVO|A Chain A, Trypsin From Fusarium Oxysporum At Ph 6
pdb|1FY5|A Chain A, Fusarium Oxysporum Trypsin At Atomic Resolution
pdb|1GDN|A Chain A, Fusarium Oxysporum Trypsin At Atomic Resolution
pdb|1FY4|A Chain A, Fusarium Oxysporum Trypsin At Atomic Resolution
pdb|1FN8|A Chain A, Fusarium Oxysporum Trypsin At Atomic Resolution
pdb|1GDQ|A Chain A, Fusarium Oxysporum Trypsin At Atomic Resolution
Length = 224
Score = 43.9 bits (102), Expect = 8e-05, Method: Compositional matrix adjust.
Identities = 28/87 (32%), Positives = 42/87 (48%), Gaps = 4/87 (4%)
Query: 30 GEVPYIVSLSLYGNLYCGGSLISLQWFLSARHCFVTENLVWNQFNPLIIAGSIYRNYKEQ 89
G+ P+IVS+S G +CGGSL++ L+A HC + Q I AGS+ R
Sbjct: 10 GDFPFIVSISRNGGPWCGGSLLNANTVLTAAHCVSG----YAQSGFQIRAGSLSRTSGGI 65
Query: 90 KRQPQLNEIALIYWHSDADLAMVKLKE 116
+ Y ++ DLA++KL
Sbjct: 66 TSSLSSVRVHPSYSGNNNDLAILKLST 92
>pdb|1PPZ|A Chain A, Trypsin Complexes At Atomic And Ultra-High Resolution
pdb|1PQA|A Chain A, Trypsin With Pmsf At Atomic Resolution
Length = 224
Score = 43.9 bits (102), Expect = 8e-05, Method: Compositional matrix adjust.
Identities = 28/87 (32%), Positives = 42/87 (48%), Gaps = 4/87 (4%)
Query: 30 GEVPYIVSLSLYGNLYCGGSLISLQWFLSARHCFVTENLVWNQFNPLIIAGSIYRNYKEQ 89
G+ P+IVS+S G +CGGSL++ L+A HC + Q I AGS+ R
Sbjct: 10 GDFPFIVSISRNGGPWCGGSLLNANTVLTAAHCVSG----YAQSGFQIRAGSLSRTSGGI 65
Query: 90 KRQPQLNEIALIYWHSDADLAMVKLKE 116
+ Y ++ DLA++KL
Sbjct: 66 TSSLSSVRVHPSYSGNNNDLAILKLST 92
>pdb|1GDU|A Chain A, Fusarium Oxysporum Trypsin At Atomic Resolution
pdb|1PQ5|A Chain A, Trypsin At Ph 5, 0.85 A
pdb|1PQ7|A Chain A, Trypsin At 0.8 A, Ph5 BORAX
pdb|1PQ8|A Chain A, Trypsin At Ph 4 At Atomic Resolution
pdb|2G51|A Chain A, Anomalous Substructure Of Trypsin (P1)
pdb|2G52|A Chain A, Anomalous Substructure Of Trypsin (P21)
pdb|1TRY|A Chain A, Structure Of Inhibited Trypsin From Fusarium Oxysporum At
1.55 Angstroms
pdb|2VU8|E Chain E, Crystal Structure Of An Insect Inhibitor With A Fungal
Trypsin
Length = 224
Score = 43.9 bits (102), Expect = 9e-05, Method: Compositional matrix adjust.
Identities = 28/87 (32%), Positives = 42/87 (48%), Gaps = 4/87 (4%)
Query: 30 GEVPYIVSLSLYGNLYCGGSLISLQWFLSARHCFVTENLVWNQFNPLIIAGSIYRNYKEQ 89
G+ P+IVS+S G +CGGSL++ L+A HC + Q I AGS+ R
Sbjct: 10 GDFPFIVSISRNGGPWCGGSLLNANTVLTAAHCVSG----YAQSGFQIRAGSLSRTSGGI 65
Query: 90 KRQPQLNEIALIYWHSDADLAMVKLKE 116
+ Y ++ DLA++KL
Sbjct: 66 TSSLSSVRVHPSYSGNNNDLAILKLST 92
>pdb|1KIG|H Chain H, Bovine Factor Xa
Length = 241
Score = 43.5 bits (101), Expect = 1e-04, Method: Compositional matrix adjust.
Identities = 56/230 (24%), Positives = 86/230 (37%), Gaps = 58/230 (25%)
Query: 30 GEVPYIVSLSLYGNL-YCGGSLISLQWFLSARHCFVTENLVWNQFNPLIIAGSIYRNYKE 88
GE P+ L N +CGG++++ + L+A HC +Q + RN ++
Sbjct: 10 GECPWQALLVNEENEGFCGGTILNEFYVLTAAHCL-------HQAKRFTVRVGD-RNTEQ 61
Query: 89 QKRQPQLNEIALIYWHS-------DADLAMVKLKEPFRQTTFVKPL-----DYYTA---- 132
++ +E+ + HS D D+A+++LK P R V P D+ A
Sbjct: 62 EEGNEMAHEVEMTVKHSRFVKETYDFDIAVLRLKTPIRFRRNVAPACLPEKDWAEATLMT 121
Query: 133 ------------RETNYINDVLSK-----TDRSEMSIVSGFGVT---------------F 160
E ++ L DRS + S F +T
Sbjct: 122 QKTGIVSGFGRTHEKGRLSSTLKMLEVPYVDRSTCKLSSSFTITPNMFCAGYDTQPEDAC 181
Query: 161 QRDKDGIVSWGIGCALGYPGIVSWGIGCAL-GYPGVYVRVDHYDPWIQSV 209
Q D G GIVSWG GCA G GVY +V ++ WI +
Sbjct: 182 QGDSGGPHVTRFKDTYFVTGIVSWGEGCARKGKFGVYTKVSNFLKWIDKI 231
>pdb|1FY1|A Chain A, [r23s,F25e]hbp, A Mutant Of Human Heparin Binding Protein
(Cap37)
Length = 225
Score = 43.5 bits (101), Expect = 1e-04, Method: Compositional matrix adjust.
Identities = 52/218 (23%), Positives = 90/218 (41%), Gaps = 41/218 (18%)
Query: 29 PGEVPYIVSLSLYGNLYCGGSLISLQWFLSARHCFVTENLVWNQFNPLIIAGSIYRNYKE 88
P + P++ S+ G+ CGG+LI ++ ++A CF ++N + +++ R +
Sbjct: 9 PRQFPFLASIQNQGSHECGGALIHARFVMTAASCFQSQN---PGVSTVVLGAYDLRRRER 65
Query: 89 QKRQ-------------PQ--LNEIALIYWHSDADL--AMVKLKEPFRQTTFVKPLDYYT 131
Q RQ PQ LN++ L+ +A+L ++ L P + T
Sbjct: 66 QSRQTFSISSMSENGYDPQQNLNDLMLLQLDREANLTSSVTILPLPLQNATVEAGTRCQV 125
Query: 132 A------------RETNYINDVLSKTDRSEMSIVSGFGVTFQRDKDGIVSWGIG----CA 175
A R ++N ++ D+ + V GV +R GI + G C
Sbjct: 126 AGWGSQRSGGRLSRFPRFVNVTVTPEDQCRPNNVC-TGVLTRR--GGICNGDGGTPLVCE 182
Query: 176 LGYPGIVSWGIG-CALGYPGVYVRVDHYDPWIQSVKNN 212
G+ S+ +G C G P + RV + WI V NN
Sbjct: 183 GLAHGVASFSLGPCGRG-PDFFTRVALFRDWIDGVLNN 219
>pdb|1ID5|H Chain H, Crystal Structure Of Bovine Thrombin Complex With Protease
Inhibitor Ecotin
Length = 256
Score = 43.5 bits (101), Expect = 1e-04, Method: Compositional matrix adjust.
Identities = 25/96 (26%), Positives = 49/96 (51%), Gaps = 13/96 (13%)
Query: 43 NLYCGGSLISLQWFLSARHCFVTENLVWNQ---FNPLIIAGSIYRNYKEQKRQPQLNEIA 99
L CG SLIS +W L+A HC + W++ + L++ + + +++ +++ +
Sbjct: 25 ELLCGASLISDRWVLTAAHCLLYPP--WDKNFTVDDLLVRIGKHSRTRYERKVEKISMLD 82
Query: 100 LIYWHS--------DADLAMVKLKEPFRQTTFVKPL 127
IY H D D+A++KLK P + ++ P+
Sbjct: 83 KIYIHPRYNWKENLDRDIALLKLKRPIELSDYIHPV 118
Score = 28.9 bits (63), Expect = 2.7, Method: Compositional matrix adjust.
Identities = 16/31 (51%), Positives = 16/31 (51%), Gaps = 1/31 (3%)
Query: 180 GIVSWGIGCAL-GYPGVYVRVDHYDPWIQSV 209
GIVSWG GC G G Y V WIQ V
Sbjct: 223 GIVSWGEGCDRDGKYGFYTHVFRLKKWIQKV 253
>pdb|1BBR|K Chain K, The Structure Of Residues 7-16 Of The A Alpha Chain Of
Human Fibrinogen Bound To Bovine Thrombin At 2.3
Angstroms Resolution
pdb|1BBR|N Chain N, The Structure Of Residues 7-16 Of The A Alpha Chain Of
Human Fibrinogen Bound To Bovine Thrombin At 2.3
Angstroms Resolution
pdb|1ETR|H Chain H, Refined 2.3 Angstroms X-Ray Crystal Structure Of Bovine
Thrombin Complexes Formed With The Benzamidine And
Arginine-Based Thrombin Inhibitors Napap, 4-Tapap And
Mqpa: A Starting Point For Improving Antithrombotics
pdb|1ETS|H Chain H, Refined 2.3 Angstroms X-Ray Crystal Structure Of Bovine
Thrombin Complexes Formed With The Benzamidine And
Arginine-Based Thrombin Inhibitors Napap, 4-Tapap And
Mqpa: A Starting Point For Improving Antithrombotics
pdb|1ETT|H Chain H, Refined 2.3 Angstroms X-Ray Crystal Structure Of Bovine
Thrombin Complexes Formed With The Benzamidine And
Arginine-Based Thrombin Inhibitors Napap, 4-Tapap And
Mqpa: A Starting Point For Improving Antithrombotics
pdb|1HRT|H Chain H, The Structure Of A Complex Of Bovine Alpha-Thrombin And
Recombinant Hirudin At 2.8 Angstroms Resolution
pdb|1TBR|H Chain H, Crystal Structure Of Insect Derived Double Domain Kazal
Inhibitor Rhodniin In Complex With Thrombin
pdb|1TBR|K Chain K, Crystal Structure Of Insect Derived Double Domain Kazal
Inhibitor Rhodniin In Complex With Thrombin
pdb|1TBQ|H Chain H, Crystal Structure Of Insect Derived Double Domain Kazal
Inhibitor Rhodniin In Complex With Thrombin
pdb|1TBQ|K Chain K, Crystal Structure Of Insect Derived Double Domain Kazal
Inhibitor Rhodniin In Complex With Thrombin
pdb|1UCY|K Chain K, Thrombin Complexed With Fibrinopeptide A Alpha (Residues
7- 19). Three Complexes, One With Epsilon-Thrombin And
Two With Alpha-Thrombin
pdb|1UCY|N Chain N, Thrombin Complexed With Fibrinopeptide A Alpha (Residues
7- 19). Three Complexes, One With Epsilon-Thrombin And
Two With Alpha-Thrombin
pdb|1VIT|H Chain H, Thrombin:hirudin 51-65 Complex
pdb|1MKW|H Chain H, The Co-Crystal Structure Of Unliganded Bovine Alpha-
Thrombin And Prethrombin-2: Movement Of The Yppw Segment
And Active Site Residues Upon Ligand Binding
pdb|1MKX|H Chain H, The Co-Crystal Structure Of Unliganded Bovine Alpha-
Thrombin And Prethrombin-2: Movement Of The Yppw Segment
And Active Site Residues Upon Ligand Binding
pdb|1TOC|B Chain B, Structure Of Serine Proteinase
pdb|1TOC|D Chain D, Structure Of Serine Proteinase
pdb|1TOC|F Chain F, Structure Of Serine Proteinase
pdb|1TOC|H Chain H, Structure Of Serine Proteinase
pdb|1UVT|H Chain H, Bovine Thrombin--Bm14.1248 Complex
pdb|1UVU|H Chain H, Bovine Thrombin--Bm12.1700 Complex
pdb|1YCP|H Chain H, The Crystal Structure Of Fibrinogen-Aa Peptide 1-23 (F8y)
Bound To Bovine Thrombin Explains Why The Mutation Of
Phe-8 To Tyrosine Strongly Inhibits Normal Cleavage At
Arginine-16
pdb|1A0H|B Chain B, The X-Ray Crystal Structure Of Ppack-Meizothrombin Desf1:
KringleTHROMBIN AND CARBOHYDRATEKRINGLETHROMBIN
INTERACTIONS AND Location Of The Linker Chain
pdb|1A0H|E Chain E, The X-Ray Crystal Structure Of Ppack-Meizothrombin Desf1:
KringleTHROMBIN AND CARBOHYDRATEKRINGLETHROMBIN
INTERACTIONS AND Location Of The Linker Chain
pdb|1AVG|H Chain H, Thrombin Inhibitor From Triatoma Pallidipennis
pdb|2A1D|B Chain B, Staphylocoagulase Bound To Bovine Thrombin
pdb|2A1D|F Chain F, Staphylocoagulase Bound To Bovine Thrombin
pdb|2ODY|B Chain B, Thrombin-bound Boophilin Displays A Functional And
Accessible Reactive-site Loop
pdb|2ODY|D Chain D, Thrombin-bound Boophilin Displays A Functional And
Accessible Reactive-site Loop
pdb|3PMA|B Chain B, 2.2 Angstrom Crystal Structure Of The Complex Between
Bovine Thrombin And Sucrose Octasulfate
pdb|3PMA|D Chain D, 2.2 Angstrom Crystal Structure Of The Complex Between
Bovine Thrombin And Sucrose Octasulfate
pdb|3PMB|B Chain B, 2.9 Angstrom Crystal Structure Of Bovine Thrombin In
Tetragonal Spacegroup
pdb|3PMB|D Chain D, 2.9 Angstrom Crystal Structure Of Bovine Thrombin In
Tetragonal Spacegroup
Length = 259
Score = 43.5 bits (101), Expect = 1e-04, Method: Compositional matrix adjust.
Identities = 25/96 (26%), Positives = 49/96 (51%), Gaps = 13/96 (13%)
Query: 43 NLYCGGSLISLQWFLSARHCFVTENLVWNQ---FNPLIIAGSIYRNYKEQKRQPQLNEIA 99
L CG SLIS +W L+A HC + W++ + L++ + + +++ +++ +
Sbjct: 25 ELLCGASLISDRWVLTAAHCLLYPP--WDKNFTVDDLLVRIGKHSRTRYERKVEKISMLD 82
Query: 100 LIYWHS--------DADLAMVKLKEPFRQTTFVKPL 127
IY H D D+A++KLK P + ++ P+
Sbjct: 83 KIYIHPRYNWKENLDRDIALLKLKRPIELSDYIHPV 118
Score = 28.9 bits (63), Expect = 2.9, Method: Compositional matrix adjust.
Identities = 16/31 (51%), Positives = 16/31 (51%), Gaps = 1/31 (3%)
Query: 180 GIVSWGIGCAL-GYPGVYVRVDHYDPWIQSV 209
GIVSWG GC G G Y V WIQ V
Sbjct: 223 GIVSWGEGCDRDGKYGFYTHVFRLKKWIQKV 253
>pdb|1H8D|H Chain H, X-Ray Structure Of The Human Alpha-Thrombin Complex With A
Tripeptide Phosphonate Inhibitor
Length = 260
Score = 43.5 bits (101), Expect = 1e-04, Method: Compositional matrix adjust.
Identities = 56/237 (23%), Positives = 87/237 (36%), Gaps = 63/237 (26%)
Query: 43 NLYCGGSLISLQWFLSARHCFVTENLVWNQ---FNPLIIAGSIYRNYKEQKRQPQLNEIA 99
L CG SLIS +W L+A HC + W++ N L++ + + ++ +++ +
Sbjct: 25 ELLCGASLISDRWVLTAAHCLLYPP--WDKNFTENDLLVRIGKHSRTRYERNIEKISMLE 82
Query: 100 LIYWHS--------DADLAMVKLKEPFRQTTFVKPLDY-------------YTARETNYI 138
IY H D D+A++KLK+P + ++ P+ Y R T +
Sbjct: 83 KIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWG 142
Query: 139 NDVLSKT--------------------DRSEMSIVSGFGVTFQRDKDGIVSWGIGCALGY 178
N L +T D + + I + +G G
Sbjct: 143 N--LKETGQPSVLQVVNLPIVERPVCKDSTRIRITDNMFCAGYKPDEGKRGDACEGDSGG 200
Query: 179 P--------------GIVSWGIGCAL-GYPGVYVRVDHYDPWIQSVKNNGDNAGVLI 220
P GIVSWG GC G G Y V WIQ V + + VLI
Sbjct: 201 PFVMKSPFNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQKVIDQFGCSSVLI 257
>pdb|1BBR|H Chain H, The Structure Of Residues 7-16 Of The A Alpha Chain Of
Human Fibrinogen Bound To Bovine Thrombin At 2.3
Angstroms Resolution
pdb|1UCY|H Chain H, Thrombin Complexed With Fibrinopeptide A Alpha (Residues
7- 19). Three Complexes, One With Epsilon-Thrombin And
Two With Alpha-Thrombin
pdb|1VIT|F Chain F, Thrombin:hirudin 51-65 Complex
pdb|1YCP|K Chain K, The Crystal Structure Of Fibrinogen-Aa Peptide 1-23 (F8y)
Bound To Bovine Thrombin Explains Why The Mutation Of
Phe-8 To Tyrosine Strongly Inhibits Normal Cleavage At
Arginine-16
Length = 150
Score = 43.1 bits (100), Expect = 1e-04, Method: Compositional matrix adjust.
Identities = 25/96 (26%), Positives = 49/96 (51%), Gaps = 13/96 (13%)
Query: 43 NLYCGGSLISLQWFLSARHCFVTENLVWNQ---FNPLIIAGSIYRNYKEQKRQPQLNEIA 99
L CG SLIS +W L+A HC + W++ + L++ + + +++ +++ +
Sbjct: 25 ELLCGASLISDRWVLTAAHCLLYPP--WDKNFTVDDLLVRIGKHSRTRYERKVEKISMLD 82
Query: 100 LIYWHS--------DADLAMVKLKEPFRQTTFVKPL 127
IY H D D+A++KLK P + ++ P+
Sbjct: 83 KIYIHPRYNWKENLDRDIALLKLKRPIELSDYIHPV 118
>pdb|2BQ6|B Chain B, Crystal Structure Of Factor Xa In Complex With 21
pdb|2BQ7|B Chain B, Crystal Structure Of Factor Xa In Complex With 43
pdb|2BQW|B Chain B, Crystal Structure Of Factor Xa In Complex With Compound 45
Length = 249
Score = 43.1 bits (100), Expect = 1e-04, Method: Compositional matrix adjust.
Identities = 55/234 (23%), Positives = 92/234 (39%), Gaps = 72/234 (30%)
Query: 30 GEVPYIVSLSLYGNL-YCGGSLISLQWFLSARHCFVTENLVWNQFNPLIIAGSIYRNYKE 88
GE P+ L N +CGG+++S + L+A HC ++ + G RN ++
Sbjct: 25 GECPWQALLINEENEGFCGGTILSEFYILTAAHC------LYQAKRFKVRVGD--RNTEQ 76
Query: 89 QKRQPQLNEIALIYWHS-------DADLAMVKLKEPFRQTTFVKPLDYYTARETNYINDV 141
++ ++E+ ++ H+ D D+A+++LK P TF + E ++
Sbjct: 77 EEGGEAVHEVEVVIKHNRFTKETYDFDIAVLRLKTPI---TFRMNVAPACLPERDWAEST 133
Query: 142 LSKTDRSEMSIVSGFGVTFQRDKDG----------------------IVSWGIGCALGY- 178
L + IVSGFG T ++ + I++ + CA GY
Sbjct: 134 LMT---QKTGIVSGFGRTHEKGRQSTRLKMLEVPYVDRNSCKLSSSFIITQNMFCA-GYD 189
Query: 179 -------------------------PGIVSWGIGCAL-GYPGVYVRVDHYDPWI 206
GIVSWG GCA G G+Y +V + WI
Sbjct: 190 TKQEDACQGDSGGPHVTRFKDTYFVTGIVSWGEGCARKGKYGIYTKVTAFLKWI 243
>pdb|1XKA|C Chain C, Factor Xa Complexed With A Synthetic Inhibitor
Fx-2212a,(2s)-(3'-
Amidino-3-Biphenylyl)-5-(4-Pyridylamino)pentanoic Acid
pdb|1XKB|C Chain C, Factor Xa Complexed With A Synthetic Inhibitor
Fx-2212a,(2s)-(3'-
Amidino-3-Biphenylyl)-5-(4-Pyridylamino)pentanoic Acid
pdb|1XKB|D Chain D, Factor Xa Complexed With A Synthetic Inhibitor
Fx-2212a,(2s)-(3'-
Amidino-3-Biphenylyl)-5-(4-Pyridylamino)pentanoic Acid
pdb|1G2L|A Chain A, Factor Xa Inhibitor Complex
pdb|1G2M|A Chain A, Factor Xa Inhibitor Complex
pdb|1IOE|A Chain A, Human Coagulation Factor Xa In Complex With M55532
pdb|1IQE|A Chain A, Human Coagulation Factor Xa In Complex With M55590
pdb|1IQF|A Chain A, Human Coagulation Factor Xa In Complex With M55165
pdb|1IQG|A Chain A, Human Coagulation Factor Xa In Complex With M55159
pdb|1IQH|A Chain A, Human Coagulation Factor Xa In Complex With M55143
pdb|1IQI|A Chain A, Human Coagulation Factor Xa In Complex With M55125
pdb|1IQJ|A Chain A, Human Coagulation Factor Xa In Complex With M55124
pdb|1IQK|A Chain A, Human Coagulation Factor Xa In Complex With M55113
pdb|1IQL|A Chain A, Human Coagulation Factor Xa In Complex With M54476
pdb|1IQM|A Chain A, Human Coagulation Factor Xa In Complex With M54471
pdb|1IQN|A Chain A, Human Coagulation Factor Xa In Complex With M55192
pdb|2P3F|H Chain H, Crystal Structure Of The Factor XaNAP5 COMPLEX
Length = 235
Score = 42.7 bits (99), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 55/234 (23%), Positives = 92/234 (39%), Gaps = 72/234 (30%)
Query: 30 GEVPYIVSLSLYGNL-YCGGSLISLQWFLSARHCFVTENLVWNQFNPLIIAGSIYRNYKE 88
GE P+ L N +CGG+++S + L+A HC ++ + G RN ++
Sbjct: 10 GECPWQALLINEENEGFCGGTILSEFYILTAAHC------LYQAKRFKVRVGD--RNTEQ 61
Query: 89 QKRQPQLNEIALIYWHS-------DADLAMVKLKEPFRQTTFVKPLDYYTARETNYINDV 141
++ ++E+ ++ H+ D D+A+++LK P TF + E ++
Sbjct: 62 EEGGEAVHEVEVVIKHNRFTKETYDFDIAVLRLKTPI---TFRMNVAPACLPERDWAEST 118
Query: 142 LSKTDRSEMSIVSGFGVTFQRDKDG----------------------IVSWGIGCALGY- 178
L + IVSGFG T ++ + I++ + CA GY
Sbjct: 119 LMT---QKTGIVSGFGRTHEKGRQSTRLKMLEVPYVDRNSCKLSSSFIITQNMFCA-GYD 174
Query: 179 -------------------------PGIVSWGIGCAL-GYPGVYVRVDHYDPWI 206
GIVSWG GCA G G+Y +V + WI
Sbjct: 175 TKQEDACQGDSGGPHVTRFKDTYFVTGIVSWGEGCARKGKYGIYTKVTAFLKWI 228
>pdb|1FAX|A Chain A, Coagulation Factor Xa Inhibitor Complex
Length = 254
Score = 42.7 bits (99), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 58/242 (23%), Positives = 95/242 (39%), Gaps = 73/242 (30%)
Query: 30 GEVPYIVSLSLYGNL-YCGGSLISLQWFLSARHCFVTENLVWNQFNPLIIAGSIYRNYKE 88
GE P+ L N +CGG+++S + L+A HC ++ + G RN
Sbjct: 10 GECPWQALLINEENEGFCGGTILSEFYILTAAHC------LYQAKRFKVRVGD--RNTAA 61
Query: 89 QKRQPQLNEIALIYWHS-------DADLAMVKLKEPFRQTTFVKPLDYYTARETNYINDV 141
++ ++E+ ++ H+ D D+A+++LK P TF + E ++
Sbjct: 62 EEGGEAVHEVEVVIKHNRFTKETYDFDIAVLRLKTPI---TFRMNVAPACLPERDWAEST 118
Query: 142 LSKTDRSEMSIVSGFGVTFQRDKDG----------------------IVSWGIGCALGY- 178
L + IVSGFG T ++ + I++ + CA GY
Sbjct: 119 LMT---QKTGIVSGFGRTHEKGRQSTRLKMLEVPYVDRNSCKLSSSFIITQNMFCA-GYD 174
Query: 179 -------------------------PGIVSWGIGCAL-GYPGVYVRVDHYDPWI-QSVKN 211
GIVSWG GCA G G+Y +V + WI +S+K
Sbjct: 175 TKQEDACQGDSGGPHVTRFKDTYFVTGIVSWGEGCARKGKYGIYTKVTAFLKWIDRSMKT 234
Query: 212 NG 213
G
Sbjct: 235 RG 236
>pdb|1MKW|K Chain K, The Co-Crystal Structure Of Unliganded Bovine Alpha-
Thrombin And Prethrombin-2: Movement Of The Yppw Segment
And Active Site Residues Upon Ligand Binding
pdb|1MKX|K Chain K, The Co-Crystal Structure Of Unliganded Bovine Alpha-
Thrombin And Prethrombin-2: Movement Of The Yppw Segment
And Active Site Residues Upon Ligand Binding
Length = 308
Score = 42.7 bits (99), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 25/96 (26%), Positives = 49/96 (51%), Gaps = 13/96 (13%)
Query: 43 NLYCGGSLISLQWFLSARHCFVTENLVWNQ---FNPLIIAGSIYRNYKEQKRQPQLNEIA 99
L CG SLIS +W L+A HC + W++ + L++ + + +++ +++ +
Sbjct: 74 ELLCGASLISDRWVLTAAHCLLYPP--WDKNFTVDDLLVRIGKHSRTRYERKVEKISMLD 131
Query: 100 LIYWHS--------DADLAMVKLKEPFRQTTFVKPL 127
IY H D D+A++KLK P + ++ P+
Sbjct: 132 KIYIHPRYNWKENLDRDIALLKLKRPIELSDYIHPV 167
Score = 29.3 bits (64), Expect = 1.9, Method: Compositional matrix adjust.
Identities = 16/31 (51%), Positives = 16/31 (51%), Gaps = 1/31 (3%)
Query: 180 GIVSWGIGCAL-GYPGVYVRVDHYDPWIQSV 209
GIVSWG GC G G Y V WIQ V
Sbjct: 272 GIVSWGEGCDRDGKYGFYTHVFRLKKWIQKV 302
>pdb|1FJS|A Chain A, Crystal Structure Of The Inhibitor Zk-807834 (Ci-1031)
Complexed With Factor Xa
pdb|1Z6E|A Chain A, Factor Xa In Complex With The Inhibitor
1-(3'-Amino-1,2-Benzisoxazol-
5'-Yl)-N-(4-(2'-((Dimethylamino)methyl)-1h-Imidazol-1-
Yl)-2-
Fluorophenyl)-3-(Trifluoromethyl)-1h-Pyrazole-5-
Carboxamide (Razaxaban; Dpc906; Bms-561389)
pdb|2BMG|B Chain B, Crystal Structure Of Factor Xa In Complex With 50
pdb|2FZZ|A Chain A, Factor Xa In Complex With The Inhibitor 1-(3-Amino-1,2-
Benzisoxazol-5-Yl)-6-(2'-(((3r)-3-Hydroxy-1-
Pyrrolidinyl)
Methyl)-4-Biphenylyl)-3-(Trifluoromethyl)-1,4,5,6-
Tetrahydro-7h-Pyrazolo[3,4-C]pyridin-7-One
pdb|2G00|A Chain A, Factor Xa In Complex With The Inhibitor 3-(6-(2'-
((Dimethylamino)methyl)-4-Biphenylyl)-7-Oxo-3-
(Trifluoromethyl)-4,5,6,7-Tetrahydro-1h-Pyrazolo[3,4-
C]pyridin-1-Yl)benzamide
pdb|2P93|A Chain A, Factor Xa In Complex With The Inhibitor
5-Chloro-N-(2-(4-(2-
Oxopyridin-1(2h)-Yl)benzamido)ethyl)thiophene-2-
Carboxamide
pdb|2P94|A Chain A, Factor Xa In Complex With The Inhibitor
3-Chloro-N-((1r,2s)-
2-(4-(2-Oxopyridin-1(2h)-Yl)benzamido)cyclohexyl)-1h-
Indole-6-Carboxamide
pdb|2P95|A Chain A, Factor Xa In Complex With The Inhibitor
5-Chloro-N-((1r,2s)-
2-(4-(2-Oxopyridin-1(2h)-Yl)benzamido) Cyclopentyl)
Thiophene-2-Carboxamide
pdb|2PR3|A Chain A, Factor Xa Inhibitor
pdb|2Q1J|A Chain A, The Discovery Of Glycine And Related Amino Acid-Based
Factor Xa Inhibitors
pdb|2P16|A Chain A, Factor Xa In Complex With The Inhibitor Apixaban (Bms-
562247) Aka 1-(4-Methoxyphenyl)-7-Oxo-6-(4-(2-Oxo-1-
Piperidinyl)phenyl)-4,5,6,7-Tetrahydro-1h-Pyrazolo[3, 4-
C]pyridine-3-Carboxamide
pdb|2RA0|A Chain A, X-Ray Structure Of Fxa In Complex With 7-Fluoroindazole
pdb|2PHB|A Chain A, An Orally Efficacious Factor Xa Inhibitor
pdb|3CEN|A Chain A, Factor Xa In Complex With The Inhibitor
N-(2-(((5-Chloro-2- Pyridinyl)
Amino)sulfonyl)phenyl)-4-(2-Oxo-1(2h)-
Pyridinyl)benzamide
pdb|3CS7|A Chain A, Factor Xa In Complex With The Inhibitor
1-(4-Methoxyphenyl)-
6-(4-(1-(Pyrrolidin-1-Ylmethyl)cyclopropyl)phenyl)-3-
(Trifluoromethyl)-5,6-Dihydro-1h-Pyrazolo[3,4-C]pyridin-
7(4h)-One
pdb|2W26|A Chain A, Factor Xa In Complex With Bay59-7939
pdb|2W3I|A Chain A, Crystal Structure Of Fxa In Complex With 4,4-disubstituted
Pyrrolidine-1,2-dicarboxamide Inhibitor 2
pdb|2W3K|A Chain A, Crystal Structure Of Fxa In Complex With 4,4-Disubstituted
Pyrrolidine-1,2-Dicarboxamide Inhibitor 1
pdb|3FFG|A Chain A, Factor Xa In Complex With The Inhibitor (R)-6-(2'-((3-
Hydroxypyrrolidin-1-Yl)methyl)biphenyl-4-Yl)-1-(3-(5-
Oxo-4, 5-Dihydro-1h-1,2,4-Triazol-3-Yl)phenyl)-3-
(Trifluoromethyl)-5,6-Dihydro-1h-Pyrazolo[3,4-C]pyridin-
7(4h)-One
pdb|3KQB|A Chain A, Factor Xa In Complex With The Inhibitor N-(3-Fluoro-2'-
(Methylsulfonyl)biphenyl-4-Yl)-1-(3-(5-Oxo-4,
5-Dihydro-1h-
Triazol-3-Yl)phenyl)-3-(Trifluoromethyl)-1h-
Pyrazole-5-Car
pdb|3KQC|A Chain A, Factor Xa In Complex With The Inhibitor 6-(2'-
(Methylsulfon Biphenyl-4-Yl)-1-(3-(5-Oxo-4,5-Dihydro-1h-
1,2,4-Triazol-3- Phenyl)-3-(Trifluoromethyl)-5,6-
Dihydro-1h-Pyrazolo[3,4-C] 7(4h)-One
pdb|3KQD|A Chain A, Factor Xa In Complex With The Inhibitor 1-(3-(5-Oxo-4,5-
Dih 2,4-Triazol-3-Yl)phenyl)-6-(2'-(Pyrrolidin-1-
Ylmethyl)biph Yl)-3-(Trifluoromethyl)-5,6-Dihydro-
1h-Pyrazolo[3,4-C]pyri One
pdb|3KQE|A Chain A, Factor Xa In Complex With The Inhibitor 3-Methyl-1-(3-(5-
Ox Dihydro-1h-1,2,4-Triazol-3-Yl)phenyl)-6-(2'-
(Pyrrolidin-1- Biphenyl-4-Yl)-5,6-Dihydro-1h-
Pyrazolo[3,4-C]pyridin-7(4h)
pdb|3LIW|A Chain A, Factor Xa In Complex With
(R)-2-(1-Adamantylcarbamoylamino)-
3-(3-Carbamidoyl-Phenyl)-N-Phenethyl-Propionic Acid
Amide
pdb|3M36|A Chain A, Factor Xa In Complex With The Inhibitor 1-[3-(Aminomethyl)
Phenyl]-N-[3-Fluoro-2'-(Methylsulfonyl)biphenyl-4-Yl]-3-
(Trifluoromethyl)-1h-Pyrazole-5-Carboxamide (Dpc423)
pdb|3M37|A Chain A, Factor Xa In Complex With The Inhibitor 1-[2-(Aminomethyl)
Phenyl]-N-(3-Fluoro-2'-Sulfamoylbiphenyl-4-Yl)-3-
(Trifluoromethyl)-1h-Pyrazole-5-Carboxamide (Dpc602)
Length = 234
Score = 42.7 bits (99), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 55/234 (23%), Positives = 92/234 (39%), Gaps = 72/234 (30%)
Query: 30 GEVPYIVSLSLYGNL-YCGGSLISLQWFLSARHCFVTENLVWNQFNPLIIAGSIYRNYKE 88
GE P+ L N +CGG+++S + L+A HC ++ + G RN ++
Sbjct: 10 GECPWQALLINEENEGFCGGTILSEFYILTAAHC------LYQAKRFKVRVGD--RNTEQ 61
Query: 89 QKRQPQLNEIALIYWHS-------DADLAMVKLKEPFRQTTFVKPLDYYTARETNYINDV 141
++ ++E+ ++ H+ D D+A+++LK P TF + E ++
Sbjct: 62 EEGGEAVHEVEVVIKHNRFTKETYDFDIAVLRLKTPI---TFRMNVAPACLPERDWAEST 118
Query: 142 LSKTDRSEMSIVSGFGVTFQRDKDG----------------------IVSWGIGCALGY- 178
L + IVSGFG T ++ + I++ + CA GY
Sbjct: 119 LMT---QKTGIVSGFGRTHEKGRQSTRLKMLEVPYVDRNSCKLSSSFIITQNMFCA-GYD 174
Query: 179 -------------------------PGIVSWGIGCAL-GYPGVYVRVDHYDPWI 206
GIVSWG GCA G G+Y +V + WI
Sbjct: 175 TKQEDACQGDSGGPHVTRFKDTYFVTGIVSWGEGCARKGKYGIYTKVTAFLKWI 228
>pdb|1MQ5|A Chain A, Crystal Structure Of
3-chloro-n-[4-chloro-2-[[(4-chlorophenyl)
Amino]carbonyl]phenyl]-4-[(4-methyl-1-
piperazinyl)methyl]-2- Thiophenecarboxamide Complexed
With Human Factor Xa
pdb|1MQ6|A Chain A, Crystal Structure Of
3-Chloro-N-[4-Chloro-2-[[(5-Chloro-2-Pyridinyl)
Amino]carbonyl]-6-Methoxyphenyl]-4-[[(4,
5-Dihydro-2-Oxazolyl)
Methylamino]methyl]-2-Thiophenecarboxamide Complexed
With Human Factor Xa
pdb|1V3X|A Chain A, Factor Xa In Complex With The Inhibitor
1-[6-Methyl-4,5,6,7-
Tetrahydrothiazolo(5,4-C)pyridin-2-Yl] Carbonyl-2-
Carbamoyl-4-(6-Chloronaphth-2-Ylsulphonyl)piperazine
pdb|1WU1|A Chain A, Factor Xa In Complex With The Inhibitor
4-[(5-Chloroindol-2-Yl)
Sulfonyl]-2-(2-Methylpropyl)-1-[[5-(Pyridin-4-Yl)
Pyrimidin-2- Yl]carbonyl]piperazine
pdb|2D1J|A Chain A, Factor Xa In Complex With The Inhibitor 2-[[4-[(5-
Chloroindol-2-Yl)sulfonyl]piperazin-1-Yl]
Carbonyl]thieno[3,2-B]pyridine N-Oxide
pdb|2H9E|H Chain H, Crystal Structure Of FxaSELECTIDENAPC2 TERNARY COMPLEX
pdb|2P3U|B Chain B, Crystal Structure Of Human Factor Xa Complexed With 3-
Chloro-N-(4-Chloro-2-{[(5-Chloropyridin-2-Yl)
Amino]carbonyl}-6-Methoxyphenyl)-4-[(1-Methyl-1h-
Imidazol- 2-Yl)methyl]thiophene-2-Carboxamide {pfizer
320663}
pdb|2P3T|B Chain B, Crystal Structure Of Human Factor Xa Complexed With 3-
Chloro-4-(2-Methylamino-Imidazol-1-Ylmethyl)-Thiophene-
2- Carboxylic Acid [4-Chloro-2-(5-Chloro-Pyridin-2-
Ylcarbamoyl)-6-Methoxy-Phenyl]-Amide
pdb|2EI6|A Chain A, Factor Xa In Complex With The Inhibitor (-)-Cis-N1-[(5-
Chloroindol-2-Yl)carbonyl]-N2-[(5-Methyl-4,5,6,7-
Tetrahydrothiazolo[5,4-C]pyridin-2-Yl)carbonyl]-1,2-
Cyclohexanediamine
pdb|2EI7|A Chain A, Factor Xa In Complex With The Inhibitor Trans-N1-[(5-
Chloroindol-2-Yl)carbonyl]-N2-[(5-Methyl-4,5,6,7-
Tetrahydrothiazolo[5,4-C]pyridin-2-Yl)carbonyl]-1,2-
Cyclohexanediamine
pdb|2EI8|A Chain A, Factor Xa In Complex With The Inhibitor (1s,2r,4s)-N1-[(5-
Chloroindol-2-Yl)carbonyl]-4-(N,N-Dimethylcarbamoyl)-N2-
[(5-Methyl-4,5,6,7-Tetrahydrothiazolo[5,
4-C]pyridin-2-Yl) Carbonyl]-1,2-Cyclohexanediamine
pdb|3IIT|A Chain A, Factor Xa In Complex With A Cis-1,2-Diaminocyclohexane
Derivative
pdb|3Q3K|A Chain A, Factor Xa In Complex With A Phenylenediamine Derivative
pdb|3TK5|A Chain A, Factor Xa In Complex With D102-4380
pdb|3TK6|A Chain A, Factor Xa In Complex With D46-5241
Length = 233
Score = 42.7 bits (99), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 55/234 (23%), Positives = 92/234 (39%), Gaps = 72/234 (30%)
Query: 30 GEVPYIVSLSLYGNL-YCGGSLISLQWFLSARHCFVTENLVWNQFNPLIIAGSIYRNYKE 88
GE P+ L N +CGG+++S + L+A HC ++ + G RN ++
Sbjct: 10 GECPWQALLINEENEGFCGGTILSEFYILTAAHC------LYQAKRFKVRVGD--RNTEQ 61
Query: 89 QKRQPQLNEIALIYWHS-------DADLAMVKLKEPFRQTTFVKPLDYYTARETNYINDV 141
++ ++E+ ++ H+ D D+A+++LK P TF + E ++
Sbjct: 62 EEGGEAVHEVEVVIKHNRFTKETYDFDIAVLRLKTPI---TFRMNVAPACLPERDWAEST 118
Query: 142 LSKTDRSEMSIVSGFGVTFQRDKDG----------------------IVSWGIGCALGY- 178
L + IVSGFG T ++ + I++ + CA GY
Sbjct: 119 LMT---QKTGIVSGFGRTHEKGRQSTRLKMLEVPYVDRNSCKLSSSFIITQNMFCA-GYD 174
Query: 179 -------------------------PGIVSWGIGCAL-GYPGVYVRVDHYDPWI 206
GIVSWG GCA G G+Y +V + WI
Sbjct: 175 TKQEDACQGDSGGPHVTRFKDTYFVTGIVSWGEGCARKGKYGIYTKVTAFLKWI 228
>pdb|1DX5|M Chain M, Crystal Structure Of The Thrombin-Thrombomodulin Complex
pdb|1DX5|N Chain N, Crystal Structure Of The Thrombin-Thrombomodulin Complex
pdb|1DX5|O Chain O, Crystal Structure Of The Thrombin-Thrombomodulin Complex
pdb|1DX5|P Chain P, Crystal Structure Of The Thrombin-Thrombomodulin Complex
pdb|1E0F|D Chain D, Crystal Structure Of The Human Alpha-Thrombin-Haemadin
Complex: An Exosite Ii-Binding Inhibitor
pdb|1E0F|F Chain F, Crystal Structure Of The Human Alpha-Thrombin-Haemadin
Complex: An Exosite Ii-Binding Inhibitor
pdb|1E0F|E Chain E, Crystal Structure Of The Human Alpha-Thrombin-Haemadin
Complex: An Exosite Ii-Binding Inhibitor
Length = 259
Score = 42.7 bits (99), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 29/97 (29%), Positives = 49/97 (50%), Gaps = 15/97 (15%)
Query: 43 NLYCGGSLISLQWFLSARHCFV----TENLVWNQFNPLIIAGSIYRNYKEQKRQPQLNEI 98
L CG SLIS +W L+A HC + +N + N L+ G R E+ + +++ +
Sbjct: 25 ELLCGASLISDRWVLTAAHCLLYPPWDKNFIENDL--LVRIGKHSRTRYERNIE-KISML 81
Query: 99 ALIYWHS--------DADLAMVKLKEPFRQTTFVKPL 127
IY H D D+A++KLK+P + ++ P+
Sbjct: 82 EKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPV 118
Score = 28.9 bits (63), Expect = 2.6, Method: Compositional matrix adjust.
Identities = 16/31 (51%), Positives = 16/31 (51%), Gaps = 1/31 (3%)
Query: 180 GIVSWGIGCAL-GYPGVYVRVDHYDPWIQSV 209
GIVSWG GC G G Y V WIQ V
Sbjct: 223 GIVSWGEGCDRDGKYGFYTHVFRLKKWIQKV 253
>pdb|3S9A|A Chain A, Russell's Viper Venom Serine Proteinase, Rvv-V
(Closed-Form)
pdb|3S9B|A Chain A, Russell's Viper Venom Serine Proteinase, Rvv-V (Open-Form)
pdb|3S9C|A Chain A, Russell's Viper Venom Serine Proteinase, Rvv-V In Complex
With The Fragment (Residues 1533-1546) Of Human Factor V
pdb|3SBK|A Chain A, Russell's Viper Venom Serine Proteinase, Rvv-V
(Ppack-Bound Form)
Length = 234
Score = 42.7 bits (99), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 30/105 (28%), Positives = 49/105 (46%), Gaps = 10/105 (9%)
Query: 28 NPGEVPYIVSL--SLYGNLYCGGSLISLQWFLSARHCFVTENLVWNQFNPLIIAGSIYRN 85
N E P++V+L S ++C G+LI+ +W L+A HC N L + RN
Sbjct: 8 NINEHPFLVALYTSASSTIHCAGALINREWVLTAAHCDRR-----NIRIKLGMHSKNIRN 62
Query: 86 YKEQKRQPQLNEIALIYWHS---DADLAMVKLKEPFRQTTFVKPL 127
EQ R P+ L D D+ +++L+ P +T + P+
Sbjct: 63 EDEQIRVPRGKYFCLNTKFPNGLDKDIMLIRLRRPVTYSTHIAPV 107
>pdb|2AIP|A Chain A, Crystal Structure Of Native Protein C Activator From The
Venom Of Copperhead Snake Agkistrodon Contortrix
Contortrix
pdb|2AIQ|A Chain A, Crystal Structure Of Benzamidine-Inhibited Protein C
Activator From The Venom Of Copperhead Snake Agkistrodon
Contortrix Contortrix
Length = 231
Score = 42.7 bits (99), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 24/83 (28%), Positives = 41/83 (49%), Gaps = 4/83 (4%)
Query: 46 CGGSLISLQWFLSARHCFVTENLVW-NQFNPLIIAGSIYRNYKEQKRQPQLNEIALIYWH 104
CGG+LI+ +W L+ARHC ++ N ++ R + ++K LN W
Sbjct: 25 CGGTLINQEWVLTARHCDRGNMRIYLGMHNLKVLNKDALRRFPKEKYF-CLNTRNDTIW- 82
Query: 105 SDADLAMVKLKEPFRQTTFVKPL 127
D D+ +++L P R + + PL
Sbjct: 83 -DKDIMLIRLNRPVRNSAHIAPL 104
>pdb|2ZCH|P Chain P, Crystal Structure Of Human Prostate Specific Antigen
Complexed With An Activating Antibody
pdb|2ZCK|P Chain P, Crystal Structure Of A Ternary Complex Between Psa, A
Substrat-Acyl Intermediate And An Activating Antibody
pdb|2ZCL|P Chain P, Crystal Structure Of Human Prostate Specific Antigen
Complexed With An Activating Antibody
pdb|3QUM|P Chain P, Crystal Structure Of Human Prostate Specific Antigen (Psa)
In Fab Sandwich With A High Affinity And A Pca Selective
Antibody
pdb|3QUM|Q Chain Q, Crystal Structure Of Human Prostate Specific Antigen (Psa)
In Fab Sandwich With A High Affinity And A Pca Selective
Antibody
Length = 237
Score = 42.4 bits (98), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 49/218 (22%), Positives = 86/218 (39%), Gaps = 43/218 (19%)
Query: 33 PYIVSLSLYGNLYCGGSLISLQWFLSARHCFVTENLVWNQFNPLIIAGSIYRNYKEQKRQ 92
P+ V ++ G CGG L+ QW L+A HC ++++ + L + ++
Sbjct: 13 PWQVLVASRGRAVCGGVLVHPQWVLTAAHCIRNKSVILLGRHSLFHPEDTGQVFQVSHSF 72
Query: 93 PQ-LNEIALIYWH-------SDADLAMVKLKEPFRQTTFVK------------------- 125
P L +++L+ S DL +++L EP T VK
Sbjct: 73 PHPLYDMSLLKNRFLRPGDDSSHDLMLLRLSEPAELTDAVKVMDLPTQEPALGTTCYASG 132
Query: 126 -----PLDYYTARETNYI------NDVLSKTDRSEMS---IVSGFGVTFQRDKDGIVSWG 171
P ++ T ++ + NDV ++ +++ + +G + G
Sbjct: 133 WGSIEPEEFLTPKKLQCVDLHVISNDVCAQVHPQKVTKFMLCAGRWTGGKSTCSGDSGGP 192
Query: 172 IGCALGYPGIVSWGI-GCALG-YPGVYVRVDHYDPWIQ 207
+ C GI SWG CAL P +Y +V HY WI+
Sbjct: 193 LVCNGVLQGITSWGSEPCALPERPSLYTKVVHYRKWIK 230
>pdb|1TQ0|B Chain B, Crystal Structure Of The Potent Anticoagulant Thrombin
Mutant W215aE217A IN FREE FORM
pdb|1TQ0|D Chain D, Crystal Structure Of The Potent Anticoagulant Thrombin
Mutant W215aE217A IN FREE FORM
pdb|1TQ7|B Chain B, Crystal Structure Of The Anticoagulant Thrombin Mutant
W215aE217A Bound To Ppack
Length = 257
Score = 42.4 bits (98), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 26/96 (27%), Positives = 49/96 (51%), Gaps = 13/96 (13%)
Query: 43 NLYCGGSLISLQWFLSARHCFVTENLVWNQ---FNPLIIAGSIYRNYKEQKRQPQLNEIA 99
L CG SLIS +W L+A HC + W++ N L++ + + ++ +++ +
Sbjct: 25 ELLCGASLISDRWVLTAAHCLLYPP--WDKNFTENDLLVRIGKHSRTRYERNIEKISMLE 82
Query: 100 LIYWHS--------DADLAMVKLKEPFRQTTFVKPL 127
IY H D D+A++KLK+P + ++ P+
Sbjct: 83 KIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPV 118
>pdb|2EEK|A Chain A, Crystal Structure Of Atlantic Cod Trypsin Complexed With
Benzamidine
Length = 220
Score = 42.4 bits (98), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 52/213 (24%), Positives = 81/213 (38%), Gaps = 64/213 (30%)
Query: 42 GNLYCGGSLISLQWFLSARHCFVTE-NLVWNQFNPLIIAGS-IYRNYKEQKRQPQLNEIA 99
G +CGGSL+S W +SA HC+ + + + + + G+ Y + R P +
Sbjct: 21 GYHFCGGSLVSKDWVVSAAHCYKSVLRVRLGEHHIRVNEGTEQYISSSSVIRHPNYSS-- 78
Query: 100 LIYWHSDADLAMVKLKEPFRQTTFVKPLDYYTARETNYINDVLSKTDRSEMSIVSGFGVT 159
++ + D+ ++KL +P +V + A T D + M VSG+G T
Sbjct: 79 ---YNINNDIMLIKLTKPATLNQYVHAV----ALPTECAAD-------ATMCTVSGWGNT 124
Query: 160 FQRDKDG---------IVSWGIGCALGYP------------------------------- 179
DG I+S CA YP
Sbjct: 125 MSSVADGDKLQCLSLPILSHA-DCANSYPGMITQSMFCAGYLEGGKDSCQGDSGGPVVCN 183
Query: 180 ----GIVSWGIGCA-LGYPGVYVRVDHYDPWIQ 207
G+VSWG GCA +PGVY +V W++
Sbjct: 184 GVLQGVVSWGYGCAERDHPGVYAKVCVLSGWVR 216
>pdb|3EE0|B Chain B, Crystal Structure Of The W215aE217A MUTANT OF HUMAN
Thrombin (Space Group P2(1)2(1)2(1))
pdb|3HKJ|B Chain B, Crystal Structure Of Human Thrombin Mutant W215aE217A IN
COMPLEX WITH The Extracellular Fragment Of Human Par1
pdb|3HKJ|E Chain E, Crystal Structure Of Human Thrombin Mutant W215aE217A IN
COMPLEX WITH The Extracellular Fragment Of Human Par1
Length = 259
Score = 42.4 bits (98), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 26/96 (27%), Positives = 49/96 (51%), Gaps = 13/96 (13%)
Query: 43 NLYCGGSLISLQWFLSARHCFVTENLVWNQ---FNPLIIAGSIYRNYKEQKRQPQLNEIA 99
L CG SLIS +W L+A HC + W++ N L++ + + ++ +++ +
Sbjct: 25 ELLCGASLISDRWVLTAAHCLLYPP--WDKNFTENDLLVRIGKHSRTRYERNIEKISMLE 82
Query: 100 LIYWHS--------DADLAMVKLKEPFRQTTFVKPL 127
IY H D D+A++KLK+P + ++ P+
Sbjct: 83 KIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPV 118
>pdb|2Y5F|A Chain A, Factor Xa - Cation Inhibitor Complex
pdb|2Y5G|A Chain A, Factor Xa - Cation Inhibitor Complex
pdb|2Y5H|A Chain A, Factor Xa - Cation Inhibitor Complex
Length = 234
Score = 42.4 bits (98), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 55/234 (23%), Positives = 92/234 (39%), Gaps = 72/234 (30%)
Query: 30 GEVPYIVSLSLYGNL-YCGGSLISLQWFLSARHCFVTENLVWNQFNPLIIAGSIYRNYKE 88
GE P+ L N +CGG+++S + L+A HC ++ + G RN ++
Sbjct: 10 GECPWQALLINEENEGFCGGTILSEFYILTAAHC------LYQAKRFKVRVGD--RNTEQ 61
Query: 89 QKRQPQLNEIALIYWHS-------DADLAMVKLKEPFRQTTFVKPLDYYTARETNYINDV 141
++ ++E+ ++ H+ D D+A+++LK P TF + E ++
Sbjct: 62 EEGGEAVHEVEVVIKHNRFTKETYDFDIAVLRLKTPI---TFRMNVAPACLPERDWAEST 118
Query: 142 LSKTDRSEMSIVSGFGVTFQRDKDG----------------------IVSWGIGCALGY- 178
L + IVSGFG T ++ + I++ + CA GY
Sbjct: 119 LMT---QKTGIVSGFGRTHEKGEQSTRLKMLEVPYVDRNSCKLSSSFIITQNMFCA-GYD 174
Query: 179 -------------------------PGIVSWGIGCAL-GYPGVYVRVDHYDPWI 206
GIVSWG GCA G G+Y +V + WI
Sbjct: 175 TKQEDACQGDSGGPHVTRFKDTYFVTGIVSWGEGCARKGKYGIYTKVTAFLKWI 228
>pdb|1MZA|A Chain A, Crystal Structure Of Human Pro-Granzyme K
pdb|1MZD|A Chain A, Crystal Structure Of Human Pro-Granzyme K
Length = 240
Score = 42.0 bits (97), Expect = 3e-04, Method: Compositional matrix adjust.
Identities = 53/226 (23%), Positives = 86/226 (38%), Gaps = 48/226 (21%)
Query: 28 NPGEVPYIVSLSLYGNLYCGGSLISLQWFLSARHCFVTENLVWNQFNPLIIAGSIYRNYK 87
+P P++ S+ G+ CGG LI QW L+A HC + +P ++ G+ +
Sbjct: 10 SPHSRPFMASIQYGGHHVCGGVLIDPQWVLTAAHC---QYRFTKGQSPTVVLGAHSLSKN 66
Query: 88 EQKRQ----------------PQLNEIALIYWHSDADLAM------VKLKEPFRQTTFVK 125
E +Q PQ N+I L+ + A L ++ K R T K
Sbjct: 67 EASKQTLEIKKFIPFSRVTSDPQSNDIMLVKLQTAAKLNKHVKMLHIRSKTSLRSGTKCK 126
Query: 126 -----PLDYYTARETNYIND----VLSKTDRSEMS-----------IVSGFGVTFQRDK- 164
D + R ++ + + VLS+ + S +V Q+D
Sbjct: 127 VTGWGATDPDSLRPSDTLREVTVTVLSRKLCNSQSYYNGDPFITKDMVCAGDAKGQKDSC 186
Query: 165 DGIVSWGIGCALGYPGIVSWGIGCALG-YPGVY-VRVDHYDPWIQS 208
G + C + IVS G C + PG+Y + Y WI+S
Sbjct: 187 KGDAGGPLICKGVFHAIVSGGHECGVATKPGIYTLLTKKYQTWIKS 232
>pdb|1B7X|B Chain B, Structure Of Human Alpha-Thrombin Y225i Mutant Bound To D-
Phe-Pro-Arg-Chloromethylketone
Length = 259
Score = 42.0 bits (97), Expect = 3e-04, Method: Compositional matrix adjust.
Identities = 26/96 (27%), Positives = 49/96 (51%), Gaps = 13/96 (13%)
Query: 43 NLYCGGSLISLQWFLSARHCFVTENLVWNQ---FNPLIIAGSIYRNYKEQKRQPQLNEIA 99
L CG SLIS +W L+A HC + W++ N L++ + + ++ +++ +
Sbjct: 25 ELLCGASLISDRWVLTAAHCLLYPP--WDKNFTENDLLVRIGKHSRTRYERNIEKISMLE 82
Query: 100 LIYWHS--------DADLAMVKLKEPFRQTTFVKPL 127
IY H D D+A++KLK+P + ++ P+
Sbjct: 83 KIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPV 118
Score = 29.3 bits (64), Expect = 2.2, Method: Compositional matrix adjust.
Identities = 16/31 (51%), Positives = 16/31 (51%), Gaps = 1/31 (3%)
Query: 180 GIVSWGIGCAL-GYPGVYVRVDHYDPWIQSV 209
GIVSWG GC G G Y V WIQ V
Sbjct: 223 GIVSWGEGCDRDGKIGFYTHVFRLKKWIQKV 253
>pdb|1JOU|B Chain B, Crystal Structure Of Native S195a Thrombin With An
Unoccupied Active Site
pdb|1JOU|D Chain D, Crystal Structure Of Native S195a Thrombin With An
Unoccupied Active Site
pdb|1JOU|F Chain F, Crystal Structure Of Native S195a Thrombin With An
Unoccupied Active Site
pdb|1TB6|H Chain H, 2.5a Crystal Structure Of The
Antithrombin-Thrombin-Heparin Ternary Complex
pdb|2B5T|B Chain B, 2.1 Angstrom Structure Of A Nonproductive Complex Between
Antithrombin, Synthetic Heparin Mimetic Sr123781 And Two
S195a Thrombin Molecules
pdb|2B5T|D Chain D, 2.1 Angstrom Structure Of A Nonproductive Complex Between
Antithrombin, Synthetic Heparin Mimetic Sr123781 And Two
S195a Thrombin Molecules
pdb|3B9F|H Chain H, 1.6 A Structure Of The Pci-Thrombin-Heparin Complex
pdb|3GIS|B Chain B, Crystal Structure Of Na-Free Thrombin In Complex With
Thrombomodulin
pdb|3GIS|D Chain D, Crystal Structure Of Na-Free Thrombin In Complex With
Thrombomodulin
pdb|3GIS|F Chain F, Crystal Structure Of Na-Free Thrombin In Complex With
Thrombomodulin
pdb|3LU9|B Chain B, Crystal Structure Of Human Thrombin Mutant S195a In
Complex Extracellular Fragment Of Human Par1
pdb|3LU9|E Chain E, Crystal Structure Of Human Thrombin Mutant S195a In
Complex Extracellular Fragment Of Human Par1
pdb|4DT7|B Chain B, Crystal Structure Of Thrombin Bound To The Activation
Domain Qedqvdprlidgkmtrrgds Of Protein C
pdb|4DT7|D Chain D, Crystal Structure Of Thrombin Bound To The Activation
Domain Qedqvdprlidgkmtrrgds Of Protein C
pdb|4DY7|B Chain B, Crystal Structures Of Protease Nexin-1 In Complex With
S195a Thrombin
pdb|4DY7|E Chain E, Crystal Structures Of Protease Nexin-1 In Complex With
S195a Thrombin
Length = 259
Score = 42.0 bits (97), Expect = 3e-04, Method: Compositional matrix adjust.
Identities = 26/96 (27%), Positives = 49/96 (51%), Gaps = 13/96 (13%)
Query: 43 NLYCGGSLISLQWFLSARHCFVTENLVWNQ---FNPLIIAGSIYRNYKEQKRQPQLNEIA 99
L CG SLIS +W L+A HC + W++ N L++ + + ++ +++ +
Sbjct: 25 ELLCGASLISDRWVLTAAHCLLYP--PWDKNFTENDLLVRIGKHSRTRYERNIEKISMLE 82
Query: 100 LIYWHS--------DADLAMVKLKEPFRQTTFVKPL 127
IY H D D+A++KLK+P + ++ P+
Sbjct: 83 KIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPV 118
Score = 28.9 bits (63), Expect = 2.5, Method: Compositional matrix adjust.
Identities = 16/31 (51%), Positives = 16/31 (51%), Gaps = 1/31 (3%)
Query: 180 GIVSWGIGCAL-GYPGVYVRVDHYDPWIQSV 209
GIVSWG GC G G Y V WIQ V
Sbjct: 223 GIVSWGEGCDRDGKYGFYTHVFRLKKWIQKV 253
>pdb|3GIC|B Chain B, Structure Of Thrombin Mutant Delta(146-149e) In The Free
Form
Length = 250
Score = 42.0 bits (97), Expect = 3e-04, Method: Compositional matrix adjust.
Identities = 26/96 (27%), Positives = 49/96 (51%), Gaps = 13/96 (13%)
Query: 43 NLYCGGSLISLQWFLSARHCFVTENLVWNQ---FNPLIIAGSIYRNYKEQKRQPQLNEIA 99
L CG SLIS +W L+A HC + W++ N L++ + + ++ +++ +
Sbjct: 25 ELLCGASLISDRWVLTAAHCLLYPP--WDKNFTENDLLVRIGKHSRTRYERNIEKISMLE 82
Query: 100 LIYWHS--------DADLAMVKLKEPFRQTTFVKPL 127
IY H D D+A++KLK+P + ++ P+
Sbjct: 83 KIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPV 118
>pdb|3JZ1|B Chain B, Crystal Structure Of Human Thrombin Mutant N143p In E:na+
Form
pdb|3JZ2|B Chain B, Crystal Structure Of Human Thrombin Mutant N143p In E Form
pdb|3QGN|B Chain B, The Allosteric E-E Equilibrium Is A Key Property Of The
Trypsin Fold
Length = 259
Score = 42.0 bits (97), Expect = 3e-04, Method: Compositional matrix adjust.
Identities = 26/96 (27%), Positives = 49/96 (51%), Gaps = 13/96 (13%)
Query: 43 NLYCGGSLISLQWFLSARHCFVTENLVWNQ---FNPLIIAGSIYRNYKEQKRQPQLNEIA 99
L CG SLIS +W L+A HC + W++ N L++ + + ++ +++ +
Sbjct: 25 ELLCGASLISDRWVLTAAHCLLYPP--WDKNFTENDLLVRIGKHSRTRYERNIEKISMLE 82
Query: 100 LIYWHS--------DADLAMVKLKEPFRQTTFVKPL 127
IY H D D+A++KLK+P + ++ P+
Sbjct: 83 KIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPV 118
Score = 28.9 bits (63), Expect = 2.6, Method: Compositional matrix adjust.
Identities = 16/31 (51%), Positives = 16/31 (51%), Gaps = 1/31 (3%)
Query: 180 GIVSWGIGCAL-GYPGVYVRVDHYDPWIQSV 209
GIVSWG GC G G Y V WIQ V
Sbjct: 223 GIVSWGEGCDRDGKYGFYTHVFRLKKWIQKV 253
>pdb|2PGB|B Chain B, Inhibitor-Free Human Thrombin Mutant C191a-C220a
pdb|2PGQ|B Chain B, Human Thrombin Mutant C191a-C220a In Complex With The
Inhibitor Ppack
Length = 259
Score = 42.0 bits (97), Expect = 3e-04, Method: Compositional matrix adjust.
Identities = 26/96 (27%), Positives = 49/96 (51%), Gaps = 13/96 (13%)
Query: 43 NLYCGGSLISLQWFLSARHCFVTENLVWNQ---FNPLIIAGSIYRNYKEQKRQPQLNEIA 99
L CG SLIS +W L+A HC + W++ N L++ + + ++ +++ +
Sbjct: 25 ELLCGASLISDRWVLTAAHCLLYP--PWDKNFTENDLLVRIGKHSRTRYERNIEKISMLE 82
Query: 100 LIYWHS--------DADLAMVKLKEPFRQTTFVKPL 127
IY H D D+A++KLK+P + ++ P+
Sbjct: 83 KIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPV 118
>pdb|2BDG|A Chain A, Human Kallikrein 4 Complex With Nickel And
P-aminobenzamidine
pdb|2BDG|B Chain B, Human Kallikrein 4 Complex With Nickel And
P-aminobenzamidine
pdb|2BDH|A Chain A, Human Kallikrein 4 Complex With Zinc And
P-Aminobenzamidine
pdb|2BDH|B Chain B, Human Kallikrein 4 Complex With Zinc And
P-Aminobenzamidine
pdb|2BDH|C Chain C, Human Kallikrein 4 Complex With Zinc And
P-Aminobenzamidine
pdb|2BDH|D Chain D, Human Kallikrein 4 Complex With Zinc And
P-Aminobenzamidine
pdb|2BDI|A Chain A, Human Kallikrein 4 Complex With Cobalt And P-
Aminobenzamidine
pdb|2BDI|B Chain B, Human Kallikrein 4 Complex With Cobalt And P-
Aminobenzamidine
pdb|2BDI|C Chain C, Human Kallikrein 4 Complex With Cobalt And P-
Aminobenzamidine
pdb|2BDI|D Chain D, Human Kallikrein 4 Complex With Cobalt And P-
Aminobenzamidine
pdb|2BDI|E Chain E, Human Kallikrein 4 Complex With Cobalt And P-
Aminobenzamidine
pdb|2BDI|F Chain F, Human Kallikrein 4 Complex With Cobalt And P-
Aminobenzamidine
pdb|2BDI|G Chain G, Human Kallikrein 4 Complex With Cobalt And P-
Aminobenzamidine
pdb|2BDI|H Chain H, Human Kallikrein 4 Complex With Cobalt And P-
Aminobenzamidine
pdb|2BDI|I Chain I, Human Kallikrein 4 Complex With Cobalt And P-
Aminobenzamidine
pdb|2BDI|J Chain J, Human Kallikrein 4 Complex With Cobalt And P-
Aminobenzamidine
pdb|2BDI|K Chain K, Human Kallikrein 4 Complex With Cobalt And P-
Aminobenzamidine
pdb|2BDI|L Chain L, Human Kallikrein 4 Complex With Cobalt And P-
Aminobenzamidine
pdb|2BDI|M Chain M, Human Kallikrein 4 Complex With Cobalt And P-
Aminobenzamidine
pdb|2BDI|N Chain N, Human Kallikrein 4 Complex With Cobalt And P-
Aminobenzamidine
pdb|2BDI|O Chain O, Human Kallikrein 4 Complex With Cobalt And P-
Aminobenzamidine
pdb|2BDI|P Chain P, Human Kallikrein 4 Complex With Cobalt And P-
Aminobenzamidine
Length = 223
Score = 42.0 bits (97), Expect = 3e-04, Method: Compositional matrix adjust.
Identities = 28/115 (24%), Positives = 49/115 (42%), Gaps = 16/115 (13%)
Query: 28 NPGEVPYIVSLSLYGNLYCGGSLISLQWFLSARHCFVTENLVWNQFNPLIIAGSIYRNYK 87
+P P+ +L + L+C G L+ QW LSA HCF N I ++
Sbjct: 8 SPHSQPWQAALVMENELFCSGVLVHPQWVLSAAHCFQ---------NSYTIGLGLHSLEA 58
Query: 88 EQKRQPQLNEIALIYWHSD-------ADLAMVKLKEPFRQTTFVKPLDYYTARET 135
+Q+ Q+ E +L H + DL ++KL E ++ ++ + + T
Sbjct: 59 DQEPGSQMVEASLSVRHPEYNRPLLANDLMLIKLDESVSESDTIRSISIASQCPT 113
>pdb|1GJ5|H Chain H, Selectivity At S1, H2o Displacement, Upa, Tpa,
Ser190ALA190 PROTEASE, Structure-Based Drug Design
pdb|1SB1|H Chain H, Novel Non-Covalent Thrombin Inhibitors Incorporating P1
4,5,6,7- Tetrahydrobenzothiazole Arginine Side Chain
Mimetics
pdb|2PW8|H Chain H, Crystal Structure Of Sulfo-Hirudin Complexed To Thrombin
pdb|3DD2|H Chain H, Crystal Structure Of An Rna Aptamer Bound To Human
Thrombin
pdb|1GJ4|H Chain H, Selectivity At S1, H2o Displacement, Upa, Tpa,
Ser190/ala190 Protease, Structure-based Drug Design
Length = 258
Score = 42.0 bits (97), Expect = 3e-04, Method: Compositional matrix adjust.
Identities = 26/96 (27%), Positives = 49/96 (51%), Gaps = 13/96 (13%)
Query: 43 NLYCGGSLISLQWFLSARHCFVTENLVWNQ---FNPLIIAGSIYRNYKEQKRQPQLNEIA 99
L CG SLIS +W L+A HC + W++ N L++ + + ++ +++ +
Sbjct: 25 ELLCGASLISDRWVLTAAHCLLYP--PWDKNFTENDLLVRIGKHSRTRYERNIEKISMLE 82
Query: 100 LIYWHS--------DADLAMVKLKEPFRQTTFVKPL 127
IY H D D+A++KLK+P + ++ P+
Sbjct: 83 KIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPV 118
Score = 28.9 bits (63), Expect = 2.7, Method: Compositional matrix adjust.
Identities = 16/31 (51%), Positives = 16/31 (51%), Gaps = 1/31 (3%)
Query: 180 GIVSWGIGCAL-GYPGVYVRVDHYDPWIQSV 209
GIVSWG GC G G Y V WIQ V
Sbjct: 223 GIVSWGEGCDRDGKYGFYTHVFRLKKWIQKV 253
>pdb|1EOJ|A Chain A, Design Of P1' And P3' Residues Of Trivalent Thrombin
Inhibitors And Their Crystal Structures
pdb|1EOL|A Chain A, Design Of P1' And P3' Residues Of Trivalent Thrombin
Inhibitors And Their Crystal Structures
Length = 289
Score = 42.0 bits (97), Expect = 3e-04, Method: Compositional matrix adjust.
Identities = 26/96 (27%), Positives = 49/96 (51%), Gaps = 13/96 (13%)
Query: 43 NLYCGGSLISLQWFLSARHCFVTENLVWNQ---FNPLIIAGSIYRNYKEQKRQPQLNEIA 99
L CG SLIS +W L+A HC + W++ N L++ + + ++ +++ +
Sbjct: 57 ELLCGASLISDRWVLTAAHCLLYP--PWDKNFTENDLLVRIGKHSRTRYERNIEKISMLE 114
Query: 100 LIYWHS--------DADLAMVKLKEPFRQTTFVKPL 127
IY H D D+A++KLK+P + ++ P+
Sbjct: 115 KIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPV 150
Score = 29.3 bits (64), Expect = 2.2, Method: Compositional matrix adjust.
Identities = 16/31 (51%), Positives = 16/31 (51%), Gaps = 1/31 (3%)
Query: 180 GIVSWGIGCAL-GYPGVYVRVDHYDPWIQSV 209
GIVSWG GC G G Y V WIQ V
Sbjct: 255 GIVSWGEGCDRDGKYGFYTHVFRLKKWIQKV 285
>pdb|1BHX|B Chain B, X-Ray Structure Of The Complex Of Human Alpha Thrombin
With The Inhibitor Sdz 229-357
pdb|1RIW|B Chain B, Thrombin In Complex With Natural Product Inhibitor
Oscillarin
pdb|2PKS|B Chain B, Thrombin In Complex With Inhibitor
pdb|3PO1|B Chain B, Thrombin In Complex With Benzothiazole Guanidine
Length = 147
Score = 42.0 bits (97), Expect = 3e-04, Method: Compositional matrix adjust.
Identities = 26/96 (27%), Positives = 49/96 (51%), Gaps = 13/96 (13%)
Query: 43 NLYCGGSLISLQWFLSARHCFVTENLVWNQ---FNPLIIAGSIYRNYKEQKRQPQLNEIA 99
L CG SLIS +W L+A HC + W++ N L++ + + ++ +++ +
Sbjct: 25 ELLCGASLISDRWVLTAAHCLLYPP--WDKNFTENDLLVRIGKHSRTRYERNIEKISMLE 82
Query: 100 LIYWHS--------DADLAMVKLKEPFRQTTFVKPL 127
IY H D D+A++KLK+P + ++ P+
Sbjct: 83 KIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPV 118
>pdb|1D9I|A Chain A, Structure Of Thrombin Complexed With Selective
Non-Electophilic Inhibitors Having Cyclohexyl Moieties
At P1
Length = 288
Score = 42.0 bits (97), Expect = 3e-04, Method: Compositional matrix adjust.
Identities = 26/96 (27%), Positives = 49/96 (51%), Gaps = 13/96 (13%)
Query: 43 NLYCGGSLISLQWFLSARHCFVTENLVWNQ---FNPLIIAGSIYRNYKEQKRQPQLNEIA 99
L CG SLIS +W L+A HC + W++ N L++ + + ++ +++ +
Sbjct: 55 ELLCGASLISDRWVLTAAHCLLYP--PWDKNFTENDLLVRIGKHSRTRYERNIEKISMLE 112
Query: 100 LIYWHS--------DADLAMVKLKEPFRQTTFVKPL 127
IY H D D+A++KLK+P + ++ P+
Sbjct: 113 KIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPV 148
Score = 29.3 bits (64), Expect = 2.0, Method: Compositional matrix adjust.
Identities = 16/31 (51%), Positives = 16/31 (51%), Gaps = 1/31 (3%)
Query: 180 GIVSWGIGCAL-GYPGVYVRVDHYDPWIQSV 209
GIVSWG GC G G Y V WIQ V
Sbjct: 253 GIVSWGEGCDRDGKYGFYTHVFRLKKWIQKV 283
>pdb|1ABI|H Chain H, Structure Of The Hirulog 3-Thrombin Complex And Nature Of
The S' Subsites Of Substrates And Inhibitors
pdb|1ABJ|H Chain H, Structure Of The Hirulog 3-Thrombin Complex And Nature Of
The S' Subsites Of Substrates And Inhibitors
pdb|1DWB|H Chain H, Crystallographic Analysis At 3.0-angstroms Resolution Of
The Binding To Human Thrombin Of Four Active
Site-directed Inhibitors
pdb|1DWC|H Chain H, Crystallographic Analysis At 3.0-Angstroms Resolution Of
The Binding To Human Thrombin Of Four Active
Site-Directed Inhibitors
pdb|1DWD|H Chain H, Crystallographic Analysis At 3.0-Angstroms Resolution Of
The Binding To Human Thrombin Of Four Active
Site-Directed Inhibitors
pdb|1DWE|H Chain H, Crystallographic Analysis At 3.0-Angstroms Resolution Of
The Binding To Human Thrombin Of Four Active
Site-Directed Inhibitors
pdb|1FPH|H Chain H, The Interaction Of Thrombin With Fibrinogen: A Structural
Basis For Its Specificity
pdb|1HGT|H Chain H, Structure Of The Hirugen And Hirulog 1 Complexes Of Alpha-
Thrombin
pdb|1IHS|H Chain H, Crystal Structure Of The Complex Of Human Alpha-thrombin
And Non- Hydrolyzable Bifunctional Inhibitors,
Hirutonin-2 And Hirutonin-6
pdb|1IHT|H Chain H, Crystal Structure Of The Complex Of Human Alpha-Thrombin
And Non- Hydrolyzable Bifunctional Inhibitors,
Hirutonin-2 And Hirutonin-6
pdb|1PPB|H Chain H, The Refined 1.9 Angstroms Crystal Structure Of Human
Alpha-Thrombin: Interaction With D-Phe-Pro-Arg
Chloromethylketone And Significance Of The
Tyr-Pro-Pro-Trp Insertion Segment
pdb|1THR|H Chain H, Structures Of Thrombin Complexes With A Designed And A
Natural Exosite Inhibitor
pdb|1THS|H Chain H, Structures Of Thrombin Complexes With A Designed And A
Natural Exosite Inhibitor
pdb|1TMB|H Chain H, Molecular Basis For The Inhibition Of Human Alpha-thrombin
By The Macrocyclic Peptide Cyclotheonamide A
pdb|2HGT|H Chain H, Structure Of The Hirugen And Hirulog 1 Complexes Of
Alpha-Thrombin
pdb|2HPP|H Chain H, Structures Of The Noncovalent Complexes Of Human And
Bovine Prothrombin Fragment 2 With Human Ppack-Thrombin
pdb|2HPQ|H Chain H, Structures Of The Noncovalent Complexes Of Human And
Bovine Prothrombin Fragment 2 With Human Ppack-thrombin
pdb|3HTC|H Chain H, The Structure Of A Complex Of Recombinant Hirudin And
Human Alpha-Thrombin
pdb|4HTC|H Chain H, The Refined Structure Of The Hirudin-Thrombin Complex
pdb|1HUT|H Chain H, The Structure Of Alpha-Thrombin Inhibited By A 15-Mer
Single-Stranded Dna Aptamer
pdb|1NRN|H Chain H, Crystallographic Structures Of Thrombin Complexed With
Thrombin Receptor Peptides: Existence Of Expected And
Novel Binding Modes
pdb|1NRO|H Chain H, Crystallographic Structures Of Thrombin Complexed With
Thrombin Receptor Peptides: Existence Of Expected And
Novel Binding Modes
pdb|1NRP|H Chain H, Crystallographic Structures Of Thrombin Complexed With
Thrombin Receptor Peptides: Existence Of Expected And
Novel Binding Modes
pdb|1NRQ|H Chain H, Crystallographic Structures Of Thrombin Complexed With
Thrombin Receptor Peptides: Existence Of Expected And
Novel Binding Modes
pdb|1NRR|H Chain H, Crystallographic Structures Of Thrombin Complexed With
Thrombin Receptor Peptides: Existence Of Expected And
Novel Binding Modes
pdb|1NRS|H Chain H, Crystallographic Structures Of Thrombin Complexed With
Thrombin Receptor Peptides: Existence Of Expected And
Novel Binding Modes
pdb|1TMT|H Chain H, Changes In Interactions In Complexes Of Hirudin
Derivatives And Human Alpha-Thrombin Due To Different
Crystal Forms
pdb|1TMU|H Chain H, Changes In Interactions In Complexes Of Hirudin
Derivatives And Human Alpha-Thrombin Due To Different
Crystal Forms
pdb|1HLT|H Chain H, The Structure Of A Nonadecapeptide Of The Fifth Egf Domain
Of Thrombomodulin Complexed With Thrombin
pdb|1HLT|K Chain K, The Structure Of A Nonadecapeptide Of The Fifth Egf Domain
Of Thrombomodulin Complexed With Thrombin
pdb|1HAH|H Chain H, The Isomorphous Structures Of Prethrombin2, Hirugen-And
Ppack- Thrombin: Changes Accompanying Activation And
Exosite Binding To Thrombin
pdb|1HAI|H Chain H, The Isomorphous Structures Of Prethrombin2, Hirugen-And
Ppack- Thrombin: Changes Accompanying Activation And
Exosite Binding To Thrombin
pdb|3HAT|H Chain H, Active Site Mimetic Inhibition Of Thrombin
pdb|1FPC|H Chain H, Active Site Mimetic Inhibition Of Thrombin
pdb|1HBT|H Chain H, Human Alpha-Thrombin Complexed With A Peptidyl Pyridinium
Methyl Ketone Containing Bivalent Inhibitor
pdb|1HDT|H Chain H, Structure Of A Retro-Binding Peptide Inhibitor Complexed
With Human Alpha-Thrombin
pdb|1HAO|H Chain H, Complex Of Human Alpha-thrombin With A 15mer
Oligonucleotide Ggttggtgtggttgg (based On Nmr Model Of
Dna)
pdb|1HAP|H Chain H, Complex Of Human Alpha-Thrombin With A 15mer
Oligonucleotide Ggttggtgtggttgg (Based On X-Ray Model Of
Dna)
pdb|1AHT|H Chain H, Crystal Structure Of Human Alpha-Thrombin Complexed With
Hirugen And P-Amidinophenylpyruvate At 1.6 Angstroms
Resolution
pdb|1DIT|H Chain H, Complex Of A Divalent Inhibitor With Thrombin
pdb|1TOM|H Chain H, Alpha-Thrombin Complexed With Hirugen
pdb|1HXF|H Chain H, Human Thrombin Complex With Hirudin Variant
pdb|1BMM|H Chain H, Human Alpha-Thrombin Complexed With
[s-(R,R)]-4-[(Aminoiminomethyl)
Amino]-N-[[1-[3-Hydroxy-2-[(2-
Naphthalenylsulfonyl)amino]-1-
Oxopropyl]-2-Pyrrolidinyl] Methyl]butanamide
(Bms-186282)
pdb|1BMN|H Chain H, Human Alpha-Thrombin Complexed With
[s-(R,R)]-1-(Aminoiminomethyl)-
N-[[1-[n-[(2-Naphthalenylsulfonyl)-L-Seryl]-
Pyrrolidinyl]methyl]-3- Piperidenecarboxamide
(Bms-189090)
pdb|1UMA|H Chain H, Alpha-Thrombin (Hirugen) Complexed With
Na-(N,N-Dimethylcarbamoyl)- Alpha-Azalysine
pdb|1LHD|H Chain H, Human Alpha-thrombin Complexed With
Ac-(d)phe-pro-borolys-oh
pdb|1LHE|H Chain H, Human Alpha-Thrombin Complexed With Ac-(D)phe-Pro-Boro-N-
Butyl-Amidino-Glycine-Oh
pdb|1LHF|H Chain H, Human Alpha-Thrombin Complexed With Ac-(D)phe-Pro-Boro-
Homolys-Oh
pdb|1LHG|H Chain H, Human Alpha-Thrombin Complexed With Ac-(D)phe-Pro-
Boroornithine-Oh
pdb|1LHC|H Chain H, Human Alpha-Thrombin Complexed With
Ac-(D)phe-Pro-Boroarg-Oh
pdb|1AD8|H Chain H, Complex Of Thrombin With And Inhibitor Containing A Novel
P1 Moiety
pdb|1AI8|H Chain H, Human Alpha-Thrombin Ternary Complex With The Exosite
Inhibitor Hirugen And Active Site Inhibitor
Phch2oco-D-Dpa-Pro-Borompg
pdb|1AIX|H Chain H, Human Alpha-Thrombin Ternary Complex With Exosite
Inhibitor Hirugen And Active Site Inhibitor
Phch2oco-D-Dpa-Pro-Boroval
pdb|1AE8|H Chain H, Human Alpha-Thrombin Inhibition By
Eoc-D-Phe-Pro-Azalys-Onp
pdb|1AFE|H Chain H, Human Alpha-Thrombin Inhibition By Cbz-Pro-Azalys-Onp
pdb|1UVS|H Chain H, Bovine Thrombin--Bm51.1011 Complex
pdb|5GDS|H Chain H, Hirunorms Are True Hirudin Mimetics. The Crystal Structure
Of Human Alpha-Thrombin:hirunorm V Complex
pdb|1AY6|H Chain H, Thrombin Inhibitor From Theonalla, Cyclotheanamide-Based
Macrocyclic Tripeptide Motif
pdb|1A46|H Chain H, Thrombin Complexed With Hirugen And A Beta-Strand Mimetic
Inhibitor
pdb|1A4W|H Chain H, Crystal Structures Of Thrombin With Thiazole-Containing
Inhibitors: Probes Of The S1' Binding Site
pdb|1A5G|H Chain H, Human Thrombin Complexed With Novel Synthetic Peptide
Mimetic Inhibitor And Hirugen
pdb|1B5G|H Chain H, Human Thrombin Complexed With Novel Synthetic Peptide
Mimetic Inhibitor And Hirugen
pdb|1TBZ|H Chain H, Human Thrombin With Active Site N-Methyl-D
Phenylalanyl-N-[5-
(Aminoiminomethyl)amino]-1-{{benzothiazolyl)carbonyl]
Butyl]-L- Prolinamide Trifluroacetate And
Exosite-Hirugen
pdb|1A2C|H Chain H, Structure Of Thrombin Inhibited By Aeruginosin298-A From A
Blue-Green Alga
pdb|1A61|H Chain H, Thrombin Complexed With A Beta-Mimetic Thiazole-Containing
Inhibitor
pdb|1A3B|H Chain H, Complex Of Human Alpha-Thrombin With The Bifunctional
Boronate Inhibitor Borolog1
pdb|1A3E|H Chain H, Complex Of Human Alpha-Thrombin With The Bifunctional
Boronate Inhibitor Borolog2
pdb|1AWF|H Chain H, Novel Covalent Thrombin Inhibitor From Plant Extract
pdb|1AWH|B Chain B, Novel Covalent Thrombin Inhibitor From Plant Extract
pdb|1AWH|D Chain D, Novel Covalent Thrombin Inhibitor From Plant Extract
pdb|1BCU|H Chain H, Alpha-Thrombin Complexed With Hirugen And Proflavin
pdb|8KME|2 Chain 2, Crystal Structure Of Human Alpha-thrombin Inhibited With
Sel2770.
pdb|1BA8|B Chain B, Thrombin Inhibitor With A Rigid Tripeptidyl Aldehydes
pdb|1BB0|B Chain B, Thrombin Inhibitors With Rigid Tripeptidyl Aldehydes
pdb|1CA8|B Chain B, Thrombin Inhibitors With Rigid Tripeptidyl Aldehydes
pdb|4THN|H Chain H, The Crystal Structure Of Alpha-Thrombin-Hirunorm Iv
Complex Reveals A Novel Specificity Site Recognition
Mode.
pdb|1QBV|H Chain H, Crystal Structure Of Thrombin Complexed With An
Guanidine-Mimetic Inhibitor
pdb|1D4P|B Chain B, Crystal Structure Of Human Alpha Thrombin In Complex With
5- Amidinoindole-4-benzylpiperidine Inhibitor
pdb|7KME|H Chain H, Crystal Structure Of Human Alpha-Thrombin Inhibited With
Sel2711.
pdb|1QHR|B Chain B, Novel Covalent Active Site Thrombin Inhibitors
pdb|1QJ1|B Chain B, Novel Covalent Active Site Thrombin Inhibitors
pdb|1QJ6|B Chain B, Novel Covalent Active Site Thrombin Inhibitors
pdb|1QJ7|B Chain B, Novel Covalent Active Site Thrombin Inhibitors
pdb|1D3P|B Chain B, Crystal Structure Of Human Aplha-Thrombin In Complex With
Benzo[b]thiophene Inhibitor 3
pdb|1D3Q|B Chain B, Crystal Structure Of Human Alpha Thrombin In Complex With
Benzo[b]thiophene Inhibitor 2
pdb|1D3T|B Chain B, Crystal Structure Of Human Alpha Thrombin In Complex With
Benzo[b]thiophene Inhibitor 1
pdb|1C4U|2 Chain 2, Selective Non Electrophilic Thrombin Inhibitors With
Cyclohexyl Moieties.
pdb|1C4V|2 Chain 2, Selective Non Electrophilic Thrombin Inhibitors With
Cyclohexyl Moieties.
pdb|1C4Y|2 Chain 2, Selective Non-Electrophilic Thrombin Inhibitors
pdb|1DE7|H Chain H, Interaction Of Factor Xiii Activation Peptide With
Alpha-Thrombin: Crystal Structure Of The
Enzyme-Substrate Complex
pdb|1DE7|K Chain K, Interaction Of Factor Xiii Activation Peptide With
Alpha-Thrombin: Crystal Structure Of The
Enzyme-Substrate Complex
pdb|1G30|B Chain B, Thrombin Inhibitor Complex
pdb|1G32|B Chain B, Thrombin Inhibitor Complex
pdb|1KTS|B Chain B, Thrombin Inhibitor Complex
pdb|1KTT|B Chain B, Thrombin Inhibitor Complex
pdb|1K21|H Chain H, Human Thrombin-Inhibitor Complex
pdb|1K22|H Chain H, Human Thrombin-inhibitor Complex
pdb|1NY2|2 Chain 2, Human Alpha Thrombin Inhibited By Rppgf And Hirugen
pdb|1O2G|H Chain H, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1OYT|H Chain H, Complex Of Recombinant Human Thrombin With A Designed
Fluorinated Inhibitor
pdb|1NO9|H Chain H, Design Of Weakly Basic Thrombin Inhibitors Incorporating
Novel P1 Binding Functions: Molecular And X-Ray
Crystallographic Studies.
pdb|1OOK|B Chain B, Crystal Structure Of The Complex Of Platelet Receptor
Gpib-alpha And Human Alpha-thrombin
pdb|1P8V|C Chain C, Crystal Structure Of The Complex Of Platelet Receptor
Gpib-alpha And Alpha-thrombin At 2.6a
pdb|1NU7|B Chain B, Staphylocoagulase-Thrombin Complex
pdb|1NU7|F Chain F, Staphylocoagulase-Thrombin Complex
pdb|1NZQ|H Chain H, D-Phe-Pro-Arg-Type Thrombin Inhibitor
pdb|1O0D|H Chain H, Human Thrombin Complexed With A D-Phe-Pro-Arg-Type
Inhibitor And A C- Terminal Hirudin Derived Exo-Site
Inhibitor
pdb|1MU6|B Chain B, Crystal Structure Of Thrombin In Complex With L-378,622
pdb|1MU8|B Chain B, Thrombin-Hirugen_l-378,650
pdb|1MUE|B Chain B, Thrombin-Hirugen-L405,426
pdb|1SR5|C Chain C, Antithrombin-Anhydrothrombin-Heparin Ternary Complex
Structure
pdb|1O5G|H Chain H, Dissecting And Designing Inhibitor Selectivity
Determinants At The S1 Site Using An Artificial Ala190
Protease (Ala190 Upa)
pdb|1XMN|B Chain B, Crystal Structure Of Thrombin Bound To Heparin
pdb|1XMN|D Chain D, Crystal Structure Of Thrombin Bound To Heparin
pdb|1XMN|F Chain F, Crystal Structure Of Thrombin Bound To Heparin
pdb|1XMN|H Chain H, Crystal Structure Of Thrombin Bound To Heparin
pdb|1WAY|B Chain B, Active Site Thrombin Inhibitors
pdb|1T4U|H Chain H, Crystal Structure Analysis Of A Novel Oxyguanidine Bound
To Thrombin
pdb|1T4V|H Chain H, Crystal Structure Analysis Of A Novel Oxyguanidine Bound
To Thrombin
pdb|2AFQ|B Chain B, 1.9 Angstrom Crytal Structure Of Wild-Type Human Thrombin
In The Sodium Free State
pdb|2AFQ|D Chain D, 1.9 Angstrom Crytal Structure Of Wild-Type Human Thrombin
In The Sodium Free State
pdb|2A45|B Chain B, Crystal Structure Of The Complex Between Thrombin And The
Central "e" Region Of Fibrin
pdb|2A45|E Chain E, Crystal Structure Of The Complex Between Thrombin And The
Central "e" Region Of Fibrin
pdb|1W7G|H Chain H, Alpha-Thrombin Complex With Sulfated Hirudin (Residues
54-65) And L- Arginine Template Inhibitor Cs107
pdb|2FES|H Chain H, Orally Active Thrombin Inhibitors
pdb|2C8W|B Chain B, Thrombin Inhibitors
pdb|2C8X|B Chain B, Thrombin Inhibitors
pdb|2C8Y|B Chain B, Thrombin Inhibitors
pdb|2C8Z|B Chain B, Thrombin Inhibitors
pdb|2C90|B Chain B, Thrombin Inhibitors
pdb|2C93|B Chain B, Thrombin Inhibitors
pdb|2FEQ|H Chain H, Orally Active Thrombin Inhibitors
pdb|2BVS|H Chain H, Human Thrombin Complexed With Fragment-Based Small
Molecules Occupying The S1 Pocket
pdb|2BVX|H Chain H, Design And Discovery Of Novel, Potent Thrombin Inhibitors
With A Solubilizing Cationic P1-P2-Linker
pdb|2BXT|H Chain H, Design And Discovery Of Novel, Potent Thrombin Inhibitors
With A Solubilizing Cationic P1-p2-linker
pdb|2BXU|H Chain H, Design And Discovery Of Novel, Potent Thrombin Inhibitors
With A Solubilizing Cationic P1-p2-linker
pdb|2A2X|H Chain H, Orally Active Thrombin Inhibitors In Complex With Thrombin
Inh12
pdb|2ANK|H Chain H, Orally Active Thrombin Inhibitors In Complex With Thrombin
And An Exosite Decapeptide
pdb|2GDE|H Chain H, Thrombin In Complex With Inhibitor
pdb|2H9T|H Chain H, Crystal Structure Of Human Alpha-Thrombin In Complex With
Suramin
pdb|2JH0|D Chain D, Human Thrombin Hirugen Inhibitor Complex
pdb|2JH5|D Chain D, Human Thrombin Hirugen Inhibitor Complex
pdb|2JH6|D Chain D, Human Thrombin Hirugen Inhibitor Complex
pdb|1C1U|H Chain H, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|1C1V|H Chain H, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|1C1W|H Chain H, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|1C5L|H Chain H, Structural Basis For Selectivity Of A Small Molecule,
S1-Binding, Sub- Micromolar Inhibitor Of Urokinase Type
Plasminogen Activator
pdb|1C5N|H Chain H, Structural Basis For Selectivity Of A Small Molecule,
S1-Binding, Sub- Micromolar Inhibitor Of Urokinase Type
Plasminogen Activator
pdb|1C5O|H Chain H, Structural Basis For Selectivity Of A Small Molecule,
S1-Binding, Sub- Micromolar Inhibitor Of Urokinase Type
Plasminogen Activator
pdb|1HXE|H Chain H, Serine Protease
pdb|2UUF|B Chain B, Thrombin-Hirugen Binary Complex At 1.26a Resolution
pdb|2UUJ|B Chain B, Thrombin-Hirugen-Gw473178 Ternary Complex At 1.32a
Resolution
pdb|2UUK|B Chain B, Thrombin-Hirugen-Gw420128 Ternary Complex At 1.39a
Resolution
pdb|3BF6|H Chain H, Thrombin:suramin Complex
pdb|2R2M|B Chain B, 2-(2-chloro-6-fluorophenyl)acetamides As Potent Thrombin
Inhibitors
pdb|3EGK|H Chain H, Knoble Inhibitor
pdb|2ZC9|H Chain H, Thrombin In Complex With Inhibitor
pdb|2ZDA|H Chain H, Exploring Thrombin S1 Pocket
pdb|2ZDV|H Chain H, Exploring Thrombin S1 Pocket
pdb|2ZF0|H Chain H, Exploring Thrombin S1 Pocket
pdb|3E6P|H Chain H, Crystal Structure Of Human Meizothrombin Desf1
pdb|2ZFF|H Chain H, Exploring Thrombin S1-Pocket
pdb|2ZFP|H Chain H, Thrombin Inibition
pdb|2ZGB|H Chain H, Thrombin Inhibition
pdb|2ZGX|H Chain H, Thrombin Inhibition
pdb|2ZFQ|H Chain H, Exploring Thrombin S3 Pocket
pdb|2ZFR|H Chain H, Exploring Thrombin S3 Pocket
pdb|2ZHQ|H Chain H, Thrombin Inhibition
pdb|2ZI2|H Chain H, Thrombin Inhibition
pdb|2ZIQ|H Chain H, Thrombin Inhibition
pdb|2ZG0|H Chain H, Exploring Thrombin S3 Pocket
pdb|2ZHE|H Chain H, Exploring Thrombin S3 Pocket
pdb|2ZHF|H Chain H, Exploring Thrombin S3 Pocket
pdb|2ZHW|H Chain H, Exploring Thrombin S3 Pocket
pdb|3C27|B Chain B, Cyanofluorophenylacetamides As Orally Efficacious Thrombin
Inhibitors
pdb|2ZNK|H Chain H, Thrombin Inhibition
pdb|2ZO3|H Chain H, Bisphenylic Thrombin Inhibitors
pdb|3D49|H Chain H, Thrombin Inhibition
pdb|3DA9|B Chain B, Crystal Structure Of Thrombin In Complex With Inhibitor
pdb|3DHK|H Chain H, Bisphenylic Thrombin Inhibitors
pdb|3DT0|H Chain H, Understanding Thrombin Inhibition
pdb|3DUX|H Chain H, Understanding Thrombin Inhibition
pdb|3EQ0|H Chain H, Thrombin Inhibitor
pdb|3F68|H Chain H, Thrombin Inhibition
pdb|3PMH|B Chain B, Mechanism Of Sulfotyrosine-Mediated Glycoprotein Ib
Interaction With Two Distinct Alpha-Thrombin Sites
pdb|3P6Z|B Chain B, Structural Basis Of Thrombin Mediated Factor V Activation:
Essential Role Of The Hirudin-Like Sequence
Glu666-Glu672 For Processing At The Heavy Chain-B Domain
Junction
pdb|3P6Z|H Chain H, Structural Basis Of Thrombin Mediated Factor V Activation:
Essential Role Of The Hirudin-Like Sequence
Glu666-Glu672 For Processing At The Heavy Chain-B Domain
Junction
pdb|3LDX|H Chain H, Discovery And Clinical Evaluation Of Rwj-671818, A
Thrombin Inhibitor With An Oxyguanidine P1 Motif
pdb|3P70|B Chain B, Structural Basis Of Thrombin-Mediated Factor V Activation:
Essential Role Of The Hirudin-Like Sequence
Glu666-Glu672 For Processing At The Heavy Chain-B Domain
Junction
pdb|3P70|D Chain D, Structural Basis Of Thrombin-Mediated Factor V Activation:
Essential Role Of The Hirudin-Like Sequence
Glu666-Glu672 For Processing At The Heavy Chain-B Domain
Junction
pdb|3P70|F Chain F, Structural Basis Of Thrombin-Mediated Factor V Activation:
Essential Role Of The Hirudin-Like Sequence
Glu666-Glu672 For Processing At The Heavy Chain-B Domain
Junction
pdb|3P70|H Chain H, Structural Basis Of Thrombin-Mediated Factor V Activation:
Essential Role Of The Hirudin-Like Sequence
Glu666-Glu672 For Processing At The Heavy Chain-B Domain
Junction
pdb|3TU7|H Chain H, Human Alpha-Thrombin Complexed With
N-(Methylsulfonyl)-D-Phenylalanyl-
N-((1-Carbamimidoyl-4-Piperidinyl)methyl)-L-Prolinamide
(Bms-189664)
pdb|3QLP|H Chain H, X-Ray Structure Of The Complex Between Human Alpha
Thrombin And A Modified Thrombin Binding Aptamer (Mtba)
pdb|3P17|H Chain H, Thrombin Inhibition By Pyridin Derivatives
pdb|3B23|B Chain B, Crystal Structure Of Thrombin-Variegin Complex: Insights
Of A Novel Mechanism Of Inhibition And Design Of Tunable
Thrombin Inhibitors
pdb|3QTO|H Chain H, Thrombin Inhibition By Pyridin Derivatives
pdb|3QTV|H Chain H, Thrombin Inhibition By Pyridin Derivatives
pdb|3QX5|H Chain H, Thrombin Inhibition By Pyridin Derivatives
pdb|3QWC|H Chain H, Thrombin Inhibition By Pyridin Derivatives
pdb|3U69|H Chain H, Unliganded Wild-Type Human Thrombin
pdb|3U8T|H Chain H, Human Thrombin Complexed With D-Phe-Pro-D-Arg-Cys
pdb|3RLW|H Chain H, Human Thrombin In Complex With Mi328
pdb|3RLY|H Chain H, Human Thrombin In Complex With Mi329
pdb|3RM0|H Chain H, Human Thrombin In Complex With Mi354
pdb|3RM2|H Chain H, Human Thrombin In Complex With Mi003
pdb|3RML|H Chain H, Human Thrombin In Complex With Mi331
pdb|3RMM|H Chain H, Human Thrombin In Complex With Mi332
pdb|3RMN|H Chain H, Human Thrombin In Complex With Mi341
pdb|3RMO|H Chain H, Human Thrombin In Complex With Mi004
pdb|3U8O|H Chain H, Human Thrombin Complexed With D-Phe-Pro-D-Arg-D-Thr
pdb|3U8R|H Chain H, Human Thrombin Complexed With D-Phe-Pro-D-Arg-Ile
pdb|3SHA|H Chain H, Human Thrombin In Complex With Ubthr97
pdb|3SHC|H Chain H, Human Thrombin In Complex With Ubthr101
pdb|3SI3|H Chain H, Human Thrombin In Complex With Ubthr103
pdb|3SI4|H Chain H, Human Thrombin In Complex With Ubthr104
pdb|3SV2|H Chain H, Human Thrombin In Complex With Ubthr105
pdb|4E7R|H Chain H, Thrombin In Complex With 3-Amidinophenylalanine Inhibitor
pdb|4E7R|G Chain G, Thrombin In Complex With 3-Amidinophenylalanine Inhibitor
pdb|4DIH|H Chain H, X-Ray Structure Of The Complex Between Human Alpha
Thrombin And Thrombin Binding Aptamer In The Presence Of
Sodium Ions
pdb|4DII|H Chain H, X-Ray Structure Of The Complex Between Human Alpha
Thrombin And Thrombin Binding Aptamer In The Presence Of
Potassium Ions
pdb|3T5F|H Chain H, Human Thrombin In Complex With Mi340
pdb|3UTU|H Chain H, High Affinity Inhibitor Of Human Thrombin
pdb|3U98|H Chain H, Human Thrombin In Complex With Mi001
pdb|3U9A|H Chain H, Human Thrombin In Complex With Mi330
pdb|4E05|H Chain H, Anophelin From The Malaria Vector Inhibits Thrombin
Through A Novel Reverse-Binding Mechanism
pdb|4E06|H Chain H, Anophelin From The Malaria Vector Inhibits Thrombin
Through A Novel Reverse-Binding Mechanism
pdb|3UWJ|H Chain H, Human Thrombin In Complex With Mi353
pdb|4BAH|B Chain B, Thrombin In Complex With Inhibitor
pdb|4BAK|B Chain B, Thrombin In Complex With Inhibitor
pdb|4BAM|B Chain B, Thrombin In Complex With Inhibitor
pdb|4BAN|B Chain B, Thrombin In Complex With Inhibitor
pdb|4BAO|B Chain B, Thrombin In Complex With Inhibitor
pdb|4BAQ|B Chain B, Thrombin In Complex With Inhibitor
Length = 259
Score = 42.0 bits (97), Expect = 3e-04, Method: Compositional matrix adjust.
Identities = 26/96 (27%), Positives = 49/96 (51%), Gaps = 13/96 (13%)
Query: 43 NLYCGGSLISLQWFLSARHCFVTENLVWNQ---FNPLIIAGSIYRNYKEQKRQPQLNEIA 99
L CG SLIS +W L+A HC + W++ N L++ + + ++ +++ +
Sbjct: 25 ELLCGASLISDRWVLTAAHCLLYP--PWDKNFTENDLLVRIGKHSRTRYERNIEKISMLE 82
Query: 100 LIYWHS--------DADLAMVKLKEPFRQTTFVKPL 127
IY H D D+A++KLK+P + ++ P+
Sbjct: 83 KIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPV 118
Score = 28.9 bits (63), Expect = 2.5, Method: Compositional matrix adjust.
Identities = 16/31 (51%), Positives = 16/31 (51%), Gaps = 1/31 (3%)
Query: 180 GIVSWGIGCAL-GYPGVYVRVDHYDPWIQSV 209
GIVSWG GC G G Y V WIQ V
Sbjct: 223 GIVSWGEGCDRDGKYGFYTHVFRLKKWIQKV 253
>pdb|1WBG|B Chain B, Active Site Thrombin Inhibitors
Length = 259
Score = 42.0 bits (97), Expect = 3e-04, Method: Compositional matrix adjust.
Identities = 26/96 (27%), Positives = 49/96 (51%), Gaps = 13/96 (13%)
Query: 43 NLYCGGSLISLQWFLSARHCFVTENLVWNQ---FNPLIIAGSIYRNYKEQKRQPQLNEIA 99
L CG SLIS +W L+A HC + W++ N L++ + + ++ +++ +
Sbjct: 25 ELLCGASLISDRWVLTAAHCLLYP--PWDKNFTENDLLVRIGKHSRTRYERNIEKISMLE 82
Query: 100 LIYWHS--------DADLAMVKLKEPFRQTTFVKPL 127
IY H D D+A++KLK+P + ++ P+
Sbjct: 83 KIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPV 118
Score = 28.5 bits (62), Expect = 3.4, Method: Compositional matrix adjust.
Identities = 16/31 (51%), Positives = 16/31 (51%), Gaps = 1/31 (3%)
Query: 180 GIVSWGIGCA-LGYPGVYVRVDHYDPWIQSV 209
GIVSWG GC G G Y V WIQ V
Sbjct: 223 GIVSWGEGCRDDGKYGFYTHVFRLKKWIQKV 253
>pdb|2BVR|H Chain H, Human Thrombin Complexed With Fragment-based Small
Molecules Occupying The S1 Pocket
Length = 252
Score = 42.0 bits (97), Expect = 3e-04, Method: Compositional matrix adjust.
Identities = 26/96 (27%), Positives = 49/96 (51%), Gaps = 13/96 (13%)
Query: 43 NLYCGGSLISLQWFLSARHCFVTENLVWNQ---FNPLIIAGSIYRNYKEQKRQPQLNEIA 99
L CG SLIS +W L+A HC + W++ N L++ + + ++ +++ +
Sbjct: 25 ELLCGASLISDRWVLTAAHCLLYPP--WDKNFTENDLLVRIGKHSRTRYERNIEKISMLE 82
Query: 100 LIYWHS--------DADLAMVKLKEPFRQTTFVKPL 127
IY H D D+A++KLK+P + ++ P+
Sbjct: 83 KIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPV 118
>pdb|1Z8I|B Chain B, Crystal Structure Of The Thrombin Mutant G193a Bound To
Ppack
Length = 259
Score = 42.0 bits (97), Expect = 3e-04, Method: Compositional matrix adjust.
Identities = 26/96 (27%), Positives = 49/96 (51%), Gaps = 13/96 (13%)
Query: 43 NLYCGGSLISLQWFLSARHCFVTENLVWNQ---FNPLIIAGSIYRNYKEQKRQPQLNEIA 99
L CG SLIS +W L+A HC + W++ N L++ + + ++ +++ +
Sbjct: 25 ELLCGASLISDRWVLTAAHCLLYP--PWDKNFTENDLLVRIGKHSRTRYERNIEKISMLE 82
Query: 100 LIYWHS--------DADLAMVKLKEPFRQTTFVKPL 127
IY H D D+A++KLK+P + ++ P+
Sbjct: 83 KIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPV 118
>pdb|1THP|B Chain B, Structure Of Human Alpha-Thrombin Y225p Mutant Bound To
D-Phe-Pro-Arg- Chloromethylketone
pdb|3S7H|B Chain B, Structure Of Thrombin Mutant Y225p In The E Form
pdb|3S7K|B Chain B, Structure Of Thrombin Mutant Y225p In The E Form
pdb|3S7K|D Chain D, Structure Of Thrombin Mutant Y225p In The E Form
Length = 259
Score = 42.0 bits (97), Expect = 3e-04, Method: Compositional matrix adjust.
Identities = 26/96 (27%), Positives = 49/96 (51%), Gaps = 13/96 (13%)
Query: 43 NLYCGGSLISLQWFLSARHCFVTENLVWNQ---FNPLIIAGSIYRNYKEQKRQPQLNEIA 99
L CG SLIS +W L+A HC + W++ N L++ + + ++ +++ +
Sbjct: 25 ELLCGASLISDRWVLTAAHCLLYP--PWDKNFTENDLLVRIGKHSRTRYERNIEKISMLE 82
Query: 100 LIYWHS--------DADLAMVKLKEPFRQTTFVKPL 127
IY H D D+A++KLK+P + ++ P+
Sbjct: 83 KIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPV 118
Score = 28.1 bits (61), Expect = 4.0, Method: Compositional matrix adjust.
Identities = 17/44 (38%), Positives = 17/44 (38%), Gaps = 13/44 (29%)
Query: 166 GIVSWGIGCALGYPGIVSWGIGCALGYPGVYVRVDHYDPWIQSV 209
GIVSWG GC G PG Y V WIQ V
Sbjct: 223 GIVSWGEGCDRD-------------GKPGFYTHVFRLKKWIQKV 253
>pdb|1QUR|H Chain H, Human Alpha-Thrombin In Complex With Bivalent,
Benzamidine-Based Synthetic Inhibitor
pdb|1D3D|B Chain B, Crystal Structure Of Human Alpha Thrombin In Complex With
Benzothiophene Inhibitor 4
pdb|1EB1|H Chain H, Complex Structure Of Human Thrombin With N-Methyl-Arginine
Inhibitor
pdb|1GHV|H Chain H, A Novel Serine Protease Inhibition Motif Involving A
Multi-Centered Short Hydrogen Bonding Network At The
Active Site
pdb|1YPE|H Chain H, Thrombin Inhibitor Complex
pdb|1YPG|H Chain H, Thrombin Inhibitor Complex
pdb|1YPJ|H Chain H, Thrombin Inhibitor Complex
pdb|1YPK|H Chain H, Thrombin Inhibitor Complex
pdb|1YPL|H Chain H, X-Ray Crystal Structure Of Thrombin Inhibited By Synthetic
Cyanopeptide Analogue Ra-1008
pdb|1YPM|H Chain H, X-ray Crystal Structure Of Thrombin Inhibited By Synthetic
Cyanopeptide Analogue Ra-1014
pdb|2ANM|H Chain H, Ternary Complex Of An Orally Active Thrombin Inhibitor
With Human Thrombin And A C-Terminal Hirudin Derived
Exo-Sit Inhibitor
pdb|2CF9|H Chain H, Complex Of Recombinant Human Thrombin With A Inhibitor
pdb|1GHX|H Chain H, A Novel Serine Protease Inhibition Motif Involving A
Multi-Centered Short Hydrogen Bonding Network At The
Active Site
pdb|1GHY|H Chain H, A Novel Serine Protease Inhibition Motif Involving A
Multi-Centered Short Hydrogen Bonding Network At The
Active Site
pdb|2CF8|H Chain H, Complex Of Recombinant Human Thrombin With A Inhibitor
pdb|2CN0|H Chain H, Complex Of Recombinant Human Thrombin With A Designed
Inhibitor
pdb|3BIU|H Chain H, Human Thrombin-In Complex With Ub-Thr10
pdb|3BIV|H Chain H, Human Thrombin-In Complex With Ub-Thr11
pdb|2V3H|H Chain H, Thrombin With 3-Cycle No F
pdb|2V3O|H Chain H, Thrombin With 3-Cycle With F
pdb|4AX9|H Chain H, Human Thrombin Complexed With Napsagatran, Ro0466240
pdb|4AYV|B Chain B, Human Thrombin - Inhibitor Complex
pdb|4AYY|B Chain B, Human Thrombin - Inhibitor Complex
pdb|4AZ2|B Chain B, Human Thrombin - Inhibitor Complex
pdb|1GHW|H Chain H, A Novel Serine Protease Inhibition Motif Involving A
Multi-centered Short Hydrogen Bonding Network At The
Active Site
Length = 257
Score = 42.0 bits (97), Expect = 3e-04, Method: Compositional matrix adjust.
Identities = 26/96 (27%), Positives = 49/96 (51%), Gaps = 13/96 (13%)
Query: 43 NLYCGGSLISLQWFLSARHCFVTENLVWNQ---FNPLIIAGSIYRNYKEQKRQPQLNEIA 99
L CG SLIS +W L+A HC + W++ N L++ + + ++ +++ +
Sbjct: 25 ELLCGASLISDRWVLTAAHCLLYP--PWDKNFTENDLLVRIGKHSRTRYERNIEKISMLE 82
Query: 100 LIYWHS--------DADLAMVKLKEPFRQTTFVKPL 127
IY H D D+A++KLK+P + ++ P+
Sbjct: 83 KIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPV 118
Score = 28.9 bits (63), Expect = 2.6, Method: Compositional matrix adjust.
Identities = 16/31 (51%), Positives = 16/31 (51%), Gaps = 1/31 (3%)
Query: 180 GIVSWGIGCAL-GYPGVYVRVDHYDPWIQSV 209
GIVSWG GC G G Y V WIQ V
Sbjct: 223 GIVSWGEGCDRDGKYGFYTHVFRLKKWIQKV 253
>pdb|1RD3|B Chain B, 2.5a Structure Of Anticoagulant Thrombin Variant E217k
pdb|1RD3|D Chain D, 2.5a Structure Of Anticoagulant Thrombin Variant E217k
Length = 259
Score = 42.0 bits (97), Expect = 3e-04, Method: Compositional matrix adjust.
Identities = 26/96 (27%), Positives = 49/96 (51%), Gaps = 13/96 (13%)
Query: 43 NLYCGGSLISLQWFLSARHCFVTENLVWNQ---FNPLIIAGSIYRNYKEQKRQPQLNEIA 99
L CG SLIS +W L+A HC + W++ N L++ + + ++ +++ +
Sbjct: 25 ELLCGASLISDRWVLTAAHCLLYP--PWDKNFTENDLLVRIGKHSRTRYERNIEKISMLE 82
Query: 100 LIYWHS--------DADLAMVKLKEPFRQTTFVKPL 127
IY H D D+A++KLK+P + ++ P+
Sbjct: 83 KIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPV 118
Score = 29.3 bits (64), Expect = 2.1, Method: Compositional matrix adjust.
Identities = 16/31 (51%), Positives = 16/31 (51%), Gaps = 1/31 (3%)
Query: 180 GIVSWGIGCAL-GYPGVYVRVDHYDPWIQSV 209
GIVSWG GC G G Y V WIQ V
Sbjct: 223 GIVSWGKGCDRDGKYGFYTHVFRLKKWIQKV 253
>pdb|1NU9|A Chain A, Staphylocoagulase-prethrombin-2 Complex
pdb|1NU9|D Chain D, Staphylocoagulase-prethrombin-2 Complex
Length = 291
Score = 42.0 bits (97), Expect = 3e-04, Method: Compositional matrix adjust.
Identities = 26/96 (27%), Positives = 49/96 (51%), Gaps = 13/96 (13%)
Query: 43 NLYCGGSLISLQWFLSARHCFVTENLVWNQ---FNPLIIAGSIYRNYKEQKRQPQLNEIA 99
L CG SLIS +W L+A HC + W++ N L++ + + ++ +++ +
Sbjct: 57 ELLCGASLISDRWVLTAAHCLLYP--PWDKNFTENDLLVRIGKHSRTRYERNIEKISMLE 114
Query: 100 LIYWHS--------DADLAMVKLKEPFRQTTFVKPL 127
IY H D D+A++KLK+P + ++ P+
Sbjct: 115 KIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPV 150
Score = 29.3 bits (64), Expect = 2.0, Method: Compositional matrix adjust.
Identities = 16/31 (51%), Positives = 16/31 (51%), Gaps = 1/31 (3%)
Query: 180 GIVSWGIGCAL-GYPGVYVRVDHYDPWIQSV 209
GIVSWG GC G G Y V WIQ V
Sbjct: 255 GIVSWGEGCDRDGKYGFYTHVFRLKKWIQKV 285
>pdb|1DM4|B Chain B, Ser195ala Mutant Of Human Thrombin Complexed With
Fibrinopeptide A (7- 16)
pdb|1JMO|H Chain H, Crystal Structure Of The Heparin Cofactor Ii-S195a
Thrombin Complex
Length = 260
Score = 42.0 bits (97), Expect = 3e-04, Method: Compositional matrix adjust.
Identities = 26/96 (27%), Positives = 49/96 (51%), Gaps = 13/96 (13%)
Query: 43 NLYCGGSLISLQWFLSARHCFVTENLVWNQ---FNPLIIAGSIYRNYKEQKRQPQLNEIA 99
L CG SLIS +W L+A HC + W++ N L++ + + ++ +++ +
Sbjct: 26 ELLCGASLISDRWVLTAAHCLLYP--PWDKNFTENDLLVRIGKHSRTRYERNIEKISMLE 83
Query: 100 LIYWHS--------DADLAMVKLKEPFRQTTFVKPL 127
IY H D D+A++KLK+P + ++ P+
Sbjct: 84 KIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPV 119
Score = 28.9 bits (63), Expect = 2.5, Method: Compositional matrix adjust.
Identities = 16/31 (51%), Positives = 16/31 (51%), Gaps = 1/31 (3%)
Query: 180 GIVSWGIGCAL-GYPGVYVRVDHYDPWIQSV 209
GIVSWG GC G G Y V WIQ V
Sbjct: 224 GIVSWGEGCDRDGKYGFYTHVFRLKKWIQKV 254
>pdb|1BTH|H Chain H, Structure Of Thrombin Complexed With Bovine Pancreatic
Trypsin Inhibitor
pdb|1BTH|K Chain K, Structure Of Thrombin Complexed With Bovine Pancreatic
Trypsin Inhibitor
Length = 259
Score = 42.0 bits (97), Expect = 3e-04, Method: Compositional matrix adjust.
Identities = 26/96 (27%), Positives = 49/96 (51%), Gaps = 13/96 (13%)
Query: 43 NLYCGGSLISLQWFLSARHCFVTENLVWNQ---FNPLIIAGSIYRNYKEQKRQPQLNEIA 99
L CG SLIS +W L+A HC + W++ N L++ + + ++ +++ +
Sbjct: 25 ELLCGASLISDRWVLTAAHCLLYP--PWDKNFTENDLLVRIGKHSRTRYERNIEKISMLE 82
Query: 100 LIYWHS--------DADLAMVKLKEPFRQTTFVKPL 127
IY H D D+A++KLK+P + ++ P+
Sbjct: 83 KIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPV 118
Score = 28.9 bits (63), Expect = 2.5, Method: Compositional matrix adjust.
Identities = 16/31 (51%), Positives = 16/31 (51%), Gaps = 1/31 (3%)
Query: 180 GIVSWGIGCAL-GYPGVYVRVDHYDPWIQSV 209
GIVSWG GC G G Y V WIQ V
Sbjct: 223 GIVSWGEGCDRDGKYGFYTHVFRLKKWIQKV 253
>pdb|1Z8J|B Chain B, Crystal Structure Of The Thrombin Mutant G193p Bound To
Ppack
Length = 259
Score = 42.0 bits (97), Expect = 3e-04, Method: Compositional matrix adjust.
Identities = 26/96 (27%), Positives = 49/96 (51%), Gaps = 13/96 (13%)
Query: 43 NLYCGGSLISLQWFLSARHCFVTENLVWNQ---FNPLIIAGSIYRNYKEQKRQPQLNEIA 99
L CG SLIS +W L+A HC + W++ N L++ + + ++ +++ +
Sbjct: 25 ELLCGASLISDRWVLTAAHCLLYP--PWDKNFTENDLLVRIGKHSRTRYERNIEKISMLE 82
Query: 100 LIYWHS--------DADLAMVKLKEPFRQTTFVKPL 127
IY H D D+A++KLK+P + ++ P+
Sbjct: 83 KIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPV 118
Score = 28.9 bits (63), Expect = 2.6, Method: Compositional matrix adjust.
Identities = 16/31 (51%), Positives = 16/31 (51%), Gaps = 1/31 (3%)
Query: 180 GIVSWGIGCAL-GYPGVYVRVDHYDPWIQSV 209
GIVSWG GC G G Y V WIQ V
Sbjct: 223 GIVSWGEGCDRDGKYGFYTHVFRLKKWIQKV 253
>pdb|2BDY|A Chain A, Thrombin In Complex With Inhibitor
Length = 289
Score = 42.0 bits (97), Expect = 3e-04, Method: Compositional matrix adjust.
Identities = 26/96 (27%), Positives = 49/96 (51%), Gaps = 13/96 (13%)
Query: 43 NLYCGGSLISLQWFLSARHCFVTENLVWNQ---FNPLIIAGSIYRNYKEQKRQPQLNEIA 99
L CG SLIS +W L+A HC + W++ N L++ + + ++ +++ +
Sbjct: 55 ELLCGASLISDRWVLTAAHCLLYP--PWDKNFTENDLLVRIGKHSRTRYERNIEKISMLE 112
Query: 100 LIYWHS--------DADLAMVKLKEPFRQTTFVKPL 127
IY H D D+A++KLK+P + ++ P+
Sbjct: 113 KIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPV 148
Score = 29.3 bits (64), Expect = 2.0, Method: Compositional matrix adjust.
Identities = 16/31 (51%), Positives = 16/31 (51%), Gaps = 1/31 (3%)
Query: 180 GIVSWGIGCAL-GYPGVYVRVDHYDPWIQSV 209
GIVSWG GC G G Y V WIQ V
Sbjct: 253 GIVSWGEGCDRDGKYGFYTHVFRLKKWIQKV 283
>pdb|2THF|B Chain B, Structure Of Human Alpha-thrombin Y225f Mutant Bound To
D-phe-pro-arg- Chloromethylketone
Length = 259
Score = 42.0 bits (97), Expect = 3e-04, Method: Compositional matrix adjust.
Identities = 26/96 (27%), Positives = 49/96 (51%), Gaps = 13/96 (13%)
Query: 43 NLYCGGSLISLQWFLSARHCFVTENLVWNQ---FNPLIIAGSIYRNYKEQKRQPQLNEIA 99
L CG SLIS +W L+A HC + W++ N L++ + + ++ +++ +
Sbjct: 25 ELLCGASLISDRWVLTAAHCLLYP--PWDKNFTENDLLVRIGKHSRTRYERNIEKISMLE 82
Query: 100 LIYWHS--------DADLAMVKLKEPFRQTTFVKPL 127
IY H D D+A++KLK+P + ++ P+
Sbjct: 83 KIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPV 118
Score = 28.9 bits (63), Expect = 2.5, Method: Compositional matrix adjust.
Identities = 16/31 (51%), Positives = 16/31 (51%), Gaps = 1/31 (3%)
Query: 180 GIVSWGIGCAL-GYPGVYVRVDHYDPWIQSV 209
GIVSWG GC G G Y V WIQ V
Sbjct: 223 GIVSWGEGCDRDGKFGFYTHVFRLKKWIQKV 253
>pdb|1NM6|A Chain A, Thrombin In Complex With Selective Macrocyclic Inhibitor
At 1.8a
pdb|1NT1|A Chain A, Thrombin In Complex With Selective Macrocyclic Inhibitor
pdb|1TA2|A Chain A, Crystal Structure Of Thrombin In Complex With Compound 1
pdb|1TA6|A Chain A, Crystal Structure Of Thrombin In Complex With Compound 14b
pdb|1SL3|A Chain A, Crystal Structue Of Thrombin In Complex With A Potent P1
Heterocycle- Aryl Based Inhibitor
pdb|1Z71|A Chain A, Thrombin And P2 Pyridine N-oxide Inhibitor Complex
Structure
pdb|1ZRB|A Chain A, Thrombin In Complex With An Azafluorenyl Inhibitor 23b
pdb|1ZGI|A Chain A, Thrombin In Complex With An Oxazolopyridine Inhibitor 21
pdb|1ZGV|A Chain A, Thrombin In Complex With An Oxazolopyridine Inhibitor 2
pdb|3C1K|A Chain A, Crystal Structure Of Thrombin In Complex With Inhibitor 15
Length = 287
Score = 42.0 bits (97), Expect = 3e-04, Method: Compositional matrix adjust.
Identities = 26/96 (27%), Positives = 49/96 (51%), Gaps = 13/96 (13%)
Query: 43 NLYCGGSLISLQWFLSARHCFVTENLVWNQ---FNPLIIAGSIYRNYKEQKRQPQLNEIA 99
L CG SLIS +W L+A HC + W++ N L++ + + ++ +++ +
Sbjct: 54 ELLCGASLISDRWVLTAAHCLLYP--PWDKNFTENDLLVRIGKHSRTRYERNIEKISMLE 111
Query: 100 LIYWHS--------DADLAMVKLKEPFRQTTFVKPL 127
IY H D D+A++KLK+P + ++ P+
Sbjct: 112 KIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPV 147
Score = 29.3 bits (64), Expect = 2.1, Method: Compositional matrix adjust.
Identities = 16/31 (51%), Positives = 16/31 (51%), Gaps = 1/31 (3%)
Query: 180 GIVSWGIGCAL-GYPGVYVRVDHYDPWIQSV 209
GIVSWG GC G G Y V WIQ V
Sbjct: 252 GIVSWGEGCDRDGKYGFYTHVFRLKKWIQKV 282
>pdb|3SQE|E Chain E, Crystal Structure Of Prethrombin-2 Mutant S195a In The
Alternative Form
pdb|3SQH|E Chain E, Crystal Structure Of Prethrombin-2 Mutant S195a In The The
Open Form
Length = 290
Score = 42.0 bits (97), Expect = 3e-04, Method: Compositional matrix adjust.
Identities = 26/96 (27%), Positives = 49/96 (51%), Gaps = 13/96 (13%)
Query: 43 NLYCGGSLISLQWFLSARHCFVTENLVWNQ---FNPLIIAGSIYRNYKEQKRQPQLNEIA 99
L CG SLIS +W L+A HC + W++ N L++ + + ++ +++ +
Sbjct: 56 ELLCGASLISDRWVLTAAHCLLYP--PWDKNFTENDLLVRIGKHSRTRYERNIEKISMLE 113
Query: 100 LIYWHS--------DADLAMVKLKEPFRQTTFVKPL 127
IY H D D+A++KLK+P + ++ P+
Sbjct: 114 KIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPV 149
Score = 29.3 bits (64), Expect = 2.0, Method: Compositional matrix adjust.
Identities = 16/31 (51%), Positives = 16/31 (51%), Gaps = 1/31 (3%)
Query: 180 GIVSWGIGCAL-GYPGVYVRVDHYDPWIQSV 209
GIVSWG GC G G Y V WIQ V
Sbjct: 254 GIVSWGEGCDRDGKYGFYTHVFRLKKWIQKV 284
>pdb|2ZGJ|A Chain A, Crystal Structure Of D86n-gzmm Complexed With Its Optimal
Synthesized Substrate
Length = 240
Score = 42.0 bits (97), Expect = 3e-04, Method: Compositional matrix adjust.
Identities = 34/137 (24%), Positives = 62/137 (45%), Gaps = 19/137 (13%)
Query: 29 PGEVPYIVSLSLYGNLYCGGSLISLQWFLSARHCFVTE----NLVWNQFNPLIIAGSIYR 84
P PY+ SL G+ CGG L+ +W L+A HC LV + L G +
Sbjct: 9 PHSRPYMASLQRNGSHLCGGVLVHPKWVLTAAHCLAQRMAQLRLVLG-LHTLDSPGLTF- 66
Query: 85 NYKEQKRQPQLNEIALIYWHSDADLAMVKLKEPFRQTTFVKPLDYYTARETNYINDVLSK 144
+ K + P+ + + + +LA+++L + + ++PL + R+ V++
Sbjct: 67 HIKAAIQHPRYKPVPAL----ENNLALLQLDGKVKPSRTIRPLALPSKRQ------VVAA 116
Query: 145 TDRSEMSIVSGFGVTFQ 161
R M +G+G+T Q
Sbjct: 117 GTRCSM---AGWGLTHQ 130
>pdb|3NXP|A Chain A, Crystal Structure Of Human Prethrombin-1
Length = 424
Score = 42.0 bits (97), Expect = 3e-04, Method: Compositional matrix adjust.
Identities = 29/97 (29%), Positives = 48/97 (49%), Gaps = 15/97 (15%)
Query: 43 NLYCGGSLISLQWFLSARHCFV----TENLVWNQFNPLIIAGSIYRNYKEQKRQPQLNEI 98
L CG SLIS +W L+A HC + +N N L+ G R E+ + +++ +
Sbjct: 190 ELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDL--LVRIGKHSRTRYERNIE-KISML 246
Query: 99 ALIYWHS--------DADLAMVKLKEPFRQTTFVKPL 127
IY H D D+A++KLK+P + ++ P+
Sbjct: 247 EKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPV 283
Score = 29.3 bits (64), Expect = 2.2, Method: Compositional matrix adjust.
Identities = 16/31 (51%), Positives = 16/31 (51%), Gaps = 1/31 (3%)
Query: 180 GIVSWGIGCAL-GYPGVYVRVDHYDPWIQSV 209
GIVSWG GC G G Y V WIQ V
Sbjct: 388 GIVSWGEGCDRDGKYGFYTHVFRLKKWIQKV 418
>pdb|1HAG|E Chain E, The Isomorphous Structures Of Prethrombin2, Hirugen-And
Ppack- Thrombin: Changes Accompanying Activation And
Exosite Binding To Thrombin
pdb|1DOJ|A Chain A, Crystal Structure Of Human Alpha-ThrombinRwj-51438 Complex
At 1.7 A
pdb|1XM1|A Chain A, Nonbasic Thrombin Inhibitor Complex
Length = 295
Score = 42.0 bits (97), Expect = 3e-04, Method: Compositional matrix adjust.
Identities = 26/96 (27%), Positives = 49/96 (51%), Gaps = 13/96 (13%)
Query: 43 NLYCGGSLISLQWFLSARHCFVTENLVWNQ---FNPLIIAGSIYRNYKEQKRQPQLNEIA 99
L CG SLIS +W L+A HC + W++ N L++ + + ++ +++ +
Sbjct: 61 ELLCGASLISDRWVLTAAHCLLYP--PWDKNFTENDLLVRIGKHSRTRYERNIEKISMLE 118
Query: 100 LIYWHS--------DADLAMVKLKEPFRQTTFVKPL 127
IY H D D+A++KLK+P + ++ P+
Sbjct: 119 KIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPV 154
Score = 29.3 bits (64), Expect = 2.0, Method: Compositional matrix adjust.
Identities = 16/31 (51%), Positives = 16/31 (51%), Gaps = 1/31 (3%)
Query: 180 GIVSWGIGCAL-GYPGVYVRVDHYDPWIQSV 209
GIVSWG GC G G Y V WIQ V
Sbjct: 259 GIVSWGEGCDRDGKYGFYTHVFRLKKWIQKV 289
>pdb|1D6W|A Chain A, Structure Of Thrombin Complexed With Selective
Non-Electrophilic Inhibitors Having Cyclohexyl Moieties
At P1
pdb|1G37|A Chain A, Crystal Structure Of Human Alpha-thrombin Complexed With
Bch-10556 And Exosite-directed Peptide
Length = 287
Score = 42.0 bits (97), Expect = 3e-04, Method: Compositional matrix adjust.
Identities = 26/96 (27%), Positives = 49/96 (51%), Gaps = 13/96 (13%)
Query: 43 NLYCGGSLISLQWFLSARHCFVTENLVWNQ---FNPLIIAGSIYRNYKEQKRQPQLNEIA 99
L CG SLIS +W L+A HC + W++ N L++ + + ++ +++ +
Sbjct: 55 ELLCGASLISDRWVLTAAHCLLYP--PWDKNFTENDLLVRIGKHSRTRYERNIEKISMLE 112
Query: 100 LIYWHS--------DADLAMVKLKEPFRQTTFVKPL 127
IY H D D+A++KLK+P + ++ P+
Sbjct: 113 KIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPV 148
Score = 29.3 bits (64), Expect = 2.0, Method: Compositional matrix adjust.
Identities = 16/31 (51%), Positives = 16/31 (51%), Gaps = 1/31 (3%)
Query: 180 GIVSWGIGCAL-GYPGVYVRVDHYDPWIQSV 209
GIVSWG GC G G Y V WIQ V
Sbjct: 253 GIVSWGEGCDRDGKYGFYTHVFRLKKWIQKV 283
>pdb|1TWX|B Chain B, Crystal Structure Of The Thrombin Mutant D221aD222K
Length = 259
Score = 42.0 bits (97), Expect = 3e-04, Method: Compositional matrix adjust.
Identities = 26/96 (27%), Positives = 49/96 (51%), Gaps = 13/96 (13%)
Query: 43 NLYCGGSLISLQWFLSARHCFVTENLVWNQ---FNPLIIAGSIYRNYKEQKRQPQLNEIA 99
L CG SLIS +W L+A HC + W++ N L++ + + ++ +++ +
Sbjct: 25 ELLCGASLISDRWVLTAAHCLLYPP--WDKNFTENDLLVRIGKHSRTRYERNIEKISMLE 82
Query: 100 LIYWHS--------DADLAMVKLKEPFRQTTFVKPL 127
IY H D D+A++KLK+P + ++ P+
Sbjct: 83 KIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPV 118
>pdb|3R3G|B Chain B, Structure Of Human Thrombin With Residues 145-150 Of
Murine Thrombin
Length = 259
Score = 42.0 bits (97), Expect = 3e-04, Method: Compositional matrix adjust.
Identities = 26/96 (27%), Positives = 49/96 (51%), Gaps = 13/96 (13%)
Query: 43 NLYCGGSLISLQWFLSARHCFVTENLVWNQ---FNPLIIAGSIYRNYKEQKRQPQLNEIA 99
L CG SLIS +W L+A HC + W++ N L++ + + ++ +++ +
Sbjct: 25 ELLCGASLISDRWVLTAAHCLLYP--PWDKNFTENDLLVRIGKHSRTRYERNIEKISMLE 82
Query: 100 LIYWHS--------DADLAMVKLKEPFRQTTFVKPL 127
IY H D D+A++KLK+P + ++ P+
Sbjct: 83 KIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPV 118
>pdb|2OD3|B Chain B, Human Thrombin Chimera With Human Residues 184a, 186,
186a, 186b, 186c And 222 Replaced By Murine Thrombin
Equivalents
Length = 259
Score = 42.0 bits (97), Expect = 3e-04, Method: Compositional matrix adjust.
Identities = 26/96 (27%), Positives = 49/96 (51%), Gaps = 13/96 (13%)
Query: 43 NLYCGGSLISLQWFLSARHCFVTENLVWNQ---FNPLIIAGSIYRNYKEQKRQPQLNEIA 99
L CG SLIS +W L+A HC + W++ N L++ + + ++ +++ +
Sbjct: 25 ELLCGASLISDRWVLTAAHCLLYP--PWDKNFTENDLLVRIGKHSRTRYERNIEKISMLE 82
Query: 100 LIYWHS--------DADLAMVKLKEPFRQTTFVKPL 127
IY H D D+A++KLK+P + ++ P+
Sbjct: 83 KIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPV 118
>pdb|1JWT|A Chain A, Crystal Structure Of Thrombin In Complex With A Novel
Bicyclic Lactam Inhibitor
Length = 305
Score = 42.0 bits (97), Expect = 3e-04, Method: Compositional matrix adjust.
Identities = 26/96 (27%), Positives = 49/96 (51%), Gaps = 13/96 (13%)
Query: 43 NLYCGGSLISLQWFLSARHCFVTENLVWNQ---FNPLIIAGSIYRNYKEQKRQPQLNEIA 99
L CG SLIS +W L+A HC + W++ N L++ + + ++ +++ +
Sbjct: 61 ELLCGASLISDRWVLTAAHCLLYP--PWDKNFTENDLLVRIGKHSRTRYERNIEKISMLE 118
Query: 100 LIYWHS--------DADLAMVKLKEPFRQTTFVKPL 127
IY H D D+A++KLK+P + ++ P+
Sbjct: 119 KIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPV 154
Score = 29.3 bits (64), Expect = 2.0, Method: Compositional matrix adjust.
Identities = 16/31 (51%), Positives = 16/31 (51%), Gaps = 1/31 (3%)
Query: 180 GIVSWGIGCAL-GYPGVYVRVDHYDPWIQSV 209
GIVSWG GC G G Y V WIQ V
Sbjct: 259 GIVSWGEGCDRDGKYGFYTHVFRLKKWIQKV 289
>pdb|1H8I|H Chain H, X-Ray Crystal Structure Of Human Alpha-Thrombin With A
Tripeptide Phosphonate Inhibitor
Length = 253
Score = 42.0 bits (97), Expect = 3e-04, Method: Compositional matrix adjust.
Identities = 26/96 (27%), Positives = 49/96 (51%), Gaps = 13/96 (13%)
Query: 43 NLYCGGSLISLQWFLSARHCFVTENLVWNQ---FNPLIIAGSIYRNYKEQKRQPQLNEIA 99
L CG SLIS +W L+A HC + W++ N L++ + + ++ +++ +
Sbjct: 25 ELLCGASLISDRWVLTAAHCLLYPP--WDKNFTENDLLVRIGKHSRTRYERNIEKISMLE 82
Query: 100 LIYWHS--------DADLAMVKLKEPFRQTTFVKPL 127
IY H D D+A++KLK+P + ++ P+
Sbjct: 83 KIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPV 118
>pdb|3K65|B Chain B, Crystal Structure Of Prethombin-2FRAGMENT-2 Complex
Length = 308
Score = 42.0 bits (97), Expect = 3e-04, Method: Compositional matrix adjust.
Identities = 26/96 (27%), Positives = 49/96 (51%), Gaps = 13/96 (13%)
Query: 43 NLYCGGSLISLQWFLSARHCFVTENLVWNQ---FNPLIIAGSIYRNYKEQKRQPQLNEIA 99
L CG SLIS +W L+A HC + W++ N L++ + + ++ +++ +
Sbjct: 74 ELLCGASLISDRWVLTAAHCLLYP--PWDKNFTENDLLVRIGKHSRTRYERNIEKISMLE 131
Query: 100 LIYWHS--------DADLAMVKLKEPFRQTTFVKPL 127
IY H D D+A++KLK+P + ++ P+
Sbjct: 132 KIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPV 167
Score = 29.3 bits (64), Expect = 1.8, Method: Compositional matrix adjust.
Identities = 16/31 (51%), Positives = 16/31 (51%), Gaps = 1/31 (3%)
Query: 180 GIVSWGIGCAL-GYPGVYVRVDHYDPWIQSV 209
GIVSWG GC G G Y V WIQ V
Sbjct: 272 GIVSWGEGCDRDGKYGFYTHVFRLKKWIQKV 302
>pdb|1VZQ|H Chain H, Complex Of Thrombin With Designed Inhibitor 7165
Length = 250
Score = 41.6 bits (96), Expect = 4e-04, Method: Compositional matrix adjust.
Identities = 29/97 (29%), Positives = 48/97 (49%), Gaps = 15/97 (15%)
Query: 43 NLYCGGSLISLQWFLSARHCFV----TENLVWNQFNPLIIAGSIYRNYKEQKRQPQLNEI 98
L CG SLIS +W L+A HC + +N N L+ G R E+ + +++ +
Sbjct: 25 ELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDL--LVRIGKHSRTAYERNIE-KISML 81
Query: 99 ALIYWHS--------DADLAMVKLKEPFRQTTFVKPL 127
IY H D D+A++KLK+P + ++ P+
Sbjct: 82 EKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPV 118
>pdb|1L2E|A Chain A, Human Kallikrein 6 (Hk6) Active Form With Benzamidine
Inhibitor
pdb|1LO6|A Chain A, Human Kallikrein 6 (Hk6) Active Form With Benzamidine
Inhibitor At 1.56 A Resolution
Length = 223
Score = 41.6 bits (96), Expect = 4e-04, Method: Compositional matrix adjust.
Identities = 50/215 (23%), Positives = 80/215 (37%), Gaps = 46/215 (21%)
Query: 33 PYIVSLSLYGNLYCGGSLISLQWFLSARHCFVTENLVWNQFNPLIIAGSIYRNYKEQKRQ 92
PY +L G+L CGG LI W L+A HC + N + G +E ++
Sbjct: 13 PYQAALYTSGHLLCGGVLIHPLWVLTAAHC--------KKPNLQVFLGKHNLRQRESSQE 64
Query: 93 PQLNEIALIYWHSDA-----DLAMVKLKEPFRQTTFVKPL-------------------- 127
A+I+ DA D+ +++L P + + ++PL
Sbjct: 65 QSSVVRAVIHPDYDAASHDQDIMLLRLARPAKLSELIQPLPLERDCSANTTSCHILGWGK 124
Query: 128 ----DYYTARETNYINDVLSKTDR-------SEMSIVSGFGVTFQRDKDGIVSWGIGCAL 176
D+ + YI+ V + ++ + +G + G + C
Sbjct: 125 TADGDFPDTIQCAYIHLVSREECEHAYPGQITQNMLCAGDEKYGKDSCQGDSGGPLVCGD 184
Query: 177 GYPGIVSWG-IGC-ALGYPGVYVRVDHYDPWIQSV 209
G+VSWG I C + PGVY V Y WIQ
Sbjct: 185 HLRGLVSWGNIPCGSKEKPGVYTNVCRYTNWIQKT 219
>pdb|2WUB|A Chain A, Crystal Structure Of Hgfa In Complex With The Allosteric
Non-Inhibitory Antibody Fab40.Deltatrp
pdb|2WUB|C Chain C, Crystal Structure Of Hgfa In Complex With The Allosteric
Non-Inhibitory Antibody Fab40.Deltatrp
pdb|2WUC|A Chain A, Crystal Structure Of Hgfa In Complex With The Allosteric
Non- Inhibitory Antibody Fab40.Deltatrp And
Ac-Kqlr-Chloromethylketone
pdb|3K2U|A Chain A, Crystal Structure Of Hgfa In Complex With The Allosteric
Inhibitory Antibody Fab40
Length = 257
Score = 41.6 bits (96), Expect = 4e-04, Method: Compositional matrix adjust.
Identities = 58/234 (24%), Positives = 94/234 (40%), Gaps = 62/234 (26%)
Query: 29 PGEVPYIVSLSLYGNLYCGGSLISLQWFLSARHCF--------VTENLVWNQFNPLIIAG 80
PG P++ ++ + G+ +C GSL+ W +SA HCF V+ L + FN
Sbjct: 9 PGSHPWLAAIYI-GDSFCAGSLVHTCWVVSAAHCFSHSPPRDSVSVVLGQHFFNRTT--- 64
Query: 81 SIYRNYKEQKRQPQLNEIALIYWHSDADLAMVKLKEP----FRQTTFVKP---------- 126
+ + + +K P + ++ SD DL +++LK+ ++ FV+P
Sbjct: 65 DVTQTFGIEKYIPY--TLYSVFNPSDHDLVLIRLKKKGDRCATRSQFVQPICLPEPGSTF 122
Query: 127 -------------LDYYTARETNYINDVLSK--------------TDRSEMSIVSGF--- 156
LD + ++ + + L D S + +G+
Sbjct: 123 PAGHKCQIAGWGHLDENVSGYSSSLREALVPLVADHKCSSPEVYGADISPNMLCAGYFDC 182
Query: 157 -GVTFQRDKDG-IVSWGIGCALGYPGIVSWGIGCA-LGYPGVYVRVDHYDPWIQ 207
Q D G + G A Y GI+SWG GC L PGVY RV +Y WI
Sbjct: 183 KSDACQGDSGGPLACEKNGVAYLY-GIISWGDGCGRLHKPGVYTRVANYVDWIN 235
>pdb|2R0L|A Chain A, Short Form Hgfa With Inhibitory Fab75
Length = 248
Score = 41.6 bits (96), Expect = 4e-04, Method: Compositional matrix adjust.
Identities = 58/234 (24%), Positives = 94/234 (40%), Gaps = 62/234 (26%)
Query: 29 PGEVPYIVSLSLYGNLYCGGSLISLQWFLSARHCF--------VTENLVWNQFNPLIIAG 80
PG P++ ++ + G+ +C GSL+ W +SA HCF V+ L + FN
Sbjct: 9 PGSHPWLAAIYI-GDSFCAGSLVHTCWVVSAAHCFSHSPPRDSVSVVLGQHFFNRTT--- 64
Query: 81 SIYRNYKEQKRQPQLNEIALIYWHSDADLAMVKLKEP----FRQTTFVKP---------- 126
+ + + +K P + ++ SD DL +++LK+ ++ FV+P
Sbjct: 65 DVTQTFGIEKYIPY--TLYSVFNPSDHDLVLIRLKKKGDRCATRSQFVQPICLPEPGSTF 122
Query: 127 -------------LDYYTARETNYINDVLSK--------------TDRSEMSIVSGF--- 156
LD + ++ + + L D S + +G+
Sbjct: 123 PAGHKCQIAGWGHLDENVSGYSSSLREALVPLVADHKCSSPEVYGADISPNMLCAGYFDC 182
Query: 157 -GVTFQRDKDG-IVSWGIGCALGYPGIVSWGIGCA-LGYPGVYVRVDHYDPWIQ 207
Q D G + G A Y GI+SWG GC L PGVY RV +Y WI
Sbjct: 183 KSDACQGDSGGPLACEKNGVAYLY-GIISWGDGCGRLHKPGVYTRVANYVDWIN 235
>pdb|3EDX|B Chain B, Crystal Structure Of The W215aE217A MUTANT OF MURINE
THROMBIN
pdb|3EDX|D Chain D, Crystal Structure Of The W215aE217A MUTANT OF MURINE
THROMBIN
pdb|3EDX|F Chain F, Crystal Structure Of The W215aE217A MUTANT OF MURINE
THROMBIN
pdb|3HK3|B Chain B, Crystal Structure Of Murine Thrombin Mutant W215aE217A
(ONE Molecule In The Asymmetric Unit)
pdb|3HK6|B Chain B, Crystal Structure Of Murine Thrombin Mutant W215aE217A
(TWO Molecules In The Asymmetric Unit)
pdb|3HK6|D Chain D, Crystal Structure Of Murine Thrombin Mutant W215aE217A
(TWO Molecules In The Asymmetric Unit)
pdb|3HKI|B Chain B, Crystal Structure Of Murine Thrombin Mutant W215a/e217a In
Complex With The Extracellular Fragment Of Human Par1
pdb|3HKI|E Chain E, Crystal Structure Of Murine Thrombin Mutant W215a/e217a In
Complex With The Extracellular Fragment Of Human Par1
Length = 258
Score = 41.6 bits (96), Expect = 4e-04, Method: Compositional matrix adjust.
Identities = 26/96 (27%), Positives = 49/96 (51%), Gaps = 13/96 (13%)
Query: 43 NLYCGGSLISLQWFLSARHCFVTENLVWNQ---FNPLIIAGSIYRNYKEQKRQPQLNEIA 99
L CG SLIS +W L+A HC + W++ N L++ + + ++ +++ +
Sbjct: 25 ELLCGASLISDRWVLTAAHCILYPP--WDKNFTENDLLVRIGKHSRTRYERNVEKISMLE 82
Query: 100 LIYWHS--------DADLAMVKLKEPFRQTTFVKPL 127
IY H D D+A++KLK+P + ++ P+
Sbjct: 83 KIYVHPRYNWRENLDRDIALLKLKKPVPFSDYIHPV 118
>pdb|2OCV|B Chain B, Structural Basis Of Na+ Activation Mimicry In Murine
Thrombin
Length = 259
Score = 41.2 bits (95), Expect = 4e-04, Method: Compositional matrix adjust.
Identities = 26/96 (27%), Positives = 49/96 (51%), Gaps = 13/96 (13%)
Query: 43 NLYCGGSLISLQWFLSARHCFVTENLVWNQ---FNPLIIAGSIYRNYKEQKRQPQLNEIA 99
L CG SLIS +W L+A HC + W++ N L++ + + ++ +++ +
Sbjct: 25 ELLCGASLISDRWVLTAAHCILYPP--WDKNFTENDLLVRIGKHSRTRYERNVEKISMLE 82
Query: 100 LIYWHS--------DADLAMVKLKEPFRQTTFVKPL 127
IY H D D+A++KLK+P + ++ P+
Sbjct: 83 KIYVHPRYNWRENLDRDIALLKLKKPVPFSDYIHPV 118
>pdb|2PUX|B Chain B, Crystal Structure Of Murine Thrombin In Complex With The
Extracellular Fragment Of Murine Par3
pdb|2PV9|B Chain B, Crystal Structure Of Murine Thrombin In Complex With The
Extracellular Fragment Of Murine Par4
Length = 258
Score = 41.2 bits (95), Expect = 5e-04, Method: Compositional matrix adjust.
Identities = 26/96 (27%), Positives = 49/96 (51%), Gaps = 13/96 (13%)
Query: 43 NLYCGGSLISLQWFLSARHCFVTENLVWNQ---FNPLIIAGSIYRNYKEQKRQPQLNEIA 99
L CG SLIS +W L+A HC + W++ N L++ + + ++ +++ +
Sbjct: 25 ELLCGASLISDRWVLTAAHCILYPP--WDKNFTENDLLVRIGKHSRTRYERNVEKISMLE 82
Query: 100 LIYWHS--------DADLAMVKLKEPFRQTTFVKPL 127
IY H D D+A++KLK+P + ++ P+
Sbjct: 83 KIYVHPRYNWRENLDRDIALLKLKKPVPFSDYIHPV 118
>pdb|1MTN|B Chain B, Bovine Alpha-Chymotrypsin:bpti Crystallization
pdb|1MTN|F Chain F, Bovine Alpha-Chymotrypsin:bpti Crystallization
pdb|1AB9|B Chain B, Crystal Structure Of Bovine Gamma-Chymotrypsin
pdb|1CA0|B Chain B, Bovine Chymotrypsin Complexed To Appi
pdb|1CA0|G Chain G, Bovine Chymotrypsin Complexed To Appi
pdb|1CBW|B Chain B, Bovine Chymotrypsin Complexed To Bpti
pdb|1CBW|G Chain G, Bovine Chymotrypsin Complexed To Bpti
pdb|1AFQ|B Chain B, Crystal Structure Of Bovine Gamma-Chymotrypsin Complexed
With A Synthetic Inhibitor
pdb|1VGC|B Chain B, Gamma-Chymotrypsin L-Para-Chloro-1-Acetamido Boronic Acid
Inhibitor Complex
pdb|2VGC|B Chain B, Gamma-Chymotrypsin D-Para-Chloro-1-Acetamido Boronic Acid
Inhibitor Complex
pdb|3VGC|B Chain B, Gamma-Chymotrypsin L-Naphthyl-1-Acetamido Boronic Acid
Acid Inhibitor Complex
pdb|4VGC|B Chain B, Gamma-Chymotrypsin D-Naphthyl-1-Acetamido Boronic Acid
Inhibitor Complex
pdb|1HJA|B Chain B, Lys 18 Variant Of Turkey Ovomucoid Inhibitor Third Domain
Complexed With Alpha-Chymotrypsin
pdb|1GG6|B Chain B, Crystal Stucture Of Gamma Chymotrypsin With N-Acetyl-
Phenylalanine Trifluoromethyl Ketone Bound At The Active
Site
pdb|1GGD|B Chain B, Crystal Stucture Of Gamma Chymotrypsin With
N-Acetyl-Leucil- Phenylalanine Aldehyde Bound At The
Active Site
pdb|1N8O|B Chain B, Crystal Structure Of A Complex Between Bovine Chymotrypsin
And Ecotin
pdb|1YPH|C Chain C, High Resolution Structure Of Bovine Alpha-Chymotrypsin
pdb|1YPH|D Chain D, High Resolution Structure Of Bovine Alpha-Chymotrypsin
pdb|2P8O|B Chain B, Crystal Structure Of A Benzohydroxamic AcidVANADATE
Complex Bound To Chymotrypsin A
pdb|1GMH|F Chain F, Refined Crystal Structure Of "aged" And "non-Aged"
Organophosphoryl Conjugates Of Gamma-Chymotrypsin
pdb|2CHA|B Chain B, The Structure Of Crystalline Alpha-Chymotrypsin, v.The
Atomic Structure Of Tosyl-Alpha-Chymotrypsin At 2
Angstroms Resolution
pdb|2CHA|F Chain F, The Structure Of Crystalline Alpha-Chymotrypsin, v.The
Atomic Structure Of Tosyl-Alpha-Chymotrypsin At 2
Angstroms Resolution
pdb|2GCH|F Chain F, Refined Crystal Structure Of Gamma-chymotrypsin At 1.9
Angstroms Resolution
pdb|4GCH|F Chain F, Structure And Activity Of Two Photoreversible Cinnamates
Bound To Chymotrypsin
pdb|5GCH|F Chain F, Chemistry Of Caged Enzymes II. Photoactivation Of
Inhibited Chymotrypsin
pdb|6GCH|F Chain F, Structure Of Chymotrypsin-Trifluoromethyl Ketone Inhibitor
Complexes. Comparison Of Slowly And Rapidly
Equilibrating Inhibitors
pdb|7GCH|F Chain F, Structure Of Chymotrypsin-Trifluoromethyl Ketone Inhibitor
Complexes. Comparison Of Slowly And Rapidly
Equilibrating Inhibitors
pdb|1CHO|F Chain F, Crystal And Molecular Structures Of The Complex Of Alpha-
Chymotrypsin With Its Inhibitor Turkey Ovomucoid Third
Domain At 1.8 Angstroms Resolution
pdb|1GHA|F Chain F, A Second Active Site In Chymotrypsin? The X-Ray Crystal
Structure Of N-Acetyl-D-Tryptophan Bound To
Gamma-Chymotrypsin
pdb|1GMC|F Chain F, The X-Ray Crystal Structure Of The Tetrahedral
Intermediate Of Gamma- Chymotrypsin In Hexane
pdb|1GMD|F Chain F, X-Ray Crystal Structure Of Gamma-Chymotrypsin In Hexane
pdb|3GCT|F Chain F, Structure Of Gamma-Chymotrypsin In The Range pH 2.0 To pH
10.5 Suggests That Gamma-Chymotrypsin Is A Covalent
Acyl-Enzyme Adduct At Low pH
pdb|4CHA|B Chain B, Structure Of Alpha-Chymotrypsin Refined At 1.68 Angstroms
Resolution
pdb|4CHA|F Chain F, Structure Of Alpha-Chymotrypsin Refined At 1.68 Angstroms
Resolution
pdb|5CHA|B Chain B, The Refinement And The Structure Of The Dimer Of Alpha-
Chymotrypsin At 1.67-Angstroms Resolution
pdb|5CHA|F Chain F, The Refinement And The Structure Of The Dimer Of Alpha-
Chymotrypsin At 1.67-Angstroms Resolution
pdb|6CHA|B Chain B, Structure Of A Tetrahedral Transition State Complex Of
Alpha-Chymotrypsin At 1.8-Angstroms Resolution
pdb|6CHA|F Chain F, Structure Of A Tetrahedral Transition State Complex Of
Alpha-Chymotrypsin At 1.8-Angstroms Resolution
pdb|8GCH|F Chain F, Gamma-Chymotrypsin Is A Complex Of Alpha-Chymotrypsin With
Its Own Autolysis Products
pdb|3BG4|B Chain B, The Crystal Structure Of Guamerin In Complex With
Chymotrypsin And The Development Of An Elastase-Specific
Inhibitor
pdb|1GCT|B Chain B, Is Gamma-Chymotrypsin A Tetrapeptide Acyl-Enzyme Adduct Of
Gamma- Chymotrypsin?
pdb|2GCT|B Chain B, Structure Of Gamma-Chymotrypsin In The Range Ph 2.0 To Ph
10.5 Suggests That Gamma-Chymotrypsin Is A Covalent
Acyl-Enzyme Adduct At Low Ph
pdb|1GHB|F Chain F, A Second Active Site In Chymotrypsin? The X-Ray Crystal
Structure Of N-Acetyl-D-Tryptophan Bound To
Gamma-Chymotrypsin
pdb|2GMT|B Chain B, Three-Dimensional Structure Of Chymotrypsin Inactivated
With (2s) N- Acetyl-L-Alanyl-L-Phenylalanyl-Chloroethyl
Ketone: Implications For The Mechanism Of Inactivation
Of Serine Proteases By Chloroketones
pdb|3GCH|B Chain B, Chemistry Of Caged Enzymes. Binding Of Photoreversible
Cinnamates To Chymotrypsin
pdb|3RU4|D Chain D, Crystal Structure Of The Bowman-Birk Serine Protease
Inhibitor Btci In Complex With Trypsin And Chymotrypsin
Length = 131
Score = 41.2 bits (95), Expect = 5e-04, Method: Compositional matrix adjust.
Identities = 33/103 (32%), Positives = 51/103 (49%), Gaps = 19/103 (18%)
Query: 29 PGEVPYIVSL-SLYGNLYCGGSLISLQWFLSARHCFVTENLVWNQFNPLIIAGSIYRNYK 87
PG P+ VSL G +CGGSLI+ W ++A HC VT + V ++AG +
Sbjct: 9 PGSWPWQVSLQDKTGFHFCGGSLINENWVVTAAHCGVTTSDV-------VVAGEFDQGSS 61
Query: 88 EQKRQPQLNEIALIYWHS-------DADLAMVKLKEP--FRQT 121
+K Q +IA ++ +S + D+ ++KL F QT
Sbjct: 62 SEKIQKL--KIAKVFKNSKYNSLTINNDITLLKLSTAASFSQT 102
>pdb|1YBW|A Chain A, Protease Domain Of Hgfa With No Inhibitor
pdb|1YBW|B Chain B, Protease Domain Of Hgfa With No Inhibitor
pdb|1YC0|A Chain A, Short Form Hgfa With First Kunitz Domain From Hai-1
pdb|2R0K|A Chain A, Protease Domain Of Hgfa With Inhibitor Fab58
Length = 283
Score = 41.2 bits (95), Expect = 5e-04, Method: Compositional matrix adjust.
Identities = 58/233 (24%), Positives = 94/233 (40%), Gaps = 62/233 (26%)
Query: 29 PGEVPYIVSLSLYGNLYCGGSLISLQWFLSARHCF--------VTENLVWNQFNPLIIAG 80
PG P++ ++ + G+ +C GSL+ W +SA HCF V+ L + FN
Sbjct: 44 PGSHPWLAAIYI-GDSFCAGSLVHTCWVVSAAHCFSHSPPRDSVSVVLGQHFFNRTT--- 99
Query: 81 SIYRNYKEQKRQPQLNEIALIYWHSDADLAMVKLKEP----FRQTTFVKP---------- 126
+ + + +K P + ++ SD DL +++LK+ ++ FV+P
Sbjct: 100 DVTQTFGIEKYIPY--TLYSVFNPSDHDLVLIRLKKKGDRCATRSQFVQPICLPEPGSTF 157
Query: 127 -------------LDYYTARETNYINDVLSK--------------TDRSEMSIVSGF--- 156
LD + ++ + + L D S + +G+
Sbjct: 158 PAGHKCQIAGWGHLDENVSGYSSSLREALVPLVADHKCSSPEVYGADISPNMLCAGYFDC 217
Query: 157 -GVTFQRDKDG-IVSWGIGCALGYPGIVSWGIGCA-LGYPGVYVRVDHYDPWI 206
Q D G + G A Y GI+SWG GC L PGVY RV +Y WI
Sbjct: 218 KSDACQGDSGGPLACEKNGVAYLY-GIISWGDGCGRLHKPGVYTRVANYVDWI 269
>pdb|1SFQ|B Chain B, Fast Form Of Thrombin Mutant R(77a)a Bound To Ppack
pdb|1SFQ|E Chain E, Fast Form Of Thrombin Mutant R(77a)a Bound To Ppack
pdb|1SG8|B Chain B, Crystal Structure Of The Procoagulant Fast Form Of
Thrombin
pdb|1SG8|E Chain E, Crystal Structure Of The Procoagulant Fast Form Of
Thrombin
pdb|1SGI|B Chain B, Crystal Structure Of The Anticoagulant Slow Form Of
Thrombin
pdb|1SGI|E Chain E, Crystal Structure Of The Anticoagulant Slow Form Of
Thrombin
pdb|1SHH|B Chain B, Slow Form Of Thrombin Bound With Ppack
pdb|1SHH|E Chain E, Slow Form Of Thrombin Bound With Ppack
pdb|2HWL|B Chain B, Crystal Structure Of Thrombin In Complex With Fibrinogen
Gamma' Peptide
pdb|2HWL|D Chain D, Crystal Structure Of Thrombin In Complex With Fibrinogen
Gamma' Peptide
pdb|3BV9|B Chain B, Structure Of Thrombin Bound To The Inhibitor Fm19
Length = 259
Score = 41.2 bits (95), Expect = 6e-04, Method: Compositional matrix adjust.
Identities = 29/97 (29%), Positives = 47/97 (48%), Gaps = 15/97 (15%)
Query: 43 NLYCGGSLISLQWFLSARHCFV----TENLVWNQFNPLIIAGSIYRNYKEQKRQPQLNEI 98
L CG SLIS +W L+A HC + +N N L+ G R E + +++ +
Sbjct: 25 ELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDL--LVRIGKHSRTRYEANIE-KISML 81
Query: 99 ALIYWHS--------DADLAMVKLKEPFRQTTFVKPL 127
IY H D D+A++KLK+P + ++ P+
Sbjct: 82 EKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPV 118
Score = 28.9 bits (63), Expect = 2.6, Method: Compositional matrix adjust.
Identities = 16/31 (51%), Positives = 16/31 (51%), Gaps = 1/31 (3%)
Query: 180 GIVSWGIGCAL-GYPGVYVRVDHYDPWIQSV 209
GIVSWG GC G G Y V WIQ V
Sbjct: 223 GIVSWGEGCDRDGKYGFYTHVFRLKKWIQKV 253
>pdb|2B9L|A Chain A, Crystal Structure Of Prophenoloxidase Activating Factor-Ii
From The Beetle Holotrichia Diomphalia
Length = 394
Score = 41.2 bits (95), Expect = 6e-04, Method: Compositional matrix adjust.
Identities = 57/242 (23%), Positives = 91/242 (37%), Gaps = 68/242 (28%)
Query: 30 GEVPYIVSL--------SLYGNLYCGGSLISLQWFLSARHCFVTENLVWNQFNPLIIAGS 81
GE P++V++ S L CGGSLI+ L+ HC N + + + I
Sbjct: 140 GEFPWMVAVLKANVIPGSGEEQLVCGGSLIAPSVVLTGAHCV---NSYQSNLDAIKIRAG 196
Query: 82 IYRNYKEQKRQP-QLNEIALIYWHSD-------ADLAMVKLKEPF------------RQT 121
+ E++R P Q +I + HS+ D+A++ L P +Q+
Sbjct: 197 EWDTLTEKERLPYQERKIRQVIIHSNFNPKTVVNDVALLLLDRPLVQADNIGTICLPQQS 256
Query: 122 TFVKPLDYYTA-----------RETNYINDV-LSKTDRSEMSIV---SGFGVTFQRDKDG 166
+ + + R +N + + L DR + + G+ F D+
Sbjct: 257 QIFDSTECFASGWGKKEFGSRHRYSNILKKIQLPTVDRDKCQADLRNTRLGLKFVLDQTF 316
Query: 167 IVSWGI----------GCALGYP-----------GIVSWGIGCA-LGYPGVYVRVDHYDP 204
+ + G G L P GIV+WGIGC PGVY V H+
Sbjct: 317 VCAGGEQGKDTCTGDGGSPLFCPDPRNPSRYMQMGIVAWGIGCGDENVPGVYANVAHFRN 376
Query: 205 WI 206
WI
Sbjct: 377 WI 378
>pdb|2A0Q|B Chain B, Structure Of Thrombin In 400 Mm Potassium Chloride
pdb|2A0Q|D Chain D, Structure Of Thrombin In 400 Mm Potassium Chloride
Length = 257
Score = 40.8 bits (94), Expect = 6e-04, Method: Compositional matrix adjust.
Identities = 29/97 (29%), Positives = 47/97 (48%), Gaps = 15/97 (15%)
Query: 43 NLYCGGSLISLQWFLSARHCFV----TENLVWNQFNPLIIAGSIYRNYKEQKRQPQLNEI 98
L CG SLIS +W L+A HC + +N N L+ G R E + +++ +
Sbjct: 25 ELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDL--LVRIGKHSRTRYEANIE-KISML 81
Query: 99 ALIYWHS--------DADLAMVKLKEPFRQTTFVKPL 127
IY H D D+A++KLK+P + ++ P+
Sbjct: 82 EKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPV 118
Score = 28.9 bits (63), Expect = 2.6, Method: Compositional matrix adjust.
Identities = 16/31 (51%), Positives = 16/31 (51%), Gaps = 1/31 (3%)
Query: 180 GIVSWGIGCAL-GYPGVYVRVDHYDPWIQSV 209
GIVSWG GC G G Y V WIQ V
Sbjct: 223 GIVSWGEGCDRDGKYGFYTHVFRLKKWIQKV 253
>pdb|1MH0|A Chain A, Crystal Structure Of The Anticoagulant Slow Form Of
Thrombin
pdb|1MH0|B Chain B, Crystal Structure Of The Anticoagulant Slow Form Of
Thrombin
Length = 287
Score = 40.8 bits (94), Expect = 6e-04, Method: Compositional matrix adjust.
Identities = 29/97 (29%), Positives = 47/97 (48%), Gaps = 15/97 (15%)
Query: 43 NLYCGGSLISLQWFLSARHCFV----TENLVWNQFNPLIIAGSIYRNYKEQKRQPQLNEI 98
L CG SLIS +W L+A HC + +N N L+ G R E + +++ +
Sbjct: 55 ELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDL--LVRIGKHSRTRYEANIE-KISML 111
Query: 99 ALIYWHS--------DADLAMVKLKEPFRQTTFVKPL 127
IY H D D+A++KLK+P + ++ P+
Sbjct: 112 EKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPV 148
Score = 29.3 bits (64), Expect = 2.1, Method: Compositional matrix adjust.
Identities = 16/31 (51%), Positives = 16/31 (51%), Gaps = 1/31 (3%)
Query: 180 GIVSWGIGCAL-GYPGVYVRVDHYDPWIQSV 209
GIVSWG GC G G Y V WIQ V
Sbjct: 253 GIVSWGEGCDRDGKYGFYTHVFRLKKWIQKV 283
>pdb|1FUJ|A Chain A, Pr3 (Myeloblastin)
pdb|1FUJ|B Chain B, Pr3 (Myeloblastin)
pdb|1FUJ|C Chain C, Pr3 (Myeloblastin)
pdb|1FUJ|D Chain D, Pr3 (Myeloblastin)
Length = 221
Score = 40.8 bits (94), Expect = 7e-04, Method: Compositional matrix adjust.
Identities = 58/222 (26%), Positives = 86/222 (38%), Gaps = 50/222 (22%)
Query: 28 NPGEVPYIVSLSLYGNL---YCGGSLISLQWFLSARHCF-----------------VTEN 67
P PY+ SL + GN +CGG+LI + L+A HC T+
Sbjct: 8 QPHSRPYMASLQMRGNPGSHFCGGTLIHPSFVLTAAHCLRDIPQRLVNVVLGAHNVRTQE 67
Query: 68 LVWNQFNPLIIAGSIYRNYKEQKRQPQLNEIALIYWHSDADL----AMVKL---KEPFRQ 120
F+ +A NY + + LN+I LI S A+L A V+L +P
Sbjct: 68 PTQQHFS---VAQVFLNNYDAENK---LNDILLIQLSSPANLSASVATVQLPQQDQPVPH 121
Query: 121 TTFVKPLDYYTARETNYINDVLSKTDRSEMSIVSGFG-----VTF-QRDKDGIVSWGIGC 174
T + + + VL + + +++V+ F TF R K GI G
Sbjct: 122 GTQCLAMGWGRVGAHDPPAQVLQELN---VTVVTFFCRPHNICTFVPRRKAGICFGDSGG 178
Query: 175 ALGYPGIVS-------WGIGCALGYPGVYVRVDHYDPWIQSV 209
L GI+ WG L +P + RV Y WI+S
Sbjct: 179 PLICDGIIQGIDSFVIWGCATRL-FPDFFTRVALYVDWIRST 219
>pdb|3BG8|A Chain A, Crystal Structure Of Factor Xia In Complex With
Clavatadine A
Length = 238
Score = 40.8 bits (94), Expect = 7e-04, Method: Compositional matrix adjust.
Identities = 58/230 (25%), Positives = 85/230 (36%), Gaps = 61/230 (26%)
Query: 30 GEVPYIVSL---SLYGNLYCGGSLISLQWFLSARHCFVTENLVWNQFNPLIIAGSIYR-- 84
GE P+ V+L S CGGS+I QW L+A HCF + +P I+ +Y
Sbjct: 10 GEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCF------YGVESPKIL--RVYSGI 61
Query: 85 -NYKEQKRQPQLNEIALIYWH-------SDADLAMVKLKEPFRQTTFVKPLDYYTARETN 136
N E K + I H S D+A++KL+ T +P+ + E N
Sbjct: 62 LNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPISLPSKGERN 121
Query: 137 YI---------------NDVLSKTDRSEMSIVS---------GFGVTFQRDKDGIVSWGI 172
I + + + ++++ +V+ G +T + G G
Sbjct: 122 VIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGK 181
Query: 173 GCALGYP---------------GIVSWGIGCA-LGYPGVYVRVDHYDPWI 206
G GI SWG GCA PGVY V Y WI
Sbjct: 182 DACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWI 231
>pdb|1VR1|H Chain H, Specifity For Plasminogen Activator Inhibitor-1
Length = 261
Score = 40.8 bits (94), Expect = 7e-04, Method: Compositional matrix adjust.
Identities = 25/93 (26%), Positives = 48/93 (51%), Gaps = 13/93 (13%)
Query: 46 CGGSLISLQWFLSARHCFVTENLVWNQ---FNPLIIAGSIYRNYKEQKRQPQLNEIALIY 102
CG SLIS +W L+A HC + W++ N L++ + + ++ +++ + IY
Sbjct: 32 CGASLISDRWVLTAAHCLLYP--PWDKNFTENDLLVRIGKHSRTRYERNIEKISMLEKIY 89
Query: 103 WHS--------DADLAMVKLKEPFRQTTFVKPL 127
H D D+A++KLK+P + ++ P+
Sbjct: 90 IHPRYNWRENLDRDIALMKLKKPVAFSDYIHPV 122
>pdb|1PJP|A Chain A, The 2.2 A Crystal Structure Of Human Chymase In Complex
With Succinyl- Ala-Ala-Pro-Phe-Chloromethylketone
pdb|1T31|A Chain A, A Dual Inhibitor Of The Leukocyte Proteases Cathepsin G
And Chymase With Therapeutic Efficacy In Animals Models
Of Inflammation
pdb|2HVX|A Chain A, Discovery Of Potent, Orally Active, Nonpeptide Inhibitors
Of Human Mast Cell Chymase By Using Structure-Based Drug
Design
pdb|3S0N|A Chain A, Crystal Structure Of Human Chymase With Benzimidazolone
Inhibitor
Length = 226
Score = 40.0 bits (92), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 51/221 (23%), Positives = 80/221 (36%), Gaps = 45/221 (20%)
Query: 28 NPGEVPYIVSLSLYGN----LYCGGSLISLQWFLSARHCFVTENLVWNQFNPLIIAGSIY 83
P PY+ L + + +CGG LI + L+A HC V + + +
Sbjct: 8 KPHSRPYMAYLEIVTSNGPSKFCGGFLIRRNFVLTAAHCAGRSITVTLGAHNITEEEDTW 67
Query: 84 RNYK--EQKRQPQLNEIALIYWHSDADLAMVKLKE-----------PF-RQTTFVKPLDY 129
+ + +Q R P+ N L + D+ ++KLKE PF Q FV P
Sbjct: 68 QKLEVIKQFRHPKYNTSTLHH-----DIMLLKLKEKASLTLAVGTLPFPSQKNFVPPGRM 122
Query: 130 YTAR---ETNYINDVLSKTDRSEMSIVSGFGVTFQRDKDGIVSWGIG------------- 173
T + ++ ++ + RD D + +G
Sbjct: 123 CRVAGWGRTGVLKPGSDTLQEVKLRLMDPQACSHFRDFDHNLQLCVGNPRKTKSAFKGDS 182
Query: 174 -----CALGYPGIVSWGIGCALGYPGVYVRVDHYDPWIQSV 209
CA GIVS+G A P V+ R+ HY PWI +
Sbjct: 183 GGPLLCAGAAQGIVSYGRSDA-KPPAVFTRISHYQPWINQI 222
>pdb|1SGF|G Chain G, Crystal Structure Of 7s Ngf: A Complex Of Nerve Growth
Factor With Four Binding Proteins (serine Proteinases)
pdb|1SGF|Z Chain Z, Crystal Structure Of 7s Ngf: A Complex Of Nerve Growth
Factor With Four Binding Proteins (serine Proteinases)
Length = 237
Score = 40.0 bits (92), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 28/103 (27%), Positives = 44/103 (42%), Gaps = 8/103 (7%)
Query: 33 PYIVSLSLYGNLYCGGSLISLQWFLSARHCFVTENLVWNQFNPLII--AGSIYRNYKEQK 90
P+ V++ Y CGG L+ W L+A HC+ VW N L + +R +
Sbjct: 13 PWHVAVYRYTQYLCGGVLLDPNWVLTAAHCYDDNYKVWLGKNNLFKDEPSAQHRFVSKAI 72
Query: 91 RQPQLN------EIALIYWHSDADLAMVKLKEPFRQTTFVKPL 127
P N I + + DL +++L +P T VKP+
Sbjct: 73 PHPGFNMSLMRKHIRFLEYDYSNDLMLLRLSKPADITDTVKPI 115
>pdb|4GSO|A Chain A, Structure Of Jararacussin-I
Length = 232
Score = 40.0 bits (92), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 28/100 (28%), Positives = 46/100 (46%), Gaps = 9/100 (9%)
Query: 31 EVPYIVSLSLYGNLYCGGSLISLQWFLSARHCFVTENLVWNQFNPLIIAGSIYRNYKEQK 90
E P++ L +G +CG +LI+ +W ++A HC T + L + N EQ
Sbjct: 11 EHPFLAFLYSHG-YFCGLTLINQEWVVTAAHCDSTNFQMQ-----LGVHSKKVLNEDEQT 64
Query: 91 RQPQLNEIALIYWHS---DADLAMVKLKEPFRQTTFVKPL 127
R P+ I S D D+ ++KL +P + + PL
Sbjct: 65 RNPKEKFICPNKNMSEVLDKDIMLIKLDKPISNSKHIAPL 104
>pdb|3RP2|A Chain A, The Structure Of Rat Mast Cell Protease Ii At
1.9-Angstroms Resolution
pdb|3RP2|B Chain B, The Structure Of Rat Mast Cell Protease Ii At
1.9-Angstroms Resolution
Length = 224
Score = 40.0 bits (92), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 57/217 (26%), Positives = 82/217 (37%), Gaps = 35/217 (16%)
Query: 29 PGEVPYIVSLSLYGN----LYCGGSLISLQWFLSARHCFVTENLVWNQFNPLIIAGSIYR 84
P PY+ L + + CGG LIS Q+ L+A HC E V + + S +
Sbjct: 9 PHSRPYMAHLDIVTEKGLRVICGGFLISRQFVLTAAHCKGREITVILGAHDVRKRESTQQ 68
Query: 85 NYKEQKR--------QPQLNEIALIYWHSDADLA----MVKLKEPFR------------- 119
K +K+ P L++I L+ +L +V L P
Sbjct: 69 KIKVEKQIIHESYNSVPNLHDIMLLKLEKKVELTPAVNVVPLPSPSDFIHPGAMCWAAGW 128
Query: 120 QTTFVKPLDYYTARETNY-INDVLSKTD----RSEMSIVSGFGVTFQRDKDGIVSWGIGC 174
T V+ YT RE I D + D + + G T + G + C
Sbjct: 129 GKTGVRDPTSYTLREVELRIMDEKACVDYRYYEYKFQVCVGSPTTLRAAFMGDSGGPLLC 188
Query: 175 ALGYPGIVSWGIGCALGYPGVYVRVDHYDPWIQSVKN 211
A GIVS+G A P ++ RV Y PWI +V N
Sbjct: 189 AGVAHGIVSYGHPDA-KPPAIFTRVSTYVPWINAVIN 224
>pdb|2GP9|B Chain B, Crystal Structure Of The Slow Form Of Thrombin In A Self-
Inhibited Conformation
pdb|3BEI|B Chain B, Crystal Structure Of The Slow Form Of Thrombin In A
Self_inhibited Conformation
pdb|3BEF|B Chain B, Crystal Structure Of Thrombin Bound To The Extracellular
Fragment Of Par1
pdb|3BEF|E Chain E, Crystal Structure Of Thrombin Bound To The Extracellular
Fragment Of Par1
pdb|3QDZ|B Chain B, Crystal Structure Of The Human Thrombin Mutant D102n In
Complex With The Extracellular Fragment Of Human Par4.
pdb|3QDZ|D Chain D, Crystal Structure Of The Human Thrombin Mutant D102n In
Complex With The Extracellular Fragment Of Human Par4
Length = 259
Score = 40.0 bits (92), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 25/96 (26%), Positives = 49/96 (51%), Gaps = 13/96 (13%)
Query: 43 NLYCGGSLISLQWFLSARHCFVTENLVWNQ---FNPLIIAGSIYRNYKEQKRQPQLNEIA 99
L CG SLIS +W L+A HC + W++ N L++ + + ++ +++ +
Sbjct: 25 ELLCGASLISDRWVLTAAHCLLYP--PWDKNFTENDLLVRIGKHSRTRYERNIEKISMLE 82
Query: 100 LIYWHS--------DADLAMVKLKEPFRQTTFVKPL 127
IY H D ++A++KLK+P + ++ P+
Sbjct: 83 KIYIHPRYNWRENLDRNIALMKLKKPVAFSDYIHPV 118
Score = 28.9 bits (63), Expect = 2.4, Method: Compositional matrix adjust.
Identities = 16/31 (51%), Positives = 16/31 (51%), Gaps = 1/31 (3%)
Query: 180 GIVSWGIGCAL-GYPGVYVRVDHYDPWIQSV 209
GIVSWG GC G G Y V WIQ V
Sbjct: 223 GIVSWGEGCDRDGKYGFYTHVFRLKKWIQKV 253
>pdb|1KDQ|A Chain A, Crystal Structure Analysis Of The Mutant S189d Rat
Chymotrypsin
Length = 131
Score = 40.0 bits (92), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 30/97 (30%), Positives = 47/97 (48%), Gaps = 17/97 (17%)
Query: 29 PGEVPYIVSL-SLYGNLYCGGSLISLQWFLSARHCFVTENLVWNQFNPLIIAGSIYRNYK 87
PG P+ VSL G +CGGSLIS W ++A HC V + V ++AG +
Sbjct: 9 PGSWPWQVSLQDKTGFHFCGGSLISEDWVVTAAHCGVKTSDV-------VVAGEFDQGSD 61
Query: 88 EQKRQPQLNEIALIYWHSD-------ADLAMVKLKEP 117
E+ Q+ +IA ++ + D+ ++KL P
Sbjct: 62 EENI--QVLKIAQVFKNPKFNMFTVRNDITLLKLATP 96
>pdb|1GVZ|A Chain A, Prostate Specific Antigen (Psa) From Stallion Seminal
Plasma
Length = 237
Score = 40.0 bits (92), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 30/108 (27%), Positives = 49/108 (45%), Gaps = 10/108 (9%)
Query: 33 PYIVSLSLYGNLYCGGSLISLQWFLSARHCFVTENLVWNQFNPLIIAGSI--YRNYKEQK 90
P+ V++ G+ CGG L+ QW L+A HC + +W + L + +
Sbjct: 13 PWQVAVYHQGHFQCGGVLVHPQWVLTAAHCMSDDYQIWLGRHNLSKDEDTAQFHQVSDSF 72
Query: 91 RQPQLNEIALI-------YWHSDADLAMVKLKEPFRQTTFVKPLDYYT 131
PQ + ++L+ Y DL +++L +P R T VK LD T
Sbjct: 73 LDPQFD-LSLLKKKYLRPYDDISHDLMLLRLAQPARITDAVKILDLPT 119
>pdb|2JET|B Chain B, Crystal Structure Of A Trypsin-Like Mutant (S189d, A226g)
Chymotrypsin
Length = 128
Score = 40.0 bits (92), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 30/97 (30%), Positives = 47/97 (48%), Gaps = 17/97 (17%)
Query: 29 PGEVPYIVSL-SLYGNLYCGGSLISLQWFLSARHCFVTENLVWNQFNPLIIAGSIYRNYK 87
PG P+ VSL G +CGGSLIS W ++A HC V + V ++AG +
Sbjct: 6 PGSWPWQVSLQDKTGFHFCGGSLISEDWVVTAAHCGVKTSDV-------VVAGEFDQGSD 58
Query: 88 EQKRQPQLNEIALIYWHSD-------ADLAMVKLKEP 117
E+ Q+ +IA ++ + D+ ++KL P
Sbjct: 59 EENI--QVLKIAQVFKNPKFNMFTVRNDITLLKLATP 93
>pdb|1OP0|A Chain A, Crystal Structure Of Aav-sp-i, A Glycosylated Snake Venom
Serine Proteinase From Agkistrodon Acutus
Length = 234
Score = 39.7 bits (91), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 49/214 (22%), Positives = 84/214 (39%), Gaps = 46/214 (21%)
Query: 34 YIVSLSLYGNLYCGGSLISLQWFLSARHCFVTENLVWNQFNPLIIAGSIYRNYKEQKRQP 93
++V+ +CGG+LI+ +W ++A HC T+ + L + N EQ R P
Sbjct: 14 FLVAFFNTTGFFCGGTLINPEWVVTAAHCDSTDFQMQ-----LGVHSKKVLNEDEQTRNP 68
Query: 94 QLNEIALIYWHS---DADLAMVKLKEPFRQTTF------------------------VKP 126
+ I ++ D D+ ++KL +P + + P
Sbjct: 69 KEKFICPNKNNNEVLDKDIMLIKLDKPISNSKHIAPLSLPSSPPSVGSVCRIMGWGSITP 128
Query: 127 L-----DYYTARETNYINDVLSKTDRSEM-----SIVSGFGVTFQRDKDGIVSWG-IGCA 175
+ D N ++ + + E+ ++ +G V +D G S G + C
Sbjct: 129 VKETFPDVPYCANINLLDHAVCQAGYPELLAEYRTLCAGI-VQGGKDTCGGDSGGPLICN 187
Query: 176 LGYPGIVSWGIG-CALG-YPGVYVRVDHYDPWIQ 207
+ GIVS+G C G PG+Y V Y WIQ
Sbjct: 188 GQFQGIVSYGAHPCGQGPKPGIYTNVFDYTDWIQ 221
>pdb|3SOR|A Chain A, Factor Xia In Complex With A Clorophenyl-tetrazole
Inhibitor
pdb|3SOS|A Chain A, Benzothiazinone Inhibitor In Complex With Fxia
Length = 238
Score = 39.3 bits (90), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 57/230 (24%), Positives = 85/230 (36%), Gaps = 61/230 (26%)
Query: 30 GEVPYIVSL---SLYGNLYCGGSLISLQWFLSARHCFVTENLVWNQFNPLIIAGSIYR-- 84
GE P+ V+L S CGGS+I QW L+A HCF + +P I+ +Y
Sbjct: 10 GEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCF------YGVESPKIL--RVYSGI 61
Query: 85 -NYKEQKRQPQLNEIALIYWH-------SDADLAMVKLKEPFRQTTFVKPLDYYTARETN 136
N E K + I H S D+A++KL+ T +P+ + + N
Sbjct: 62 LNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPISLPSKGDRN 121
Query: 137 YI---------------NDVLSKTDRSEMSIVS---------GFGVTFQRDKDGIVSWGI 172
I + + + ++++ +V+ G +T + G G
Sbjct: 122 VIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGK 181
Query: 173 GCALGYP---------------GIVSWGIGCA-LGYPGVYVRVDHYDPWI 206
G GI SWG GCA PGVY V Y WI
Sbjct: 182 DACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWI 231
>pdb|3N7O|A Chain A, X-Ray Structure Of Human Chymase In Complex With Small
Molecule Inhibitor
Length = 226
Score = 39.3 bits (90), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 51/221 (23%), Positives = 80/221 (36%), Gaps = 45/221 (20%)
Query: 28 NPGEVPYIVSLSLYGN----LYCGGSLISLQWFLSARHCFVTENLVWNQFNPLIIAGSIY 83
P PY+ L + + +CGG LI + L+A HC V + + +
Sbjct: 8 KPHSRPYMAYLEIVTSNGPSKFCGGFLIRRNFVLTAAHCAGRSITVTLGAHNITEEEDTW 67
Query: 84 RNYK--EQKRQPQLNEIALIYWHSDADLAMVKLKE-----------PF-RQTTFVKPLDY 129
+ + +Q R P+ N L + D+ ++KLKE PF Q FV P
Sbjct: 68 QKLEVIKQFRHPKYNTSTLHH-----DIMLLKLKEKASLTLAVGTLPFPSQFNFVPPGRM 122
Query: 130 YTAR---ETNYINDVLSKTDRSEMSIVSGFGVTFQRDKDGIVSWGIG------------- 173
T + ++ ++ + RD D + +G
Sbjct: 123 CRVAGWGRTGVLKPGSDTLQEVKLRLMDPQACSHFRDFDHNLQLCVGNPRKTKSAFKGDS 182
Query: 174 -----CALGYPGIVSWGIGCALGYPGVYVRVDHYDPWIQSV 209
CA GIVS+G A P V+ R+ HY PWI +
Sbjct: 183 GGPLLCAGAAQGIVSYGRSDA-KPPAVFTRISHYQPWINQI 222
>pdb|1LTO|A Chain A, Human Alpha1-Tryptase
pdb|1LTO|B Chain B, Human Alpha1-Tryptase
pdb|1LTO|C Chain C, Human Alpha1-Tryptase
pdb|1LTO|D Chain D, Human Alpha1-Tryptase
Length = 245
Score = 39.3 bits (90), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 34/115 (29%), Positives = 54/115 (46%), Gaps = 21/115 (18%)
Query: 33 PYIVSLSL---YGNLYCGGSLISLQWFLSARHCFVTENLVWNQFNPLIIAGSIYRNYKEQ 89
P+ VSL + Y +CGGSLI QW L+A HC + + ++ +EQ
Sbjct: 13 PWQVSLRVRDRYWMHFCGGSLIHPQWVLTAAHCLGPD---------VKDLATLRVQLREQ 63
Query: 90 KR--QPQLNEIALIYWH-------SDADLAMVKLKEPFRQTTFVKPLDYYTARET 135
Q QL ++ I H + AD+A+++L+EP ++ V + A ET
Sbjct: 64 HLYYQDQLLPVSRIIVHPQFYIIQTGADIALLELEEPVNISSRVHTVMLPPASET 118
>pdb|1OSS|A Chain A, T190p Streptomyces Griseus Trypsin In Complex With
Benzamidine
Length = 223
Score = 39.3 bits (90), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 53/219 (24%), Positives = 77/219 (35%), Gaps = 48/219 (21%)
Query: 30 GEVPYIVSLSLYGNLYCGGSLISLQWFLSARHCFVTENLVWNQFNPLIIAGSIYRNYKEQ 89
GE P++V LS+ CGG+L + L+A HC + G +
Sbjct: 10 GEFPFMVRLSMG----CGGALYAQDIVLTAAHCVSGSG----NNTSITATGGVVDLQSSS 61
Query: 90 KRQPQLNEI--ALIYWHSDADLAMVKLKEPFRQTTF-VKPLDYYTARETNYINDVLSKTD 146
+ + ++ A Y + D A++KL +P Q T + Y ++
Sbjct: 62 AVKVRSTKVLQAPGYNGTGKDWALIKLAQPINQPTLKIATTTAYNQGTFTVAGWGANREG 121
Query: 147 RSEMSIVSGFGVTFQRDKDGIVSWGIG-------CALGYP-------------------- 179
S+ + V F D ++G CA GYP
Sbjct: 122 GSQQRYLLKANVPFVSDAACRSAYGNELVANEEICA-GYPDTGGVDPCQGDSGGPMFRKD 180
Query: 180 --------GIVSWGIGCAL-GYPGVYVRVDHYDPWIQSV 209
GIVSWG GCA GYPGVY V + I S
Sbjct: 181 NADEWIQVGIVSWGYGCARPGYPGVYTEVSTFASAIASA 219
>pdb|1OS8|A Chain A, Recombinant Streptomyces Griseus Trypsin
Length = 223
Score = 39.3 bits (90), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 53/219 (24%), Positives = 77/219 (35%), Gaps = 48/219 (21%)
Query: 30 GEVPYIVSLSLYGNLYCGGSLISLQWFLSARHCFVTENLVWNQFNPLIIAGSIYRNYKEQ 89
GE P++V LS+ CGG+L + L+A HC + G +
Sbjct: 10 GEFPFMVRLSMG----CGGALYAQDIVLTAAHCVSGSG----NNTSITATGGVVDLQSSS 61
Query: 90 KRQPQLNEI--ALIYWHSDADLAMVKLKEPFRQTTF-VKPLDYYTARETNYINDVLSKTD 146
+ + ++ A Y + D A++KL +P Q T + Y ++
Sbjct: 62 AVKVRSTKVLQAPGYNGTGKDWALIKLAQPINQPTLKIATTTAYNQGTFTVAGWGANREG 121
Query: 147 RSEMSIVSGFGVTFQRDKDGIVSWGIG-------CALGYP-------------------- 179
S+ + V F D ++G CA GYP
Sbjct: 122 GSQQRYLLKANVPFVSDAACRSAYGNELVANEEICA-GYPDTGGVDTCQGDSGGPMFRKD 180
Query: 180 --------GIVSWGIGCAL-GYPGVYVRVDHYDPWIQSV 209
GIVSWG GCA GYPGVY V + I S
Sbjct: 181 NADEWIQVGIVSWGYGCARPGYPGVYTEVSTFASAIASA 219
>pdb|1EPT|A Chain A, Refined 1.8 Angstroms Resolution Crystal Structure Of
Porcine Epsilon-Trypsin
Length = 43
Score = 38.9 bits (89), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 18/33 (54%), Positives = 25/33 (75%), Gaps = 1/33 (3%)
Query: 31 EVPYIVSLSLYGNLYCGGSLISLQWFLSARHCF 63
+PY VSL+ G+ +CGGSLI+ QW +SA HC+
Sbjct: 11 SIPYQVSLNS-GSHFCGGSLINSQWVVSAAHCY 42
>pdb|1OP2|A Chain A, Crystal Structure Of Aav-Sp-Ii, A Glycosylated Snake Venom
Serine Proteinase From Agkistrodon Acutus
Length = 234
Score = 38.9 bits (89), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 49/214 (22%), Positives = 83/214 (38%), Gaps = 46/214 (21%)
Query: 34 YIVSLSLYGNLYCGGSLISLQWFLSARHCFVTENLVWNQFNPLIIAGSIYRNYKEQKRQP 93
++V+ +CGG+LI+ +W ++A HC T + L + N EQ R P
Sbjct: 14 FLVAFFNTTGFFCGGTLINPEWVVTAAHCDSTNFQMQ-----LGVHSKKVLNEDEQTRNP 68
Query: 94 QLNEIALIYWHS---DADLAMVKLKEPFRQTTF------------------------VKP 126
+ I ++ D D+ ++KL +P + + P
Sbjct: 69 KEKFICPNKNNNEVLDKDIMLIKLDKPISNSKHIAPLSLPSSPPSVGSVCRIMGWGSITP 128
Query: 127 L-----DYYTARETNYINDVLSKTDRSEM-----SIVSGFGVTFQRDKDGIVSWG-IGCA 175
+ D N ++ + + E+ ++ +G V +D G S G + C
Sbjct: 129 VKETFPDVPYCANINLLDHAVCQAGYPELLAEYRTLCAGI-VQGGKDTCGGDSGGPLICN 187
Query: 176 LGYPGIVSWGIG-CALG-YPGVYVRVDHYDPWIQ 207
+ GIVS+G C G PG+Y V Y WIQ
Sbjct: 188 GQFQGIVSYGAHPCGQGPKPGIYTNVFDYTDWIQ 221
>pdb|2F9O|A Chain A, Crystal Structure Of The Recombinant Human Alpha I
Tryptase Mutant D216g
pdb|2F9O|B Chain B, Crystal Structure Of The Recombinant Human Alpha I
Tryptase Mutant D216g
pdb|2F9O|C Chain C, Crystal Structure Of The Recombinant Human Alpha I
Tryptase Mutant D216g
pdb|2F9O|D Chain D, Crystal Structure Of The Recombinant Human Alpha I
Tryptase Mutant D216g
pdb|2F9P|A Chain A, Crystal Structure Of The Recombinant Human Alpha I
Tryptase Mutant D216g In Complex With Leupeptin
pdb|2F9P|B Chain B, Crystal Structure Of The Recombinant Human Alpha I
Tryptase Mutant D216g In Complex With Leupeptin
pdb|2F9P|C Chain C, Crystal Structure Of The Recombinant Human Alpha I
Tryptase Mutant D216g In Complex With Leupeptin
pdb|2F9P|D Chain D, Crystal Structure Of The Recombinant Human Alpha I
Tryptase Mutant D216g In Complex With Leupeptin
Length = 245
Score = 38.9 bits (89), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 34/115 (29%), Positives = 54/115 (46%), Gaps = 21/115 (18%)
Query: 33 PYIVSLSL---YGNLYCGGSLISLQWFLSARHCFVTENLVWNQFNPLIIAGSIYRNYKEQ 89
P+ VSL + Y +CGGSLI QW L+A HC + + ++ +EQ
Sbjct: 13 PWQVSLRVRDRYWMHFCGGSLIHPQWVLTAAHCVGPD---------VKDLATLRVQLREQ 63
Query: 90 KR--QPQLNEIALIYWH-------SDADLAMVKLKEPFRQTTFVKPLDYYTARET 135
Q QL ++ I H + AD+A+++L+EP ++ V + A ET
Sbjct: 64 HLYYQDQLLPVSRIIVHPQFYIIQTGADIALLELEEPVNISSRVHTVMLPPASET 118
Score = 28.9 bits (63), Expect = 3.0, Method: Compositional matrix adjust.
Identities = 16/42 (38%), Positives = 19/42 (45%), Gaps = 13/42 (30%)
Query: 166 GIVSWGIGCALGYPGIVSWGIGCALGYPGVYVRVDHYDPWIQ 207
G+VSWG GCA PG+Y RV +Y WI
Sbjct: 210 GVVSWGEGCA-------------QPNRPGIYTRVTYYLDWIH 238
>pdb|2F9N|A Chain A, Crystal Structure Of The Recombinant Human Alpha I
Tryptase Mutant K192qD216G IN COMPLEX WITH LEUPEPTIN
pdb|2F9N|B Chain B, Crystal Structure Of The Recombinant Human Alpha I
Tryptase Mutant K192qD216G IN COMPLEX WITH LEUPEPTIN
pdb|2F9N|C Chain C, Crystal Structure Of The Recombinant Human Alpha I
Tryptase Mutant K192qD216G IN COMPLEX WITH LEUPEPTIN
pdb|2F9N|D Chain D, Crystal Structure Of The Recombinant Human Alpha I
Tryptase Mutant K192qD216G IN COMPLEX WITH LEUPEPTIN
Length = 245
Score = 38.9 bits (89), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 34/115 (29%), Positives = 54/115 (46%), Gaps = 21/115 (18%)
Query: 33 PYIVSLSL---YGNLYCGGSLISLQWFLSARHCFVTENLVWNQFNPLIIAGSIYRNYKEQ 89
P+ VSL + Y +CGGSLI QW L+A HC + + ++ +EQ
Sbjct: 13 PWQVSLRVRDRYWMHFCGGSLIHPQWVLTAAHCVGPD---------VKDLATLRVQLREQ 63
Query: 90 KR--QPQLNEIALIYWH-------SDADLAMVKLKEPFRQTTFVKPLDYYTARET 135
Q QL ++ I H + AD+A+++L+EP ++ V + A ET
Sbjct: 64 HLYYQDQLLPVSRIIVHPQFYIIQTGADIALLELEEPVNISSRVHTVMLPPASET 118
Score = 28.5 bits (62), Expect = 3.0, Method: Compositional matrix adjust.
Identities = 16/42 (38%), Positives = 19/42 (45%), Gaps = 13/42 (30%)
Query: 166 GIVSWGIGCALGYPGIVSWGIGCALGYPGVYVRVDHYDPWIQ 207
G+VSWG GCA PG+Y RV +Y WI
Sbjct: 210 GVVSWGEGCA-------------QPNRPGIYTRVTYYLDWIH 238
>pdb|1SGF|A Chain A, Crystal Structure Of 7s Ngf: A Complex Of Nerve Growth
Factor With Four Binding Proteins (serine Proteinases)
pdb|1SGF|X Chain X, Crystal Structure Of 7s Ngf: A Complex Of Nerve Growth
Factor With Four Binding Proteins (serine Proteinases)
Length = 240
Score = 38.9 bits (89), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 28/110 (25%), Positives = 48/110 (43%), Gaps = 10/110 (9%)
Query: 33 PYIVSLSLYGNLYCGGSLISLQWFLSARHCFVTENLVWNQFNPLI--IAGSIYRNYKEQK 90
P+ V++ + CGG L+ W L+A HC+ + VW N + +R +
Sbjct: 16 PWHVAVYRFNKYQCGGVLLDRNWVLTAAHCYNDKYQVWLGKNNFLEDEPSDQHRLVSKAI 75
Query: 91 RQPQLNEIALIYWHSDA-------DLAMVKLKEPFRQTTFVKPLDYYTAR 133
P N ++L+ H+ DL +++L +P T VKP+ T
Sbjct: 76 PHPDFN-MSLLNEHTPQPEDDYSNDLMLLRLSKPADITDVVKPITLPTEE 124
>pdb|1ZPZ|A Chain A, Factor Xi Catalytic Domain Complexed With N-((R)-1-(4-
Bromophenyl)ethyl)urea-Asn-Val-Arg-Alpha-Ketothiazole
pdb|1ZRK|A Chain A, Factor Xi Complexed With 3-Hydroxypropyl 3-(7-
Amidinonaphthalene-1-Carboxamido)benzenesulfonate
pdb|1ZSL|A Chain A, Factor Xi Complexed With A Pyrimidinone Inhibitor
Length = 238
Score = 38.5 bits (88), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 52/222 (23%), Positives = 82/222 (36%), Gaps = 45/222 (20%)
Query: 30 GEVPYIVSL---SLYGNLYCGGSLISLQWFLSARHCF--VTENLVWNQFNPLIIAGSIYR 84
GE P+ V+L S CGGS+I QW L+A HCF V + ++ ++ I
Sbjct: 10 GEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIAE 69
Query: 85 NYKEQKRQPQLNEIALIYWHSDADLAMVKLKEPFRQTTFVKPLDYYTARETNYI------ 138
+ Q + S D+A++KL+ T +P+ + + N I
Sbjct: 70 DTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPISLPSKGDRNVIYTDCWV 129
Query: 139 ---------NDVLSKTDRSEMSIVS---------GFGVTFQRDKDGIVSWGIGCALGYP- 179
+ + + ++++ +V+ G +T + G G G
Sbjct: 130 TGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSG 189
Query: 180 --------------GIVSWGIGCA-LGYPGVYVRVDHYDPWI 206
GI SWG GCA PGVY V Y WI
Sbjct: 190 GPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWI 231
>pdb|1SGT|A Chain A, Refined Crystal Structure Of Streptomyces Griseus Trypsin
At 1.7 Angstroms Resolution
Length = 223
Score = 38.5 bits (88), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 55/219 (25%), Positives = 79/219 (36%), Gaps = 48/219 (21%)
Query: 30 GEVPYIVSLSLYGNLYCGGSLISLQWFLSARHCFVTENLVWNQFNPLIIAG--SIYRNYK 87
GE P++V LS+ CGG+L + L+A HC N + G +
Sbjct: 10 GEFPFMVRLSMG----CGGALYAQDIVLTAAHCVSGSG---NNTSITATGGVVDLQSGAA 62
Query: 88 EQKRQPQLNEIALIYWHSDADLAMVKLKEPFRQTTF-VKPLDYYTARETNYINDVLSKTD 146
+ R ++ + A Y + D A++KL +P Q T + Y ++
Sbjct: 63 VKVRSTKVLQ-APGYNGTGKDWALIKLAQPINQPTLKIATTTAYNQGTFTVAGWGANREG 121
Query: 147 RSEMSIVSGFGVTFQRDKDGIVSWGIG-------CALGYP-------------------- 179
S+ + V F D ++G CA GYP
Sbjct: 122 GSQQRYLLKANVPFVSDAACRSAYGNELVANEEICA-GYPDTGGVDTCQGDSGGPMFRKD 180
Query: 180 --------GIVSWGIGCAL-GYPGVYVRVDHYDPWIQSV 209
GIVSWG GCA GYPGVY V + I S
Sbjct: 181 NADEWIQVGIVSWGYGCARPGYPGVYTEVSTFASAIASA 219
>pdb|3F6U|H Chain H, Crystal Structure Of Human Activated Protein C (Apc)
Complexed With Ppack
Length = 240
Score = 38.5 bits (88), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 53/234 (22%), Positives = 84/234 (35%), Gaps = 64/234 (27%)
Query: 30 GEVPY-IVSLSLYGNLYCGGSLISLQWFLSARHCFVTENLVWNQFNPLIIAGSIYRNYKE 88
G+ P+ +V L L CG LI W L+A HC ++ L++ Y +
Sbjct: 10 GDSPWQVVLLDSKKKLACGAVLIHPSWVLTAAHCM-------DESKKLLVRLGEYDLRRW 62
Query: 89 QKRQPQLNEIALIYWH-------SDADLAMVKLKEPFR---------------------- 119
+K + L+ I ++ H +D D+A++ L +P
Sbjct: 63 EKWELDLD-IKEVFVHPNYSKSTTDNDIALLHLAQPATLSQTIVPICLPDSGLAERELNQ 121
Query: 120 --QTTFVKPLDYYTARET--------------------NYINDVLSKTDRSEM---SIVS 154
Q T V Y+++RE N ++V+S M I+
Sbjct: 122 AGQETLVTGWGYHSSREKEAKRNRTFVLNFIKIPVVPHNECSEVMSNMVSENMLCAGILG 181
Query: 155 GFGVTFQRDKDGIVSWGIGCALGYPGIVSWGIGCALGYP-GVYVRVDHYDPWIQ 207
+ D G + G+VSWG GC L + GVY +V Y WI
Sbjct: 182 DRQDACEGDSGGPMVASFHGTWFLVGLVSWGEGCGLLHNYGVYTKVSRYLDWIH 235
>pdb|1AUT|C Chain C, Human Activated Protein C
Length = 250
Score = 38.5 bits (88), Expect = 0.004, Method: Compositional matrix adjust.
Identities = 53/234 (22%), Positives = 84/234 (35%), Gaps = 64/234 (27%)
Query: 30 GEVPY-IVSLSLYGNLYCGGSLISLQWFLSARHCFVTENLVWNQFNPLIIAGSIYRNYKE 88
G+ P+ +V L L CG LI W L+A HC ++ L++ Y +
Sbjct: 10 GDSPWQVVLLDSKKKLACGAVLIHPSWVLTAAHCM-------DESKKLLVRLGEYDLRRW 62
Query: 89 QKRQPQLNEIALIYWH-------SDADLAMVKLKEPFR---------------------- 119
+K + L+ I ++ H +D D+A++ L +P
Sbjct: 63 EKWELDLD-IKEVFVHPNYSKSTTDNDIALLHLAQPATLSQTIVPICLPDSGLAERELNQ 121
Query: 120 --QTTFVKPLDYYTARET--------------------NYINDVLSKTDRSEM---SIVS 154
Q T V Y+++RE N ++V+S M I+
Sbjct: 122 AGQETLVTGWGYHSSREKEAKRNRTFVLNFIKIPVVPHNECSEVMSNMVSENMLCAGILG 181
Query: 155 GFGVTFQRDKDGIVSWGIGCALGYPGIVSWGIGCALGYP-GVYVRVDHYDPWIQ 207
+ D G + G+VSWG GC L + GVY +V Y WI
Sbjct: 182 DRQDACEGDSGGPMVASFHGTWFLVGLVSWGEGCGLLHNYGVYTKVSRYLDWIH 235
>pdb|1OP8|A Chain A, Crystal Structure Of Human Granzyme A
pdb|1OP8|B Chain B, Crystal Structure Of Human Granzyme A
pdb|1OP8|C Chain C, Crystal Structure Of Human Granzyme A
pdb|1OP8|D Chain D, Crystal Structure Of Human Granzyme A
pdb|1OP8|E Chain E, Crystal Structure Of Human Granzyme A
pdb|1OP8|F Chain F, Crystal Structure Of Human Granzyme A
Length = 234
Score = 38.5 bits (88), Expect = 0.004, Method: Compositional matrix adjust.
Identities = 32/102 (31%), Positives = 49/102 (48%), Gaps = 14/102 (13%)
Query: 29 PGEVPYIVSLSLYGNLYCGGSLISLQWFLSARHCFVTENLVWNQFNPLII-AGSIYRNYK 87
P PY+V LSL C G+LI+ W L+A HC + N+ + +I+ A SI R +
Sbjct: 9 PHSRPYMVLLSLDRKTICAGALIAKDWVLTAAHCNL------NKRSQVILGAHSITR--E 60
Query: 88 EQKRQPQLNEIALIYWHSD-----ADLAMVKLKEPFRQTTFV 124
E +Q L + Y D DL +++L E + +V
Sbjct: 61 EPTKQIMLVKKEFPYPCYDPATREGDLKLLQLTEKAKINKYV 102
>pdb|1ORF|A Chain A, The Oligomeric Structure Of Human Granzyme A Reveals The
Molecular Determinants Of Substrate Specificity
Length = 234
Score = 38.5 bits (88), Expect = 0.004, Method: Compositional matrix adjust.
Identities = 34/102 (33%), Positives = 50/102 (49%), Gaps = 14/102 (13%)
Query: 29 PGEVPYIVSLSLYGNLYCGGSLISLQWFLSARHCFVTENLVWNQFNPLII-AGSIYRNYK 87
P PY+V LSL C G+LI+ W L+A HC NL N+ + +I+ A SI R +
Sbjct: 9 PHSRPYMVLLSLDRKTICAGALIAKDWVLTAAHC----NL--NKRSQVILGAHSITR--E 60
Query: 88 EQKRQPQLNEIALIYWHSD-----ADLAMVKLKEPFRQTTFV 124
E +Q L + Y D DL +++L E + +V
Sbjct: 61 EPTKQIMLVKKEFPYPCYDPATREGDLKLLQLTEKAKINKYV 102
>pdb|1AO5|A Chain A, Mouse Glandular Kallikrein-13 (Prorenin Converting Enzyme)
pdb|1AO5|B Chain B, Mouse Glandular Kallikrein-13 (Prorenin Converting Enzyme)
Length = 237
Score = 38.5 bits (88), Expect = 0.004, Method: Compositional matrix adjust.
Identities = 29/110 (26%), Positives = 48/110 (43%), Gaps = 10/110 (9%)
Query: 33 PYIVSLSLYGNLYCGGSLISLQWFLSARHCFVTENLVWNQFNPLII--AGSIYRNYKEQK 90
P+ V++ CGG L+ W L+A HC+V + VW N L + +R +
Sbjct: 13 PWQVAVYYQKEHICGGVLLDRNWVLTAAHCYVDQYEVWLGKNKLFQEEPSAQHRLVSKSF 72
Query: 91 RQPQLNEIALIYWHS-------DADLAMVKLKEPFRQTTFVKPLDYYTAR 133
P N ++L+ + DL +++L +P T VKP+ T
Sbjct: 73 PHPGFN-MSLLMLQTIPPGADFSDDLMLLRLSKPADITDVVKPIALPTKE 121
>pdb|1XX9|A Chain A, Crystal Structure Of The Fxia Catalytic Domain In Complex
With Ecotinm84r
pdb|1XX9|B Chain B, Crystal Structure Of The Fxia Catalytic Domain In Complex
With Ecotinm84r
Length = 238
Score = 38.5 bits (88), Expect = 0.004, Method: Compositional matrix adjust.
Identities = 57/230 (24%), Positives = 85/230 (36%), Gaps = 61/230 (26%)
Query: 30 GEVPYIVSL---SLYGNLYCGGSLISLQWFLSARHCFVTENLVWNQFNPLIIAGSIYR-- 84
GE P+ V+L S CGGS+I QW L+A HCF + +P I+ +Y
Sbjct: 10 GEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCF------YGVESPKIL--RVYSGI 61
Query: 85 -NYKEQKRQPQLNEIALIYWH-------SDADLAMVKLKEPFRQTTFVKPLDYYTARETN 136
N E K + I H S D+A++KL+ T +P+ + + N
Sbjct: 62 LNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRN 121
Query: 137 YI---------------NDVLSKTDRSEMSIVS---------GFGVTFQRDKDGIVSWGI 172
I + + + ++++ +V+ G +T + G G
Sbjct: 122 VIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGK 181
Query: 173 GCALGYP---------------GIVSWGIGCA-LGYPGVYVRVDHYDPWI 206
G GI SWG GCA PGVY V Y WI
Sbjct: 182 DACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWI 231
>pdb|3S69|A Chain A, Crystal Structure Of Saxthrombin
Length = 234
Score = 38.1 bits (87), Expect = 0.004, Method: Compositional matrix adjust.
Identities = 50/206 (24%), Positives = 80/206 (38%), Gaps = 46/206 (22%)
Query: 44 LYCGGSLISLQWFLSARHCFVTENLVWNQFNPLIIAGSIYRNYKEQKRQPQLNEIALIYW 103
+C G+LI+ +W L+A HC T N L + N EQ R P+ I
Sbjct: 24 FFCSGTLINEEWVLTAAHCDNT-----NFQMKLGVHSKKVLNEDEQTRNPKEKFICPNKK 78
Query: 104 HS---DADLAMVKLKEPFRQTTFV------------------------KPL-----DYYT 131
+ D D+ ++KL + + P+ D
Sbjct: 79 NDEVLDKDIMLIKLDSRVSNSEHIVPLSLPSSPPSVGSVCHIMGWGSITPIKVTYPDVPY 138
Query: 132 ARETNYINDVLSKTDRSEM-----SIVSGFGVTFQRDKDGIVSWG-IGCALGYPGIVSWG 185
N ++D + + E+ ++ +G + +D G S G + C + GIVS+G
Sbjct: 139 CAYINLLDDAVCQAGYPELLTEYRTLCAGI-LEGGKDTCGGDSGGPLICNGQFQGIVSFG 197
Query: 186 IG-CALGY-PGVYVRVDHYDPWIQSV 209
C G PGVY +V Y+ WIQS+
Sbjct: 198 AHPCGQGLKPGVYTKVFDYNHWIQSI 223
>pdb|1FIW|A Chain A, Three-Dimensional Structure Of Beta-Acrosin From Ram
Spermatozoa
Length = 290
Score = 38.1 bits (87), Expect = 0.004, Method: Compositional matrix adjust.
Identities = 35/114 (30%), Positives = 52/114 (45%), Gaps = 21/114 (18%)
Query: 30 GEVPYIVSLSLY----GNLY--CGGSLISLQWFLSARHCFVTENLV--WNQFNPLIIAGS 81
G P++VSL ++ Y CGGSL++ QW L+A HCF + V W LI
Sbjct: 10 GAWPWMVSLQIFTYHNNRRYHVCGGSLLNSQWLLTAAHCFRIKKKVTDWR----LIFGAK 65
Query: 82 IYRNYKEQKRQPQLNE--IALIYWH------SDA-DLAMVKLKEPFRQTTFVKP 126
+ +P L E + I H S+A D+A++K+ P F+ P
Sbjct: 66 EVEWGTNKPVKPPLQERYVEKIIIHEKYSASSEANDIALMKITPPVTCGHFIGP 119
>pdb|1FIZ|A Chain A, Three Dimensional Structure Of Beta-Acrosin From Boar
Spermatozoa
Length = 263
Score = 38.1 bits (87), Expect = 0.004, Method: Compositional matrix adjust.
Identities = 60/246 (24%), Positives = 88/246 (35%), Gaps = 72/246 (29%)
Query: 28 NPGEVPYIVSLSLYGNLY--------CGGSLISLQWFLSARHCFVTENLV--WNQFNPLI 77
PG P++VSL ++ +Y CGG L++ W L+A HCF + V W LI
Sbjct: 8 EPGAWPWMVSLQIF--MYHNNRRYHTCGGILLNSHWVLTAAHCFKNKKKVTDWR----LI 61
Query: 78 IAGSIYRNYKEQKRQPQLNE--IALIYWHSD-------ADLAMVKLKEPFRQTTFVKP-- 126
+ + +P L E + I H D+A++K+ P F+ P
Sbjct: 62 FGANEVVWGSNKPVKPPLQERFVEEIIIHEKYVSGLEINDIALIKITPPVPCGPFIGPGC 121
Query: 127 LDYYT-----ARETNYIND---VLSKTDRSEMSIVSGFGVTFQRDKDGIVSWGIG----- 173
L + A +T ++ + K R+ ++ + W G
Sbjct: 122 LPQFKAGPPRAPQTCWVTGWGYLKEKGPRTSPTLQEARVALIDLELCNSTRWYNGRIRST 181
Query: 174 --CALGYP----------------------------GIVSWGIGCALG-YPGVYVRVDHY 202
CA GYP GI SWG+GCA PGVY Y
Sbjct: 182 NVCA-GYPRGKIDTCQGDSGGPLMCRDRAENTFVVVGITSWGVGCARAKRPGVYTSTWPY 240
Query: 203 DPWIQS 208
WI S
Sbjct: 241 LNWIAS 246
>pdb|2JET|C Chain C, Crystal Structure Of A Trypsin-Like Mutant (S189d, A226g)
Chymotrypsin
Length = 99
Score = 38.1 bits (87), Expect = 0.004, Method: Compositional matrix adjust.
Identities = 27/76 (35%), Positives = 37/76 (48%), Gaps = 10/76 (13%)
Query: 136 NYINDVLSKTDRSEM-SIVSGFGVTFQRDKDGIVSWGIGCALGYPGIVSWGIG-CALGYP 193
+ I DV++ S + S + G KDG+ W + GIVSWG G C+ P
Sbjct: 28 SKITDVMTCAGASGVDSCMGDSGGPLVCQKDGV--WTLA------GIVSWGSGVCSTSTP 79
Query: 194 GVYVRVDHYDPWIQSV 209
GVY RV PW+Q +
Sbjct: 80 GVYSRVTALMPWVQQI 95
>pdb|2F83|A Chain A, Crystal Structure At 2.9 Angstroms Resolution Of Human
Plasma Coagulation Factor Xi Zymogen
Length = 625
Score = 38.1 bits (87), Expect = 0.004, Method: Compositional matrix adjust.
Identities = 57/230 (24%), Positives = 85/230 (36%), Gaps = 61/230 (26%)
Query: 30 GEVPYIVSL---SLYGNLYCGGSLISLQWFLSARHCFVTENLVWNQFNPLIIAGSIYR-- 84
GE P+ V+L S CGGS+I QW L+A HCF + +P I+ +Y
Sbjct: 397 GEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCF------YGVESPKIL--RVYSGI 448
Query: 85 -NYKEQKRQPQLNEIALIYWH-------SDADLAMVKLKEPFRQTTFVKPLDYYTARETN 136
N E K + I H S D+A++KL+ T +P+ + + N
Sbjct: 449 LNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRN 508
Query: 137 YI---------------NDVLSKTDRSEMSIVS---------GFGVTFQRDKDGIVSWGI 172
I + + + ++++ +V+ G +T + G G
Sbjct: 509 VIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGK 568
Query: 173 GCALGYP---------------GIVSWGIGCA-LGYPGVYVRVDHYDPWI 206
G GI SWG GCA PGVY V Y WI
Sbjct: 569 DACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWI 618
>pdb|1FI8|A Chain A, Rat Granzyme B [n66q] Complexed To Ecotin [81-84 Iepd]
pdb|1FI8|B Chain B, Rat Granzyme B [n66q] Complexed To Ecotin [81-84 Iepd]
Length = 228
Score = 38.1 bits (87), Expect = 0.005, Method: Compositional matrix adjust.
Identities = 31/112 (27%), Positives = 51/112 (45%), Gaps = 21/112 (18%)
Query: 28 NPGEVPYIVSLSLY----GNLYCGGSLISLQWFLSARHCFVTENLVWNQFNPLIIAGSIY 83
P PY+ L + G+ CGG LI + L+A HC ++ V G+
Sbjct: 8 KPHSRPYMAYLQIMDEYSGSKKCGGFLIREDFVLTAAHCSGSKIQV--------TLGA-- 57
Query: 84 RNYKEQKRQPQLNEIALIYWHS-------DADLAMVKLKEPFRQTTFVKPLD 128
N KEQ++ Q+ + I H D+ ++KLK ++++ VKPL+
Sbjct: 58 HNIKEQEKMQQIIPVVKIIPHPAYNSKTISNDIMLLKLKSKAKRSSAVKPLN 109
>pdb|1ZJD|A Chain A, Crystal Structure Of The Catalytic Domain Of Coagulation
Factor Xi In Complex With Kunitz Protease Inhibitor
Domain Of Protease Nexin Ii
Length = 237
Score = 37.4 bits (85), Expect = 0.007, Method: Compositional matrix adjust.
Identities = 56/230 (24%), Positives = 84/230 (36%), Gaps = 61/230 (26%)
Query: 30 GEVPYIVSL---SLYGNLYCGGSLISLQWFLSARHCFVTENLVWNQFNPLIIAGSIYR-- 84
GE P+ V+L S CGGS+I QW L+A HCF + +P I+ +Y
Sbjct: 10 GEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCF------YGVESPKIL--RVYSGI 61
Query: 85 -NYKEQKRQPQLNEIALIYWH-------SDADLAMVKLKEPFRQTTFVKPLDYYTARETN 136
N E K + I H S D+A++KL+ +P+ + + N
Sbjct: 62 LNQAEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYADSQRPISLPSKGDRN 121
Query: 137 YI---------------NDVLSKTDRSEMSIVS---------GFGVTFQRDKDGIVSWGI 172
I + + + ++++ +V+ G +T + G G
Sbjct: 122 VIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGK 181
Query: 173 GCALGYP---------------GIVSWGIGCA-LGYPGVYVRVDHYDPWI 206
G GI SWG GCA PGVY V Y WI
Sbjct: 182 DACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWI 231
>pdb|4E7N|A Chain A, Crystal Structure Of Ahv_tl-I, A Glycosylated Snake-Venom
Thrombin- Like Enzyme From Agkistrodon Halys
Length = 238
Score = 37.4 bits (85), Expect = 0.007, Method: Compositional matrix adjust.
Identities = 28/102 (27%), Positives = 46/102 (45%), Gaps = 10/102 (9%)
Query: 28 NPGEVPYIVSL--SLYGNLYCGGSLISLQWFLSARHCFVTENLVWNQFNPLIIAGSIYRN 85
N E ++V+L S L+CGG+LI+ +W L+A HC + L + N
Sbjct: 8 NINEHRFLVALYTSRSRTLFCGGTLINQEWVLTAAHCDRKNFRI-----KLGMHSKKVPN 62
Query: 86 YKEQKRQPQLNEIALI---YWHSDADLAMVKLKEPFRQTTFV 124
EQ R P+ L Y D D+ +++L P + + +
Sbjct: 63 EDEQTRVPKEKFFCLSSKNYTLWDKDIMLIRLDSPVKNSKHI 104
>pdb|4AFQ|A Chain A, Human Chymase - Fynomer Complex
pdb|4AFQ|B Chain B, Human Chymase - Fynomer Complex
pdb|4AFS|A Chain A, Human Chymase - Fynomer Complex
pdb|4AFU|A Chain A, Human Chymase - Fynomer Complex
pdb|4AFU|B Chain B, Human Chymase - Fynomer Complex
pdb|4AFZ|A Chain A, Human Chymase - Fynomer Complex
pdb|4AFZ|B Chain B, Human Chymase - Fynomer Complex
pdb|4AG1|A Chain A, Human Chymase - Fynomer Complex
pdb|4AG2|A Chain A, Human Chymase - Fynomer Complex
pdb|4AG2|B Chain B, Human Chymase - Fynomer Complex
Length = 226
Score = 37.4 bits (85), Expect = 0.007, Method: Compositional matrix adjust.
Identities = 51/221 (23%), Positives = 80/221 (36%), Gaps = 45/221 (20%)
Query: 28 NPGEVPYIVSLSLYGN----LYCGGSLISLQWFLSARHCFVTENLVWNQFNPLIIAGSIY 83
P PY+ L + + +CGG LI + L+A HC V + + +
Sbjct: 8 KPHSRPYMAYLEIVTSNGPSKFCGGFLIRRNFVLTAAHCAGRSITVTLGAHNITEEEDTW 67
Query: 84 RNYK--EQKRQPQLNEIALIYWHSDADLAMVKLKE-----------PF-RQTTFVKPLDY 129
+ + +Q R P+ N L + D+ ++KLKE PF Q FV P
Sbjct: 68 QKLEVIKQFRHPKYNTSTLHH-----DIMLLKLKEKASLTLAVGTLPFPSQFNFVPPGRM 122
Query: 130 YTAR---ETNYINDVLSKTDRSEMSIVSGFGVTFQRDKDGIVSWGIG------------- 173
T + ++ ++ + RD D + +G
Sbjct: 123 CRVAGWGRTGVLKPGSDTLQEVKLRLMDPQACSHFRDFDHNLQLCVGNPRKTKSAFKGDS 182
Query: 174 -----CALGYPGIVSWGIGCALGYPGVYVRVDHYDPWIQSV 209
CA GIVS+G A P V+ R+ HY PWI +
Sbjct: 183 GGPLLCAGVAQGIVSYGRSDA-KPPAVFTRISHYRPWINQI 222
>pdb|1KLT|A Chain A, Crystal Structure Of Pmsf-Treated Human Chymase At 1.9
Angstroms Resolution
Length = 226
Score = 37.4 bits (85), Expect = 0.007, Method: Compositional matrix adjust.
Identities = 51/221 (23%), Positives = 80/221 (36%), Gaps = 45/221 (20%)
Query: 28 NPGEVPYIVSLSLYGN----LYCGGSLISLQWFLSARHCFVTENLVWNQFNPLIIAGSIY 83
P PY+ L + + +CGG LI + L+A HC V + + +
Sbjct: 8 KPHSRPYMAYLEIVTSNGPSKFCGGFLIRRNFVLTAAHCAGRSITVTLGAHNITEEEDTW 67
Query: 84 RNYK--EQKRQPQLNEIALIYWHSDADLAMVKLKE-----------PF-RQTTFVKPLDY 129
+ + +Q R P+ N L + D+ ++KLKE PF Q FV P
Sbjct: 68 QKLEVIKQFRHPKYNTSTLHH-----DIMLLKLKEKASLTLAVGTLPFPSQFNFVPPGRM 122
Query: 130 YTAR---ETNYINDVLSKTDRSEMSIVSGFGVTFQRDKDGIVSWGIG------------- 173
T + ++ ++ + RD D + +G
Sbjct: 123 CRVAGWGRTGVLKPGSDTLQEVKLRLMDPQACSHFRDFDHNLQLCVGNPRKTKSAFKGDS 182
Query: 174 -----CALGYPGIVSWGIGCALGYPGVYVRVDHYDPWIQSV 209
CA GIVS+G A P V+ R+ HY PWI +
Sbjct: 183 GGPLLCAGVAQGIVSYGRSDA-KPPAVFTRISHYRPWINQI 222
>pdb|1NN6|A Chain A, Human Pro-Chymase
Length = 228
Score = 37.4 bits (85), Expect = 0.008, Method: Compositional matrix adjust.
Identities = 51/221 (23%), Positives = 80/221 (36%), Gaps = 45/221 (20%)
Query: 28 NPGEVPYIVSLSLYGN----LYCGGSLISLQWFLSARHCFVTENLVWNQFNPLIIAGSIY 83
P PY+ L + + +CGG LI + L+A HC V + + +
Sbjct: 10 KPHSRPYMAYLEIVTSNGPSKFCGGFLIRRNFVLTAAHCAGRSITVTLGAHNITEEEDTW 69
Query: 84 RNYK--EQKRQPQLNEIALIYWHSDADLAMVKLKE-----------PF-RQTTFVKPLDY 129
+ + +Q R P+ N L + D+ ++KLKE PF Q FV P
Sbjct: 70 QKLEVIKQFRHPKYNTSTLHH-----DIMLLKLKEKASLTLAVGTLPFPSQFNFVPPGRM 124
Query: 130 YTAR---ETNYINDVLSKTDRSEMSIVSGFGVTFQRDKDGIVSWGIG------------- 173
T + ++ ++ + RD D + +G
Sbjct: 125 CRVAGWGRTGVLKPGSDTLQEVKLRLMDPQACSHFRDFDHNLQLCVGNPRKTKSAFKGDS 184
Query: 174 -----CALGYPGIVSWGIGCALGYPGVYVRVDHYDPWIQSV 209
CA GIVS+G A P V+ R+ HY PWI +
Sbjct: 185 GGPLLCAGVAQGIVSYGRSDA-KPPAVFTRISHYRPWINQI 224
>pdb|3GOV|B Chain B, Crystal Structure Of The Catalytic Region Of Human Masp-1
pdb|4DJZ|B Chain B, Catalytic Fragment Of Masp-1 In Complex With Its Specific
Inhibitor Developed By Directed Evolution On Sgci
Scaffold
pdb|4DJZ|D Chain D, Catalytic Fragment Of Masp-1 In Complex With Its Specific
Inhibitor Developed By Directed Evolution On Sgci
Scaffold
Length = 251
Score = 37.4 bits (85), Expect = 0.008, Method: Compositional matrix adjust.
Identities = 39/149 (26%), Positives = 63/149 (42%), Gaps = 31/149 (20%)
Query: 30 GEVPYIVSLS-LYGNLYCGGSLISLQWFLSARHCF----------VTENLVWNQFNPLII 78
G P+I LS L G +CGGSL+ W ++A HC + ++ + + + II
Sbjct: 10 GTTPWIAMLSHLNGQPFCGGSLLGSSWIVTAAHCLHQSLDPKDPTLRDSDLLSPSDFKII 69
Query: 79 AGSIYRNYKEQKRQPQLNEIALIYWHSDA-----DLAMVKLKEPFRQTTFVKPLDYYTAR 133
G +R ++ Q + ++ D D+A+V+L E FV P+
Sbjct: 70 LGKHWRLRSDENEQHLGVKHTTLHPQYDPNTFENDVALVELLESPVLNAFVMPI------ 123
Query: 134 ETNYINDVLSKTDRSE--MSIVSGFGVTF 160
L + + E M IVSG+G F
Sbjct: 124 -------CLPEGPQQEGAMVIVSGWGKQF 145
>pdb|1ZLR|A Chain A, Factor Xi Catalytic Domain Complexed With
2-Guanidino-1-(4-(4,4,5,5-
Tetramethyl-1,3,2-Dioxaborolan-2-Yl)phenyl)ethyl
Nicotinate
Length = 237
Score = 37.4 bits (85), Expect = 0.008, Method: Compositional matrix adjust.
Identities = 51/222 (22%), Positives = 81/222 (36%), Gaps = 45/222 (20%)
Query: 30 GEVPYIVSL---SLYGNLYCGGSLISLQWFLSARHCF--VTENLVWNQFNPLIIAGSIYR 84
GE P+ V+L S CGGS+I QW L+A HCF V + ++ ++ I
Sbjct: 10 GEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQAEIAE 69
Query: 85 NYKEQKRQPQLNEIALIYWHSDADLAMVKLKEPFRQTTFVKPLDYYTARETNYI------ 138
+ Q + S D+A++KL+ +P+ + + N I
Sbjct: 70 DTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYADSQRPISLPSKGDRNVIYTDCWV 129
Query: 139 ---------NDVLSKTDRSEMSIVS---------GFGVTFQRDKDGIVSWGIGCALGYP- 179
+ + + ++++ +V+ G +T + G G G
Sbjct: 130 TGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSG 189
Query: 180 --------------GIVSWGIGCA-LGYPGVYVRVDHYDPWI 206
GI SWG GCA PGVY V Y WI
Sbjct: 190 GPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWI 231
>pdb|1ZHR|A Chain A, Crystal Structure Of The Catalytic Domain Of Coagulation
Factor Xi In Complex With Benzamidine
(S434a-T475a-C482s-K437a Mutant)
pdb|1ZPB|A Chain A, Crystal Structure Of The Catalytic Domain Of Coagulation
Factor Xi In Complex With 4-Methyl-Pentanoic Acid {1-[4-
Guanidino-1-(Thiazole-2-Carbonyl)-Butylcarbamoyl]-2-
Methyl- Propyl}-Amide
pdb|1ZPC|A Chain A, Crystal Structure Of The Catalytic Domain Of Coagulation
Factor Xi In Complex With
2-[2-(3-Chloro-Phenyl)-2-Hydroxy-
Acetylamino]-N-[4-Guanidino-1-(Thiazole-2-Carbonyl)-
Butyl]- 3-Methyl-Butyramide
pdb|2FDA|A Chain A, Crystal Structure Of The Catalytic Domain Of Human
Coagulation Factor Xia In Complex With
Alpha-Ketothiazole Arginine Derived Ligand
pdb|1ZMJ|A Chain A, Crystal Structure Of The Catalytic Domain Of Factor Xi In
Complex With 4-(Guanidinomethyl)-Phenylboronic Acid
pdb|1ZML|A Chain A, Crystal Structure Of The Catalytic Domain Of Factor Xi In
Complex With (R)-1-(4-(4-(Hydroxymethyl)-1,3,2-
Dioxaborolan-2-Yl)phenethyl)guanidine
pdb|1ZMN|A Chain A, Crystal Structure Of The Catalytic Domain Of Coagulation
Factor Xi In Complex With
(R)-1-(4-(4-(Hydroxymethyl)-1,3,
2-Dioxaborolan-2-Yl)phenyl)guanidine
pdb|1ZOM|A Chain A, Crystal Structure Of The Catalytic Domain Of Coagulation
Factor Xi In Complex With A Peptidomimetic Inhibitor
pdb|1ZSJ|A Chain A, Crystal Structure Of The Catalytic Domain Of Coagulation
Factor Xi In Complex With
N-(7-Carbamimidoyl-Naphthalen-1-
Yl)-3-Hydroxy-2-Methyl-Benzamide
pdb|1ZSK|A Chain A, Crystal Structure Of The Catalytic Domain Of Coagulation
Factor Xi In Complex With
6-Carbamimidoyl-4-(3-Hydroxy-2-
Methyl-Benzoylamino)-Naphthalene-2-Carboxylic Acid
Methyl Ester
pdb|1ZTJ|A Chain A, Crystal Structure Of The Catalytic Domain Of Coagulation
Factor Xi In Complex With 2-(5-Benzylamino-2-
Methylsulfanyl-6-Oxo-6h-Pyrimidin-1-Yl)-N-[4-Guanidino-
1- (Thiazole-2-Carbonyl)-Butyl]-Acetamide
pdb|1ZTK|A Chain A, Crystal Structure Of The Catalytic Domain Of Coagulation
Factor Xi In Complex With 2-(5-Amino-6-Oxo-2-M-Tolyl-6h-
Pyrimidin-1-Yl)-N-[4-Guanidino-1-(Thiazole-2-Carbonyl)-
Butyl]-Acetamide
pdb|1ZTL|A Chain A, Crystal Structure Of The Catalytic Domain Of Coagulation
Factor Xi In Complex With N-[4-Guanidino-1-(Thiazole-2-
Carbonyl)-Butyl]-2-{6-Oxo-5-[(Quinolin-8-Ylmethyl)-
Amino]- 2-M-Tolyl-6h-Pyrimidin-1-Yl}-Acetamide
Length = 238
Score = 37.4 bits (85), Expect = 0.008, Method: Compositional matrix adjust.
Identities = 51/222 (22%), Positives = 81/222 (36%), Gaps = 45/222 (20%)
Query: 30 GEVPYIVSL---SLYGNLYCGGSLISLQWFLSARHCF--VTENLVWNQFNPLIIAGSIYR 84
GE P+ V+L S CGGS+I QW L+A HCF V + ++ ++ I
Sbjct: 10 GEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQAEIAE 69
Query: 85 NYKEQKRQPQLNEIALIYWHSDADLAMVKLKEPFRQTTFVKPLDYYTARETNYI------ 138
+ Q + S D+A++KL+ +P+ + + N I
Sbjct: 70 DTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYADSQRPISLPSKGDRNVIYTDCWV 129
Query: 139 ---------NDVLSKTDRSEMSIVS---------GFGVTFQRDKDGIVSWGIGCALGYP- 179
+ + + ++++ +V+ G +T + G G G
Sbjct: 130 TGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSG 189
Query: 180 --------------GIVSWGIGCA-LGYPGVYVRVDHYDPWI 206
GI SWG GCA PGVY V Y WI
Sbjct: 190 GPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWI 231
>pdb|1ELV|A Chain A, Crystal Structure Of The Catalytic Domain Of Human
Complement C1s Protease
Length = 333
Score = 37.0 bits (84), Expect = 0.010, Method: Compositional matrix adjust.
Identities = 34/139 (24%), Positives = 62/139 (44%), Gaps = 28/139 (20%)
Query: 40 LYGNLYCGGSLISLQWFLSARHCFVTENLVWNQFNPLIIAGS----IYRNYKEQKRQPQ- 94
+ N + GG+LI+ W L+A H +V P + GS R K + P+
Sbjct: 99 FFDNPWAGGALINEYWVLTAAH------VVEGNREPTMYVGSTSVQTSRLAKSKMLTPEH 152
Query: 95 --------LNEIALIYWHSDADLAMVKLKEPFRQTTFVKPLDYY-TARETNYINDVLSKT 145
L + + D D+A+V+LK+P + V P+ T+ + N ++
Sbjct: 153 VFIHPGWKLLAVPEGRTNFDNDIALVRLKDPVKMGPTVSPICLPGTSSDYNLMD------ 206
Query: 146 DRSEMSIVSGFGVTFQRDK 164
++ ++SG+G T +RD+
Sbjct: 207 --GDLGLISGWGRTEKRDR 223
Score = 27.3 bits (59), Expect = 7.6, Method: Compositional matrix adjust.
Identities = 14/27 (51%), Positives = 17/27 (62%), Gaps = 2/27 (7%)
Query: 180 GIVSWGIGCALGYPGVYVRVDHYDPWI 206
G+VSWG C G G+Y RV +Y WI
Sbjct: 296 GLVSWGPQC--GTYGLYTRVKNYVDWI 320
>pdb|4IGD|A Chain A, Crystal Structure Of The Zymogen Catalytic Region Of Human
Masp-1
Length = 406
Score = 36.6 bits (83), Expect = 0.011, Method: Compositional matrix adjust.
Identities = 39/149 (26%), Positives = 63/149 (42%), Gaps = 31/149 (20%)
Query: 30 GEVPYIVSLS-LYGNLYCGGSLISLQWFLSARHCF----------VTENLVWNQFNPLII 78
G P+I LS L G +CGGSL+ W ++A HC + ++ + + + II
Sbjct: 165 GTTPWIAMLSHLNGQPFCGGSLLGSSWIVTAAHCLHQSLDPEDPTLRDSDLLSPSDFKII 224
Query: 79 AGSIYRNYKEQKRQPQLNEIALIYWHSDA-----DLAMVKLKEPFRQTTFVKPLDYYTAR 133
G +R ++ Q + ++ D D+A+V+L E FV P+
Sbjct: 225 LGKHWRLRSDENEQHLGVKHTTLHPQYDPNTFENDVALVELLESPVLNAFVMPI------ 278
Query: 134 ETNYINDVLSKTDRSE--MSIVSGFGVTF 160
L + + E M IVSG+G F
Sbjct: 279 -------CLPEGPQQEGAMVIVSGWGKQF 300
>pdb|1GVL|A Chain A, Human Prokallikrein 6 (Hk6) PROZYME PROPROTEASE M
Proneurosin
Length = 223
Score = 36.6 bits (83), Expect = 0.013, Method: Compositional matrix adjust.
Identities = 50/217 (23%), Positives = 80/217 (36%), Gaps = 50/217 (23%)
Query: 33 PYIVSLSLYGNLYCGGSLISLQWFLSARHCFVTENLVWNQFNPLIIAGSIYRNYKEQKRQ 92
PY +L G+L CGG LI W L+A HC + N + G N ++Q+
Sbjct: 14 PYQAALYTSGHLLCGGVLIHPLWVLTAAHC--------KKPNLQVFLGK--HNLRQQESS 63
Query: 93 PQLNEIALIYWHSDADLA-------MVKLKEPFRQTTFVKPL------------------ 127
+ + + H D D A +++L P + + ++PL
Sbjct: 64 QEQSSVVRAVIHPDYDAASHDQDIMLLRLARPAKLSELIQPLPLERDCSAQTTSCHILGW 123
Query: 128 ------DYYTARETNYINDVLSKTDR-------SEMSIVSGFGVTFQRDKDGIVSWGIGC 174
D+ + YI+ V + ++ + +G + G + C
Sbjct: 124 GKTADGDFPDTIQCAYIHLVSREECEHAYPGQITQNMLCAGDEKYGKDSCQGDSGGPLVC 183
Query: 175 ALGYPGIVSWG-IGC-ALGYPGVYVRVDHYDPWIQSV 209
G+VSWG I C + PGVY V Y WIQ
Sbjct: 184 GDHLRGLVSWGNIPCGSKEKPGVYTNVCRYTNWIQKT 220
>pdb|1ZHP|A Chain A, Crystal Structure Of The Catalytic Domain Of Coagulation
Factor Xi In Complex With Benzamidine (S434a-T475a-K505
Mutant)
Length = 238
Score = 36.6 bits (83), Expect = 0.013, Method: Compositional matrix adjust.
Identities = 56/230 (24%), Positives = 84/230 (36%), Gaps = 61/230 (26%)
Query: 30 GEVPYIVSL---SLYGNLYCGGSLISLQWFLSARHCFVTENLVWNQFNPLIIAGSIYR-- 84
GE P+ V+L S CGGS+I QW L+A HCF + +P I+ +Y
Sbjct: 10 GEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCF------YGVESPKIL--RVYSGI 61
Query: 85 -NYKEQKRQPQLNEIALIYWH-------SDADLAMVKLKEPFRQTTFVKPLDYYTARETN 136
N E K + I H S D+A++KL+ +P+ + + N
Sbjct: 62 LNQAEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYADSQRPICLPSKGDRN 121
Query: 137 YI---------------NDVLSKTDRSEMSIVS---------GFGVTFQRDKDGIVSWGI 172
I + + + ++++ +V+ G +T + G G
Sbjct: 122 VIYTDCWVTGWGYRALRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGK 181
Query: 173 GCALGYP---------------GIVSWGIGCA-LGYPGVYVRVDHYDPWI 206
G GI SWG GCA PGVY V Y WI
Sbjct: 182 DACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWI 231
>pdb|1XXD|A Chain A, Crystal Structure Of The Fxia Catalytic Domain In Complex
With Mutated Ecotin
pdb|1XXD|B Chain B, Crystal Structure Of The Fxia Catalytic Domain In Complex
With Mutated Ecotin
pdb|1XXF|A Chain A, Crystal Structure Of The Fxia Catalytic Domain In Complex
With Ecotin Mutant (Ecotinp)
pdb|1XXF|B Chain B, Crystal Structure Of The Fxia Catalytic Domain In Complex
With Ecotin Mutant (Ecotinp)
Length = 238
Score = 36.6 bits (83), Expect = 0.013, Method: Compositional matrix adjust.
Identities = 56/230 (24%), Positives = 84/230 (36%), Gaps = 61/230 (26%)
Query: 30 GEVPYIVSL---SLYGNLYCGGSLISLQWFLSARHCFVTENLVWNQFNPLIIAGSIYR-- 84
GE P+ V+L S CGGS+I QW L+A HCF + +P I+ +Y
Sbjct: 10 GEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCF------YGVESPKIL--RVYSGI 61
Query: 85 -NYKEQKRQPQLNEIALIYWH-------SDADLAMVKLKEPFRQTTFVKPLDYYTARETN 136
N E K + I H S D+A++KL+ +P+ + + N
Sbjct: 62 LNQAEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYADSQRPICLPSKGDRN 121
Query: 137 YI---------------NDVLSKTDRSEMSIVS---------GFGVTFQRDKDGIVSWGI 172
I + + + ++++ +V+ G +T + G G
Sbjct: 122 VIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGK 181
Query: 173 GCALGYP---------------GIVSWGIGCA-LGYPGVYVRVDHYDPWI 206
G GI SWG GCA PGVY V Y WI
Sbjct: 182 DACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWI 231
>pdb|2I6Q|A Chain A, Complement Component C2a
pdb|2I6S|A Chain A, Complement Component C2a
Length = 517
Score = 36.6 bits (83), Expect = 0.014, Method: Compositional matrix adjust.
Identities = 31/117 (26%), Positives = 53/117 (45%), Gaps = 17/117 (14%)
Query: 32 VPYIVSLSLYGNLYCGGSLISLQWFLSARHCFVTEN--LVW--NQFNP--------LIIA 79
P+ V++ C G+LIS QW L+A HCF N +W N +P LI
Sbjct: 243 TPWHVTIKPKSQETCRGALISDQWVLTAAHCFRDGNDHSLWRVNVGDPKSQWGKEFLIEK 302
Query: 80 GSIYRNYKEQKRQPQLNEIALIYWHSDADLAMVKLKEPFRQTTFVKPLDYYTARETN 136
I + ++ Q ++ ++ D D+A++KL + + +T +P+ E N
Sbjct: 303 AVISPGFDVFAKKNQ----GILEFYGD-DIALLKLAQKVKMSTHARPICLPCTMEAN 354
>pdb|4D8N|A Chain A, Human Kallikrein 6 Inhibitors With A
Para-Amidobenzylanmine P1 Group Carry A High Binding
Efficiency
pdb|3VFE|A Chain A, Virtual Screening And X-Ray Crystallography For Human
Kallikrein 6 Inhibitors With An Amidinothiophene P1
Group
Length = 223
Score = 36.2 bits (82), Expect = 0.014, Method: Compositional matrix adjust.
Identities = 48/221 (21%), Positives = 77/221 (34%), Gaps = 58/221 (26%)
Query: 33 PYIVSLSLYGNLYCGGSLISLQWFLSARHCFVTENLVWNQFNPL-----------IIAGS 81
PY +L G+L CGG LI W L+A HC V+ + L ++
Sbjct: 13 PYQAALYTSGHLLCGGVLIHPLWVLTAAHCKKPNLQVFLGKHNLGQQESSQEQSSVVRAV 72
Query: 82 IYRNYKEQKRQPQLNEIALIYWHSDADLAMVKLKEPFRQTTFVKPL-------------- 127
I+ +Y D D+ +++L P + + ++PL
Sbjct: 73 IHPDYDAASH--------------DQDIMLLRLARPAKLSELIQPLPLERDCSAQTTSCH 118
Query: 128 ----------DYYTARETNYINDVLSKTDR-------SEMSIVSGFGVTFQRDKDGIVSW 170
D+ + YI+ V + ++ + +G + G
Sbjct: 119 ILGWGKTADGDFPDTIQCAYIHLVSREECEHAYPGQITQNMLCAGDEKYGKDSCQGDSGG 178
Query: 171 GIGCALGYPGIVSWG-IGC-ALGYPGVYVRVDHYDPWIQSV 209
+ C G+VSWG I C + PGVY V Y WIQ
Sbjct: 179 PLVCGDHLRGLVSWGNIPCGSKEKPGVYTNVCRYTNWIQKT 219
>pdb|2ODP|A Chain A, Complement Component C2a, The Catalytic Fragment Of C3-
And C5- Convertase Of Human Complement
pdb|2ODQ|A Chain A, Complement Component C2a, The Catalytic Fragment Of C3-
And C5- Convertase Of Human Complement
Length = 509
Score = 36.2 bits (82), Expect = 0.015, Method: Compositional matrix adjust.
Identities = 31/117 (26%), Positives = 53/117 (45%), Gaps = 17/117 (14%)
Query: 32 VPYIVSLSLYGNLYCGGSLISLQWFLSARHCFVTEN--LVW--NQFNP--------LIIA 79
P+ V++ C G+LIS QW L+A HCF N +W N +P LI
Sbjct: 235 TPWHVTIKPKSQETCRGALISDQWVLTAAHCFRDGNDHSLWRVNVGDPKSQWGKEFLIEK 294
Query: 80 GSIYRNYKEQKRQPQLNEIALIYWHSDADLAMVKLKEPFRQTTFVKPLDYYTARETN 136
I + ++ Q ++ ++ D D+A++KL + + +T +P+ E N
Sbjct: 295 AVISPGFDVFAKKNQ----GILEFYGD-DIALLKLAQKVKMSTHARPICLPCTMEAN 346
>pdb|3I77|A Chain A, 3599170-Loops Of Fxa In Sgt
Length = 230
Score = 36.2 bits (82), Expect = 0.015, Method: Compositional matrix adjust.
Identities = 18/31 (58%), Positives = 19/31 (61%), Gaps = 1/31 (3%)
Query: 180 GIVSWGIGCAL-GYPGVYVRVDHYDPWIQSV 209
GIVSWG GCA GYPGVY V + I S
Sbjct: 196 GIVSWGYGCARPGYPGVYTEVSTFASAIASA 226
>pdb|1KDQ|B Chain B, Crystal Structure Analysis Of The Mutant S189d Rat
Chymotrypsin
Length = 99
Score = 36.2 bits (82), Expect = 0.016, Method: Compositional matrix adjust.
Identities = 26/76 (34%), Positives = 36/76 (47%), Gaps = 10/76 (13%)
Query: 136 NYINDVLSKTDRSEM-SIVSGFGVTFQRDKDGIVSWGIGCALGYPGIVSWGIG-CALGYP 193
+ I DV++ S + S + G KDG+ W + GIVSWG G C+ P
Sbjct: 28 SKITDVMTCAGASGVDSCMGDSGGPLVCQKDGV--WTLA------GIVSWGSGVCSTSTP 79
Query: 194 GVYVRVDHYDPWIQSV 209
VY RV PW+Q +
Sbjct: 80 AVYSRVTALMPWVQQI 95
>pdb|1ZHM|A Chain A, Crystal Structure Of The Catalytic Domain Of The
Coagulation Factor Xia In Complex With Benzamidine
(s434a- T475a-k437 Mutant)
Length = 238
Score = 36.2 bits (82), Expect = 0.016, Method: Compositional matrix adjust.
Identities = 51/222 (22%), Positives = 81/222 (36%), Gaps = 45/222 (20%)
Query: 30 GEVPYIVSL---SLYGNLYCGGSLISLQWFLSARHCF--VTENLVWNQFNPLIIAGSIYR 84
GE P+ V+L S CGGS+I QW L+A HCF V + ++ ++ I
Sbjct: 10 GEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQAEIAE 69
Query: 85 NYKEQKRQPQLNEIALIYWHSDADLAMVKLKEPFRQTTFVKPLDYYTARETNYI------ 138
+ Q + S D+A++KL+ +P+ + + N I
Sbjct: 70 DTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYADSQRPICLPSKGDRNVIYTDCWV 129
Query: 139 ---------NDVLSKTDRSEMSIVS---------GFGVTFQRDKDGIVSWGIGCALGYP- 179
+ + + ++++ +V+ G +T + G G G
Sbjct: 130 TGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSG 189
Query: 180 --------------GIVSWGIGCA-LGYPGVYVRVDHYDPWI 206
GI SWG GCA PGVY V Y WI
Sbjct: 190 GPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWI 231
>pdb|1HNE|E Chain E, Structure Of Human Neutrophil Elastase In Complex With A
Peptide Chloromethyl Ketone Inhibitor At 1.84-Angstroms
Resolution
Length = 218
Score = 36.2 bits (82), Expect = 0.016, Method: Compositional matrix adjust.
Identities = 14/30 (46%), Positives = 21/30 (70%)
Query: 33 PYIVSLSLYGNLYCGGSLISLQWFLSARHC 62
P++VSL L G +CG +LI+ + +SA HC
Sbjct: 13 PFMVSLQLRGGHFCGATLIAPNFVMSAAHC 42
>pdb|2RG3|A Chain A, Covalent Complex Structure Of Elastase
Length = 218
Score = 36.2 bits (82), Expect = 0.017, Method: Compositional matrix adjust.
Identities = 14/30 (46%), Positives = 21/30 (70%)
Query: 33 PYIVSLSLYGNLYCGGSLISLQWFLSARHC 62
P++VSL L G +CG +LI+ + +SA HC
Sbjct: 13 PFMVSLQLRGGHFCGATLIAPNFVMSAAHC 42
>pdb|1PPG|E Chain E, The Refined 2.3 Angstroms Crystal Structure Of Human
Leukocyte Elastase In A Complex With A Valine
Chloromethyl Ketone Inhibitor
pdb|1H1B|A Chain A, Crystal Structure Of Human Neutrophil Elastase Complexed
With An Inhibitor (Gw475151)
pdb|1H1B|B Chain B, Crystal Structure Of Human Neutrophil Elastase Complexed
With An Inhibitor (Gw475151)
pdb|2Z7F|E Chain E, Crystal Structure Of The Complex Of Human Neutrophil
Elastase With 12SLPI
pdb|3Q76|A Chain A, Structure Of Human Neutrophil Elastase (uncomplexed)
pdb|3Q76|B Chain B, Structure Of Human Neutrophil Elastase (uncomplexed)
pdb|3Q77|A Chain A, Structure Of Human Neutrophil Elastase In Complex With A
Dihydropyrimidone Inhibitor
Length = 218
Score = 36.2 bits (82), Expect = 0.017, Method: Compositional matrix adjust.
Identities = 14/30 (46%), Positives = 21/30 (70%)
Query: 33 PYIVSLSLYGNLYCGGSLISLQWFLSARHC 62
P++VSL L G +CG +LI+ + +SA HC
Sbjct: 13 PFMVSLQLRGGHFCGATLIAPNFVMSAAHC 42
>pdb|1PPF|E Chain E, X-Ray Crystal Structure Of The Complex Of Human
Leukocyte Elastase (Pmn Elastase) And The Third Domain
Of The Turkey Ovomucoid Inhibitor
Length = 218
Score = 36.2 bits (82), Expect = 0.017, Method: Compositional matrix adjust.
Identities = 14/30 (46%), Positives = 21/30 (70%)
Query: 33 PYIVSLSLYGNLYCGGSLISLQWFLSARHC 62
P++VSL L G +CG +LI+ + +SA HC
Sbjct: 13 PFMVSLQLRGGHFCGATLIAPNFVMSAAHC 42
>pdb|1B0F|A Chain A, Crystal Structure Of Human Neutrophil Elastase With Mdl
101, 146
Length = 218
Score = 36.2 bits (82), Expect = 0.018, Method: Compositional matrix adjust.
Identities = 14/30 (46%), Positives = 21/30 (70%)
Query: 33 PYIVSLSLYGNLYCGGSLISLQWFLSARHC 62
P++VSL L G +CG +LI+ + +SA HC
Sbjct: 13 PFMVSLQLAGGHFCGATLIAPNFVMSAAHC 42
>pdb|3H7O|A Chain A, Crystal Structure Of Scabies Mite Inactivated Protease
Paralogue S-I1 (Smipp-S-I1)
pdb|3H7O|B Chain B, Crystal Structure Of Scabies Mite Inactivated Protease
Paralogue S-I1 (Smipp-S-I1)
Length = 228
Score = 35.4 bits (80), Expect = 0.027, Method: Compositional matrix adjust.
Identities = 35/136 (25%), Positives = 65/136 (47%), Gaps = 24/136 (17%)
Query: 31 EVPYIVSLSLY---GNLYCGGSLISLQWF-LSARHCFVTENLVWNQFNPLIIAGSIYRNY 86
+VP+ V++ Y +L CGG+++S QWF L+A HC V++Q I+ N
Sbjct: 10 QVPWTVAVRTYPGEESLTCGGAILS-QWFVLTAAHC------VFDQKPETIVIQYESTNL 62
Query: 87 KEQ--KRQPQLNEIALIYWHSDA---DLAMVKLKEPFRQTTFVKPLDYYTARETNYINDV 141
E K P ++ + L ++ + D+A+++L P + LD ++ + D+
Sbjct: 63 WEDPGKSDPYVSHVYLSFYRQETMENDIAILELSRPLK-------LDGLKSKPAK-LPDI 114
Query: 142 LSKTDRSEMSIVSGFG 157
+ +VSG+G
Sbjct: 115 EFRPKTGSDVLVSGYG 130
>pdb|1SPJ|A Chain A, Structure Of Mature Human Tissue Kallikrein (Human
Kallikrein 1 Or Klk1) At 1.70 Angstrom Resolution With
Vacant Active Site
Length = 238
Score = 35.0 bits (79), Expect = 0.034, Method: Compositional matrix adjust.
Identities = 27/101 (26%), Positives = 43/101 (42%), Gaps = 14/101 (13%)
Query: 33 PYIVSLSLYGNLYCGGSLISLQWFLSARHCFVTENLVW----NQFNPLIIAGSIYRNYKE 88
P+ +L + CGG L+ QW L+A HC +W N F+ A ++ E
Sbjct: 13 PWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVH--VSE 70
Query: 89 QKRQPQLNEIALIYWHS-------DADLAMVKLKEPFRQTT 122
P N ++L+ H+ DL +++L EP T
Sbjct: 71 SFPHPGFN-MSLLENHTRQADEDYSHDLMLLRLTEPADTIT 110
>pdb|1RTF|B Chain B, Complex Of Benzamidine With The Catalytic Domain Of Human
Two Chain Tissue Plasminogen Activator [(Tc)-T-Pa]
pdb|1A5H|A Chain A, Catalytic Domain Of Human Two-Chain Tissue Plasminogen
Activator Complex Of A Bis-Benzamidine
pdb|1A5H|B Chain B, Catalytic Domain Of Human Two-Chain Tissue Plasminogen
Activator Complex Of A Bis-Benzamidine
Length = 252
Score = 35.0 bits (79), Expect = 0.040, Method: Compositional matrix adjust.
Identities = 26/78 (33%), Positives = 37/78 (47%), Gaps = 14/78 (17%)
Query: 46 CGGSLISLQWFLSARHCFVTENLVWNQFNP---LIIAGSIYRNYKEQKRQPQLNEIALIY 102
CGG LIS W LSA HCF +F P +I G YR ++ Q E +++
Sbjct: 32 CGGILISSCWILSAAHCF------QERFPPHHLTVILGRTYRVVPGEEEQKFEVEKYIVH 85
Query: 103 WHSDA-----DLAMVKLK 115
D D+A+++LK
Sbjct: 86 KEFDDDTYDNDIALLQLK 103
Score = 29.6 bits (65), Expect = 1.7, Method: Compositional matrix adjust.
Identities = 15/42 (35%), Positives = 20/42 (47%), Gaps = 13/42 (30%)
Query: 166 GIVSWGIGCALGYPGIVSWGIGCALGYPGVYVRVDHYDPWIQ 207
GI+SWG+GC PGVY +V +Y WI+
Sbjct: 219 GIISWGLGCG-------------QKDVPGVYTKVTNYLDWIR 247
>pdb|1BDA|A Chain A, Catalytic Domain Of Human Single Chain Tissue Plasminogen
Activator In Complex With Dansyl-Egr-Cmk
(Dansyl-Glu-Gly-Arg Chloromethyl Ketone)
pdb|1BDA|B Chain B, Catalytic Domain Of Human Single Chain Tissue Plasminogen
Activator In Complex With Dansyl-Egr-Cmk
(Dansyl-Glu-Gly-Arg Chloromethyl Ketone)
Length = 265
Score = 34.7 bits (78), Expect = 0.043, Method: Compositional matrix adjust.
Identities = 26/78 (33%), Positives = 37/78 (47%), Gaps = 14/78 (17%)
Query: 46 CGGSLISLQWFLSARHCFVTENLVWNQFNP---LIIAGSIYRNYKEQKRQPQLNEIALIY 102
CGG LIS W LSA HCF +F P +I G YR ++ Q E +++
Sbjct: 45 CGGILISSCWILSAAHCF------QERFPPHHLTVILGRTYRVVPGEEEQKFEVEKYIVH 98
Query: 103 WHSDA-----DLAMVKLK 115
D D+A+++LK
Sbjct: 99 KEFDDDTYDNDIALLQLK 116
Score = 29.6 bits (65), Expect = 1.7, Method: Compositional matrix adjust.
Identities = 15/42 (35%), Positives = 20/42 (47%), Gaps = 13/42 (30%)
Query: 166 GIVSWGIGCALGYPGIVSWGIGCALGYPGVYVRVDHYDPWIQ 207
GI+SWG+GC PGVY +V +Y WI+
Sbjct: 232 GIISWGLGCG-------------QKDVPGVYTKVTNYLDWIR 260
>pdb|2PSX|A Chain A, Crystal Structure Of Human Kallikrein 5 In Complex With
Leupeptin
pdb|2PSY|A Chain A, Crystal Structure Of Human Kallikrein 5 In Complex With
Leupeptin And Zinc
Length = 227
Score = 34.3 bits (77), Expect = 0.057, Method: Compositional matrix adjust.
Identities = 29/100 (29%), Positives = 44/100 (44%), Gaps = 9/100 (9%)
Query: 33 PYIVSLSLYGN-LYCGGSLISLQWFLSARHC---FVTENLVWNQFNPLIIAGSIYRNYKE 88
P+ +L L N LYCG L+ QW L+A HC L +P+ +G +
Sbjct: 13 PWQAALLLRPNQLYCGAVLVHPQWLLTAAHCRKKVFRVRLGHYSLSPVYESGQQMFQGVK 72
Query: 89 QKRQPQLNEIALIYWHSDADLAMVKLKEPFRQTTFVKPLD 128
P + HS+ DL ++KL R T V+P++
Sbjct: 73 SIPHPGYSHPG----HSN-DLMLIKLNRRIRPTKDVRPIN 107
>pdb|1NPM|A Chain A, Neuropsin, A Serine Protease Expressed In The Limbic
System Of Mouse Brain
pdb|1NPM|B Chain B, Neuropsin, A Serine Protease Expressed In The Limbic
System Of Mouse Brain
Length = 225
Score = 34.3 bits (77), Expect = 0.061, Method: Compositional matrix adjust.
Identities = 51/221 (23%), Positives = 86/221 (38%), Gaps = 46/221 (20%)
Query: 29 PGEVPYIVSLSLYGNLYCGGSLISLQWFLSARHC-------FVTENLVWNQFNP---LII 78
P P+ +L L CGG L+ +W L+A HC + ++ + ++ P + +
Sbjct: 9 PHSQPWQAALFQGERLICGGVLVGDRWVLTAAHCKKQKYSVRLGDHSLQSRDQPEQEIQV 68
Query: 79 AGSI-YRNYKEQKRQPQLNEIALIYWHSDADLA-------MVKLKEPFRQTTFVKPLDYY 130
A SI + Y + ++I LI + A+L + L Q +
Sbjct: 69 AQSIQHPCYNNSNPEDHSHDIMLIRLQNSANLGDKVKPVQLANLCPKVGQKCIISGWGTV 128
Query: 131 TARETNYINDVLSKTDRSEMSIVSGFGVTFQRDKDGIVSWGIGCA------------LGY 178
T+ + N+ N + + +E+ I S +R G ++ G+ CA G
Sbjct: 129 TSPQENFPNTL----NCAEVKIYSQN--KCERAYPGKITEGMVCAGSSNGADTCQGDSGG 182
Query: 179 P--------GIVSWGIG-CAL-GYPGVYVRVDHYDPWIQSV 209
P GI SWG C PGVY ++ Y WI+
Sbjct: 183 PLVCDGMLQGITSWGSDPCGKPEKPGVYTKICRYTTWIKKT 223
>pdb|1ELT|A Chain A, Structure Of Native Pancreatic Elastase From North
Atlantic Salmon At 1.61 Angstroms Resolution
Length = 236
Score = 33.1 bits (74), Expect = 0.12, Method: Compositional matrix adjust.
Identities = 30/98 (30%), Positives = 43/98 (43%), Gaps = 17/98 (17%)
Query: 29 PGEVPYIVSLSL-YGNLY---CGGSLISLQWFLSARHCFVTENLVWNQFNPLIIAGSIYR 84
P P+ +SL G+ Y CGGSLI W ++A HC V W ++ G
Sbjct: 9 PNSWPWQISLQYKSGSSYYHTCGGSLIRQGWVMTAAHC-VDSARTWR-----VVLGEHNL 62
Query: 85 NYKEQKRQPQLNEIALIY--WHSDA-----DLAMVKLK 115
N E K Q I+ W+SD D+A+++L
Sbjct: 63 NTNEGKEQIMTVNSVFIHSGWNSDDVAGGYDIALLRLN 100
>pdb|2KAI|A Chain A, Refined 2.5 Angstroms X-Ray Crystal Structure Of The
Complex Formed By Porcine Kallikrein A And The Bovine
Pancreatic Trypsin Inhibitor. Crystallization,
Patterson Search, Structure Determination, Refinement,
Structure And Comparison With Its Components And With
The Bovine Trypsin- Pancreatic Trypsin Inhibitor
Complex
pdb|2PKA|A Chain A, Refined 2 Angstroms X-Ray Crystal Structure Of Porcine
Pancreatic Kallikrein A, A Specific Trypsin-Like Serine
Proteinase. Crystallization, Structure Determination,
Crystallographic Refinement, Structure And Its
Comparison With Bovine Trypsin
pdb|2PKA|X Chain X, Refined 2 Angstroms X-Ray Crystal Structure Of Porcine
Pancreatic Kallikrein A, A Specific Trypsin-Like Serine
Proteinase. Crystallization, Structure Determination,
Crystallographic Refinement, Structure And Its
Comparison With Bovine Trypsin
pdb|1HIA|A Chain A, Kallikrein Complexed With Hirustasin
pdb|1HIA|X Chain X, Kallikrein Complexed With Hirustasin
Length = 80
Score = 33.1 bits (74), Expect = 0.13, Method: Compositional matrix adjust.
Identities = 14/38 (36%), Positives = 22/38 (57%)
Query: 33 PYIVSLSLYGNLYCGGSLISLQWFLSARHCFVTENLVW 70
P+ V++ Y + CGG L++ +W L+A HC VW
Sbjct: 13 PWQVAIYHYSSFQCGGVLVNPKWVLTAAHCKNDNYEVW 50
>pdb|4GAW|A Chain A, Crystal Structure Of Active Human Granzyme H
pdb|4GAW|B Chain B, Crystal Structure Of Active Human Granzyme H
pdb|4GAW|C Chain C, Crystal Structure Of Active Human Granzyme H
pdb|4GAW|D Chain D, Crystal Structure Of Active Human Granzyme H
pdb|4GAW|E Chain E, Crystal Structure Of Active Human Granzyme H
pdb|4GAW|F Chain F, Crystal Structure Of Active Human Granzyme H
pdb|4GAW|G Chain G, Crystal Structure Of Active Human Granzyme H
pdb|4GAW|H Chain H, Crystal Structure Of Active Human Granzyme H
pdb|4GAW|I Chain I, Crystal Structure Of Active Human Granzyme H
pdb|4GAW|J Chain J, Crystal Structure Of Active Human Granzyme H
pdb|4GAW|K Chain K, Crystal Structure Of Active Human Granzyme H
pdb|4GAW|L Chain L, Crystal Structure Of Active Human Granzyme H
Length = 226
Score = 33.1 bits (74), Expect = 0.13, Method: Compositional matrix adjust.
Identities = 45/203 (22%), Positives = 74/203 (36%), Gaps = 52/203 (25%)
Query: 46 CGGSLISLQWFLSARHCFVTENLVWNQFNPLIIAGSIYRNYKEQKRQPQLNEIALIYWHS 105
CGG L+ + L+A HC + N + A N KEQ+R Q + H
Sbjct: 29 CGGILVRKDFVLTAAHC------QGSSINVTLGA----HNIKEQERTQQFIPVKRPIPHP 78
Query: 106 -------DADLAMVKLKEPFRQTTFVKPLDYYTARET------------NYINDVLSKTD 146
D+ +++L+ + TT V+PL +++ Y++ T
Sbjct: 79 AYNPKNFSNDIMLLQLERKAKWTTAVRPLRLPSSKAQVKPGQLCSVAGWGYVSMSTLATT 138
Query: 147 RSEMSIVSGFGVTFQRDKDGIVSWGIGCALGYP----------------------GIVSW 184
E+ + +R G S +G P GI+S+
Sbjct: 139 LQEVLLTVQKDCQCERLFHGNYSRATEICVGDPKKTQTGFKGDSGGPLVCKDVAQGILSY 198
Query: 185 GIGCALGYPGVYVRVDHYDPWIQ 207
G PGVY++V H+ PWI+
Sbjct: 199 GNKKGTP-PGVYIKVSHFLPWIK 220
>pdb|1A5I|A Chain A, Catalytic Domain Of Vampire Bat (Desmodus Rotundus) Saliva
Plasminogen Activator In Complex With Egr-Cmk
(Glu-Gly-Arg Chloromethyl Ketone)
Length = 265
Score = 33.1 bits (74), Expect = 0.16, Method: Compositional matrix adjust.
Identities = 23/75 (30%), Positives = 39/75 (52%), Gaps = 8/75 (10%)
Query: 46 CGGSLISLQWFLSARHCFVTENLVWNQFNPLIIAGSIYRNYKEQKRQPQLNEIALIYWHS 105
CGG LIS W L+A HCF E+ + +Q ++ G YR ++ Q + +++
Sbjct: 45 CGGILISSCWVLTAAHCF-QESYLPDQLK--VVLGRTYRVKPGEEEQTFKVKKYIVHKEF 101
Query: 106 DA-----DLAMVKLK 115
D D+A+++LK
Sbjct: 102 DDDTYNNDIALLQLK 116
Score = 30.0 bits (66), Expect = 1.2, Method: Compositional matrix adjust.
Identities = 15/42 (35%), Positives = 20/42 (47%), Gaps = 13/42 (30%)
Query: 166 GIVSWGIGCALGYPGIVSWGIGCALGYPGVYVRVDHYDPWIQ 207
GI+SWG+GC PGVY +V +Y WI+
Sbjct: 232 GIISWGVGCG-------------EKDVPGVYTKVTNYLGWIR 260
>pdb|2OLG|A Chain A, Crystal Structure Of The Serine Protease Domain Of
Prophenoloxidase Activating Factor-I In A Zymogen Form
Length = 278
Score = 32.7 bits (73), Expect = 0.16, Method: Compositional matrix adjust.
Identities = 49/246 (19%), Positives = 86/246 (34%), Gaps = 70/246 (28%)
Query: 29 PGEVPYIVSL-----SLYGNLYCGGSLISLQWFLSARHCFVTENL------------VWN 71
P E P+ + S + CGGSLI+ ++ ++A HC L WN
Sbjct: 31 PEEFPWTAMIGYKNSSNFEQFACGGSLINNRYIVTAAHCVAGRVLRVVGALNKVRLGEWN 90
Query: 72 QFNPLIIAGSIY---------RNYKEQKRQPQLNEIALIYWHSDADLAMVKLKEPFRQTT 122
G++ +E + P + + +H D+A+++L T
Sbjct: 91 TATDPDCYGAVRVCVPDKPIDLGIEETIQHPDYVDGSKDRYH---DIALIRLNRQVEFTN 147
Query: 123 FVKPLDYYTARETNYINDVLS-----KTDRSEMSIVS---------------GFGVTFQR 162
+++P+ E + L+ +T+ + S + FG R
Sbjct: 148 YIRPVCLPQPNEEVQVGQRLTVVGWGRTETGQYSTIKQKLAVPVVHAEQCAKTFGAAGVR 207
Query: 163 DKDGIVSWG-------IGCALGYP-------------GIVSWGIGCAL-GYPGVYVRVDH 201
+ + G G G P G+VS+G C G+PG+Y +V
Sbjct: 208 VRSSQLCAGGEKAKDSCGGDSGGPLLAERANQQFFLEGLVSFGATCGTEGWPGIYTKVGK 267
Query: 202 YDPWIQ 207
Y WI+
Sbjct: 268 YRDWIE 273
>pdb|2FMJ|A Chain A, 220-Loop Mutant Of Streptomyces Griseus Trypsin
Length = 222
Score = 32.0 bits (71), Expect = 0.29, Method: Compositional matrix adjust.
Identities = 51/217 (23%), Positives = 78/217 (35%), Gaps = 45/217 (20%)
Query: 30 GEVPYIVSLSLYGNLYCGGSLISLQWFLSARHCFVTENLVWNQFNPLIIAGSIYRNYKEQ 89
GE P++V LS+ CGG+L + L+A HC + G +
Sbjct: 10 GEFPFMVRLSMG----CGGALYAQDIVLTAAHCVSGS----GNNTSITATGGVVDLQSSS 61
Query: 90 KRQPQLNEI--ALIYWHSDADLAMVKLKEPFRQTTF-VKPLDYYTA-----------RET 135
+ + ++ A Y + D A++KL +P Q T + Y RE
Sbjct: 62 AVKVRSTKVLQAPGYNGTGKDWALIKLAQPINQPTLKIATTTAYNQGTFTVAGWGANREG 121
Query: 136 NYINDVLSKTD---RSEMSIVSGFGVTFQRDKD---GIVSWGIGCALGYP---------- 179
L K + S+ + S +G +++ G + G+ G
Sbjct: 122 GSQQRYLLKANVPFVSDAACRSAYGNELVANEEICAGYDTGGVDTCQGDSGGPMFRKDNA 181
Query: 180 ------GIVSWGIGCAL-GYPGVYVRVDHYDPWIQSV 209
GIVSWG GCA G GVY V + I S
Sbjct: 182 DEWIQVGIVSWGEGCARKGKYGVYTEVSTFASAIASA 218
>pdb|1HYL|A Chain A, The 1.8 A Structure Of Collagenase From Hypoderma
Lineatum
pdb|1HYL|B Chain B, The 1.8 A Structure Of Collagenase From Hypoderma
Lineatum
pdb|2HLC|A Chain A, Hl Collagenase Structure At 1.7a Resolution
pdb|2HLC|B Chain B, Hl Collagenase Structure At 1.7a Resolution
Length = 230
Score = 31.6 bits (70), Expect = 0.35, Method: Compositional matrix adjust.
Identities = 12/27 (44%), Positives = 18/27 (66%)
Query: 36 VSLSLYGNLYCGGSLISLQWFLSARHC 62
++L ++CGGSLI +W L+A HC
Sbjct: 20 ITLQDQRRVWCGGSLIDNKWILTAAHC 46
>pdb|1EPT|C Chain C, Refined 1.8 Angstroms Resolution Crystal Structure Of
Porcine Epsilon-Trypsin
pdb|1AKS|B Chain B, Crystal Structure Of The First Active Autolysate Form Of
The Porcine Alpha Trypsin
Length = 98
Score = 31.6 bits (70), Expect = 0.35, Method: Compositional matrix adjust.
Identities = 21/54 (38%), Positives = 23/54 (42%), Gaps = 13/54 (24%)
Query: 154 SGFGVTFQRDKDGIVSWGIGCALGYPGIVSWGIGCALGYPGVYVRVDHYDPWIQ 207
SG V GIVSWG GCA PGVY +V +Y WIQ
Sbjct: 52 SGGPVVCNGQLQGIVSWGYGCA-------------QKNKPGVYTKVCNYVNWIQ 92
>pdb|1HAX|B Chain B, Snapshots Of Serine Protease Catalysis: (A) Acyl-Enzyme
Intermediate Between Porcine Pancreatic Elastase And
Human Beta-Casomorphin-7 At Ph 5
pdb|1HAY|B Chain B, Snapshots Of Serine Protease Catalysis: (B) Acyl-Enzyme
Intermediate Between Porcine Pancreatic Elastase And
Human Beta-Casomorphin-7 Jumped To Ph 10 For 10 Seconds
pdb|1HB0|B Chain B, Snapshots Of Serine Protease Catalysis: (D) Acyl-Enzyme
Intermediate Between Porcine Pancreatic Elastase And
Human Beta-Casomorphin-7 Jumped To Ph 10 For 2 Minutes
Length = 240
Score = 31.6 bits (70), Expect = 0.40, Method: Compositional matrix adjust.
Identities = 19/85 (22%), Positives = 40/85 (47%), Gaps = 9/85 (10%)
Query: 46 CGGSLISLQWFLSARHCFVTENLVWNQFNPLIIAGSIYRNYKEQKRQPQLNEIALIYWHS 105
CGG+LI W ++A HC E F ++ ++ +N ++ + YW++
Sbjct: 30 CGGTLIRQNWVMTAAHCVDRELT----FRVVVGEHNLNQNNGTEQYVGVQKIVVHPYWNT 85
Query: 106 DA-----DLAMVKLKEPFRQTTFVK 125
D D+A+++L + ++V+
Sbjct: 86 DDVAAGYDIALLRLAQSVTLNSYVQ 110
>pdb|1MTN|C Chain C, Bovine Alpha-Chymotrypsin:bpti Crystallization
pdb|1MTN|G Chain G, Bovine Alpha-Chymotrypsin:bpti Crystallization
pdb|1AB9|C Chain C, Crystal Structure Of Bovine Gamma-Chymotrypsin
pdb|1CA0|C Chain C, Bovine Chymotrypsin Complexed To Appi
pdb|1CA0|H Chain H, Bovine Chymotrypsin Complexed To Appi
pdb|1CBW|C Chain C, Bovine Chymotrypsin Complexed To Bpti
pdb|1CBW|H Chain H, Bovine Chymotrypsin Complexed To Bpti
pdb|1VGC|C Chain C, Gamma-Chymotrypsin L-Para-Chloro-1-Acetamido Boronic Acid
Inhibitor Complex
pdb|2VGC|C Chain C, Gamma-Chymotrypsin D-Para-Chloro-1-Acetamido Boronic Acid
Inhibitor Complex
pdb|3VGC|C Chain C, Gamma-Chymotrypsin L-Naphthyl-1-Acetamido Boronic Acid
Acid Inhibitor Complex
pdb|4VGC|C Chain C, Gamma-Chymotrypsin D-Naphthyl-1-Acetamido Boronic Acid
Inhibitor Complex
pdb|1HJA|C Chain C, Lys 18 Variant Of Turkey Ovomucoid Inhibitor Third Domain
Complexed With Alpha-Chymotrypsin
pdb|1GG6|C Chain C, Crystal Stucture Of Gamma Chymotrypsin With N-Acetyl-
Phenylalanine Trifluoromethyl Ketone Bound At The Active
Site
pdb|1GGD|C Chain C, Crystal Stucture Of Gamma Chymotrypsin With
N-Acetyl-Leucil- Phenylalanine Aldehyde Bound At The
Active Site
pdb|1N8O|C Chain C, Crystal Structure Of A Complex Between Bovine Chymotrypsin
And Ecotin
pdb|1YPH|E Chain E, High Resolution Structure Of Bovine Alpha-Chymotrypsin
pdb|1YPH|F Chain F, High Resolution Structure Of Bovine Alpha-Chymotrypsin
pdb|2P8O|C Chain C, Crystal Structure Of A Benzohydroxamic AcidVANADATE
Complex Bound To Chymotrypsin A
pdb|1GMH|G Chain G, Refined Crystal Structure Of "aged" And "non-Aged"
Organophosphoryl Conjugates Of Gamma-Chymotrypsin
pdb|2CHA|C Chain C, The Structure Of Crystalline Alpha-Chymotrypsin, v.The
Atomic Structure Of Tosyl-Alpha-Chymotrypsin At 2
Angstroms Resolution
pdb|2CHA|G Chain G, The Structure Of Crystalline Alpha-Chymotrypsin, v.The
Atomic Structure Of Tosyl-Alpha-Chymotrypsin At 2
Angstroms Resolution
pdb|2GCH|G Chain G, Refined Crystal Structure Of Gamma-chymotrypsin At 1.9
Angstroms Resolution
pdb|4GCH|G Chain G, Structure And Activity Of Two Photoreversible Cinnamates
Bound To Chymotrypsin
pdb|5GCH|G Chain G, Chemistry Of Caged Enzymes II. Photoactivation Of
Inhibited Chymotrypsin
pdb|6GCH|G Chain G, Structure Of Chymotrypsin-Trifluoromethyl Ketone Inhibitor
Complexes. Comparison Of Slowly And Rapidly
Equilibrating Inhibitors
pdb|7GCH|G Chain G, Structure Of Chymotrypsin-Trifluoromethyl Ketone Inhibitor
Complexes. Comparison Of Slowly And Rapidly
Equilibrating Inhibitors
pdb|1CHO|G Chain G, Crystal And Molecular Structures Of The Complex Of Alpha-
Chymotrypsin With Its Inhibitor Turkey Ovomucoid Third
Domain At 1.8 Angstroms Resolution
pdb|1GHA|G Chain G, A Second Active Site In Chymotrypsin? The X-Ray Crystal
Structure Of N-Acetyl-D-Tryptophan Bound To
Gamma-Chymotrypsin
pdb|1GMC|G Chain G, The X-Ray Crystal Structure Of The Tetrahedral
Intermediate Of Gamma- Chymotrypsin In Hexane
pdb|1GMD|G Chain G, X-Ray Crystal Structure Of Gamma-Chymotrypsin In Hexane
pdb|3GCT|G Chain G, Structure Of Gamma-Chymotrypsin In The Range pH 2.0 To pH
10.5 Suggests That Gamma-Chymotrypsin Is A Covalent
Acyl-Enzyme Adduct At Low pH
pdb|4CHA|C Chain C, Structure Of Alpha-Chymotrypsin Refined At 1.68 Angstroms
Resolution
pdb|4CHA|G Chain G, Structure Of Alpha-Chymotrypsin Refined At 1.68 Angstroms
Resolution
pdb|5CHA|C Chain C, The Refinement And The Structure Of The Dimer Of Alpha-
Chymotrypsin At 1.67-Angstroms Resolution
pdb|5CHA|G Chain G, The Refinement And The Structure Of The Dimer Of Alpha-
Chymotrypsin At 1.67-Angstroms Resolution
pdb|6CHA|C Chain C, Structure Of A Tetrahedral Transition State Complex Of
Alpha-Chymotrypsin At 1.8-Angstroms Resolution
pdb|6CHA|G Chain G, Structure Of A Tetrahedral Transition State Complex Of
Alpha-Chymotrypsin At 1.8-Angstroms Resolution
pdb|8GCH|G Chain G, Gamma-Chymotrypsin Is A Complex Of Alpha-Chymotrypsin With
Its Own Autolysis Products
pdb|3BG4|C Chain C, The Crystal Structure Of Guamerin In Complex With
Chymotrypsin And The Development Of An Elastase-Specific
Inhibitor
pdb|1GCT|C Chain C, Is Gamma-Chymotrypsin A Tetrapeptide Acyl-Enzyme Adduct Of
Gamma- Chymotrypsin?
pdb|2GCT|C Chain C, Structure Of Gamma-Chymotrypsin In The Range Ph 2.0 To Ph
10.5 Suggests That Gamma-Chymotrypsin Is A Covalent
Acyl-Enzyme Adduct At Low Ph
pdb|1GHB|G Chain G, A Second Active Site In Chymotrypsin? The X-Ray Crystal
Structure Of N-Acetyl-D-Tryptophan Bound To
Gamma-Chymotrypsin
pdb|2GMT|C Chain C, Three-Dimensional Structure Of Chymotrypsin Inactivated
With (2s) N- Acetyl-L-Alanyl-L-Phenylalanyl-Chloroethyl
Ketone: Implications For The Mechanism Of Inactivation
Of Serine Proteases By Chloroketones
pdb|3GCH|C Chain C, Chemistry Of Caged Enzymes. Binding Of Photoreversible
Cinnamates To Chymotrypsin
Length = 97
Score = 31.6 bits (70), Expect = 0.40, Method: Compositional matrix adjust.
Identities = 15/29 (51%), Positives = 17/29 (58%), Gaps = 1/29 (3%)
Query: 180 GIVSWGIG-CALGYPGVYVRVDHYDPWIQ 207
GIVSWG C+ PGVY RV W+Q
Sbjct: 63 GIVSWGSSTCSTSTPGVYARVTALVNWVQ 91
>pdb|2EST|E Chain E, Crystallographic Study Of The Binding Of A Trifluoroacetyl
Dipeptide Anilide Inhibitor With Elastase
pdb|4EST|E Chain E, Crystal Structure Of The Covalent Complex Formed By A
Peptidyl Alpha, Alpha-Difluoro-Beta-Keto Amide With
Porcine Pancreatic Elastase At 1.78-Angstroms Resolution
pdb|5EST|E Chain E, Crystallographic Analysis Of The Inhibition Of Porcine
Pancreatic Elastase By A Peptidyl Boronic Acid:
Structure Of A Reaction Intermediate
pdb|7EST|E Chain E, Interaction Of The Peptide Cf3-Leu-Ala-Nh-C6h4-Cf3(Tfla)
With Porcine Pancreatic Elastase. X-Ray Studies At 1.8
Angstroms
pdb|8EST|E Chain E, Reaction Of Porcine Pancreatic Elastase With 7-substituted
3-alkoxy-4-chloroisocoumarins: Design Of Potent
Inhibitors Using The Crystal Structure Of The Complex
Formed With 4- Chloro-3-ethoxy-7-guanidino-isocoumarin
pdb|1ELA|A Chain A, Analogous Inhibitors Of Elastase Do Not Always Bind
Analogously
pdb|1ELC|A Chain A, Analogous Inhibitors Of Elastase Do Not Always Bind
Analogously
pdb|1ELB|A Chain A, Analogous Inhibitors Of Elastase Do Not Always Bind
Analogously
pdb|1ELD|E Chain E, Structural Analysis Of The Active Site Of Porcine
Pancreatic Elastase Based On The X-Ray Crystal
Structures Of Complexes With
Trifluoroacetyl-Dipeptide-Anilide Inhibitors
pdb|1ELE|E Chain E, Structural Analysis Of The Active Site Of Porcine
Pancreatic Elastase Based On The X-Ray Crystal
Structures Of Complexes With
Trifluoroacetyl-Dipeptide-Anilide Inhibitors
pdb|1NES|E Chain E, Structure Of The Product Complex Of Acetyl-ala-pro-ala
With Porcine Pancreatic Elastase At 1.65 Angstroms
Resolution
pdb|1BMA|A Chain A, Benzyl Methyl Aminimide Inhibitor Complexed To Porcine
Pancreatic Elastase
pdb|1FLE|E Chain E, Crystal Structure Of Elafin Complexed With Porcine
Pancreatic Elastase
pdb|1B0E|A Chain A, Crystal Structure Of Porcine Pancreatic Elastase With Mdl
101,146
pdb|1QGF|A Chain A, Porcine Pancreatic Elastase Complexed With (3r, 4s)n-Para-
Toluenesulphonyl-3-Ethyl-4-(Carboxylic
Acid)pyrrolidin-2- One
pdb|1QIX|B Chain B, Porcine Pancreatic Elastase Complexed With Human
Beta-casomorphin-7
pdb|1QR3|E Chain E, Structure Of Porcine Pancreatic Elastase In Complex With
Fr901277, A Novel Macrocyclic Inhibitor Of Elastases At
1.6 Angstrom Resolution
pdb|1E34|B Chain B, Porcine Pancreatic Elastase Complexed With (3s, 4s)n-Para-
Toluenesulphonyl-3-Ethyl-4-(Carboxylic Acid)
Pyrrolidin-2- One Soaked In Ph 9 Buffer For One Minute
pdb|1E35|B Chain B, Porcine Pancreatic Elastase Complexed With (3s, 4s)n-Para-
Toluenesulphonyl-3-Ethyl-4-(Carboxylic
Acid)pyrrolidin-2- One Soaked In Ph 9 Buffer For Two
Minutes
pdb|1E36|B Chain B, Porcine Pancreatic Elastase Complexed With (3s, 4s)n-Para-
Nitrobenzenesulphonyl-3-Ethyl-4-(Carboxylic Acid)
Pyrrolidin-2-One
pdb|1E37|B Chain B, Porcine Pancreatic Elastase Complexed With (3s, 4s)n-Para-
Nitrobenzenesulphonyl-3-Ethyl-4-(Carboxylic Acid)
Pyrrolidin-2-One Soaked In Ph 9 Buffer For 1 Minute
pdb|1E38|B Chain B, Porcine Pancreatic Elastase Complexed With (3s, 4s)n-Para-
Nitrobenzenesulphonyl-3-Ethyl-4-(Carboxylic Acid)
Pyrrolidin-2-One Soaked In Ph 9 Buffer For 2 Minutes
pdb|1HAZ|B Chain B, Snapshots Of Serine Protease Catalysis: (c) Acyl-enzyme
Intermediate Between Porcine Pancreatic Elastase And
Human Beta-casomorphin-7 Jumped To Ph 9 For 1 Minute
pdb|1H9L|B Chain B, Porcine Pancreatic Elastase Complexed With
Acetyl-Val-Glu-Pro-Ile-Cooh
pdb|1OKX|A Chain A, Binding Structure Of Elastase Inhibitor Scyptolin A
pdb|1OKX|B Chain B, Binding Structure Of Elastase Inhibitor Scyptolin A
pdb|2FO9|A Chain A, Structure Of Porcine Pancreatic Elastase In 95% Acetone
pdb|2FOA|A Chain A, Structure Of Porcine Pancreatic Elastase In 405010 %
BENZENE
pdb|2FOB|A Chain A, Structure Of Porcine Pancreatic Elastase In 405010
CYCLOHEXANE
pdb|2FOC|A Chain A, Structure Of Porcine Pancreatic Elastase In 55%
Dimethylformamide
pdb|2FOD|A Chain A, Structure Of Porcine Pancreatic Elastase In 80% Ethanol
pdb|2FOE|A Chain A, Structure Of Porcine Pancreatic Elastase In 80% Hexane
pdb|2FOF|A Chain A, Structure Of Porcine Pancreatic Elastase In 80%
Isopropanol
pdb|2FOG|A Chain A, Structure Of Porcine Pancreatic Elastase In 40%
Trifluoroethanol
pdb|2FOH|A Chain A, Structure Of Porcine Pancreatic Elastase In 40%
Trifluoroethanol
pdb|2BD4|A Chain A, Porcine Pancreatic Elastase Complexed With
Beta-Casomorphin- 7 And Lys-Ser At Ph 5.0
pdb|2BD5|A Chain A, Porcine Pancreatic Elastase Complexed With
Beta-Casomorphin-7 And Lys- Ser At Ph 5 And Immersed In
Ph 9 Buffer For 30 Seconds
pdb|2BD9|A Chain A, Porcine Pancreatic Elastase Complexed With
Beta-casomorphin-7 And Arg- Phe At Ph 5.0 (50 Min Soak)
And Immersed In Ph 9 Buffer For 28 Seconds (2nd Ph Jump)
pdb|2BDC|A Chain A, Porcine Pancreatic Elastase Complexed With Asn-pro-ile At
Ph 5.0
pdb|2H1U|A Chain A, Porcine Pancreatic Elastase Complexed With Metpheleuglu At
Ph 5.0
pdb|1BTU|A Chain A, Porcine Pancreatic Elastase Complexed With (3s, 4r)-1-
Toluenesulphonyl-3-Ethyl-Azetidin-2-One-4-Carboxylic
Acid
pdb|1EAS|A Chain A, Nonpeptidic Inhibitors Of Human Leukocyte Elastase. 3.
Design, Synthesis, X-Ray Crystallographic Analysis, And
Structure-Activity Relationships For A Series Of Orally
Active 3-Amino-6-Phenylpyridin- 2-One Trifluoromethyl
Ketones
pdb|1EAT|A Chain A, Nonpeptidic Inhibitors Of Human Leukocyte Elastase. 5.
Design, Synthesis, And X-Ray Crystallography Of A Series
Of Orally Active 5- Amino-Pyrimidin-6-One-Containing
Trifluoromethylketones
pdb|1EAU|A Chain A, Nonpeptidic Inhibitors Of Human Leukocyte Elastase. 6.
Design Of A Potent, Intratracheally Active,
Pyridone-Based Trifluoromethyl Ketone
pdb|1ELF|A Chain A, Nature Of The Inactivation Of Elastase By N-Peptidyl-O-
Aroyl Hydroxylamine As A Function Of Ph
pdb|1ELG|A Chain A, Nature Of The Inactivation Of Elastase By N-Peptidyl-O-
Aroyl Hydroxylamine As A Function Of Ph
pdb|1ESA|A Chain A, Direct Structure Observation Of An Acyl-Enzyme
Intermediate In The Hydrolysis Of An Ester Substrate By
Elastase
pdb|1EST|A Chain A, The Atomic Structure Of Crystalline Porcine Pancreatic
Elastase At 2.5 Angstroms Resolution. Comparisons With
The Structure Of Alpha- Chymotrypsin
pdb|1INC|A Chain A, Crystal Structures Of The Complex Of Porcine Pancreatic
Elastase With Two Valine-Derived Benzoxazinone
Inhibitors
pdb|1JIM|A Chain A, Stereospecific Reaction Of 3-Methoxy-4-Chloro-7-
Aminoisocoumarin With Crystalline Porcine Pancreatic
Elastase
pdb|1LVY|A Chain A, Porcine Elastase
pdb|3EST|A Chain A, Structure Of Native Porcine Pancreatic Elastase At 1.65
Angstroms Resolution
pdb|6EST|A Chain A, Interaction Of The Peptide Cf3-Leu-Ala-Nh-C6h4-Cf3(Tfla)
With Porcine Pancreatic Elastase. X-Ray Studies At 1.8
Angstroms
pdb|9EST|A Chain A, Structural Study Of Porcine Pancreatic Elastase Complexed
With 7- Amino-3-(2-Bromoethoxy)-4-Chloroisocoumarin As A
Nonreactivatable Doubly Covalent Enzyme-Inhibitor
Complex
pdb|1GVK|B Chain B, Porcine Pancreatic Elastase Acyl Enzyme At 0.95 A
Resolution
pdb|3E3T|A Chain A, Structure Of Porcine Pancreatic Elastase With The Magic
Triangle I3c
pdb|3MNB|A Chain A, Investigation Of Global And Local Effects Of Radiation
Damage On Porcine Pancreatic Elastase. First Stage Of
Radiation Damage
pdb|3MNC|A Chain A, Investigation Of Global And Local Effects Of Radiation
Damage On Porcine Pancreatic Elastase. Second Stage Of
Radiation Damage
pdb|3MNS|A Chain A, Investigation Of Global And Local Effects Of Radiation
Damage On Porcine Pancreatic Elastase. Third Stage Of
Radiation Damage
pdb|3MNX|A Chain A, Investigation Of Global And Local Effects Of Radiation
Damage On Porcine Pancreatic Elastase. Fourth Stage Of
Radiation Damage
pdb|3MO3|A Chain A, Investigation Of Global And Local Effects Of Radiation
Damage On Porcine Pancreatic Elastase. Fifth Stage Of
Radiation Damage
pdb|3MO6|A Chain A, Investigation Of Global And Local Effects Of Radiation
Damage On Porcine Pancreatic Elastase. Sixth Stage Of
Radiation Damage
pdb|3MO9|A Chain A, Investigation Of Global And Local Effects Of Radiation
Damage On Porcine Pancreatic Elastase. Seventh Stage Of
Radiation Damage
pdb|3MOC|A Chain A, Investigation Of Global And Local Effects Of Radiation
Damage On Porcine Pancreatic Elastase. Eighth Stage Of
Radiation Damage
pdb|3MTY|A Chain A, Comparison Of The Character And The Speed Of X-Ray-Induced
Structural Changes Of Porcine Pancreatic Elastase At Two
Temperatures, 100 And 15k. The Data Set Was Collected
From Region A Of The Crystal. First Step Of Radiation
Damage
pdb|3MU0|A Chain A, Comparison Of The Character And The Speed Of X-Ray-Induced
Structural Changes Of Porcine Pancreatic Elastase At Two
Temperatures, 100 And 15k. The Data Set Was Collected
From Region A Of The Crystal. Third Step Of Radiation
Damage
pdb|3MU1|A Chain A, Comparison Of The Character And The Speed Of X-Ray-Induced
Structural Changes Of Porcine Pancreatic Elastase At Two
Temperatures, 100 And 15k. The Data Set Was Collected
From Region A Of The Crystal. Fifth Step Of Radiation
Damage
pdb|3MU4|A Chain A, Comparison Of The Character And The Speed Of X-Ray-Induced
Structural Changes Of Porcine Pancreatic Elastase At Two
Temperatures, 100 And 15k. The Data Set Was Collected
From Region B Of The Crystal. First Step Of Radiation
Damage
pdb|3MU5|A Chain A, Comparison Of The Character And The Speed Of X-Ray-Induced
Structural Changes Of Porcine Pancreatic Elastase At Two
Temperatures, 100 And 15k. The Data Set Was Collected
From Region B Of The Crystal. Third Step Of Radiation
Damage
pdb|3MU8|A Chain A, Comparison Of The Character And The Speed Of X-Ray-Induced
Structural Changes Of Porcine Pancreatic Elastase At Two
Temperatures, 100 And 15k. The Data Set Was Collected
From Region B Of The Crystal. Fifth Step Of Radiation
Damage
pdb|3ODD|A Chain A, Comparison Of The Character And The Speed Of X-Ray-Induced
Structural Changes Of Porcine Pancreatic Elastase At Two
Temperatures, 100 And 15k. The Data Set Was Collected
From Region B Of The Crystal. Second Step Of Radiation
Damage
pdb|3ODF|A Chain A, Comparison Of The Character And The Speed Of X-Ray-Induced
Structural Changes Of Porcine Pancreatic Elastase At Two
Temperatures, 100 And 15k. The Data Set Was Collected
From Region A Of The Crystal. Second Step Of Radiation
Damage
pdb|2BB4|A Chain A, Porcine Pancreatic Elastase Complexed With
Beta-Casomorphin-7 And Asp- Phe At Ph 5.0
pdb|2BD2|A Chain A, Porcine Pancreatic Elastase Complexed With
Beta-casomorphin-7 And Arg- Phe At Ph 5.0
pdb|2BD3|A Chain A, Porcine Pancreatic Elastase Complexed With
Beta-casomorphin-7 And Lys- Ala-nh2 At Ph 5.0
pdb|2BD7|A Chain A, Porcine Pancreatic Elastase Complexed With
Beta-Casomorphin-7 And Arg- Phe At Ph 5.0 (50 Min Soak)
pdb|2BD8|A Chain A, Porcine Pancreatic Elastase Complexed With
Beta-Casomorphin-7 And Arg- Phe At Ph 5.0 (50 Min Soak)
And Immersed In Ph 9 Buffer For 30 Seconds
pdb|2BDA|A Chain A, Porcine Pancreatic Elastase Complexed With N-Acetyl-Npi
And Ala-Ala At Ph 5.0
pdb|2BDB|A Chain A, Porcine Pancreatic Elastase Complexed With Asn-pro-ile And
Ala-ala At Ph 5.0
pdb|1ESB|A Chain A, Direct Structure Observation Of An Acyl-Enzyme
Intermediate In The Hydrolysis Of An Ester Substrate By
Elastase
pdb|4GVU|A Chain A, Lyngbyastatin 7-porcine Pancreatic Elastase Co-crystal
Structure
Length = 240
Score = 31.6 bits (70), Expect = 0.42, Method: Compositional matrix adjust.
Identities = 19/85 (22%), Positives = 40/85 (47%), Gaps = 9/85 (10%)
Query: 46 CGGSLISLQWFLSARHCFVTENLVWNQFNPLIIAGSIYRNYKEQKRQPQLNEIALIYWHS 105
CGG+LI W ++A HC E F ++ ++ +N ++ + YW++
Sbjct: 30 CGGTLIRQNWVMTAAHCVDRELT----FRVVVGEHNLNQNNGTEQYVGVQKIVVHPYWNT 85
Query: 106 DA-----DLAMVKLKEPFRQTTFVK 125
D D+A+++L + ++V+
Sbjct: 86 DDVAAGYDIALLRLAQSVTLNSYVQ 110
>pdb|1UHB|B Chain B, Crystal Structure Of Porcine Alpha Trypsin Bound With Auto
Catalyticaly Produced Native Peptide At 2.15 A
Resolution
Length = 98
Score = 31.6 bits (70), Expect = 0.43, Method: Compositional matrix adjust.
Identities = 21/54 (38%), Positives = 23/54 (42%), Gaps = 13/54 (24%)
Query: 154 SGFGVTFQRDKDGIVSWGIGCALGYPGIVSWGIGCALGYPGVYVRVDHYDPWIQ 207
SG V GIVSWG GCA PGVY +V +Y WIQ
Sbjct: 52 SGGPVVCNGQLQGIVSWGYGCA-------------QKNKPGVYTKVCNYVNWIQ 92
>pdb|1AFQ|C Chain C, Crystal Structure Of Bovine Gamma-Chymotrypsin Complexed
With A Synthetic Inhibitor
pdb|3RU4|E Chain E, Crystal Structure Of The Bowman-Birk Serine Protease
Inhibitor Btci In Complex With Trypsin And Chymotrypsin
Length = 96
Score = 31.6 bits (70), Expect = 0.43, Method: Compositional matrix adjust.
Identities = 15/29 (51%), Positives = 17/29 (58%), Gaps = 1/29 (3%)
Query: 180 GIVSWGIG-CALGYPGVYVRVDHYDPWIQ 207
GIVSWG C+ PGVY RV W+Q
Sbjct: 62 GIVSWGSSTCSTSTPGVYARVTALVNWVQ 90
>pdb|1TON|A Chain A, Rat Submaxillary Gland Serine Protease, Tonin. Structure
Solution And Refinement At 1.8 Angstroms Resolution
Length = 235
Score = 31.6 bits (70), Expect = 0.45, Method: Compositional matrix adjust.
Identities = 25/103 (24%), Positives = 45/103 (43%), Gaps = 22/103 (21%)
Query: 46 CGGSLISLQWFLSARHCFVTENLVWNQFNPLIIAGSIYRN--------YKEQKRQPQLNE 97
CGG LI W ++A HC+ N + L+ +++++ ++ R P
Sbjct: 24 CGGVLIDPSWVITAAHCYS------NNYQVLLGRNNLFKDEPFAQRRLVRQSFRHPDYIP 77
Query: 98 IAL-------IYWHSDADLAMVKLKEPFRQTTFVKPLDYYTAR 133
+ + ++ HS+ DL ++ L EP T VK +D T
Sbjct: 78 LIVTNDTEQPVHDHSN-DLMLLHLSEPADITGGVKVIDLPTKE 119
>pdb|1GPZ|A Chain A, The Crystal Structure Of The Zymogen Catalytic Domain Of
Complement Protease C1r
pdb|1GPZ|B Chain B, The Crystal Structure Of The Zymogen Catalytic Domain Of
Complement Protease C1r
Length = 399
Score = 31.6 bits (70), Expect = 0.46, Method: Compositional matrix adjust.
Identities = 18/49 (36%), Positives = 22/49 (44%), Gaps = 15/49 (30%)
Query: 166 GIVSWGIGCALGYPGIVSWGIGCALGYPGVYVRVDHYDPWIQSVKNNGD 214
GIVSWGIGC+ GY G Y +V +Y WI+ D
Sbjct: 366 GIVSWGIGCSRGY---------------GFYTKVLNYVDWIKKEMEEED 399
>pdb|3TJU|A Chain A, Crystal Structure Of Human Granzyme H With An Inhibitor
pdb|3TJV|A Chain A, Crystal Structure Of Human Granzyme H With A Peptidyl
Substrate
pdb|3TK9|A Chain A, Crystal Structure Of Human Granzyme H
Length = 226
Score = 31.2 bits (69), Expect = 0.47, Method: Compositional matrix adjust.
Identities = 44/203 (21%), Positives = 74/203 (36%), Gaps = 52/203 (25%)
Query: 46 CGGSLISLQWFLSARHCFVTENLVWNQFNPLIIAGSIYRNYKEQKRQPQLNEIALIYWHS 105
CGG L+ + L+A HC + N + A N KEQ+R Q + H
Sbjct: 29 CGGILVRKDFVLTAAHC------QGSSINVTLGA----HNIKEQERTQQFIPVKRPIPHP 78
Query: 106 -------DADLAMVKLKEPFRQTTFVKPLDYYTARET------------NYINDVLSKTD 146
++ +++L+ + TT V+PL +++ Y++ T
Sbjct: 79 AYNPKNFSNNIMLLQLERKAKWTTAVRPLRLPSSKAQVKPGQLCSVAGWGYVSMSTLATT 138
Query: 147 RSEMSIVSGFGVTFQRDKDGIVSWGIGCALGYP----------------------GIVSW 184
E+ + +R G S +G P GI+S+
Sbjct: 139 LQEVLLTVQKDCQCERLFHGNYSRATEICVGDPKKTQTGFKGDSGGPLVCKDVAQGILSY 198
Query: 185 GIGCALGYPGVYVRVDHYDPWIQ 207
G PGVY++V H+ PWI+
Sbjct: 199 GNKKGTP-PGVYIKVSHFLPWIK 220
>pdb|2XRC|A Chain A, Human Complement Factor I
pdb|2XRC|B Chain B, Human Complement Factor I
pdb|2XRC|C Chain C, Human Complement Factor I
pdb|2XRC|D Chain D, Human Complement Factor I
Length = 565
Score = 31.2 bits (69), Expect = 0.48, Method: Compositional matrix adjust.
Identities = 14/28 (50%), Positives = 18/28 (64%), Gaps = 1/28 (3%)
Query: 180 GIVSWGIGCAL-GYPGVYVRVDHYDPWI 206
G+VSWG C +PGVY +V +Y WI
Sbjct: 524 GVVSWGENCGKPEFPGVYTKVANYFDWI 551
Score = 30.0 bits (66), Expect = 1.1, Method: Compositional matrix adjust.
Identities = 12/34 (35%), Positives = 19/34 (55%)
Query: 30 GEVPYIVSLSLYGNLYCGGSLISLQWFLSARHCF 63
G++P+ V++ + CGG I W L+A HC
Sbjct: 331 GDLPWQVAIKDASGITCGGIYIGGCWILTAAHCL 364
>pdb|2HNT|C Chain C, Crystallographic Structure Of Human Gamma-Thrombin
Length = 70
Score = 31.2 bits (69), Expect = 0.49, Method: Compositional matrix adjust.
Identities = 12/22 (54%), Positives = 15/22 (68%)
Query: 43 NLYCGGSLISLQWFLSARHCFV 64
L CG SLIS +W L+A HC +
Sbjct: 25 ELLCGASLISDRWVLTAAHCLL 46
>pdb|1EAI|A Chain A, Complex Of Ascaris Chymotrpsin/elastase Inhibitor With
Porcine Elastase
pdb|1EAI|B Chain B, Complex Of Ascaris Chymotrpsin/elastase Inhibitor With
Porcine Elastase
pdb|1C1M|A Chain A, Porcine Elastase Under Xenon Pressure (8 Bar)
pdb|1HV7|A Chain A, Porcine Pancreatic Elastase Complexed With Gw311616a
pdb|1FZZ|A Chain A, The Crystal Structure Of The Complex Of Non-Peptidic
Inhibitor Ono-6818 And Porcine Pancreatic Elastase.
pdb|1GWA|A Chain A, Triiodide Derivative Of Porcine Pancreas Elastase
pdb|1L0Z|A Chain A, The Structure Of Porcine Pancreatic Elastase Complexed
With Xenon And Bromide, Cryoprotected With Dry Paraffin
Oil
pdb|1L1G|A Chain A, The Structure Of Porcine Pancreatic Elastase Complexed
With Xenon And Bromide, Cryoprotected With Glycerol
pdb|1LKA|A Chain A, Porcine Pancreatic ElastaseCA-Complex
pdb|1LKB|A Chain A, Porcine Pancreatic Elastase/na-complex
pdb|1MMJ|N Chain N, Porcine Pancreatic Elastase Complexed With A Potent
Peptidyl Inhibitor, Fr136706
pdb|1MCV|A Chain A, Crystal Structure Analysis Of A Hybrid Squash Inhibitor In
Complex With Porcine Pancreatic Elastase
pdb|1UO6|A Chain A, Porcine Pancreatic ElastaseXE-Complex
pdb|1UVO|A Chain A, Structure Of The Complex Of Porcine Pancreatic Elastase In
Complex With Cadmium Refined At 1.85 A Resolution
(crystal A)
pdb|1UVP|A Chain A, Structure Of The Complex Of Porcine Pancreatic Elastase In
Complex With Cadmium Refined At 1.85 A Resolution
(Crystal B)
pdb|2A7C|A Chain A, On The Routine Use Of Soft X-rays In Macromolecular
Crystallography, Part Iii- The Optimal Data Collection
Wavelength
pdb|2A7J|A Chain A, On The Routine Use Of Soft X-Rays In Macromolecular
Crystallography, Part Iii- The Optimal Data Collection
Wavelength
pdb|2BLO|A Chain A, Elastase Before A High Dose X-Ray "burn"
pdb|2BLQ|A Chain A, Elastase After A High Dose X-Ray "burn"
pdb|2D26|C Chain C, Active Site Distortion Is Sufficient For Proteinase
Inhibit Second Crystal Structure Of Covalent
Serpin-Proteinase Complex
pdb|2CV3|A Chain A, Crystal Structure Of Porcine Pancreatic Elastase Complexed
With A Macroclyclic Peptide Inhibitor
pdb|2DE8|A Chain A, Crystal Structure Of Porcine Pancreatic Elastase With A
Unique Conformation Induced By Tris
pdb|2DE9|A Chain A, Crystal Structure Of Porcine Pancreatic Elastase Complexed
With Tris After Soaking A Tris-Free Solution
pdb|2G4T|A Chain A, Anomalous Substructure Of Porcine Pancreatic Elastase (na)
pdb|2G4U|A Chain A, Anomalous Substructure Of Porcine Pancreatic Elastaase
(ca)
pdb|2OQU|A Chain A, High Pressure Cryocooling Of Capillary Sample
Cryoprotection And Diffraction Phasing At Long
Wavelengths
pdb|1QNJ|A Chain A, The Structure Of Native Porcine Pancreatic Elastase At
Atomic Resolution (1.1 A)
pdb|2IOT|A Chain A, Clavulanic Acid Bound To Elastase
pdb|2V0B|A Chain A, Sad Structure Solution Porcine Pancreatic Elastase From A
Selenate Derivative
pdb|2V35|A Chain A, Porcine Pancreatic Elastase In Complex With Inhibitor Jm54
pdb|3HGP|A Chain A, Structure Of Porcine Pancreatic Elastase Complexed With A
Potent Peptidyl Inhibitor Fr130180 Determined By High
Resolution Crystallography
pdb|3HGN|A Chain A, Structure Of Porcine Pancreatic Elastase Complexed With A
Potent Peptidyl Inhibitor Fr130180 Determined By Neutron
Crystallography
pdb|3UOU|A Chain A, Crystal Structure Of The Kunitz-Type Protease Inhibitor
Shpi-1 Lys13leu Mutant In Complex With Pancreatic
Elastase
Length = 240
Score = 31.2 bits (69), Expect = 0.51, Method: Compositional matrix adjust.
Identities = 19/85 (22%), Positives = 40/85 (47%), Gaps = 9/85 (10%)
Query: 46 CGGSLISLQWFLSARHCFVTENLVWNQFNPLIIAGSIYRNYKEQKRQPQLNEIALIYWHS 105
CGG+LI W ++A HC E F ++ ++ +N ++ + YW++
Sbjct: 30 CGGTLIRQNWVMTAAHCVDRELT----FRVVVGEHNLNQNDGTEQYVGVQKIVVHPYWNT 85
Query: 106 DA-----DLAMVKLKEPFRQTTFVK 125
D D+A+++L + ++V+
Sbjct: 86 DDVAAGYDIALLRLAQSVTLNSYVQ 110
>pdb|1BQY|A Chain A, Plasminogen Activator (tsv-pa) From Snake Venom
pdb|1BQY|B Chain B, Plasminogen Activator (tsv-pa) From Snake Venom
Length = 234
Score = 31.2 bits (69), Expect = 0.52, Method: Compositional matrix adjust.
Identities = 50/207 (24%), Positives = 74/207 (35%), Gaps = 48/207 (23%)
Query: 44 LYCGGSLISLQWFLSARHCFVTENLVWNQFNPLI-IAGSIYRNYKEQKRQPQLNEIALIY 102
CGG+LI+ W ++A HC N F L + N EQ R P+
Sbjct: 24 FLCGGTLINQDWVVTAAHCDS------NNFQLLFGVHSKKILNEDEQTRDPKEKFFCPNR 77
Query: 103 WHSD---ADLAMVKLKEPFRQTTFVKPL-----------------------------DYY 130
D D+ ++KL + + PL D
Sbjct: 78 KKDDEVDKDIMLIKLDSSVSNSEHIAPLSLPSSPPSVGSVCRIMGWGKTIPTKEIYPDVP 137
Query: 131 TARETNYINDVLSKTDRS-----EMSIVSGFGVTFQRDKDGIVSWG-IGCALGYPGIVSW 184
N ++ + +T S ++ +G + RD S G + C + GIVSW
Sbjct: 138 HCANINILDHAVCRTAYSWRQVANTTLCAGI-LQGGRDTCHFDSGGPLICNGIFQGIVSW 196
Query: 185 G-IGCAL-GYPGVYVRVDHYDPWIQSV 209
G C G PGVY +V Y WI+S+
Sbjct: 197 GGHPCGQPGEPGVYTKVFDYLDWIKSI 223
>pdb|1MD8|A Chain A, Monomeric Structure Of The Active Catalytic Domain Of
Complement Protease C1r
Length = 329
Score = 30.8 bits (68), Expect = 0.60, Method: Compositional matrix adjust.
Identities = 17/43 (39%), Positives = 21/43 (48%), Gaps = 15/43 (34%)
Query: 166 GIVSWGIGCALGYPGIVSWGIGCALGYPGVYVRVDHYDPWIQS 208
GIVSWGIGC+ GY G Y +V +Y WI+
Sbjct: 298 GIVSWGIGCSRGY---------------GFYTKVLNYVDWIKK 325
>pdb|2QY0|B Chain B, Active Dimeric Structure Of The Catalytic Domain Of C1r
Reveals Enzyme-product Like Contacts
pdb|2QY0|D Chain D, Active Dimeric Structure Of The Catalytic Domain Of C1r
Reveals Enzyme-product Like Contacts
Length = 242
Score = 30.8 bits (68), Expect = 0.61, Method: Compositional matrix adjust.
Identities = 18/49 (36%), Positives = 22/49 (44%), Gaps = 15/49 (30%)
Query: 166 GIVSWGIGCALGYPGIVSWGIGCALGYPGVYVRVDHYDPWIQSVKNNGD 214
GIVSWGIGC+ GY G Y +V +Y WI+ D
Sbjct: 209 GIVSWGIGCSRGY---------------GFYTKVLNYVDWIKKEMEEED 242
>pdb|1MD7|A Chain A, Monomeric Structure Of The Zymogen Of Complement Protease
C1r
Length = 328
Score = 30.8 bits (68), Expect = 0.61, Method: Compositional matrix adjust.
Identities = 17/43 (39%), Positives = 21/43 (48%), Gaps = 15/43 (34%)
Query: 166 GIVSWGIGCALGYPGIVSWGIGCALGYPGVYVRVDHYDPWIQS 208
GIVSWGIGC+ GY G Y +V +Y WI+
Sbjct: 298 GIVSWGIGCSRGY---------------GFYTKVLNYVDWIKK 325
>pdb|1BRU|P Chain P, Structure Of Porcine Pancreatic Elastase Complexed With
The Elastase Inhibitor Gr143783
Length = 241
Score = 30.8 bits (68), Expect = 0.69, Method: Compositional matrix adjust.
Identities = 57/236 (24%), Positives = 89/236 (37%), Gaps = 56/236 (23%)
Query: 29 PGEVPYIVSL----SLYGNLYCGGSLISLQWFLSARHCFVTENLVWNQFNPLIIAGSIYR 84
P P+ VSL S CGG+L+ W L+A HC + + ++ S+
Sbjct: 9 PNSWPWQVSLQYDSSGQWRHTCGGTLVDQSWVLTAAHCISSSRT----YRVVLGRHSLST 64
Query: 85 NYKEQKRQPQLNEIALIYWHSDA-----DLAMVKLKEPFRQTTFVK-----------PLD 128
N + W+S+ D+A++KL P T ++ P +
Sbjct: 65 NEPGSLAVKVSKLVVHQDWNSNQLSNGNDIALLKLASPVSLTDKIQLGCLPAAGTILPNN 124
Query: 129 Y------YTARETNYIN-DVLSK-----TDRSEMSIVSGFGVTFQRD-----KDGIVSWG 171
Y + +TN + D+L + D + S +G T + + DGI+S
Sbjct: 125 YVCYVTGWGRLQTNGASPDILQQGQLLVVDYATCSKPGWWGSTVKTNMICAGGDGIISSC 184
Query: 172 IGCALG------------YPGIVSWGIGCALGY---PGVYVRVDHYDPWIQSVKNN 212
G + G GIVS+G Y P V+ RV +Y WI SV N
Sbjct: 185 NGDSGGPLNCQGANGQWQVHGIVSFGSSLGCNYYHKPSVFTRVSNYIDWINSVIAN 240
>pdb|1FON|A Chain A, Crystal Structure Of Bovine Procarboxypeptidase A-S6
Subunit Iii, A Highly Structured Truncated Zymogen E
pdb|1FON|B Chain B, Crystal Structure Of Bovine Procarboxypeptidase A-S6
Subunit Iii, A Highly Structured Truncated Zymogen E
Length = 240
Score = 30.8 bits (68), Expect = 0.72, Method: Compositional matrix adjust.
Identities = 23/77 (29%), Positives = 36/77 (46%), Gaps = 9/77 (11%)
Query: 46 CGGSLISLQWFLSARHCFVTE---NLVWNQFNPLIIAGS---IYRNYKEQKRQPQLNEIA 99
CGGSLI+ W ++A HC T +V +++ ++ GS I N + P N
Sbjct: 28 CGGSLIAPDWVVTAGHCISTSRTYQVVLGEYDRSVLEGSEQVIPINAGDLFVHPLWNSNC 87
Query: 100 LIYWHSDADLAMVKLKE 116
+ D+A+VKL
Sbjct: 88 VA---CGNDIALVKLSR 101
>pdb|1PYT|C Chain C, Ternary Complex Of Procarboxypeptidase A, Proproteinase E,
And Chymotrypsinogen C
Length = 253
Score = 30.8 bits (68), Expect = 0.75, Method: Compositional matrix adjust.
Identities = 23/77 (29%), Positives = 36/77 (46%), Gaps = 9/77 (11%)
Query: 46 CGGSLISLQWFLSARHCFVTE---NLVWNQFNPLIIAGS---IYRNYKEQKRQPQLNEIA 99
CGGSLI+ W ++A HC T +V +++ ++ GS I N + P N
Sbjct: 41 CGGSLIAPDWVVTAGHCISTSRTYQVVLGEYDRSVLQGSEQVIPINAGDLFVHPLWNSNC 100
Query: 100 LIYWHSDADLAMVKLKE 116
+ D+A+VKL
Sbjct: 101 VA---CGNDIALVKLSR 114
>pdb|1KYN|B Chain B, Cathepsin-G
pdb|1KYN|A Chain A, Cathepsin-G
Length = 235
Score = 30.4 bits (67), Expect = 0.80, Method: Compositional matrix adjust.
Identities = 50/221 (22%), Positives = 82/221 (37%), Gaps = 46/221 (20%)
Query: 28 NPGEVPYIVSLSLY---GNLYCGGSLISLQWFLSARHCFVTENLVWNQFNPLIIAGSIYR 84
P PY+ L + G CGG L+ + L+A HC+ + N + A +I R
Sbjct: 8 RPHSRPYMAYLQIQSPAGQSRCGGFLVREDFVLTAAHCW------GSNINVTLGAHNIQR 61
Query: 85 NYKEQK--------RQPQLNE------IALIYWH-------SDADLAMVKLKEPFRQTTF 123
Q+ R PQ N+ I L+ + +A+ + +E R T
Sbjct: 62 RENTQQHITARRAIRHPQYNQRTIQNDIMLLQLSRRVRRNRNVNPVALPRAQEGLRPGTL 121
Query: 124 VKPLDY---YTARETNYINDVLSKT--DRSEMSIVSGFGVTFQ------RDKDGIVSWGI 172
+ R T+ + +V + DR + I + Q R++
Sbjct: 122 CTVAGWGRVSMRRGTDTLREVQLRVQRDRQCLRIFGSYDPRRQICVGDRRERKAAFKGDS 181
Query: 173 G----CALGYPGIVSWGIGCALGYPGVYVRVDHYDPWIQSV 209
G C GIVS+G + P V+ RV + PWI++
Sbjct: 182 GGPLLCNNVAHGIVSYGKSSGV-PPEVFTRVSSFLPWIRTT 221
>pdb|3BEU|A Chain A, Na+-Dependent Allostery Mediates Coagulation Factor
Protease Active Site Selectivity
pdb|3BEU|B Chain B, Na+-Dependent Allostery Mediates Coagulation Factor
Protease Active Site Selectivity
Length = 224
Score = 30.4 bits (67), Expect = 0.81, Method: Compositional matrix adjust.
Identities = 55/225 (24%), Positives = 78/225 (34%), Gaps = 59/225 (26%)
Query: 30 GEVPYIVSLSLYGNLYCGGSLISLQWFLSARHCFVTENLVWNQFNPLIIAGSI---YRNY 86
GE P++V LS+ CGG+L + L+A HC N + G + +
Sbjct: 10 GEFPFMVRLSMG----CGGALYAQDIVLTAAHCVSGSG---NNTSITATGGVVDLQSSSA 62
Query: 87 KEQKRQPQLNEIALIYWHSDADLAMVKLKEPFRQTTF-VKPLDYYTA-----------RE 134
+ + L D A++KL +P Q T + Y RE
Sbjct: 63 VKVRSTKVLQAPGFTKETYGKDWALIKLAQPINQPTLKIATTTAYNQGTFTVAGWGANRE 122
Query: 135 TN------------YINDVLSKTDRS------EMSIVSGFGV----TFQRD-------KD 165
+++D ++ S EM I +G+ T Q D KD
Sbjct: 123 GGSQQRYLLKANVPFVSDAACRSSSSFILVANEM-ICAGYDTKQEDTCQGDSGGPMFRKD 181
Query: 166 GIVSWGIGCALGYPGIVSWGIGCAL-GYPGVYVRVDHYDPWIQSV 209
W GIVSWG GCA G GVY V + I S
Sbjct: 182 NADEW------VQVGIVSWGEGCARKGKYGVYTEVSTFASAIASA 220
>pdb|1AU8|A Chain A, Human Cathepsin G
pdb|1T32|A Chain A, A Dual Inhibitor Of The Leukocyte Proteases Cathepsin G
And Chymase With Therapeutic Efficacy In Animals Models
Of Inflammation
pdb|1CGH|A Chain A, Human Cathepsin G
Length = 224
Score = 30.4 bits (67), Expect = 0.85, Method: Compositional matrix adjust.
Identities = 50/221 (22%), Positives = 82/221 (37%), Gaps = 46/221 (20%)
Query: 28 NPGEVPYIVSLSLY---GNLYCGGSLISLQWFLSARHCFVTENLVWNQFNPLIIAGSIYR 84
P PY+ L + G CGG L+ + L+A HC+ + N + A +I R
Sbjct: 8 RPHSRPYMAYLQIQSPAGQSRCGGFLVREDFVLTAAHCW------GSNINVTLGAHNIQR 61
Query: 85 NYKEQK--------RQPQLNE------IALIYWH-------SDADLAMVKLKEPFRQTTF 123
Q+ R PQ N+ I L+ + +A+ + +E R T
Sbjct: 62 RENTQQHITARRAIRHPQYNQRTIQNDIMLLQLSRRVRRNRNVNPVALPRAQEGLRPGTL 121
Query: 124 VKPLDY---YTARETNYINDVLSKT--DRSEMSIVSGFGVTFQ------RDKDGIVSWGI 172
+ R T+ + +V + DR + I + Q R++
Sbjct: 122 CTVAGWGRVSMRRGTDTLREVQLRVQRDRQCLRIFGSYDPRRQICVGDRRERKAAFKGDS 181
Query: 173 G----CALGYPGIVSWGIGCALGYPGVYVRVDHYDPWIQSV 209
G C GIVS+G + P V+ RV + PWI++
Sbjct: 182 GGPLLCNNVAHGIVSYGKSSGV-PPEVFTRVSSFLPWIRTT 221
>pdb|4FXG|H Chain H, Complement C4 In Complex With Masp-2
pdb|4FXG|J Chain J, Complement C4 In Complex With Masp-2
Length = 242
Score = 30.0 bits (66), Expect = 1.0, Method: Compositional matrix adjust.
Identities = 16/32 (50%), Positives = 22/32 (68%), Gaps = 2/32 (6%)
Query: 180 GIVSWG-IGCA-LGYPGVYVRVDHYDPWIQSV 209
GIVSWG + C G GVY +V +Y PWI+++
Sbjct: 207 GIVSWGSMNCGEAGQYGVYTKVINYIPWIENI 238
>pdb|3TVJ|B Chain B, Catalytic Fragment Of Masp-2 In Complex With Its Specific
Inhibitor Developed By Directed Evolution On Sgci
Scaffold
Length = 242
Score = 30.0 bits (66), Expect = 1.1, Method: Compositional matrix adjust.
Identities = 16/32 (50%), Positives = 22/32 (68%), Gaps = 2/32 (6%)
Query: 180 GIVSWG-IGCA-LGYPGVYVRVDHYDPWIQSV 209
GIVSWG + C G GVY +V +Y PWI+++
Sbjct: 207 GIVSWGSMNCGEAGQYGVYTKVINYIPWIENI 238
>pdb|1Q3X|A Chain A, Crystal Structure Of The Catalytic Region Of Human Masp-2
pdb|1Q3X|B Chain B, Crystal Structure Of The Catalytic Region Of Human Masp-2
Length = 328
Score = 30.0 bits (66), Expect = 1.2, Method: Compositional matrix adjust.
Identities = 16/32 (50%), Positives = 22/32 (68%), Gaps = 2/32 (6%)
Query: 180 GIVSWG-IGCA-LGYPGVYVRVDHYDPWIQSV 209
GIVSWG + C G GVY +V +Y PWI+++
Sbjct: 293 GIVSWGSMNCGEAGQYGVYTKVINYIPWIENI 324
>pdb|1ZJK|A Chain A, Crystal Structure Of The Zymogen Catalytic Region Of Human
Masp-2
Length = 403
Score = 29.6 bits (65), Expect = 1.3, Method: Compositional matrix adjust.
Identities = 16/32 (50%), Positives = 22/32 (68%), Gaps = 2/32 (6%)
Query: 180 GIVSWG-IGCA-LGYPGVYVRVDHYDPWIQSV 209
GIVSWG + C G GVY +V +Y PWI+++
Sbjct: 368 GIVSWGSMNCGEAGQYGVYTKVINYIPWIENI 399
>pdb|3G01|A Chain A, Structure Of Grc Mutant E192rE193G
pdb|3G01|B Chain B, Structure Of Grc Mutant E192rE193G
Length = 227
Score = 29.6 bits (65), Expect = 1.4, Method: Compositional matrix adjust.
Identities = 22/93 (23%), Positives = 42/93 (45%), Gaps = 17/93 (18%)
Query: 43 NLYCGGSLISLQWFLSARHCFVTENLVWNQFNPLIIAGSIYRNYKEQKRQPQLNEIALIY 102
++CGG L+ ++ L+A HC + + G+ N K ++ Q+ +A
Sbjct: 27 KMFCGGFLVRDKFVLTAAHC--------KGRSMTVTLGA--HNIKAKEETQQIIPVAKAI 76
Query: 103 WHSD-------ADLAMVKLKEPFRQTTFVKPLD 128
H D D+ ++KL ++T V+PL+
Sbjct: 77 PHPDYNPDDRSNDIMLLKLVRNAKRTRAVRPLN 109
>pdb|3FZZ|A Chain A, Structure Of Grc
pdb|3FZZ|B Chain B, Structure Of Grc
Length = 227
Score = 29.6 bits (65), Expect = 1.6, Method: Compositional matrix adjust.
Identities = 22/93 (23%), Positives = 42/93 (45%), Gaps = 17/93 (18%)
Query: 43 NLYCGGSLISLQWFLSARHCFVTENLVWNQFNPLIIAGSIYRNYKEQKRQPQLNEIALIY 102
++CGG L+ ++ L+A HC + + G+ N K ++ Q+ +A
Sbjct: 27 KMFCGGFLVRDKFVLTAAHC--------KGRSMTVTLGA--HNIKAKEETQQIIPVAKAI 76
Query: 103 WHSD-------ADLAMVKLKEPFRQTTFVKPLD 128
H D D+ ++KL ++T V+PL+
Sbjct: 77 PHPDYNPDDRSNDIMLLKLVRNAKRTRAVRPLN 109
>pdb|2WIN|I Chain I, C3 Convertase (C3bbb) Stabilized By Scin
pdb|2WIN|J Chain J, C3 Convertase (C3bbb) Stabilized By Scin
pdb|2WIN|K Chain K, C3 Convertase (C3bbb) Stabilized By Scin
pdb|2WIN|L Chain L, C3 Convertase (C3bbb) Stabilized By Scin
Length = 507
Score = 29.3 bits (64), Expect = 2.1, Method: Compositional matrix adjust.
Identities = 21/102 (20%), Positives = 43/102 (42%), Gaps = 29/102 (28%)
Query: 42 GNLYCGGSLISLQWFLSARHCFVTENLVWNQFNPLIIAGSIYRNYKEQKRQPQLNEIALI 101
G+ C G+++S + L+A HCF ++ + + + G R+ EI ++
Sbjct: 248 GHESCMGAVVSEYFVLTAAHCFTVDD---KEHSIKVSVGGEKRDL----------EIEVV 294
Query: 102 YWHS----------------DADLAMVKLKEPFRQTTFVKPL 127
+H D D+A++KLK + ++P+
Sbjct: 295 LFHPNYNINGKKEAGIPEFYDYDVALIKLKNKLKYGQTIRPI 336
>pdb|1RRK|A Chain A, Crystal Structure Analysis Of The Bb Segment Of Factor B
pdb|1RS0|A Chain A, Crystal Structure Analysis Of The Bb Segment Of Factor B
Complexed With Di-Isopropyl-Phosphate (Dip)
pdb|1RTK|A Chain A, Crystal Structure Analysis Of The Bb Segment Of Factor B
Complexed With 4-Guanidinobenzoic Acid
Length = 497
Score = 29.3 bits (64), Expect = 2.1, Method: Compositional matrix adjust.
Identities = 21/102 (20%), Positives = 43/102 (42%), Gaps = 29/102 (28%)
Query: 42 GNLYCGGSLISLQWFLSARHCFVTENLVWNQFNPLIIAGSIYRNYKEQKRQPQLNEIALI 101
G+ C G+++S + L+A HCF ++ + + + G R+ EI ++
Sbjct: 240 GHESCMGAVVSEYFVLTAAHCFTVDD---KEHSIKVSVGGEKRDL----------EIEVV 286
Query: 102 YWHS----------------DADLAMVKLKEPFRQTTFVKPL 127
+H D D+A++KLK + ++P+
Sbjct: 287 LFHPNYNINGKKEAGIPEFYDYDVALIKLKNKLKYGQTIRPI 328
>pdb|4GD5|A Chain A, X-Ray Crystal Structure Of A Putative Phosphate Abc
Transporter Substrate-Binding Protein With Bound
Phosphate From Clostridium Perfringens
pdb|4GD5|B Chain B, X-Ray Crystal Structure Of A Putative Phosphate Abc
Transporter Substrate-Binding Protein With Bound
Phosphate From Clostridium Perfringens
Length = 279
Score = 29.3 bits (64), Expect = 2.2, Method: Compositional matrix adjust.
Identities = 16/58 (27%), Positives = 27/58 (46%), Gaps = 3/58 (5%)
Query: 80 GSIYRNYKEQKRQPQLNEIALIYWHSDADLAMVKLKEPFRQTTFVKPLDYYTARETNY 137
G R+ K +++Q L E+ + Y D + P + T V+ D YT + TN+
Sbjct: 89 GXASRDLKGEEKQAGLKEVEIAY---DGIALITHKNNPVKDLTLVQIKDIYTGKITNW 143
>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796
pdb|3NPC|B Chain B, Crystal Structure Of Jnk2 Complexed With Birb796
Length = 364
Score = 29.3 bits (64), Expect = 2.2, Method: Compositional matrix adjust.
Identities = 16/58 (27%), Positives = 27/58 (46%), Gaps = 5/58 (8%)
Query: 176 LGYPGIVS-WGIGCALGY----PGVYVRVDHYDPWIQSVKNNGDNAGVLISALHMTYR 228
+GY V W +GC +G ++ DH D W + ++ G + ++AL T R
Sbjct: 200 MGYAANVDIWSVGCIMGELVKGCVIFQGTDHIDQWNKVIEQLGTPSAEFMAALQPTVR 257
>pdb|3I78|A Chain A, 3599170186220-Loops Of Fxa In Sgt
Length = 229
Score = 28.9 bits (63), Expect = 2.3, Method: Compositional matrix adjust.
Identities = 16/31 (51%), Positives = 17/31 (54%), Gaps = 1/31 (3%)
Query: 180 GIVSWGIGCAL-GYPGVYVRVDHYDPWIQSV 209
GIVSWG GCA G GVY V + I S
Sbjct: 195 GIVSWGEGCARKGKYGVYTEVSTFASAIASA 225
>pdb|1DLE|A Chain A, Factor B Serine Protease Domain
pdb|1DLE|B Chain B, Factor B Serine Protease Domain
Length = 298
Score = 28.9 bits (63), Expect = 2.6, Method: Compositional matrix adjust.
Identities = 21/102 (20%), Positives = 43/102 (42%), Gaps = 29/102 (28%)
Query: 42 GNLYCGGSLISLQWFLSARHCFVTENLVWNQFNPLIIAGSIYRNYKEQKRQPQLNEIALI 101
G+ C G+++S + L+A HCF ++ + + + G R+ EI ++
Sbjct: 41 GHESCMGAVVSEYFVLTAAHCFTVDD---KEHSIKVSVGGEKRDL----------EIEVV 87
Query: 102 YWHS----------------DADLAMVKLKEPFRQTTFVKPL 127
+H D D+A++KLK + ++P+
Sbjct: 88 LFHPNYNINGKKEAGIPEFYDYDVALIKLKNKLKYGQTIRPI 129
>pdb|2XWB|F Chain F, Crystal Structure Of Complement C3b In Complex With
Factors B And D
pdb|2XWB|H Chain H, Crystal Structure Of Complement C3b In Complex With
Factors B And D
Length = 732
Score = 28.9 bits (63), Expect = 2.7, Method: Compositional matrix adjust.
Identities = 21/102 (20%), Positives = 43/102 (42%), Gaps = 29/102 (28%)
Query: 42 GNLYCGGSLISLQWFLSARHCFVTENLVWNQFNPLIIAGSIYRNYKEQKRQPQLNEIALI 101
G+ C G+++S + L+A HCF ++ + + + G R+ EI ++
Sbjct: 473 GHESCMGAVVSEYFVLTAAHCFTVDD---KEHSIKVSVGGEKRDL----------EIEVV 519
Query: 102 YWHS----------------DADLAMVKLKEPFRQTTFVKPL 127
+H D D+A++KLK + ++P+
Sbjct: 520 LFHPNYNINGKKEAGIPEFYDYDVALIKLKNKLKYGQTIRPI 561
>pdb|3HRZ|D Chain D, Cobra Venom Factor (Cvf) In Complex With Human Factor B
pdb|3HS0|D Chain D, Cobra Venom Factor (Cvf) In Complex With Human Factor B
pdb|3HS0|I Chain I, Cobra Venom Factor (Cvf) In Complex With Human Factor B
pdb|2XWJ|I Chain I, Crystal Structure Of Complement C3b In Complex With Factor
B
pdb|2XWJ|J Chain J, Crystal Structure Of Complement C3b In Complex With Factor
B
pdb|2XWJ|K Chain K, Crystal Structure Of Complement C3b In Complex With Factor
B
pdb|2XWJ|L Chain L, Crystal Structure Of Complement C3b In Complex With Factor
B
Length = 741
Score = 28.9 bits (63), Expect = 2.8, Method: Compositional matrix adjust.
Identities = 21/102 (20%), Positives = 43/102 (42%), Gaps = 29/102 (28%)
Query: 42 GNLYCGGSLISLQWFLSARHCFVTENLVWNQFNPLIIAGSIYRNYKEQKRQPQLNEIALI 101
G+ C G+++S + L+A HCF ++ + + + G R+ EI ++
Sbjct: 482 GHESCMGAVVSEYFVLTAAHCFTVDD---KEHSIKVSVGGEKRDL----------EIEVV 528
Query: 102 YWHS----------------DADLAMVKLKEPFRQTTFVKPL 127
+H D D+A++KLK + ++P+
Sbjct: 529 LFHPNYNINGKKEAGIPEFYDYDVALIKLKNKLKYGQTIRPI 570
>pdb|2OK5|A Chain A, Human Complement Factor B
Length = 752
Score = 28.9 bits (63), Expect = 2.9, Method: Compositional matrix adjust.
Identities = 21/102 (20%), Positives = 43/102 (42%), Gaps = 29/102 (28%)
Query: 42 GNLYCGGSLISLQWFLSARHCFVTENLVWNQFNPLIIAGSIYRNYKEQKRQPQLNEIALI 101
G+ C G+++S + L+A HCF ++ + + + G R+ EI ++
Sbjct: 492 GHESCMGAVVSEYFVLTAAHCFTVDD---KEHSIKVSVGGEKRDL----------EIEVV 538
Query: 102 YWHS----------------DADLAMVKLKEPFRQTTFVKPL 127
+H D D+A++KLK + ++P+
Sbjct: 539 LFHPNYNINGKKEAGIPEFYDYDVALIKLKNKLKYGQTIRPI 580
>pdb|2HNT|F Chain F, Crystallographic Structure Of Human Gamma-Thrombin
pdb|1BHX|F Chain F, X-Ray Structure Of The Complex Of Human Alpha Thrombin
With The Inhibitor Sdz 229-357
pdb|1RIW|C Chain C, Thrombin In Complex With Natural Product Inhibitor
Oscillarin
Length = 105
Score = 28.1 bits (61), Expect = 3.9, Method: Compositional matrix adjust.
Identities = 16/31 (51%), Positives = 16/31 (51%), Gaps = 1/31 (3%)
Query: 180 GIVSWGIGCAL-GYPGVYVRVDHYDPWIQSV 209
GIVSWG GC G G Y V WIQ V
Sbjct: 69 GIVSWGEGCDRDGKYGFYTHVFRLKKWIQKV 99
>pdb|1BBR|E Chain E, The Structure Of Residues 7-16 Of The A Alpha Chain Of
Human Fibrinogen Bound To Bovine Thrombin At 2.3
Angstroms Resolution
pdb|1UCY|E Chain E, Thrombin Complexed With Fibrinopeptide A Alpha (Residues
7- 19). Three Complexes, One With Epsilon-Thrombin And
Two With Alpha-Thrombin
pdb|1VIT|G Chain G, Thrombin:hirudin 51-65 Complex
pdb|1YCP|M Chain M, The Crystal Structure Of Fibrinogen-Aa Peptide 1-23 (F8y)
Bound To Bovine Thrombin Explains Why The Mutation Of
Phe-8 To Tyrosine Strongly Inhibits Normal Cleavage At
Arginine-16
Length = 109
Score = 28.1 bits (61), Expect = 4.0, Method: Compositional matrix adjust.
Identities = 16/31 (51%), Positives = 16/31 (51%), Gaps = 1/31 (3%)
Query: 180 GIVSWGIGCAL-GYPGVYVRVDHYDPWIQSV 209
GIVSWG GC G G Y V WIQ V
Sbjct: 73 GIVSWGEGCDRDGKYGFYTHVFRLKKWIQKV 103
>pdb|2PKS|C Chain C, Thrombin In Complex With Inhibitor
pdb|3PO1|C Chain C, Thrombin In Complex With Benzothiazole Guanidine
Length = 102
Score = 28.1 bits (61), Expect = 4.3, Method: Compositional matrix adjust.
Identities = 16/31 (51%), Positives = 16/31 (51%), Gaps = 1/31 (3%)
Query: 180 GIVSWGIGCAL-GYPGVYVRVDHYDPWIQSV 209
GIVSWG GC G G Y V WIQ V
Sbjct: 69 GIVSWGEGCDRDGKYGFYTHVFRLKKWIQKV 99
>pdb|2RDL|A Chain A, Hamster Chymase 2
pdb|2RDL|B Chain B, Hamster Chymase 2
Length = 226
Score = 28.1 bits (61), Expect = 5.0, Method: Compositional matrix adjust.
Identities = 14/36 (38%), Positives = 19/36 (52%), Gaps = 1/36 (2%)
Query: 174 CALGYPGIVSWGIGCALGYPGVYVRVDHYDPWIQSV 209
CA GI S+ + A P V+ R+ HY PWI +
Sbjct: 188 CAGIAQGIASYVLRNA-KPPSVFTRISHYRPWINKI 222
>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2
pdb|3E7O|B Chain B, Crystal Structure Of Jnk2
Length = 360
Score = 27.7 bits (60), Expect = 5.8, Method: Compositional matrix adjust.
Identities = 26/109 (23%), Positives = 50/109 (45%), Gaps = 20/109 (18%)
Query: 124 VKPLDYYTAR--ETNYIND--VLSKTDRSEMSIVSGFGVTFQRDKDGIVSWGIGCALGYP 179
+K LD+ AR TN++ V+++ R+ ++ G G K+ + W +GC +G
Sbjct: 163 LKILDFGLARTASTNFMMTPYVVTRYYRAP-EVILGMGY-----KENVDIWSVGCIMG-- 214
Query: 180 GIVSWGIGCALGYPGVYVRVDHYDPWIQSVKNNGDNAGVLISALHMTYR 228
+V + ++ DH D W + ++ G + ++AL T R
Sbjct: 215 ELVKGSV--------IFQGTDHIDQWNKVIEQLGTPSAEFMAALQPTVR 255
>pdb|2DPP|B Chain B, Crystal Structure Of Thermostable Bacillus Sp. Rapc8
Nitrile Hydratase
Length = 229
Score = 27.3 bits (59), Expect = 7.4, Method: Compositional matrix adjust.
Identities = 17/54 (31%), Positives = 25/54 (46%)
Query: 166 GIVSWGIGCALGYPGIVSWGIGCALGYPGVYVRVDHYDPWIQSVKNNGDNAGVL 219
G+V+ + LG + IG L P Y+ +Y WI +V N + GVL
Sbjct: 37 GLVAGCMAQGLGMKAFDEFRIGIELMRPVDYLTSSYYGHWIATVAYNLVDTGVL 90
>pdb|3HHT|B Chain B, A Mutant Of The Nitrile Hydratase From Geobacillus
Pallidus Having Enhanced Thermostability
Length = 229
Score = 27.3 bits (59), Expect = 7.8, Method: Compositional matrix adjust.
Identities = 17/54 (31%), Positives = 25/54 (46%)
Query: 166 GIVSWGIGCALGYPGIVSWGIGCALGYPGVYVRVDHYDPWIQSVKNNGDNAGVL 219
G+V+ + LG + IG L P Y+ +Y WI +V N + GVL
Sbjct: 37 GLVAGCMAQGLGMKAFDEFRIGIELMRPVDYLTSSYYGHWIATVAYNLVDTGVL 90
>pdb|4ECO|A Chain A, Crystal Structure Of A Hypothetical Protein (Bacegg_03329)
From Bacteroides Eggerthii Dsm 20697 At 2.70 A
Resolution
pdb|4ECO|B Chain B, Crystal Structure Of A Hypothetical Protein (Bacegg_03329)
From Bacteroides Eggerthii Dsm 20697 At 2.70 A
Resolution
Length = 636
Score = 26.9 bits (58), Expect = 9.3, Method: Compositional matrix adjust.
Identities = 24/80 (30%), Positives = 33/80 (41%), Gaps = 8/80 (10%)
Query: 111 MVKLKEPFRQTTFVKPLDYYTARETNYINDVLSKTDRSEMSIVSGFGVTFQRDKDG---I 167
+ KL + FR TT L Y + +Y + T S + GFG+ QRD G +
Sbjct: 500 LTKLSDDFRATT----LPYLVGIDLSYNSFSKFPTQPLNSSTLKGFGIRNQRDAQGNRTL 555
Query: 168 VSWGIGCALGYPGIVSWGIG 187
W G L P + IG
Sbjct: 556 REWPEGITL-CPSLTQLQIG 574
Database: pdbaa
Posted date: Mar 3, 2013 10:34 PM
Number of letters in database: 14,973,337
Number of sequences in database: 62,578
Lambda K H
0.322 0.139 0.436
Lambda K H
0.267 0.0410 0.140
Matrix: BLOSUM62
Gap Penalties: Existence: 11, Extension: 1
Number of Hits to DB: 7,176,307
Number of Sequences: 62578
Number of extensions: 307128
Number of successful extensions: 1704
Number of sequences better than 100.0: 351
Number of HSP's better than 100.0 without gapping: 292
Number of HSP's successfully gapped in prelim test: 59
Number of HSP's that attempted gapping in prelim test: 654
Number of HSP's gapped (non-prelim): 720
length of query: 238
length of database: 14,973,337
effective HSP length: 96
effective length of query: 142
effective length of database: 8,965,849
effective search space: 1273150558
effective search space used: 1273150558
T: 11
A: 40
X1: 16 ( 7.4 bits)
X2: 38 (14.6 bits)
X3: 64 (24.7 bits)
S1: 41 (21.9 bits)
S2: 50 (23.9 bits)